"companyid","keydevid","transcriptid","headline","mostimportantdateutc","keydeveventtypename","companyname","speakertypename","componenttextpreview","word_count","componenttext"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Fourth Quarter and Full Year 2010 Earnings Conference Call. My name is Celeste and I will be your conference operator today. [Operator Instructions] At this time, I would like to turn the c",58,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Fourth Quarter and Full Year 2010 Earnings Conference Call. My name is Celeste and I will be your conference operator today. [Operator Instructions] At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Celeste, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, the Chief Financia",130,"Thank you, Celeste, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, the Chief Financial Officer. By now, you should have received the copy of or fourth quarter and full year 2010 earnings release. It can be found on the company's website, www.lorillard.com, under News Releases.
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to risks and uncertainties as described in the company's earnings release and in other filings with the SEC. 
I'd now like to turn the call over to Murray Kessler."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. I am pleased to report to you that our fourth quarter finished strong. Based on a consistently strong performance all year long, Lorillard finished the year with record high levels of net sales, operating income",1066,"Thank you, Bob, and good morning, everyone. I am pleased to report to you that our fourth quarter finished strong. Based on a consistently strong performance all year long, Lorillard finished the year with record high levels of net sales, operating income, net income, diluted earnings per share and market share. The company earned over $1 billion in net income for the first time in its 250-year history. Needless to say, my comments regarding the strength of our brands, people and business model during our last conference call remain intact, and provide the basis for the strategic planning process we are engaged in.  I will touch on the status of that process in just a few minutes, but first, let me give you a few highlights from the quarter and the year.
Lorillard continued to bout industry trends growing domestic wholesale shipments plus 4.6% in the fourth quarter in the backdrop of industry domestic wholesale shipments, which declined 4.7%. That's over a nine percentage point out-performance against the industry. Within that plus 4.6% increase, our flagship brand, Newport, grew 2.2%, benefiting from the launch of Newport Non-Menthol, partially offset by a fourth quarter 2010 versus 2009 comparative reduction in inventory position.
Newport Non-Menthol is gaining trial in the marketplace, and volume continues to grow week to week. It's too early to assess this long-term potential, but we are encouraged with what we've seen so far. 
As you would expect, when our volume trend exceeds that of the industry, we gain market share. Total Lorillard market share in the fourth quarter increased 120 basis points to 13.2%. About half of a share point of that was associated with the Newport Non-Menthol launch.
Total volume growth, along with higher prices and lower promotion spending, translated to a 7.8% increase in net sales versus a year ago. Coupled with an increase in gross margin, and the accretive impact of the companies share repurchase program, diluted earnings per share increased 14.5% versus a year ago to $1.74 for the quarter. 
For the year, Lorillard domestic wholesale shipments increased 5.3% versus a year ago, while the industry declined 3.8%. Net sales increased to a record $5.9 billion. Diluted earnings per share increased 17.7% to a record high $6.78 and our market share increased 1.1 share points to a record high 12.9%. 
Our key financial officer, David Keller, will provide more details on these numbers in just a few minutes. But first, I'd like to take a couple of minutes to underscore the strength of these numbers by putting them into the context of our strategic planning process and also make a few comments regarding TPSAC.
In regards to the strategic plans, we are well into the process. It is my goal to complete it shortly, communicated internally and then share it externally, that will take place over the next few months. While we are not ready to share the full plan right now, let me give you a couple of thoughts. 
First, our analysis clearly shows that our core business has running room. The two leading cigarette companies in the U.S. saw declines in sticks sold of approximately $45 billion and $30 billion respectively during the last five years. While our volumes over the same period time increased over $2.6 billion We believe the fundamentals remain in place for our strong brands, led by Newport to continue to out pace the industry. So as I said in our last conference call, Lorillard is not in need of a course correction.
Second, we do see and we announced the support that there is an opportunity for organic portfolio expansion at geographic expansion beyond our core markets for further upside, albeit these must be pursued carefully and with discipline.
Third, there is a need for some capability improvements to navigate through the rapidly changing external environment and to be able to pursue those adjacencies. Examples of this would be strengthening in the areas of regulatory affairs and new product development. 
And finally, fourth, we will continue to be a strong cash flow generator and clearly understand the need for our investors to share in that strong cash flow. In the roughly two and a half years since our staff really returned over $3.5 million to shareholders in the form of share repurchases and dividends.
Turning to the potential for the increased regulation of menthol cigarettes, our position hasn't changed since we spoke last. Congress mandated that the FDA evaluated the impact of menthol in cigarettes on the public health. Lorillard continues to believe that the best available scientific evidence does not support an absorption that menthol and cigarettes negatively or disproportionately impact the public's health.  Second, we acknowledge smoking has serious risks, but menthol does not contribute to those risk.  Third, a move like banning menthol would dramatically expand the cigarette black market, making it easier for underage kids to gain access. Such a black market would likely increase crime, cost jobs and reduce tax and MSA revenue. These counter-veiling effects are also mandated to be take into account by the FDA.  In summary, a menthol cigarette is just another cigarette and should be regulated no differently in totally or for any demographic group.
As it relates to TPSAC, we remain concerned that this committee is being more driven by politics than by science, and therefore don't rule anything out for their March 23 non-binding recommendation. To help understand what Lorillard believes are the realities versus some of the miss surrounding the menthol debate, a new presentation has been added this morning to the ""Understanding Menthol"" website. This website, sponsored by Lorillard, is designed to educate interested parties on the impact of the use of menthol in cigarettes.
We do believe that when the issue is evaluated by the FDA itself, hard science will prevail and as a result, menthol will not ultimately be banned. It's just difficult to assess the duration of the evaluation, but it's likely to take years. So while we continue to be actively involved in the menthol review process, rest assured, we will not take our eye off of responsibly building our business for both today and the future.  We remain committed to consistently delivering a double-digit total shareholder return as measured by EPS growth and the dividend yield over the long-term. 
And with that, I'll turn the call over to David Taylor, our Chief Financial Officer. David?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Murray. And good morning, everyone. After I briefly go to the financial results, we'll open the line for questions. Lorillard's 2010 fourth quarter results were very strong, capping an outstanding 2010. Net sales for the fourth quarter of 201",861,"Thank you, Murray. And good morning, everyone. After I briefly go to the financial results, we'll open the line for questions. Lorillard's 2010 fourth quarter results were very strong, capping an outstanding 2010. 
Net sales for the fourth quarter of 2010 increased 7.8% to $1.486 billion compared to the fourth quarter of 2009. It was driven by a 4.5% increase in total shipment volume, higher net average selling prices and lower sales promotion costs which are accounted for as a reduction in sales. 
The increase in unit shipped when compared to last year's fourth quarter in light of the industry's decline reflects the underlying strength of our brands, which continued to gain share. Unit volumes for Newport were up 2.2%, and Maverick were up 25.2%. The stability of Newport Menthol and the growth of Maverick have been common themes, and you've heard them before, and this year's fourth quarter also reflect the introduction of Newport Non-Menthol on November 1.
While the quarter shipments included the introduction of Newport Non-Menthol, Newport Menthol continued its very strong trend. In fact, as we look at the shipments from wholesale to retail in or database, which is a better indicator of consumer take away, Newport Menthol's volume was flat to slightly up for the quarter. 
We have the increase in wholesale prices uncertain of or cigarette  brands, including Newport on November 30, which amounted to approximately 1.5% on our brand portfolio. As a typical for quarters where it anticipates price increase, such as the fourth quarters of both this year and last year, changes in wholesale inventory patterns skewed the volume comparisons a bit for the quarter. 
Wholesale inventories increased modestly during the fourth quarter of last year, making the year-over-year comparison a little tougher. We estimate that in inventory dynamic dragged the unit volume comparison by about 1.5 percentage points. So adjusted for wholesale inventory changes, we estimate total Lorillard volume to be up about 6%. Needless to say, this makes the quarter's performance much more fresh.
This outstanding volume performance for the quarter brings the annual numbers for 2010 for record levels. Total domestic unit volume for the year grew by 5.3% from 2009, in the face of an industry decline of about 3.8%. The increase in volume in the fourth quarter combined with the higher average net selling prices drives the increase in net sales before excise taxes of 9% for the fourth quarter and 10% for the year.
Gross profit in the fourth quarter of 2010 increased by $57 million to $538 million when compared to the fourth quarter of 2009. Cost of goods sold in the fourth quarter reflects increases over last year in certain costs, including increased FDA fees. Amounts due under the State Settlement Agreements and the Tobacco Growers Assessment increased to $24 million compared to last year quarter. 
Selling, general administered of costs increased $22 million from last year's fourth quarter, mainly from legal fees and expenses associated with increased litigation activity during the quarter. But also some higher compensation expenses this year due to the CEO transition and incentive compensation accrual.
Fourth quarter operating income increased 8.8% to $433 million or 29.1% of sales from $398 million or 28.9% of sales in last year's fourth quarter. Operating income per unit shipped for the year increased about 6.6% compared with 2009.
Fully diluted earnings per share for the fourth quarter increased 14.5% from last year's fourth quarter to $1.74 per share. It increased 17.7% for the year to $6.78. Those results reflect the strong performance we've already discussed, but also the effect of a lower average share count this year. The lower share count increased reported EPS for the fourth quarter about $0.11 a share.
So 2010 was an outstanding year for Lorillard, and it's finished on a strong note: Outperforming the rest of the industry, and frankly most reasonable expectations on almost every measure. We saw unit volume increase in the face of industry-wide increase market share increases to record levels and net sales increased to record levels. We saw gross margins increase, operating margin increase and operating income per unit increase. We saw net income exceed $1 billion for the first time, and we saw a double-digit increase in EPS.  Obviously, a great way to end 2010. 
Also, during 2010, we substantially increased our dividend and continued to repurchase shares in the market. Through December 31, we had repurchased approximately 4.5 million shares at a cost of $376 million under our $1 billion share repurchase authorization as we announced last fall. I won't comment on the future pace of share repurchases during this call, and I will not be able to comment about the level or our timing of future dividend declarations by the board or capital structure activity such as further debt issuances and the like. I will tell you that we have not changed our longer-term leverage target of approximately 1.5x EBITDA, nor have we change our long-term target of paying dividend approximating 70% to 75%. 
Once again, we are very pleased with the company's performance this quarter and for the year.  And with that, we'd like to open the line for questions."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs.",15,"[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, as you go through your strategic plan and you get more clarity on what tip side is potentially thinking, are you making any contingency plans or tweaking your strategic plans to potentially account for some of the regulatory changes that we can ex",44,"Murray, as you go through your strategic plan and you get more clarity on what tip side is potentially thinking, are you making any contingency plans or tweaking your strategic plans to potentially account for some of the regulatory changes that we can expect?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","As the appropriate time, I guess would be the answer. From my perspective, Judy, there is an awful lot of weight at the very least of this perception in March. And in March, is a nonbinding recommendation from the TPSAC group. Concurrently, there is indus",136,"As the appropriate time, I guess would be the answer. From my perspective, Judy, there is an awful lot of weight at the very least of this perception in March. And in March, is a nonbinding recommendation from the TPSAC group. Concurrently, there is industry recommendation that has been recommended from the FDA, and that's the prologue or chapter one in a very long book. And from there, it will be years. So as it's appropriate and as it progresses, if this becomes a real and meaningful issue that could affect our business would be on contingency plans and when we discuss that, sure, of course but I just want to caution everybody that there are some focus in March and we see that is a very long process and March is the beginning of that."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","To the extent that after margin and at some point FDA comes back with their final proposal on what happens with the menthol, can you just maybe help us understand what your realistic assumptions might be in terms of Newport's ability to retain its current",55,"To the extent that after margin and at some point FDA comes back with their final proposal on what happens with the menthol, can you just maybe help us understand what your realistic assumptions might be in terms of Newport's ability to retain its current volume in the event of Draconian regulatory change in menthol?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Let me talk process first, and then I'll give you the very highest level because it's premature to say the answer. But process wide again, be clear the FDA never has to come back if they don't want to. The FDA, the only requirement I progress was that wit",320,"Let me talk process first, and then I'll give you the very highest level because it's premature to say the answer. But process wide again, be clear the FDA never has to come back if they don't want to. The FDA, the only requirement I progress was that within the year or by March 23, that a non-binding advisory committee have to submit a recommendation. We will see down the line where FDA prioritizes, and when they get to it and if they get to it. Having said that, there is a lot more to the Newport brand, a lot more to the Newport brand than menthol. Our product are preferred in taste testing and as I dig into it and dug on to the strategic plan as the core of that everything from tobacco plants to the designing of the cigarettes to huge brand equity. And in that respect to the extent that cigarette smokers or menthol cigarette smokers choose to continue smoking, Newport smokers most likely, are going to want to stay with that brand and will be able to formulate a new product, better in my opinion than anybody else might be able to do so to retain those. So if someone's going to continue smoking, that is a Newport smoker, I believe we will obtain the bulk of those. The second part of it is will a percentage quit and people, their behavior versus what they say today they're going to do tends to differ and history says that very few quit in this type of situation. So that's probably less of a factor. And then the final issue, which is concerning is that whenever we get to a draconian move would be the a black market and all the debit taking about affect that would come out of because remember Congress passes bill in order to create regulation and ordering control not to create chaos."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On the Newport Reds launch, it seems like you talked about the brand already gaining about half a share point, but it seems like volume is actually growing on a week by week basis. So at this point, can you talk about what the run rate for this market sha",83,"On the Newport Reds launch, it seems like you talked about the brand already gaining about half a share point, but it seems like volume is actually growing on a week by week basis. So at this point, can you talk about what the run rate for this market share looks like and where is the volume coming from in terms of is it menthol or is it premium not menthol is a discount maybe help us understand where the trial's coming from?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","It's still premature, Judy. If you are correct, the way the dynamics work is we get some pipeline sales and the kind of database we use, which is in a purist scan retail database to get sort of benefit of the first week or two. And then you settle into se",135,"It's still premature, Judy. If you are correct, the way the dynamics work is we get some pipeline sales and the kind of database we use, which is in a purist scan retail database to get sort of benefit of the first week or two. And then you settle into see where the real trial and real repeat is going to be. And it continues to grow week to week including in a write off there last week. That is slowly progressing. I couldn't tell you now. Right now at the stage where you begin to gather real data on source of volume, et cetera. It's our belief that while there could be a little bit slight cannibalization of Newport Menthol to me that it would be very, very little from what we've seen."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","First, Murray, can you talk about your view and the board's view about share repurchases in the event that there's a very negative TPSAC recommendation?",25,"First, Murray, can you talk about your view and the board's view about share repurchases in the event that there's a very negative TPSAC recommendation?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","This is David Taylor. We did spend roughly $376 million of the  $1 billion which means we enter 2011 with $600 million of that authorization get to spend. We don't know when the TPSAC recommendation is going to be and so therefore we don't know what kind",79,"This is David Taylor. We did spend roughly $376 million of the  $1 billion which means we enter 2011 with $600 million of that authorization get to spend. We don't know when the TPSAC recommendation is going to be and so therefore we don't know what kind of volatility to expect in the share price, but we do have a significant amount of money here to spend in 2011 which we'll do in the most meaningful and prudent way."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Just to be clear, if there were a hostile recommendation with respect to menthol, the board would be comfortably continuing to buyback stock. Is that a true statement?",28,"Just to be clear, if there were a hostile recommendation with respect to menthol, the board would be comfortably continuing to buyback stock. Is that a true statement?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","David, we haven't really put a resolution in front of the board to increase share repurchases or continue share repurchases. But we would take it up with them.",28,"David, we haven't really put a resolution in front of the board to increase share repurchases or continue share repurchases. But we would take it up with them."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","David, I'll add to that. We had discussions about TPSAC in our board meetings, and just as I said to you, we don't rule anything out with this group. They're a bunch of antismoking folks, they have what they believe in. But whether this is an unbiased gro",86,"David, I'll add to that. We had discussions about TPSAC in our board meetings, and just as I said to you, we don't rule anything out with this group. They're a bunch of antismoking folks, they have what they believe in. But whether this is an unbiased group of scientists, we believe it's questionable. There are a number conflicted on this panel, et cetera, so we discussed that in the board we have our share program in place. And I don't see that changing from TPSAC."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On Newport Non-Menthol, I realize this is a difficult question, but how much of the brand's success to date do you think is price? Because in many markets, obviously, it will be the lowest or among the lowest priced brand and certainly, the lowest priced",51,"On Newport Non-Menthol, I realize this is a difficult question, but how much of the brand's success to date do you think is price? Because in many markets, obviously, it will be the lowest or among the lowest priced brand and certainly, the lowest priced brand that's a premium brand."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I'd answer the question almost with your own survey, right, which show that at varying price points you get higher levels of trial. On any new product, it's over the same period of time it's going to be the repeat level and in fact with the quality of the",153,"I'd answer the question almost with your own survey, right, which show that at varying price points you get higher levels of trial. On any new product, it's over the same period of time it's going to be the repeat level and in fact with the quality of the product, and that's what allows you to bring it up to its premium time price over time. We're not hitting their Newport Non-Menthol today. Very early on, it's encouraging. I believe that the Newport Randy is strong enough that we can begin to pursue adjacencies that I think other examples in the industry know that show that significant and meaningful contributors to profitably to take time to build the franchise and we are fortunate enough to have strong brands and profitability in trends to be able to make some investments or the long-term while we continue to print the numbers in the short-term."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, can you talk about the direction of SG&A, the reasons were highlighted and was obviously up year-on-year considerably in the fourth quarter, you're talking about wanting to make certain investment spending to come out of this strategic review. Wha",54,"Murray, can you talk about the direction of SG&A, the reasons were highlighted and was obviously up year-on-year considerably in the fourth quarter, you're talking about wanting to make certain investment spending to come out of this strategic review. What's the potential range of magnitude of SG&A increases over the next year or two?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I said this in a couple of conferences that I've spoken at. What I'm talking about it in terms of investment, until you get to where you're really investing the launch to new products are, some people in some process, that's not the driver that went on in",123,"I said this in a couple of conferences that I've spoken at. What I'm talking about it in terms of investment, until you get to where you're really investing the launch to new products are, some people in some process, that's not the driver that went on in the fourth quarter. That was overlaps of CEO and legal. We had some cases that were in trial, There were a number of things going on, you have Engle progeny cases, these are not massive changes. And certainly within the context of our ongoing businesses are less than the adjustments we get on, user fees and things like that. They're manageable. I wouldn't be building it some model some significant step change on SG&A."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Lastly, how do you assess new ports, Newport Menthol, the traditional bland performance through the year. It was like the retail market share was more or less flat through the year? Is that the generally fair characterization and what's you're overall ass",54,"Lastly, how do you assess new ports, Newport Menthol, the traditional bland performance through the year. It was like the retail market share was more or less flat through the year? Is that the generally fair characterization and what's you're overall assessment of the competition it's facing and how it's performing in the market?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I think that when I get to show you the strategic plan and sort of what is the drivers and the core of Newport Menthol, you'll see that the brand performed consistently with the way it performed in prior years. Basically, sort of the share moves around it",229,"I think that when I get to show you the strategic plan and sort of what is the drivers and the core of Newport Menthol, you'll see that the brand performed consistently with the way it performed in prior years. Basically, sort of the share moves around it, it has its own solid core. And the trend on that solid core and I'm going to detail this at great length when we have our Investor Day in the next few months, but what you're going to find is that our core business is basically stable in a market that is declining at a faster rate around it. That didn't change in the fourth quarter. The trend, the growth trend in Newport Menthol at the core didn't change at all. That resulted in significant increase in market share in the first quarter that held all year and for the finish of the year, marked the eighth consecutive year of share growth for Newport Menthol. But as long as that core business trend and again in the fourth quarter, Newport Menthol, if you adjust for inventories and if you adjust for Newport Non-Menthol take that out, Newport Menthol's volume was flat in the industry is down 4% or 4.5% as long as we keep outperforming the industry by three or four percentage points, we're are going to grow our own share."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley from Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley from Deutsche Bank."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Putting the TPSAC side, you mentioned that you don't believe that they have actually respond to this report I was wondering if you can talk about have you had any contact with it the leadership itself about how they'll approach the Newport and specificall",84,"Putting the TPSAC side, you mentioned that you don't believe that they have actually respond to this report I was wondering if you can talk about have you had any contact with it the leadership itself about how they'll approach the Newport and specifically how they would respond to a negative feedback from TPSAC if it's based less on and off hard science state and more on the demographic issues, if you think that would be adequate face FDA to restrict menthol or not?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I think I'll give you a three worst answer is yes with leadership I went down and I meant with Director Mason at the Center for Tobacco Products in Washington. I met with him in his whole staff and we had a very lengthy discussion about the process and so",246,"I think I'll give you a three worst answer is yes with leadership I went down and I meant with Director Mason at the Center for Tobacco Products in Washington. I met with him in his whole staff and we had a very lengthy discussion about the process and sort of my background and involvement. And they made it very clear that they intended to follow a scientific process and that they also made it very clear that TPSAC's recommendation was a non-binding recommendation. We also had a stakeholder meeting, an industry stakeholder meeting in Raleigh, more recently, and in that meeting, Director Jason Stauntz stood in front of the room and some of the smaller manufacturers started to get more vocal and he stood in front of that room and you have never heard the word banned come out of the FDA and it sort of silenced the room. he point to be one example where you heard hearing the word ban me from the FBI thought that was kind of poignant. And then as our continuing dialogues came along, we third fault which was when he kicked off all committee meetings, the TPSAC committee meetings. You look TPSAC in the add said you have a very important job to do and we're going to be looking at your recommendation and I expect it to be a science-based recommendation and remember that the FDA will only consider science-based recognition as part of this process."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Going back to the so-called key plan, there is some kind of restriction, last quarter you implied that the launch of Newport Red would not be the contingency product. Could you talk more about how you might reposition the portfolio if you had to if Newpor",52,"Going back to the so-called key plan, there is some kind of restriction, last quarter you implied that the launch of Newport Red would not be the contingency product. Could you talk more about how you might reposition the portfolio if you had to if Newport Red isn't the answer there?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","It gives more credence to where we are in the process than it should be. I'm not going to answer that. Right now, we are years and years away from having to consider that and I stand behind my word last time that Newport Red isn't how I would do it.",51,"It gives more credence to where we are in the process than it should be. I'm not going to answer that. Right now, we are years and years away from having to consider that and I stand behind my word last time that Newport Red isn't how I would do it."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On the share repurchase, when you went over the strategic review process, you mentioned the importance of the cash return. Would there be any major change to the company's leverage targets or strategy to return cash to shareholders when that review conclu",42,"On the share repurchase, when you went over the strategic review process, you mentioned the importance of the cash return. Would there be any major change to the company's leverage targets or strategy to return cash to shareholders when that review concludes?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Right now, we're working towards the promises we made, right, which is we're working towards getting up to 1.5x leverage and we're working towards making sure we're paying out between 70% to 75% of our earnings in dividends. Because we've been growing so",51,"Right now, we're working towards the promises we made, right, which is we're working towards getting up to 1.5x leverage and we're working towards making sure we're paying out between 70% to 75% of our earnings in dividends. Because we've been growing so fast, we have to keep pace with that."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I noticed you didn't mention Smokeless in your comment is not going to be ruled out at this point?",20,"I noticed you didn't mention Smokeless in your comment is not going to be ruled out at this point?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I'll talk about Smokeless within the context of the strategic plan. That original test market, the way Lorillard had talked about, I thought was on hold and would be considered as part of the strategic plan. We'll be with you shortly on that within the ne",151,"I'll talk about Smokeless within the context of the strategic plan. That original test market, the way Lorillard had talked about, I thought was on hold and would be considered as part of the strategic plan. We'll be with you shortly on that within the next couple of months. I just need to communicate where we are to the whole organization to get less input, et cetera, and we'll be digging in. But the heart of this strategy goes back to that quote I put in my comments there. Lorillard is a different animal than the tobacco industry. Our competitors one of them was off reporting the other 1 billion over the other, 30 billion sticks over the past five years and were up 2 billion. Those branching out and diversifications are strategies that make sense for them. For us, we have to look for what makes sense for us."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America-Merrill Lynch.",16,"Your next question comes from the line of Christine Farkas with Bank of America-Merrill Lynch."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I'm wondering if you can characterize the pricing environment, fourth quarter obviously strong but in the first quarter, how would you look at the market in light of perhaps state excise taxes or the overall competitive environment?",38,"I'm wondering if you can characterize the pricing environment, fourth quarter obviously strong but in the first quarter, how would you look at the market in light of perhaps state excise taxes or the overall competitive environment?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","How can you characterize the pricing here in 2011?",9,"How can you characterize the pricing here in 2011?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","The work quarter was quite strong there's been some commentary in the industry that it's both competitive I'm curious how you would refer to the environment.",27,"The work quarter was quite strong there's been some commentary in the industry that it's both competitive I'm curious how you would refer to the environment."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Based on what we've seen, it has remained competitive and it remains competitive. I don't think there's been a change in the level of activity here in the first part of 2011.",33,"Based on what we've seen, it has remained competitive and it remains competitive. I don't think there's been a change in the level of activity here in the first part of 2011."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, you answered part of this question with respect to stay-tuned post the strategic review, you commented about opportunity for expansion, and I just want to understand that was both product and geographic meaning within the U.S. in terms of geograph",48,"Murray, you answered part of this question with respect to stay-tuned post the strategic review, you commented about opportunity for expansion, and I just want to understand that was both product and geographic meaning within the U.S. in terms of geographic expansion across states where you are underrepresented?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Yes, I think as a starting point, I don't rule anything out over the long-term. But yes, I was saying if you look at or business, I don't think it's a surprise that we have strong geographic SKUs. We've done a lot of work identifying the strength of the b",126,"Yes, I think as a starting point, I don't rule anything out over the long-term. But yes, I was saying if you look at or business, I don't think it's a surprise that we have strong geographic SKUs. We've done a lot of work identifying the strength of the brand nationally and different go-to-market strategies, et cetera. and also the product portfolio and how it performs within every segment or segments we don't perform in at all. And if you look at that, there's just a whole lot of white space. The key thing is to go slowly to with discipline, not mess up your current core franchise, and that's job one because that franchise is performing well and we believe we'll continue to perform well."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I'll ask about some of the investments you talked about early on you to the they're not going to be significant the those investments start now or is that come maybe one your prepared to launch this whole strategic review and tell us the final study?",47,"I'll ask about some of the investments you talked about early on you to the they're not going to be significant the those investments start now or is that come maybe one your prepared to launch this whole strategic review and tell us the final study?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","The investments in people and process start now. So we are, as an example, we'll bring in some talent that has strength in new products that has strength and regulatory compliance. We will put in, I used talk a lot about the new product model I'd like to",85,"The investments in people and process start now. So we are, as an example, we'll bring in some talent that has strength in new products that has strength and regulatory compliance. We will put in, I used talk a lot about the new product model I'd like to offer with that bring some rigor to the new product process. But they don't take a lot of dollars. It takes talent, and it takes process and people sort of are in the right strategy and focus."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Two questions regarding Newport Red, have you gotten any new distribution for the brand, any new outlook replaces the product you distributed? And the second question relates question can you give us in the quarter market share or perhaps are you see here",60,"Two questions regarding Newport Red, have you gotten any new distribution for the brand, any new outlook replaces the product you distributed? And the second question relates question can you give us in the quarter market share or perhaps are you see here January you mentioned is keeping? I wondered if you can provide a little more clarity on that?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","The question on distribution is a good one but I don't have that sitting here in front of me. We went out, we hit the objective, sales force the beautiful job of going national with the stores that we selected on a national basis for the initial launch an",113,"The question on distribution is a good one but I don't have that sitting here in front of me. We went out, we hit the objective, sales force the beautiful job of going national with the stores that we selected on a national basis for the initial launch and at this point, you're assessing how it's performing at one area versus another area in places where you need to take any of this adjustments to plans where they might've build them distribution relative to the whole plan. We can sort of comment on that more on strategic plan too. Obvious there's a lot of interest on the call. But its very early."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","It's early launch in stores or markets where you're already present with the Newport brand.",16,"It's early launch in stores or markets where you're already present with the Newport brand."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We're present everything.",4,"We're present everything."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Regarding price gaps for premium products which remain on a percentage basis pretty narrow. We're seeing good market share growth for premium brands across the industry, including Newport. Do you see the opportunity, not maybe tomorrow, but maybe over the",66,"Regarding price gaps for premium products which remain on a percentage basis pretty narrow. We're seeing good market share growth for premium brands across the industry, including Newport. Do you see the opportunity, not maybe tomorrow, but maybe over the year or next year in that sense for contingent on the consumer other factors you should consider for that price gaps to expand it from here?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Just a point of clarification the price point at discount or the price point from competitors?",16,"Just a point of clarification the price point at discount or the price point from competitors?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I meant the discounts.",4,"I meant the discounts."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Chris, I think we have to evaluate price increases on our discount brand based a lot on the trends that we see and the strength of the consumer. It a depend on the consumer in terms of the discount presence, in terms of strength of the economy. But the st",76,"Chris, I think we have to evaluate price increases on our discount brand based a lot on the trends that we see and the strength of the consumer. It a depend on the consumer in terms of the discount presence, in terms of strength of the economy. But the state excise taxes, the state will play a role in the consumers' ultimate price for the packaged cigarette. So we have and we're talking about price increase."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I would add to it to honestly because we don't really measure our business or price our business as a gap relative to discounts. We tend to be the most premium priced product in the marketplace and we just don't want to get too far ahead of any of the oth",100,"I would add to it to honestly because we don't really measure our business or price our business as a gap relative to discounts. We tend to be the most premium priced product in the marketplace and we just don't want to get too far ahead of any of the other premium brands. So we look at where the premium market is and try to stay close to that, but at the high end or the highest. It's sort of not the way we focus on the business, although we know the did the industry is there for sure."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","But we have to be careful we're not commenting on the pace of any future price increases for Newport or any other brand.",24,"But we have to be careful we're not commenting on the pace of any future price increases for Newport or any other brand."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivian Easer from Citigroup.",12,"Your next question comes from the line of Vivian Easer from Citigroup."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Maverick is obviously still a very small share in discounts and it benefits from two things. It benefits from the fact that it is a good quality product that is recognized by consumers, and the second thing it benefits from is it dates within our total sh",189,"Maverick is obviously still a very small share in discounts and it benefits from two things. It benefits from the fact that it is a good quality product that is recognized by consumers, and the second thing it benefits from is it dates within our total share and narrow product line. It gets good visibility at retail because we're 12, 13 share overall, but we get that done at Newport Red at relatively small number of SKUs which means there's room for Newport Non-Menthol and there's room for Maverick and while we're not front and center, there is still more space than some of the smaller brands. So and that result of that as we think good visibility and a great products and a great price of brand and it has lots of running room. Having said that, I would also say that Maverick is not necessarily the lowest priced brand. Some of or competitors have sort of other in their program, sort of limit the price Maverick can be at and we have to deal with that in the marketplace but that Maverick is competitively priced this year."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Vivian, it's not here in front of me but I can put my hand on it right this second.",19,"Vivian, it's not here in front of me but I can put my hand on it right this second."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Vivian, as you know, most of the variability in our SG&A arrived at the variability in our legal cost and that's legal defense costs associated with trial activity. And its activity-driven. It's going to be the number of trials and cases that we're involv",183,"Vivian, as you know, most of the variability in our SG&A arrived at the variability in our legal cost and that's legal defense costs associated with trial activity. And its activity-driven. It's going to be the number of trials and cases that we're involved in from period to period, year-to-year. And its very difficult to forecast and project the number of cases that we might or might not be involved in. So to the extent that there's more litigation activity for Lorillard in 2011 and more defense costs required then you can see legal costs go up. The opposite is true.  Let me add to that we know that we budget for those things, we have that volatility here in a year out it's just part of our core competency in managing the business, and we take that into account where we build are internal estimates that ultimately lead me to a statement that while we don't give guidance, we leave we will be able to deliver double-digit shareholder return on a consistent long-term cost basis with accounting EPS growth and dividend yield."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your next question comes from the line of Ann Gurkin with Davenport.",14,"[Operator Instructions] Your next question comes from the line of Ann Gurkin with Davenport."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Could you comment on the level of lease inventories you currently have are you reducing those inventories or the durations?",20,"Could you comment on the level of lease inventories you currently have are you reducing those inventories or the durations?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We are not.",3,"We are not."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Secondly, there has been some chatter, some speculation that the TPSAC may rule before or make recommendations before March 23. Do you have any comment on that?",27,"Secondly, there has been some chatter, some speculation that the TPSAC may rule before or make recommendations before March 23. Do you have any comment on that?"
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We have no more knowledge that you do other than theoretically there could be some discussion of chapter in these upcoming meetings which people will probably speculate on as well. You'll get comment on their chapter, obviously while the industry reports.",41,"We have no more knowledge that you do other than theoretically there could be some discussion of chapter in these upcoming meetings which people will probably speculate on as well. You'll get comment on their chapter, obviously while the industry reports."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","And I'll turn the call back over to Mr. Kessler for any closing remarks.",15,"And I'll turn the call back over to Mr. Kessler for any closing remarks."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Once again, we are pleased to have delivered an outstanding record-producing 2010. I'll reiterate to everybody that in March is a non-binding recommendation and only the very beginning of the process and not some endpoint. We appreciate you're continued i",73,"Once again, we are pleased to have delivered an outstanding record-producing 2010. I'll reiterate to everybody that in March is a non-binding recommendation and only the very beginning of the process and not some endpoint. We appreciate you're continued interest in Lorillard and will contain to focus on growing our businesses and look forward to getting together with the over the next few months to share the strategic plan. Thank you very much."
4180255,118540471,99902,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Ladies and gentlemen, this concludes the Lorillard Fourth Quarter and Full Year 2010 Earnings Conference Call. For a replay of this call, please dial 1-800-642-1687 for international, 706-645-9291 and enter and ID number 38327446. You may now disconnect.",39,"Ladies and gentlemen, this concludes the Lorillard Fourth Quarter and Full Year 2010 Earnings Conference Call. For a replay of this call, please dial 1-800-642-1687 for international, 706-645-9291 and enter and ID number 38327446. You may now disconnect. ."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Fourth Quarter and Full Year 2010 Earnings Conference Call. My name is Celeste, and I will be your conference operator today. [Operator Instructions] At this time, I would like to turn the",58,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Fourth Quarter and Full Year 2010 Earnings Conference Call. My name is Celeste, and I will be your conference operator today. [Operator Instructions] At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Celeste, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financia",131,"Thank you, Celeste, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. By now, you should have received the copy of our fourth quarter and full year 2010 earnings release. It can be found on the company's website, lorillard.com, under News Releases.
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties as described in the company's earnings release and in other filings with the SEC. 
I'd now like to turn the call over to Murray Kessler."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. I am pleased to report to you that our fourth quarter finished strong. Based on a consistently strong performance all year long, Lorillard finished the year with record high levels of net sales, operating income",1064,"Thank you, Bob, and good morning, everyone. I am pleased to report to you that our fourth quarter finished strong. Based on a consistently strong performance all year long, Lorillard finished the year with record high levels of net sales, operating income, net income, diluted earnings per share and market share. The company earned over $1 billion in net income for the first time in its 250-year history. Needless to say, my comments regarding the strength of our brands, people and business model during our last conference call remain intact and provide the basis for the strategic planning process we are engaged in. I will touch on the status of that process in just a few minutes, but first, let me give you a few highlights from the quarter and the year.
Lorillard continued to buck industry trends growing domestic wholesale shipments plus-4.6% in the fourth quarter in the backdrop of industry domestic wholesale shipments, which declined 4.7%. That's over a nine percentage point outperformance against the industry. Within that plus-4.6% increase, our flagship brand, Newport, grew 2.2%, benefiting from the launch of Newport Non-Menthol, partially offset by a fourth quarter 2010 versus 2009 comparative reduction in inventory position.
Newport Non-Menthol is gaining trial in the marketplace, and volume continues to grow week to week. It's too early to assess its long-term potential, but we are encouraged with what we see so far. 
As you would expect, when our volume trend exceeds that of the industry, we gain market share. Total Lorillard market share in the fourth quarter increased 120 basis points to 13.2%. About half of a share point of that was associated with the Newport Non-Menthol launch.
Total volume growth, along with higher prices and lower promotion spending, translated to a 7.8% increase in net sales versus year ago. Coupled with an increase in gross margin and the accretive impact of the company's share repurchase program, diluted earnings per share increased 14.5% versus year ago to $1.74 for the quarter. 
For the year, Lorillard domestic wholesale shipments increased 5.3% versus year ago, while the industry declined 3.8%. Net sales increased to a record $5.9 billion. Diluted earnings per share increased 17.7% to a record high $6.78, and our market share increased 1.1 share points to a record high 12.9%. 
Our Chief Financial Officer, David Keller, will provide more details on these numbers in just a few minutes. But first, I'd like to take a couple of minutes to underscore the strength of these numbers by putting them into the context of our strategic planning process and also make a few comments regarding TPSAC.
In regards to the strategic plans, we are well into the process. It is my goal to complete it shortly, communicate it internally and then share it externally. That'll take place over the next few months. While we are not ready to share the full plan right now, let me give you a couple of thoughts. 
First, our analysis clearly shows that our core business has running room. The two leading cigarette companies in the U.S. saw declines in sticks sold of approximately 45 billion and 30 billion respectively during the last five years, while our volumes over the same period of time increased over 2.6 billion. We believe the fundamentals remain in place for our strong brands, led by Newport, to continue to outpace the industry. So as I said on our last conference call, Lorillard is not in need of a course correction.
Second, we do see and we announced the support that there is an opportunity for organic portfolio expansion and geographic expansion beyond our core markets for further upside, albeit these must be pursued carefully and with discipline.
Third, there is a need for some capability improvements to navigate through the rapidly changing external environment and to be able to pursue those adjacencies. Examples of this would be strengthening in the areas of regulatory affairs and new product development. 
And finally, fourth, we will continue to be a strong cash flow generator and clearly understand the need for our investors to share in that strong cash flow. In the roughly two and a half years since our step up, we've already returned over $3.5 billion to shareholders in the form of share repurchases and dividends.
Turning to the potential for an increased regulation of menthol cigarettes. Our position hasn't changed since we spoke last. Congress mandated that the FDA evaluate the impact of menthol in cigarettes on the public's health. Lorillard continues to believe that the best available scientific evidence does not support an assertion that menthol and cigarettes negatively or disproportionately impacts the public's health. 
Second, we acknowledge smoking has serious risks, but menthol does not contribute to those risks.  Third, a draconian move like banning menthol would dramatically expand the cigarette black market, making it easier for underage kids to gain access. Such a black market would likely increase crime, cost jobs and reduce tax and MSA revenue. These countervailing effects are also mandated to be take into account by the FDA. In summary, a menthol cigarette is just another cigarette and should be regulated no differently in totality or for any demographic group.
As it relates to TPSAC, we remain concerned that this committee is being more driven by politics than by science and therefore, don't rule anything out for their March 23 non-binding recommendation. To help understand what Lorillard believes are the realities versus some of the mists surrounding the menthol debate, a new presentation has been added this morning to the ""Understanding Menthol"" website. This website, sponsored by Lorillard, is designed to educate interested parties on the impact of the use of menthol in cigarettes.
We do believe that when the issue is evaluated by the FDA itself, hard science will prevail, and as a result, menthol will not ultimately be banned. It's just difficult to assess the duration of the evaluation, but it's likely to take years. So while we continue to be actively involved in the menthol review process, rest assured, we will not take our eye off of responsibly building our business for both today and the future. We remain committed to consistently delivering a double-digit total shareholder return as measured by EPS growth and the dividend yield over the long-term. 
And with that, I'll turn the call over to David Taylor, our Chief Financial Officer. David?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. After I briefly go through the financial results, we'll open the line for questions. Lorillard's 2010 fourth quarter results were very strong, capping an outstanding 2010. Net sales for the fourth quarter of 2",868,"Thanks, Murray, and good morning, everyone. After I briefly go through the financial results, we'll open the line for questions. Lorillard's 2010 fourth quarter results were very strong, capping an outstanding 2010. 
Net sales for the fourth quarter of 2010 increased 7.8% to $1.486 billion compared to the fourth quarter of 2009. It was driven by a 4.5% increase in total shipment volume, higher net average selling prices and lower sales promotion costs, which are accounted for as a reduction in sales. 
The increase in unit shipped when compared to last year's fourth quarter in light of the industry's decline reflects the underlying strength of our brands, which continue to gain share. Unit volumes for Newport were up 2.2%, and Maverick volumes were up 25.2%. The stability of Newport Menthol and the growth of Maverick have been common themes, and you've heard them before. And this year's fourth quarter also reflect the introduction of Newport Non-Menthol on November 1.
While the quarter shipments included the introduction of Newport Non-Menthol, Newport Menthol continued its very strong trend. In fact, as I look at the shipments from wholesale to retail in our database, which is a better indicator of consumer take away, Newport Menthol's volume was flat to slightly up for the quarter. 
We announced an increase in wholesale list prices on certain of our cigarette  brands, including Newport, on November 30, which amounted to approximately 1.5% on our brand portfolio. As is typical for quarters in which the trade anticipates price increase, such as the fourth quarters of both this year and last year, changes in wholesale inventory patterns skewed the volume comparisons a bit for the quarter. 
Total wholesale inventories increased modestly during the fourth quarter of last year, making the year-over-year comparison a little tougher. We estimate that this inventory dynamic dragged the unit volume comparison by about 1.5 percentage points. So adjusted for wholesale inventory changes, we estimate total Lorillard volume to be up about 6%. Needless to say, this makes the quarter's performance that much more impressive.
This outstanding volume performance for the quarter brings the annual numbers for 2010 to record levels. Total domestic unit volume for the year grew by 5.3% from 2009, in the face of an industry decline of about 3.8%. The increase in volume in the fourth quarter combined with the higher average net selling prices drives the increase in net sales before excise taxes of 9% for the fourth quarter and 10% for the year.
Gross profit in the fourth quarter of 2010 increased by $57 million to $538 million when compared to the fourth quarter of 2009. Cost of goods sold in the fourth quarter reflects increases over last year in certain costs, including increased FDA user fees. Amounts due under the State Settlement Agreements and the Tobacco Growers Assessment increased $24 million compared to last year's quarter. 
Selling, general and administrative costs increased $22 million from last year's fourth quarter, mainly from legal fees and expenses associated with increased litigation activity during the quarter but also some higher compensation expenses this year due to the CEO transition and incentive compensation accrual.
Fourth quarter operating income increased 8.8% to $433 million or 29.1% of sales from $398 million or 28.9% of sales in last year's fourth quarter. Operating income per unit shipped for the year increased about 6.6% compared with 2009.
Fully diluted earnings per share for the fourth quarter increased 14.5% from last year's fourth quarter to $1.74 per share. It increased 17.7% for the year to $6.78. Those results reflect the strong performance we've already discussed but also the effect of a lower average share count this year. The lower share count increased reported EPS for the fourth quarter about $0.11 a share.
So 2010 was an outstanding year for Lorillard, and it's finished on a strong note, outperforming the rest of the industry and frankly most reasonable expectations on almost every measure. We saw unit volumes increase in the face of industry-wide decrease. Market share increases to record levels and net sales increased to record level. we saw gross margins increase. Operating margins increase and operating income per unit increase. We saw net income exceed $1 billion for the first time, and we saw a double-digit increase in EPS.  Obviously, a great way to end 2010. 
Also, during 2010, we substantially increased our dividend and continued to repurchase shares in the market. Through December 31, we had repurchased approximately 4.5 million shares at a cost of $376 million under our $1 billion share repurchase authorization that we announced last fall. I won't comment on the future pace of share repurchases during this call, and I will not be able to comment about the level or our timing of future dividend declarations by the board or capital structure activity such as further debt issuances and the like. I will tell you that we have not changed our longer-term leverage target of approximately 1.5x EBITDA, nor have we changed our long-term target of paying dividend approximating 70% to 75% of earnings. 
Once again, we're very pleased with the company's performance this quarter and for the year.  And with that, we'd like to open the line for questions."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs.",15,"[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, as you go through your strategic plan and you get more clarity on what tip side is potentially sinking, are you making any contingency plans or tweaking your strategic plans to potentially account for some of the regulatory changes that we can exp",44,"Murray, as you go through your strategic plan and you get more clarity on what tip side is potentially sinking, are you making any contingency plans or tweaking your strategic plans to potentially account for some of the regulatory changes that we can expect?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","At the appropriate time, I guess would be the answer. From my perspective, Judy, there is an awful lot of weight and at the very least, misperception of what's going here in March. In March is a nonbinding recommendation from the TPSAC group. Concurrently",136,"At the appropriate time, I guess would be the answer. From my perspective, Judy, there is an awful lot of weight and at the very least, misperception of what's going here in March. In March is a nonbinding recommendation from the TPSAC group. Concurrently, there is industry recommendation that has been recommended from the FDA, and that's the prologue or chapter one in a very long book. And from there, it'll be years. So we add as appropriate and that's if this becomes a real and meaningful issue that could affect our business, would be our contingency plans and do we discuss that? Sure, of course, but I just want to caution everybody that there are some focused on March. And we see this is a very long process and March is the beginning of that."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","To the extent that after margin and at some point, FDA comes back with their final proposal on what happens with the menthol, can you just maybe help us understand what your realistic assumptions might be in terms of Newport's ability to retain its curren",55,"To the extent that after margin and at some point, FDA comes back with their final proposal on what happens with the menthol, can you just maybe help us understand what your realistic assumptions might be in terms of Newport's ability to retain its current volume in the event of Draconian regulatory change on menthol?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Let me talk process first, and then I'll give you the very highest level because it's premature to dig in to the answer. But process-wide again, be clear the FDA never has to come back if they don't want to. The FDA, the only requirement by progress was t",320,"Let me talk process first, and then I'll give you the very highest level because it's premature to dig in to the answer. But process-wide again, be clear the FDA never has to come back if they don't want to. The FDA, the only requirement by progress was that if within a year or by March 23, that a non-binding advisory committee have to submit a recommendation. We will see down the line where FDA prioritizes and when they get to it and if they get to it. Having said that, there is a lot more to the Newport brand, a lot more to the Newport brand than menthol flavoring. Our products are preferred in taste testing and as I dig into it and I've dug into on the strategic plan, at the core of that is everything from tobacco plants to the design of the cigarette to huge brand equity. And in that respect, to the extent that cigarette smokers or menthol cigarette smokers choose to continue with smoking, Newport smokers most likely, are going to want to stay with that brand and will be able to formulate a product, better in my opinion than anybody else might be able to do so to retain them. 
So if someone's going to continue smoking, that is a Newport smoker, I believe we will retain the bulk of them. The second part of it is, will a percentage quit and people, their behavior versus what they say they're going to do tends to differ and history says that very few quit in this type of situation. So that's probably less of a factor. And then the final issue, which is concerning, is that whenever we get to a draconian move would be the black market and all the devastating effects that could come out. Because remember Congress passes bill in order to create regulation and ordering control not to create chaos."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On the Newport Reds launch, it seems like you talked about the brand already gaining about half a share point, but it seems like volume is actually growing on a week-by-week basis. So at this point, can you talk about what the run rate for this market sha",83,"On the Newport Reds launch, it seems like you talked about the brand already gaining about half a share point, but it seems like volume is actually growing on a week-by-week basis. So at this point, can you talk about what the run rate for this market share looks like? And then where is the volume coming from in terms of, is it Menthol or is it Other Premium Non-menthol is it discount, maybe just help us understand where the trial's coming from?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","It's still premature, Judy. If you are correct, the way the dynamics work is you get the pipeline filled and the kind of database we use, which is in a pure scan retail database, you get sort of that benefit of the first week or two, and then you settle i",137,"It's still premature, Judy. If you are correct, the way the dynamics work is you get the pipeline filled and the kind of database we use, which is in a pure scan retail database, you get sort of that benefit of the first week or two, and then you settle in to see where the real trial and real repeat is going to be. And it continues to grow week to week including right out there last week. Well, that's slowly progressing. Where that'll top up. I couldn't tell you now. We're right now at the stage where you begin to gather real data on source of volume, et cetera. It's our belief that while there could be a little bit slight cannibalization of Newport Menthol that would be very, very little from what we've seen."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","First, Murray, can you talk about your view and the board's view about share repurchases in the event that there's a very negative TPSAC recommendation?",25,"First, Murray, can you talk about your view and the board's view about share repurchases in the event that there's a very negative TPSAC recommendation?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","This is David Taylor. We did spend roughly $376 million of the $1 billion, which means we entered 2011 with $600 million of that authorization yet to spend. We don't know when that TPSAC recommendation is going to be and so therefore we don't know what ki",79,"This is David Taylor. We did spend roughly $376 million of the $1 billion, which means we entered 2011 with $600 million of that authorization yet to spend. We don't know when that TPSAC recommendation is going to be and so therefore we don't know what kind of volatility to expect in the share price, but we do have a significant amount of money here to spend in 2011 which we'll do in the most meaningful and prudent way."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Just to be clear, if there were a hostile recommendation with respect to Menthol, the board would be comfortably continuing to buyback stock. Is that a true statement?",28,"Just to be clear, if there were a hostile recommendation with respect to Menthol, the board would be comfortably continuing to buyback stock. Is that a true statement?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","David, we haven't really put a resolution in front of the board to increase share repurchases or continue share repurchases. But we would take it up with them.",28,"David, we haven't really put a resolution in front of the board to increase share repurchases or continue share repurchases. But we would take it up with them."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","David, I'll add to that. We've had discussions about TPSAC in our board meetings, and just as I said to you, we don't rule anything out with this group. They're a bunch of anti-smoking folks. They have what they believe in. But whether this is an unbiased",87,"David, I'll add to that. We've had discussions about TPSAC in our board meetings, and just as I said to you, we don't rule anything out with this group. They're a bunch of anti-smoking folks. They have what they believe in. But whether this is an unbiased group of scientists, we believe it's questionable. There are a number of conflicted on this panel, et cetera, so we discussed that in the board we have our share program in place. And I don't see that changing from TPSAC."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On Newport Non-Menthol, and I realize this is a difficult question, but how much of the brand's success to date do you think is price? Because in many markets, obviously, it will be the lowest or among the lowest priced brand and certainly, the lowest pri",52,"On Newport Non-Menthol, and I realize this is a difficult question, but how much of the brand's success to date do you think is price? Because in many markets, obviously, it will be the lowest or among the lowest priced brand and certainly, the lowest priced brand that's a premium brand."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I'd answer the question almost with your own survey, right? Which showed that at varying price points, you can get higher levels of trial. On any new product, it's over the same period of time it's going to be the repeat level and the satisfaction with th",159,"I'd answer the question almost with your own survey, right? Which showed that at varying price points, you can get higher levels of trial. On any new product, it's over the same period of time it's going to be the repeat level and the satisfaction with the quality of the product. And that's what allows you to bring it up to its premium price over time. We're not putting our client victory on Newport Non-Menthol today. Very early on, it's encouraging. I believe that the Newport brand is strong enough that we can begin to pursue adjacencies that I think that other examples in the industry know that show that core become significant and meaningful contributors to profitably to take time to build the franchise. And we are fortunate enough to have strong brands and profitability in trends to be able to make some investments for the long-term while we continue to print good numbers in the short-term."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, can you talk about sort of the direction of SG&A? The reasons were highlighted. It was obviously up year-on-year considerably in the fourth quarter. You're talking about wanting to make certain investment spending to come out of this strategic rev",56,"Murray, can you talk about sort of the direction of SG&A? The reasons were highlighted. It was obviously up year-on-year considerably in the fourth quarter. You're talking about wanting to make certain investment spending to come out of this strategic review. What's the potential range of magnitude of SG&A increases over the next year or two?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I said this in a couple of conferences that I've spoken at. What I'm talking about in terms of investment, until you get to where you're really investing to launch new products or some people and some process, that's not the driver of went on in the fourt",121,"I said this in a couple of conferences that I've spoken at. What I'm talking about in terms of investment, until you get to where you're really investing to launch new products or some people and some process, that's not the driver of went on in the fourth quarter. That was overlaps of CEO and legal. We had some cases that were in trial. There were a number of things going on. You got Engle progeny cases. These are not massive changes and certainly, within the context of our ongoing businesses, are less any adjustments we get on user fees and things like that. So they're manageable. I wouldn't be building into your models some significant step change on SG&A."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","And then lastly, Murray, how do you assess Newport Menthol, the traditional brand's performance through the year. It looks like its retail market share was more or less flat through the year. Is that a generally fair characterization? And what's your over",55,"And then lastly, Murray, how do you assess Newport Menthol, the traditional brand's performance through the year. It looks like its retail market share was more or less flat through the year. Is that a generally fair characterization? And what's your overall assessment of the competition its facing and how it's performing in the market?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I think that when I get to show you in the strategic plan sort of what is the driver for the core of Newport Menthol, you'll see that the brand performed consistently with the way it performed in prior years. Basically, sort of the share moves around it b",226,"I think that when I get to show you in the strategic plan sort of what is the driver for the core of Newport Menthol, you'll see that the brand performed consistently with the way it performed in prior years. Basically, sort of the share moves around it but it has its own solid core. And the trends on that solid core, and I'm going to detail this at great length when we have our Investor Day in the next few months, but what you're going to find is that our core business is basically stable in a market that is declining at a faster rate around it. That didn't change in the fourth quarter. The trends, the growth trends of Newport Menthol, the core, didn't change at all. That resulted in significant increase in market share in the first quarter that held all year and for the finish of the year, marked the eighth consecutive year of share growth for Newport Menthol. But as long as that core business trend and again in the fourth quarter Newport Menthol if you adjust for inventories, if you adjust for Newport Non-Menthol take that out, Newport Menthol's volume was flat in an industry that's down 4% or 4.5%. As long as we keep outperforming the industry by three or four percentage points, we're going to keep growing share."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Putting the TPSAC side, you mentioned that you don't believe they have to actually respond to TPSAC report, but I was wondering if you could talk about, have you had any contact with FDA leadership itself about how they'll approach the report and specific",86,"Putting the TPSAC side, you mentioned that you don't believe they have to actually respond to TPSAC report, but I was wondering if you could talk about, have you had any contact with FDA leadership itself about how they'll approach the report and specifically, how they would respond to a negative finding from TPSAC if it's based less on the hard science data and more on the demographic issues, if you think that would be adequate sets of data for FDA to restrict menthol or not?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","The answer is yes. Have we met with leadership? I went down and I met with Director Deyton at the Center for Tobacco Products in Washington. I met with him and his whole staff and had a very lengthy discussion about the process and sort of my background a",242,"The answer is yes. Have we met with leadership? I went down and I met with Director Deyton at the Center for Tobacco Products in Washington. I met with him and his whole staff and had a very lengthy discussion about the process and sort of my background and involvement. And they made it very clear that they intended to follow a scientific process and that they also made it very clear that TPSAC's recommendation was a non-binding recommendation. We also had a stakeholder meeting, an industry stakeholder meeting in Raleigh, more recently, and in that meeting, Director Deyton stood in front of the room and some of the smaller manufacturers started to get more vocal. And he stood in front of that room and said, you have never heard the word ""banned"" come out of the FDA. And he sort of silenced the room. To point to the one example where you heard the word banned come from the FDA, I thought that was kind of poignant. And then as our continuing dialogues come along, I'll end the third quote, which was when he kicked off all the TPSAC committee meetings, he looked TPSAC in the eye and he said you have a very important job to do. And we're going to be looking at your recommendation, and I expect it to be a science-based recommendation and remember that the FDA will only consider science-based recommendations as part of this process."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","And then just going back to the so-called contingency plan, if there is some kind of restriction, last quarter you implied that the launch of Newport Red wouldn't be the contingency product. Could you talk more about how you might reposition the portfolio",55,"And then just going back to the so-called contingency plan, if there is some kind of restriction, last quarter you implied that the launch of Newport Red wouldn't be the contingency product. Could you talk more about how you might reposition the portfolio if you had to if Newport Red isn't the answer there?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","It gives more credence to where we are in the process than it should be. I'm not going to answer that. Right now, we are years and years away from having to consider that, and I stand behind my word last time that Newport Red isn't how I would do it.",51,"It gives more credence to where we are in the process than it should be. I'm not going to answer that. Right now, we are years and years away from having to consider that, and I stand behind my word last time that Newport Red isn't how I would do it."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On the share repurchase, when you went over the strategic review process, you mentioned the importance of the cash return. Would there be any major change to the company's leverage targets or strategy to return cash to shareholders when that review conclu",42,"On the share repurchase, when you went over the strategic review process, you mentioned the importance of the cash return. Would there be any major change to the company's leverage targets or strategy to return cash to shareholders when that review concludes?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Right now, we're working towards the promises we made, right? Which is, we're working towards getting up to 1.5x leverage, and we're working towards making sure we're paying out between 70% to 75% of our earnings in dividends. Because we've been growing s",51,"Right now, we're working towards the promises we made, right? Which is, we're working towards getting up to 1.5x leverage, and we're working towards making sure we're paying out between 70% to 75% of our earnings in dividends. Because we've been growing so fast, we've got to keep pace with that."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I noticed you didn't mention Smokeless in your comments, is that being ruled out at this point?",18,"I noticed you didn't mention Smokeless in your comments, is that being ruled out at this point?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I'll talk about Smokeless within the context of the strategic plan. That original test market, the way Lorillard had talked about, I told you was on hold and would be considered as part of the strategic plan. We'll be with you shortly on that within the n",149,"I'll talk about Smokeless within the context of the strategic plan. That original test market, the way Lorillard had talked about, I told you was on hold and would be considered as part of the strategic plan. We'll be with you shortly on that within the next couple of months. I just need to communicate where we are to the whole organization to get less input, et cetera, and then we'll be digging in. But the heart of this strategy goes back to that quote I put in my comments there. Lorillard's a different animal in the tobacco industry. Our competitors, one of them was off reporting 1 billion sticks, the other, 30 billion sticks over the past five years and we're up 2 billion. Those branching out and diversifications are strategies that make sense for them. For us, we have to look what makes sense for us."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America-Merrill Lynch.",16,"Your next question comes from the line of Christine Farkas with Bank of America-Merrill Lynch."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I'm wondering if you can characterize the pricing environment. Fourth quarter, obviously strong but in the first quarter, how would you look at the market in light of perhaps state excise taxes or the overall competitive environment?",38,"I'm wondering if you can characterize the pricing environment. Fourth quarter, obviously strong but in the first quarter, how would you look at the market in light of perhaps state excise taxes or the overall competitive environment?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","How can you characterize the pricing here in 2011?",9,"How can you characterize the pricing here in 2011?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Well, the fourth quarter was quite strong. There's been some commentary in the industry that it's ""competitive,"" and I'm just curious how you would refer to the environment.",28,"Well, the fourth quarter was quite strong. There's been some commentary in the industry that it's ""competitive,"" and I'm just curious how you would refer to the environment."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Based on what we've seen, it has been competitive and remains competitive. I don't think that there's been a key change in the level of activity here in the first part of 2011.",34,"Based on what we've seen, it has been competitive and remains competitive. I don't think that there's been a key change in the level of activity here in the first part of 2011."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, you answered part of this question with respect to stay tuned post the strategic review. You commented about opportunity for expansion, and I just want to understand that was both product and geographic, meaning within the U.S. in terms of geograp",48,"Murray, you answered part of this question with respect to stay tuned post the strategic review. You commented about opportunity for expansion, and I just want to understand that was both product and geographic, meaning within the U.S. in terms of geographic expansion across states where you're under-represented?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Yes, I think as a starting point, I don't rule anything out over the long-term. But yes, I was saying if you look at or business, I don't think it's a surprise that we have strong geographic SKUs. But we've done a lot of work identifying the strength of t",128,"Yes, I think as a starting point, I don't rule anything out over the long-term. But yes, I was saying if you look at or business, I don't think it's a surprise that we have strong geographic SKUs. But we've done a lot of work identifying the strength of the brand nationally and different go-to-market strategies, et cetera and also the product portfolio and how it performs within every segment or segments we don't perform in at all. And if you look at that, there's just a whole lot of white space. The key thing is to go slowly, do it with discipline, not mess up your current core franchise. And that's job one because that franchise is performing well, and we believe we'll continue to perform well."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I just wanted to ask you first about some of the investments you talked about early on. You made it pretty clear they're not going to be significant. Do those investments still start now? Or does that come maybe when you're prepared to kind of launch this",56,"I just wanted to ask you first about some of the investments you talked about early on. You made it pretty clear they're not going to be significant. Do those investments still start now? Or does that come maybe when you're prepared to kind of launch this whole strategic review and tell us the full study?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","The investments in people and process start now. So we are, as an example, we'll bring in some talent that has strength in new products that has strength in regulatory compliance. We will put in, I used to talk a lot about the new product model I'd like t",84,"The investments in people and process start now. So we are, as an example, we'll bring in some talent that has strength in new products that has strength in regulatory compliance. We will put in, I used to talk a lot about the new product model I'd like to offer with that will bring some rigor to the new product process. But they don't take a lot of dollars. It takes talent, and it takes process and people and the right strategy and focus."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I had two questions for you regarding Newport Red, have you gotten any new distribution for the brand, any new outlets or places with the products you distribute in? And the second question, can you give us the end-of-quarter market share or perhaps maybe",67,"I had two questions for you regarding Newport Red, have you gotten any new distribution for the brand, any new outlets or places with the products you distribute in? And the second question, can you give us the end-of-quarter market share or perhaps maybe where you see here it ending? You mentioned it keeps building. I wondered if you could provide a little more clarity on that."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","The question on distribution's a good one, but I don't have that sitting here in front of me. We went out. We hit the objective. Sales force did into all of the stores that we had selected on a national basis for the initial launch. And at this point, I t",114,"The question on distribution's a good one, but I don't have that sitting here in front of me. We went out. We hit the objective. Sales force did into all of the stores that we had selected on a national basis for the initial launch. And at this point, I think as you're assessing how it's performing in one area versus another area in places, whether you need to make any of this adjustments to plans, they might've build some distribution relative to the whole plan. We can sort of comment on that more on the strategic plan, too because there's obviously a lot of interest on the call, but it's very early."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","So you really launched in stores or markets where you're already present with the Newport Menthol brand.",18,"So you really launched in stores or markets where you're already present with the Newport Menthol brand."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We're present everywhere.",4,"We're present everywhere."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I have a question regarding price gaps for premium products, which remain, on a percentage basis, pretty narrow. We're seeing good market share growth for premium brands across the industry, including Newport. Do you see the opportunity and not maybe tomo",78,"I have a question regarding price gaps for premium products, which remain, on a percentage basis, pretty narrow. We're seeing good market share growth for premium brands across the industry, including Newport. Do you see the opportunity and not maybe tomorrow but over the year maybe next year that you can expand further, is it really contingent on the consumer or are there any other factors you should consider for that price gaps to expand it from here?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Just a point of clarification, the price gaps to discount or the price gaps from us to competitors?",18,"Just a point of clarification, the price gaps to discount or the price gaps from us to competitors?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I meant the discount.",4,"I meant the discount."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Chris, I think we have to evaluate price increases on our discount brand based a lot on the trends that we see and the strength of the consumer. It may depend on the consumer in terms of the discount presence, in terms of strength of the economy. But the",82,"Chris, I think we have to evaluate price increases on our discount brand based a lot on the trends that we see and the strength of the consumer. It may depend on the consumer in terms of the discount presence, in terms of strength of the economy. But the state excise taxes, the state will play a role in the consumers' ultimate price for a pack of cigarette. So we have to be conscious of that when we're talking about price increase."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I would add to it, too. I hesitated for a second honestly, because we don't really measure our business or price our business as a gap relative to discounts. We tend to be the most premium priced product on the marketplace, and we just don't want to get t",101,"I would add to it, too. I hesitated for a second honestly, because we don't really measure our business or price our business as a gap relative to discounts. We tend to be the most premium priced product on the marketplace, and we just don't want to get too far ahead of any of the other premium brands. So we look at where the premium market is and try to stay close to that but at the high end or the highest. It's sort of not the way we focus on the business, although I know the industry does for sure."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","But we need to be careful we're not commenting on the pace of any kind of future price increases for Newport or any other brand.",26,"But we need to be careful we're not commenting on the pace of any kind of future price increases for Newport or any other brand."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivian Acer with Citigroup.",12,"Your next question comes from the line of Vivian Acer with Citigroup."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I was wondering if you could comment a little bit on the growth that you're seeing in Maverick and how much more runway you think there is with that brand and what your pricing and promotions strategy is and is there any change in there?",46,"I was wondering if you could comment a little bit on the growth that you're seeing in Maverick and how much more runway you think there is with that brand and what your pricing and promotions strategy is and is there any change in there?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Maverick is obviously still a very small share within discount, and it benefits from two things. It benefits from the fact that it is a good quality product that is recognized by consumers, and the second thing it benefits from is it stays within our tota",188,"Maverick is obviously still a very small share within discount, and it benefits from two things. It benefits from the fact that it is a good quality product that is recognized by consumers, and the second thing it benefits from is it stays within our total share and narrow product line. It gets good visibility at retail because we're 12, 13 share overall. We get that done on Newport with relatively small number of SKUs, which means there's room for Newport Non-Menthol and there's room for Maverick. And while we're not front and center, there is still more space than some of the smaller brands. And that result of that is I think we have good visibility and a great product and a great price of brand and lots of running room. Having said that, I would also say that Maverick is not necessarily the lowest-priced brand. Some of our competitors have, by design of their program, limit the price Maverick can be at. And we have to deal with that in the marketplace, but the overall result is, is that Maverick is competitively priced at the mid-tier."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Just on a separate topic, a housekeeping item, can you guys tell us what your litigation expense was for the full year in 2010?",24,"Just on a separate topic, a housekeeping item, can you guys tell us what your litigation expense was for the full year in 2010?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Vivian, it's here in front of me, but I can't put my hand on it right this second.",18,"Vivian, it's here in front of me, but I can't put my hand on it right this second."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","But given the double-digit increases that we've seen in your legal costs over the last two years and the step up that you guys commented on in the fourth quarter, how should we think about legal expense going forward?",40,"But given the double-digit increases that we've seen in your legal costs over the last two years and the step up that you guys commented on in the fourth quarter, how should we think about legal expense going forward?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Vivian, as you know, most of the variability in our SG&A arrived at the variability in legal costs, and that's legal defense costs associated with all the trial activity. And it's activity-driven. It's going to be the number of trials and cases that we're",101,"Vivian, as you know, most of the variability in our SG&A arrived at the variability in legal costs, and that's legal defense costs associated with all the trial activity. And it's activity-driven. It's going to be the number of trials and cases that we're involved in from period-to-period, year-to-year. And it's very difficult to forecast and project the number of cases that we might or might not be involved in. So to the extent that there's more litigation activity for Lorillard in 2011 and more defense costs required, then you could see legal costs go up. And the opposite is true."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Let me add to that, Vivian, too. We know that. We budget for those things. We have that volatility year in year, and it's just part of our core competency in our managing the business. And we take that into account when we build our internal estimates tha",84,"Let me add to that, Vivian, too. We know that. We budget for those things. We have that volatility year in year, and it's just part of our core competency in our managing the business. And we take that into account when we build our internal estimates that ultimately lead me to a statement that while we don't give guidance, we believe we'll be able to deliver double-digit shareholder return on a consistent long-term cost basis with accounting EPS growth and the dividend yield."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your next question comes from the line of Ann Gurkin with Davenport.",14,"[Operator Instructions] Your next question comes from the line of Ann Gurkin with Davenport."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Could you comment on the level of lease inventories you currently have? Are you reducing those inventories or the durations?",20,"Could you comment on the level of lease inventories you currently have? Are you reducing those inventories or the durations?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We are not.",3,"We are not."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Secondly, there's been some chatter, some speculation that the TPSAC might rule before or make the recommendation before March 23. Do you have any comments on that?",27,"Secondly, there's been some chatter, some speculation that the TPSAC might rule before or make the recommendation before March 23. Do you have any comments on that?"
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We have no more knowledge that you do other than there theoretically could be some discussion of chapter in these upcoming meetings, which people will probably speculate on as well. You'll get comments on their chapter, but you obviously won't see the ind",44,"We have no more knowledge that you do other than there theoretically could be some discussion of chapter in these upcoming meetings, which people will probably speculate on as well. You'll get comments on their chapter, but you obviously won't see the industry report."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","And I'll turn the call back over to Mr. Kessler for any closing remarks.",15,"And I'll turn the call back over to Mr. Kessler for any closing remarks."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Once again, we are pleased to have delivered an outstanding record-producing 2010. I'll reiterate to everybody that in March there's a non-binding recommendation and only the very beginning of the process and not some endpoint. We appreciate your continue",73,"Once again, we are pleased to have delivered an outstanding record-producing 2010. I'll reiterate to everybody that in March there's a non-binding recommendation and only the very beginning of the process and not some endpoint. We appreciate your continued interest in Lorillard, and we'll contain to focus on growing our businesses and look forward to getting together with you over the next few months to share the strategic plan. Thank you very much."
4180255,118540471,99992,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Ladies and gentlemen, this concludes the Lorillard Fourth Quarter and Full Year 2010 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 or international (706) 645-9291 and enter an ID number: 38327446. You may now disconnect",41,"Ladies and gentlemen, this concludes the Lorillard Fourth Quarter and Full Year 2010 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 or international (706) 645-9291 and enter an ID number: 38327446. You may now disconnect."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Fourth Quarter and Full Year 2010 Earnings Conference Call. My name is Celeste, and I will be your conference operator today. [Operator Instructions] At this time, I would like to turn the",58,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Fourth Quarter and Full Year 2010 Earnings Conference Call. My name is Celeste, and I will be your conference operator today. [Operator Instructions] At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Celeste, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, Chief Financial Of",130,"Thank you, Celeste, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, Chief Financial Officer. By now, you should have received a copy of our fourth quarter and full year 2010 earnings release. It can be found on the company's website, lorillard.com, under News Releases.
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties as described in the company's earnings release and in other filings with the SEC. 
I'd now like to turn the call over to Murray Kessler."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. I am pleased to report to you that our fourth quarter finished strong. Based on a consistently strong performance all year long, Lorillard finished the year with record high levels of net sales, operating income",1063,"Thank you, Bob, and good morning, everyone. I am pleased to report to you that our fourth quarter finished strong. Based on a consistently strong performance all year long, Lorillard finished the year with record high levels of net sales, operating income, net income, diluted earnings per share and market share. The company earned over $1 billion in net income for the first time in its 250-year history. Needless to say, my comments regarding the strength of our brands, people and business model during our last conference call remain intact and provide the basis for the strategic planning process we are engaged in. I will touch on the status of that process in just a few minutes, but first, let me give you a few highlights from the quarter and the year.
Lorillard continued to buck industry trends growing domestic wholesale shipments plus-4.6% in the fourth quarter in the backdrop of industry domestic wholesale shipments, which declined 4.7%. That's over a nine percentage point outperformance against the industry. Within that plus-4.6% increase, our flagship brand, Newport, grew 2.2%, benefiting from the launch of Newport Non-Menthol, partially offset by a fourth quarter 2010 versus 2009 comparative reduction in inventory position.
Newport Non-Menthol is gaining trial in the marketplace, and volume continues to grow week to week. It's too early to assess its long-term potential, but we are encouraged with what we see so far. 
As you would expect, when our volume trend exceeds that of the industry, we gain market share. Total Lorillard market share in the fourth quarter increased 120 basis points to 13.2%. About half of a share point of that was associated with the Newport Non-Menthol launch.
Total volume growth, along with higher prices and lower promotion spending, translated to a 7.8% increase in net sales versus year ago. Coupled with an increase in gross margin and the accretive impact of the company's share repurchase program, diluted earnings per share increased 14% versus year ago to $1.74 for the quarter. 
For the year, Lorillard domestic wholesale shipments increased 5.3% versus year ago, while the industry declined 3.8%. Net sales increased to a record $5.9 billion. Diluted earnings per share increased 17.7% to a record high $6.78, and our market share increased 1.1 share point to a record high 12.9%. 
Our Chief Financial Officer, David Taylor, will provide more details on these numbers in just a few minutes. But first, I'd like to take a couple of minutes to underscore the strength of these numbers by putting them into the context of our strategic planning process and also make a few comments regarding TPSAC.
In regards to the strategic plan, we are well into the process. It is my goal to complete it shortly, communicate it internally and then share it externally. That'll take place over the next few months. While we are not ready to share the full plan right now, let me give you a couple of thoughts. 
First, our analysis clearly shows that our core business has running room. The two leading cigarette companies in the U.S. saw declines in sticks sold of approximately 45 billion and 30 billion respectively during the last five years, while our volume over the same period of time increased over 2 billion sticks. We believe the fundamentals remain in place for our strong brands, led by Newport, to continue to outpace the industry. So as I said on our last conference call, Lorillard is not in need of a course correction.
Second, we do see and the analysis supports that there is an opportunity for organic portfolio expansion and geographic expansion beyond our core markets for further upside, albeit these must be pursued carefully and with discipline.
Third, there is a need for some capability improvements to navigate through the rapidly changing external environment and to be able to pursue those adjacencies. Examples of this would be strengthening in the areas of regulatory affairs and new product development. 
And finally, fourth, we will continue to be a strong cash flow generator and clearly understand the need for our investors to share in that strong cash flow. In the roughly two and a half years since our step-up, we've already returned over $3.5 billion to shareholders in the form of share repurchases and dividends.
Turning to the potential for an increased regulation of menthol cigarettes. Our position hasn't changed since we spoke last. Congress mandated that the FDA evaluate the impact of menthol in cigarettes on the public's health. Lorillard continues to believe that the best available scientific evidence does not support an assertion that menthol and cigarettes negatively or disproportionately impacts the public's health. 
Second, we acknowledge smoking has serious risks, but menthol does not contribute to those risks. Third, a draconian move like banning menthol would dramatically expand the cigarette black market, making it easier for underage kids to gain access. Such a black market would likely increase crime, cost jobs and reduce tax and MSA revenue. These countervailing effects are also mandated to be taken into account by the FDA. In summary, a menthol cigarette is just another cigarette and should be regulated no differently in totality or for any demographic group.
As it relates to TPSAC, we remain concerned that this committee is being more driven by politics than by science, and therefore, don't rule anything out for their March 23 non-binding recommendation. To help understand what Lorillard believes are the realities versus some of the mists surrounding the menthol debate, a new presentation has been added this morning to the ""Understanding Menthol"" website. This website, sponsored by Lorillard, is designed to educate interested parties on the impact of the use of menthol in cigarettes.
We do believe that when the issue is evaluated by the FDA itself, hard science will prevail, and as a result, menthol will not ultimately be banned. It's just difficult to assess the duration of the evaluation, but it's likely to take years. So while we continue to be actively involved in the menthol review process, rest assured, we will not take our eye off of responsibly building our business for both today and the future. We remain committed to consistently delivering a double-digit total shareholder return as measured by EPS growth and the dividend yield over the long-term. 
And with that, I'll turn the call over to David Taylor, our Chief Financial Officer. David?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. After I briefly go through the financial results, we'll open the line for questions. Lorillard's 2010 fourth quarter results were very strong and cap an outstanding 2010. Net sales for the fourth quarter of 20",868,"Thanks, Murray, and good morning, everyone. After I briefly go through the financial results, we'll open the line for questions. Lorillard's 2010 fourth quarter results were very strong and cap an outstanding 2010. 
Net sales for the fourth quarter of 2010 increased 7.8% to $1.486 billion compared to the fourth quarter of 2009. It was driven by a 4.5% increase in total shipment volume, higher net average selling prices and lower sales promotion costs, which are accounted for as a reduction in sales. 
The increase in units shipped when compared to last year's fourth quarter in light of the industry's decline reflects the underlying strength of our brands, which continue to gain share. Unit volumes for Newport were up 2.2%, and Maverick volumes were up 25.2%. The stability of Newport Menthol and the growth of Maverick have been common themes, and you've heard them before. And this year's fourth quarter also reflect the introduction of Newport Non-Menthol on November 1.
While the quarter shipments included the introduction of Newport Non-Menthol, Newport Menthol continued its very strong trend. In fact, as I look at the shipments from wholesale to retail in our database, which is a better indicator of consumer take away, Newport Menthol's volume was flat to slightly up for the quarter. 
We announced an increase in wholesale list prices on certain of our cigarette brands, including Newport, on November 30, which amounted to approximately 1% on our brand portfolio. As is typical for quarters in which the trade anticipates price increases, such as the fourth quarters of both this year and last year, changes in wholesale inventory patterns skewed the volume comparisons a bit for the quarter.
Total wholesale inventories increased modestly during the fourth quarter of last year, making the year-over-year comparison a little tougher. We estimate that this inventory dynamic dragged the unit volume comparison by about 1 percentage points. So adjusted for wholesale inventory changes, we estimate total Lorillard volume to be up about 6%. Needless to say, this makes the quarter's performance that much more impressive.
This outstanding volume performance for the quarter brings the annual numbers for 2010 to record levels. Total domestic unit volume for the year grew by 5.3% from 2009, in the face of an industry decline of about 3.8%. The increase in volume in the fourth quarter combined with the higher average net selling prices drives the increase in net sales before excise taxes of 9% for the fourth quarter and 10% for the year.
Gross profit in the fourth quarter of 2010 increased by $57 million to $538 million when compared to the fourth quarter of 2009. Cost of goods sold in the fourth quarter reflects increases over last year in certain costs, including increased FDA user fees. Amounts due under the State Settlement Agreements and the Tobacco Growers Assessment increased $24 million compared to last year's quarter. 
Selling, general and administrative costs increased $22 million from last year's fourth quarter, mainly from legal fees and expenses associated with increased litigation activity during the quarter but also some higher compensation expenses this year due to the CEO transition and incentive compensation accrual.
Fourth quarter operating income increased 8.8% to $433 million or 29.1% of sales from $398 million or 28.9% of sales in last year's fourth quarter. Operating income per unit shipped for the year increased about 6.6% compared with 2009.
Fully diluted earnings per share for the fourth quarter increased 14.5% from last year's fourth quarter to $1.74 per share. It increased 17.7% for the year to $6.78. Those results reflect the strong performance we've already discussed but also the effect of a lower average share count this year. The lower share count increased reported EPS for the fourth quarter about $0.11 a share.
So 2010 was an outstanding year for Lorillard, and it's finished on a strong note, outperforming the rest of the industry and frankly most reasonable expectations on almost every measure. We saw unit volumes increase in the face of industry-wide decrease, market share increases to record levels and net sales increased to record level. We saw gross margins increase, operating margins increase and operating income per unit increase. We saw net income exceed $1 billion for the first time, and we saw a double-digit increase in EPS. Obviously, a great way to end 2010. 
Also, during 2010, we substantially increased our dividend and continued to repurchase shares in the market. Through December 31, we had repurchased approximately 4.5 million shares at a cost of $376 million under our $1 billion share repurchase authorization that we announced last fall. I won't comment on the future pace of share repurchases during this call, and I will not be able to comment about the level or timing of future dividend declarations by the board or capital structure activity such as further debt issuances and the like. I will tell you that we have not changed our longer-term leverage target of approximately 1.5x EBITDA, nor have we changed our long-term target of paying dividends approximating 70% to 75% of earnings. 
Once again, we're very pleased with the company's performance this quarter and for the year. And with that, we'd like to open the line for questions."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs.",15,"[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, as you go through your strategic plan and you get  we expect that you get more clarity on what tip side is potentially sinking, are you making any contingency plans or tweaking your strategic plans to potentially account for some of the regulat",50,"Murray, as you go through your strategic plan and you get  we expect that you get more clarity on what tip side is potentially sinking, are you making any contingency plans or tweaking your strategic plans to potentially account for some of the regulatory changes that we can expect?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","At the appropriate time, I guess would be the answer. From my perspective, Judy, there is an awful lot of weight and at the very least, misperception of what's going on here in March. In March is a nonbinding recommendation from the TPSAC group. Concurren",138,"At the appropriate time, I guess would be the answer. From my perspective, Judy, there is an awful lot of weight and at the very least, misperception of what's going on here in March. In March is a nonbinding recommendation from the TPSAC group. Concurrently, there is industry recommendation that has been recommended from the FDA, and that's the prologue or chapter one in a very long book. And from there, it'll be years. So as its appropriate and as it progresses, if this becomes a real and meaningful issue that could affect our business, would we have contingency plans and do we discuss that? Sure, of course, but I just want to caution everybody that theyre so focused on March, and we see this as a very long process and March is just the beginning of that."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","To the extent that after margin and at some point, FDA comes back with their final proposal on what happens with the menthol, can you just maybe help us understand what your realistic assumptions might be in terms of Newport's ability to retain its curren",58,"To the extent that after margin and at some point, FDA comes back with their final proposal on what happens with the menthol, can you just maybe help us understand what your realistic assumptions might be in terms of Newport's ability to retain its current volume in the event that there is a Draconian regulatory change on menthol?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Let me talk process first, and then I'll give you the very highest level because it's premature to dig in to that answer. But process-wise again, be clear the FDA never has to come back if they don't want to. The FDA, the only requirement by Congress was",327,"Let me talk process first, and then I'll give you the very highest level because it's premature to dig in to that answer. But process-wise again, be clear the FDA never has to come back if they don't want to. The FDA, the only requirement by Congress was that if within a year or by March 23, that a non-binding advisory committee had to submit a recommendation. We will see down the line where FDA prioritizes this and when they get to it and if they get to it. Having said that, theres a lot more to the Newport brand, a lot more to the Newport brand than menthol flavoring. Our products are preferred in taste testing and as I dig into it and I've dug into it on the strategic plan, at the core of that is everything from tobacco plants to the design of the cigarette to huge brand equity. And in that respect, to the extent that cigarette smokers or menthol cigarette smokers choose to continue smoking, Newport smokers most likely, are going to want to stay with that brand and well be able to formulate a product, better in my opinion than anybody else might be able to do so to retain them. 
So if someone's going to continue smoking, that is a Newport smoker, I believe we will retain the bulk of them. The second part of it is, will a percentage quit and people, their behavior versus what they say that they're going to do tends to differ and history says that very few would quit in this type of situation. So that's probably less of a factor. And then the final issue, which is concerning, if this was ever to get to a draconian move would be a black market and all the devastating effects that could come out of this. Because remember Congress passed this bill in order to create regulation and order and control not to create chaos."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On the Newport Reds launch, it seems like you talked about the brand already gaining about half a share point, but it seems like volume is actually growing on a week-by-week basis. So at this point, can you talk about what the run rate for this market sha",83,"On the Newport Reds launch, it seems like you talked about the brand already gaining about half a share point, but it seems like volume is actually growing on a week-by-week basis. So at this point, can you talk about what the run rate for this market share looks like? And then where is the volume coming from in terms of, is it Menthol or is it Other Premium Non-menthol, is it discount, maybe just help us understand where the trial's coming from?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","It's still premature, Judy. If you are correct, then the way the dynamics work is you get the pipeline filled and in the kind of database we use, which isnt a pure scan retail database, you get sort of that benefit in the first week or two, and then yo",139,"It's still premature, Judy. If you are correct, then the way the dynamics work is you get the pipeline filled and in the kind of database we use, which isnt a pure scan retail database, you get sort of that benefit in the first week or two, and then you settle in to see where the real trial and real repeats going to be. And it continues to grow week to week including right out through last week. So that's slowly progressing. Now where that'll top up, I couldn't tell you now. We're right now at the stage where you begin to gather real data on source of volume, et cetera. It's our belief that while there could be a little bit slight cannibalization of Newport Menthol that it would be very, very little from what we've seen."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","First, Murray, can you talk about your view and the board's view about share repurchases in the event that there's a very negative TPSAC recommendation?",25,"First, Murray, can you talk about your view and the board's view about share repurchases in the event that there's a very negative TPSAC recommendation?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","This is David Taylor. We did spend roughly $376 million of the $1 billion, which means we entered 2011 with $600 million of that authorization yet to spend. We don't know what the TPSAC recommendation is going to be and so therefore we don't know what kin",79,"This is David Taylor. We did spend roughly $376 million of the $1 billion, which means we entered 2011 with $600 million of that authorization yet to spend. We don't know what the TPSAC recommendation is going to be and so therefore we don't know what kind of volatility to expect in the share price, but we do have a significant amount of money here to spend in 2011 which we'll do in the most meaningful and prudent way."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","But just to be clear, if there were a hostile recommendation with respect to Menthol, the board would be comfortable continuing to buy back stock. Is that a true statement?",30,"But just to be clear, if there were a hostile recommendation with respect to Menthol, the board would be comfortable continuing to buy back stock. Is that a true statement?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","David, we haven't really put a resolution in front of the board to increase share repurchases or continue share repurchases. But we would take it up with them.",28,"David, we haven't really put a resolution in front of the board to increase share repurchases or continue share repurchases. But we would take it up with them."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","David, I'll add to that. We've had discussions about TPSAC in our board meetings, and just as I said to you, we don't rule anything out with this group. They're a bunch of anti-smoking folks. They have what they believe in. But whether this is an unbiased",89,"David, I'll add to that. We've had discussions about TPSAC in our board meetings, and just as I said to you, we don't rule anything out with this group. They're a bunch of anti-smoking folks. They have what they believe in. But whether this is an unbiased group of scientists, we believe is questionable. There are a number of conflicted on this panel, et cetera, so I mean weve discussed that in the board. We have our share program in place, and I don't see that changing from TPSAC."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On Newport Non-Menthol, and I realize this is a difficult question, but how much of the brand's success to date do you think is price? Because in many markets, obviously, it will be the lowest or among the lowest priced brand and certainly, the lowest pri",52,"On Newport Non-Menthol, and I realize this is a difficult question, but how much of the brand's success to date do you think is price? Because in many markets, obviously, it will be the lowest or among the lowest priced brand and certainly, the lowest priced brand that's a premium brand."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I'd answer the question almost with your own survey, right? Which showed that at varying price points, you can get higher levels of trial. On any new product, it's over the same period of time it's going to be the repeat level and the satisfaction with th",161,"I'd answer the question almost with your own survey, right? Which showed that at varying price points, you can get higher levels of trial. On any new product, it's over the same period of time it's going to be the repeat level and the satisfaction with the quality of the product. And that's what allows you to bring it up to its premium price over time. We're not sitting here claiming victory on Newport Non-Menthol today. Its very early on, it's encouraging. I believe that the Newport brand is strong enough that we can begin to pursue adjacencies that -- I think that other examples in the industry though that show that before it becomes significant and meaningful contributors to profitability it takes time to build the franchise. And we are fortunate enough to have strong brands and profitability entrenched to be able to make some investments for the long-term while we continue to print good numbers in the short-term."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, can you talk about sort of the direction of SG&A? The reasons were highlighted. It was obviously up year-on-year considerably in the fourth quarter. You're talking about wanting to make certain investment spending to come out of this strategic rev",56,"Murray, can you talk about sort of the direction of SG&A? The reasons were highlighted. It was obviously up year-on-year considerably in the fourth quarter. You're talking about wanting to make certain investment spending to come out of this strategic review. What's the potential range of magnitude of SG&A increases over the next year or two?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I said this in a couple of conferences that I've spoken at. What I'm talking about in terms of investment, until you get to where you're really investing to launch new products or some people and some process, that's not the driver of what went on in the",124,"I said this in a couple of conferences that I've spoken at. What I'm talking about in terms of investment, until you get to where you're really investing to launch new products or some people and some process, that's not the driver of what went on in the fourth quarter. That was overlaps of CEO and legal. We had some cases that were in trial. There were a number of things going on. You got Engle progeny cases. These are not massive changes and certainly within the context of our ongoing businesses, are less than any adjustments we get on user fees and things like that. So they're manageable. I wouldn't be building into your model some significant step change though on SG&A."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","And then lastly, Murray, how do you assess Newport Menthol, the traditional brand's performance through the year? It looks like its retail market share was more or less flat through the year. Is that a generally fair characterization? And what's your over",55,"And then lastly, Murray, how do you assess Newport Menthol, the traditional brand's performance through the year? It looks like its retail market share was more or less flat through the year. Is that a generally fair characterization? And what's your overall assessment of the competition its facing and how it's performing in the market?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I think that when I get to show you in the strategic plan sort of what is the drivers of sort of the core of Newport Menthol, you'll see that the brand performed consistently with the way it performed in prior years. Basically, sort of the share moves aro",231,"I think that when I get to show you in the strategic plan sort of what is the drivers of sort of the core of Newport Menthol, you'll see that the brand performed consistently with the way it performed in prior years. Basically, sort of the share moves around it but it has its own sort of solid core. And the trend on that solid core, and I'm going to detail this at great length when we have our Investor Day in the next few months, but what you're going to find is that our core business is basically stable in a market that is declining at a faster rate around it. That didn't change in the fourth quarter. The trends, the growth trends of Newport Menthol, at the core, didn't change at all. That resulted in significant increase in market share in the first quarter that held all year and for the finish of the year, marked the eighth consecutive year of share growth for Newport Menthol. But as long as that core business trend and again in the fourth quarter Newport Menthol if you adjust for inventories, if you adjust for Newport Non-Menthol, take that out, Newport Menthol's volume was flat in an industry that's down 4% or 4%. As long as we keep outperforming the industry by three or four percentage points, we're going to keep growing share."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Putting the TPSAC aside, you mentioned that you don't believe they have to actually respond to the TPSAC report, so I was wondering if you could talk about, have you had any contact with FDA leadership itself about how they'll approach the report and spec",87,"Putting the TPSAC aside, you mentioned that you don't believe they have to actually respond to the TPSAC report, so I was wondering if you could talk about, have you had any contact with FDA leadership itself about how they'll approach the report and specifically, how they would respond to a negative finding from TPSAC if it's based less on the hard science data and more on the demographic issues, if you think that would be adequate sets of data for FDA to restrict menthol or not?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I can give you three quotes. The first answer is yes. Have I met with leadership? I went down and I met with Director Deyton at the Center for Tobacco Products in Washington. I met with him and his whole staff and had a very lengthy discussion about the p",252,"I can give you three quotes. The first answer is yes. Have I met with leadership? I went down and I met with Director Deyton at the Center for Tobacco Products in Washington. I met with him and his whole staff and had a very lengthy discussion about the process and sort of my background and involvement. And they made it very clear that they intended to follow a scientific process and that they also made it very clear that TPSAC's recommendation was a non-binding recommendation. We also had a stakeholder meeting, an industry stakeholder meeting in Raleigh, more recently, and in that meeting, Director Deyton stood in front of the room and some of the smaller manufacturers started to get more vocal. And he stood in front of that room and said, you have never heard the word ""banned"" come out of the FDA. And he sort of silenced the room. And he said, You point to me one example where you heard the word banned come from the FDA. I thought that was kind of poignant. And then as our continuing dialogues come along, I'll end with the third quote, which was when he kicked off all the TPSAC committee meetings, he looked TPSAC in the eye and he said, You have a very important job to do. And we're going to be looking at your recommendation. I expect it to be a science-based recommendation and remember that the FDA will only consider science-based recommendations as part of this process."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","And then just going back to the so-called contingency plan if there is some kind of restriction, last quarter you implied that the launch of Newport Red wouldn't be the contingency product. Could you talk more about how you might reposition the portfolio",55,"And then just going back to the so-called contingency plan if there is some kind of restriction, last quarter you implied that the launch of Newport Red wouldn't be the contingency product. Could you talk more about how you might reposition the portfolio if you had to if Newport Red isn't the answer there?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","It gives more credence to where we are in the process than it should be. I'm not going to add to that. Right now, we are years and years away from having to consider that, and I stand behind my word last time that Newport Red isn't how I would do it.",52,"It gives more credence to where we are in the process than it should be. I'm not going to add to that. Right now, we are years and years away from having to consider that, and I stand behind my word last time that Newport Red isn't how I would do it."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","On the share repurchase, when you went over the strategic review process, you mentioned the importance of the cash return. Would there be any major change to the company's leverage targets or strategy to return cash to shareholders when that review conclu",42,"On the share repurchase, when you went over the strategic review process, you mentioned the importance of the cash return. Would there be any major change to the company's leverage targets or strategy to return cash to shareholders when that review concludes?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Right now, we're working towards the promises we made, right? Which is, we're working towards getting up to 1.5x leverage, and we're working towards making sure we're paying out between 70% to 75% of our earnings in dividends. Because we've been growing s",51,"Right now, we're working towards the promises we made, right? Which is, we're working towards getting up to 1.5x leverage, and we're working towards making sure we're paying out between 70% to 75% of our earnings in dividends. Because we've been growing so fast, we've got to keep pace with that."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I notice you didn't mention Smokeless in your comments, is that being ruled out at this point?",18,"I notice you didn't mention Smokeless in your comments, is that being ruled out at this point?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I'll talk about Smokeless within the context of the strategic plan. That original test market, the way Lorillard had talked about, I told you was on hold and would be considered as part of the strategic plan. We'll be with you shortly on that within the n",149,"I'll talk about Smokeless within the context of the strategic plan. That original test market, the way Lorillard had talked about, I told you was on hold and would be considered as part of the strategic plan. We'll be with you shortly on that within the next couple of months. I just need to communicate where we are to the whole organization to get mass input, et cetera, and then we'll be digging in. But the heart of this strategy goes back to that quote I put in my comments there. Lorillard's a different animal in the tobacco industry. Our competitors, one of them was off over 40 billion sticks, the other, 30 billion sticks over the past five years and we're up 2 billion. Those branching out and diversifications are strategies that make sense for them. For us, we have to look what makes sense for us."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America-Merrill Lynch.",16,"Your next question comes from the line of Christine Farkas with Bank of America-Merrill Lynch."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I'm wondering if you can characterize the pricing environment. Fourth quarter, obviously strong but in the first quarter, how would you look at the market in light of perhaps state excise taxes or the overall competitive environment?",38,"I'm wondering if you can characterize the pricing environment. Fourth quarter, obviously strong but in the first quarter, how would you look at the market in light of perhaps state excise taxes or the overall competitive environment?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","How can you characterize the pricing here in 2011?",9,"How can you characterize the pricing here in 2011?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Well, the fourth quarter was quite strong. There's been some commentary in the industry that it's ""competitive,"" and I'm just curious how you would refer to the environment.",28,"Well, the fourth quarter was quite strong. There's been some commentary in the industry that it's ""competitive,"" and I'm just curious how you would refer to the environment."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Based on what we've seen, it has been competitive and remains competitive. I don't think that there's been a sea change in the level of activity here in the first part of 2011.",34,"Based on what we've seen, it has been competitive and remains competitive. I don't think that there's been a sea change in the level of activity here in the first part of 2011."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Murray, you answered part of this question with respect to stay tuned post the strategic review. You commented about opportunity for expansion, and I just want to understand that was both product and geographic, meaning within the U.S. in terms of geograp",48,"Murray, you answered part of this question with respect to stay tuned post the strategic review. You commented about opportunity for expansion, and I just want to understand that was both product and geographic, meaning within the U.S. in terms of geographic expansion across states where you're under-representative?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Yes, I think as a starting point, I don't rule anything out over the long-term. But yes, I was saying if you look at or business, I don't think it's a surprise that we have strong geographic SKUs. But we've done a lot of work identifying the strength of t",128,"Yes, I think as a starting point, I don't rule anything out over the long-term. But yes, I was saying if you look at or business, I don't think it's a surprise that we have strong geographic SKUs. But we've done a lot of work identifying the strength of the brand nationally and different go-to-market strategies, et cetera and also the product portfolio and how it performs within every segment or segments we don't perform in at all. And if you look at that, there's just a whole lot of white space. The key thing is to go slowly, do it with discipline, not mess up your current core franchise. And that's job one because that franchise is performing well, and we believe will continue to perform well."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I just wanted to ask you first about some of the investments you talked about early on. You made it pretty clear they're not going to be significant. Do those investments still start now? Or does that come maybe when you're prepared to kind of launch this",59,"I just wanted to ask you first about some of the investments you talked about early on. You made it pretty clear they're not going to be significant. Do those investments still start now? Or does that come maybe when you're prepared to kind of launch this whole strategic review and tell us the findings of the full study?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","The investments in people and process start now. So we are, as an example, we'll bring in some talent that has strength in new products, that has strength in regulatory compliance. We will put in, I used to talk a lot about a new product model I'd like to",84,"The investments in people and process start now. So we are, as an example, we'll bring in some talent that has strength in new products, that has strength in regulatory compliance. We will put in, I used to talk a lot about a new product model I'd like to operate with that will bring some rigor to the new product process. But they don't take a lot of dollars. It takes talent, and it takes process and people and the right strategy and focus."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I had two questions for you regarding Newport Red. Have you gotten any new distribution for the brand, any new outlets or places with the products you distribute in? And the second question, can you give us the end-of-quarter market share or perhaps maybe",68,"I had two questions for you regarding Newport Red. Have you gotten any new distribution for the brand, any new outlets or places with the products you distribute in? And the second question, can you give us the end-of-quarter market share or perhaps maybe where you see it here in January? You mentioned it keeps building. I wondered if you could provide a little more clarity on that."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Too early. The question on distribution's a good one, but I don't have that sitting here in front of me. We went out. We hit the objective. Sales force did a beautiful job of going national with it, getting into all of the stores that we had selected on a",123,"Too early. The question on distribution's a good one, but I don't have that sitting here in front of me. We went out. We hit the objective. Sales force did a beautiful job of going national with it, getting into all of the stores that we had selected on a national basis for the initial launch. And at this point, I think as you're assessing how it's performing in one area versus another area in places, whether you need to make any adjustments to plans, they might have built some distribution relative to the whole plan. We can sort of comment on that more on the strategic plan, too because there's obviously a lot of interest on the call, but it's very early."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","So its primarily launched in stores or markets where you're already present with the Newport Menthol brand. Correct?",19,"So its primarily launched in stores or markets where you're already present with the Newport Menthol brand. Correct?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We're present everywhere.",4,"We're present everywhere."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I have a final question regarding price gaps for premium products, which remain, on a percentage basis, pretty narrow. We're seeing good market share growth for premium brands across the industry, including Newport. Do you see the opportunity and not mayb",85,"I have a final question regarding price gaps for premium products, which remain, on a percentage basis, pretty narrow. We're seeing good market share growth for premium brands across the industry, including Newport. Do you see the opportunity and not maybe tomorrow but over the year maybe over the next two years for that gap to expand further, or is it really contingent on the consumer or are there any other factors we should consider for that price gap to expand a bit from here?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Just a point of clarification, the price gap to discount or the price gap from us to a competitor?",19,"Just a point of clarification, the price gap to discount or the price gap from us to a competitor?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I meant the discount.",4,"I meant the discount."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Chris, I think wed have to evaluate price increases on our discount brand based a lot on the trends that we see and the strength of the consumer. It may depend on the consumer in terms of the discount presence, in terms of strength of the economy. But",82,"Chris, I think wed have to evaluate price increases on our discount brand based a lot on the trends that we see and the strength of the consumer. It may depend on the consumer in terms of the discount presence, in terms of strength of the economy. But the state excise taxes, the state will play a role in the consumers' ultimate price for a pack of cigarette. So we have to be cognizant of that when we're talking about price increase."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","I would add to it, too. I hesitated for a second honestly, because we don't really measure our business or price our business as a gap relative to discount. We tend to be the most premium priced product on the marketplace, and we just don't want to get to",102,"I would add to it, too. I hesitated for a second honestly, because we don't really measure our business or price our business as a gap relative to discount. We tend to be the most premium priced product on the marketplace, and we just don't want to get too far ahead of any of the other premium brands. So we look at where the premium market is and try to stay close to that but at the high end or the highest. So it's sort of not the way we focus on the business, although I know the industry does for sure."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","But we need to be careful we're not commenting on the pace of any kind of future price increases for Newport or any other brand.",26,"But we need to be careful we're not commenting on the pace of any kind of future price increases for Newport or any other brand."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivian Acer with Citigroup.",12,"Your next question comes from the line of Vivian Acer with Citigroup."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","I was wondering if you could comment a little bit on the growth that you're seeing in Maverick and how much more runway you think there is with that brand and what your pricing and promotion strategy is there and is there any changes there?",46,"I was wondering if you could comment a little bit on the growth that you're seeing in Maverick and how much more runway you think there is with that brand and what your pricing and promotion strategy is there and is there any changes there?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Maverick is obviously still a very small share within discount, and it benefits from two things. It benefits from the fact that it is a good quality product that is recognized by consumers, and the second thing it benefits from is states within our total",193,"Maverick is obviously still a very small share within discount, and it benefits from two things. It benefits from the fact that it is a good quality product that is recognized by consumers, and the second thing it benefits from is states within our total share and narrow product line, it gets good visibility at retail because we're 12, 13 share overall. But we get that done on Newport with a relatively small number of SKUs, which means there's room for Newport Non-Menthol and there's room for Maverick. And while we're not front and center, there is still more space than some of the smaller brands. So the net result of that is that I think with good visibility and a great product and a great price of brand, it has lots of running room. Having said that, I would also say that Maverick is not necessarily the lowest-priced brand. Some of our competitors have, sort of by the design of their program, limit the price Maverick can be at. And we have to deal with that in the marketplace, but net result is, is that Maverick is competitively priced at the mid-tier."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Just on a separate topic, a housekeeping item, can you guys tell us what your litigation expense was for the full year in 2010?",24,"Just on a separate topic, a housekeeping item, can you guys tell us what your litigation expense was for the full year in 2010?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Vivian, that's here in front of me, but I can't put my hand on it right this second.",18,"Vivian, that's here in front of me, but I can't put my hand on it right this second."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","But given the double-digit increases that we've seen in your legal costs over the last two years and the step-up that you guys commented on in the fourth quarter, how should we think about legal expense going forward?",39,"But given the double-digit increases that we've seen in your legal costs over the last two years and the step-up that you guys commented on in the fourth quarter, how should we think about legal expense going forward?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Vivian, as you know, most of the variability in our SG&A arrived at the variability in legal costs, and that's legal defense costs associated with all the trial activity. And it's activity-driven. It's going to be the number of trials and cases that we're",101,"Vivian, as you know, most of the variability in our SG&A arrived at the variability in legal costs, and that's legal defense costs associated with all the trial activity. And it's activity-driven. It's going to be the number of trials and cases that we're involved in from period-to-period, year-to-year. And it's very difficult to forecast and project the number of cases that we might or might not be involved in. So to the extent that there's more litigation activity for Lorillard in 2011 and more defense costs required, then you could see legal costs go up. And the opposite is true."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","And Id just add to that, Vivian, too. We know that. We budget for those things. We have that volatility year-in year-in, it's just part of our core competency in our managing the business. And we take that into account when we build our internal estima",83,"And Id just add to that, Vivian, too. We know that. We budget for those things. We have that volatility year-in year-in, it's just part of our core competency in our managing the business. And we take that into account when we build our internal estimates that ultimately lead me to a statement that while we don't give guidances, we believe we'll be able to deliver a double-digit shareholder return on a consistent long-term basis counting EPS growth and the dividend yield."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your next question comes from the line of Ann Gurkin with Davenport.",14,"[Operator Instructions] Your next question comes from the line of Ann Gurkin with Davenport."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Could you comment on the level of lease inventories you currently have? Are you reducing those inventories or their durations?",20,"Could you comment on the level of lease inventories you currently have? Are you reducing those inventories or their durations?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We are not.",3,"We are not."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Analysts","Secondly, there's been some chatter, some speculation that the TPSAC might rule before or make the recommendation before March 23. Do you have any comments on that?",27,"Secondly, there's been some chatter, some speculation that the TPSAC might rule before or make the recommendation before March 23. Do you have any comments on that?"
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","We have no more knowledge than you do other than there theoretically could be some discussion of chapter in these upcoming meetings, which people will probably speculate on as well. You'll get comments on their chapter, but you obviously won't see the ind",44,"We have no more knowledge than you do other than there theoretically could be some discussion of chapter in these upcoming meetings, which people will probably speculate on as well. You'll get comments on their chapter, but you obviously won't see the industry report."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","And I'll turn the call back over to Mr. Kessler for any closing remarks.",15,"And I'll turn the call back over to Mr. Kessler for any closing remarks."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Executives","Once again, we are pleased to have delivered an outstanding record-producing 2010. I'll reiterate to everybody that in March there's a non-binding recommendation and only the very beginning of the process and not some endpoint. We appreciate your continue",73,"Once again, we are pleased to have delivered an outstanding record-producing 2010. I'll reiterate to everybody that in March there's a non-binding recommendation and only the very beginning of the process and not some endpoint. We appreciate your continued interest in Lorillard, and we'll contain to focus on growing our businesses and look forward to getting together with you over the next few months to share the strategic plan. Thank you very much."
4180255,118540471,100058,"Lorillard, Inc., Q4 2010 Earnings Call, Feb 07, 2011",2011-02-07,"Earnings Calls","Lorillard, LLC","Operator","Ladies and gentlemen, this concludes the Lorillard Fourth Quarter and Full Year 2010 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 or international (706) 645-9291 and enter an ID number: 38327446. You may now disconnect",41,"Ladies and gentlemen, this concludes the Lorillard Fourth Quarter and Full Year 2010 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 or international (706) 645-9291 and enter an ID number: 38327446. You may now disconnect."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen. And welcome to the Lorillard, Incorporated First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call [Operator Instructions] I'd like to turn the conference over",53,"Good day, ladies and gentlemen. And welcome to the Lorillard, Incorporated First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call [Operator Instructions] I'd like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",128,"Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. By now, you should have received a copy of our 2011 earnings release. They can be found on the company's website, lorillard.com, under News Releases. But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties as described in the company's earnings release and in other filings with the SEC. And I would now like to turn the call over to Murray Kessler."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be sharin",555,"Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be sharing our results and strategies going forward in great detail at the company's investor day next week. The  meeting will be held Wednesday, May 4, from 9 A.M. to 12 P.M. at the Mandarin Hotel in New York City. We hope you can join us in person or by webcast.
Starting with volume, for the first quarter Lorillard's domestic wholesale shipments increased 9.4%, versus a year ago, while industry in total, declined 3.4%. That's a pretty remarkable difference in trend totaling 12.8 points.
Even after adjusting for the industry-wide benefit of 1 extra shipping day in the quarter and slightly offset by the year-to-year inventory fluctuations, we estimate that Lorillard's domestic volume was up 8.3% versus a year ago.
Lorillard's domestic volume growth was driven by an 8% increase in total in Newport, a 22.7% increase in Maverick, and a 26% increase in Old Gold.
Encouraging, Newport Non-Menthol, was a solid contributor to the quarter, as weekly volume and share in this new brand continue to grow.
As Lorillard volume trends continue to outperform the industry, we gain market share. Total Lorillard retail market share as measured by our proprietary retail database, Excel, in the first quarter increased 150 basis points versus a year ago to 14.1%.
Newport Non-Menthol achieved about 3 quarters of a share point by the end of the quarter. Our core  Newport Menthol business also gained share versus a year ago, up 38 basis points, and sequentially versus the fourth quarter of 63 basis points.
Our discount brands, Maverick and Old Gold, also continued to gain share.
Total volume growth along with higher prices net of promotion, translated to a 12.9% increase in net sales. Strong net sales growth coupled with the accretive impact of the company's share repurchase plan resulted in a 14% year-over-year gain in earnings per share. EPS finished at a $1.71 for the quarter. 
A quick word on potential menthol regulation. The issue is now with the FDA and out of the hands of TPSAC. We believe that the evidence presented in both the industry reports and even in the TPSAC report itself supports the company's position that disproportionate menthol regulation is warranted.
We believe that this is further supported by the [ph] from Vanderbilt University, funded by the National Cancer Institute, which was surprisingly published only moments after the March 23 deadline for reports on this topic.
Beyond the scientific evidence, we believe that when the countervailing effects are seriously studied, such as the black market importations of additional menthol restrictions, that the case of there should be no disproportionate menthol regulation becomes obvious.
So in conclusion, the Lorillard story for quarter 1 remains the same:  Strong volume, good cost control and a focus on returning cash to shareholders. 
Remember, we recently increased the dividend on February 17, and we continue to repurchase company's stock. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer, who will review the company's strong first quarter results in more detail. After David completes his review, we will answer your questions. David?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive, volume market share and profitability trends that experienced all last year.Net sales f",779,"Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive, volume market share and profitability trends that experienced all last year.
Net sales for the first quarter of 2011 increased to 12.9%, to $1.535 billion as compared to the first quarter of 2010. Driven by the 9 1/2% increase in total shipment volume and higher average net selling prices, partially offset by higher sales promotion costs associated with the launch of Newport Non-Menthol. 
Unit volumes for Newport were up 8.2%, and Maverick volumes were up 22.7%. Shipments of Newport Non-Menthol, which was launched in the first quarter of last year, was a significant factor in the year-over-year comparison.
Fluctuations in wholesale inventory levels in this year and last year had some dampening effect on our volume comparison, but was not significant factor. It was about 1/2 of 1%. So after adjusting for the 1 additional shipping day in the first quarter this year and the modest effect of different trade inventory patterns, we estimate that our total volume was up 8.3%.
While the quarter shipments included the introduction of Newport Non-Menthol, Newport Menthol continued its very strong trend.
In fact as I look at the shipments from wholesale to retail in our database, which is a better indicator of consumer takeaway, Newport Menthol's volume was slightly up for the quarter. 
In addition, net pricing was up for the quarter compared to last year, as the significant price realization on Newport Menthol overshadowed the impact of the mix change, both from the Newport Non-Menthol and from higher Maverick volume.
Gross profit in the first quarter of 2011 increased by $65 million to $543 million from $478 million in last year's first quarter.
Cost of goods sold in 2011 first quarter reflects increases over last year uncertain cost, including FDA user fees.
Amounts due under the State Settlement Agreements and Tobacco Growers' Assessment, increased $36 million compared to last year's first quarter.
Selling, general and administrative cost increased $26 million from last year's first quarter, primarily due to legal fees and expenses associated with increased litigation activities during the quarter.
This increase in litigation costs actually comprised most of the increase in SG&A, and is primarily due to an unusually high number of active trials this year as compared to last year, many of which are in Engle progeny cases underway in Florida. 
For example, this year we had 3 [ph] trials in the first quarter: A filter case trial, the City of Saint Louise trial and various post trial motions in the Evan's case. Now that may not sound high for some, but it's high for Lorillard so it impacts the comparison. Some other items included in SG&A were also higher this year than last. This includes various costs and expenses of all the activities surrounding company's position and industry report to the FDA regarding menthol and some additional advertising and brand-building cost in support of 
Newport Non-Menthol. 
So first quarter operating income increased 10.2% to $421 million, or 27.4% of sales from $382 million or 28.1% of sales in last year's first quarter.
Net sales per unit and operating income per unit were both up compared to last year's first quarter. Fully diluted earnings per share for the quarter increased 14% from last year's first quarter to $1.71 per share. Those results reflects the strong performance we've already discussed, but also the effect of the lower average share count this year. The lower share count as compared to the year ago quarter added $0.11 per share to EPS for this year's first quarter.
During the first quarter of 2011, we substantially increased our dividend, by 16% to an annualized dividend of $5.20 per share, and we continue to repurchase shares in the market.
For the quarter, through March 31, we repurchased approximately 3.8 million shares at a cost of $289 million under the $1 billion share repurchase authorization that we announced last fall. That's an average cost of $76.76 per share. 
As of March 31, we still had to do $325 million remaining on that program.
So, we're off to good start in 2011, and we're pleased with the company's performance thus far. 
Of course, challenges remain for us  on a number of fronts: Macro economic, competitive, and regulatory. We believe that we had the ability to meet these challenges and continue to build value for our shareholders over the long-term. And with that, we'd like to open the lines for questions. Operator, can you help us with that?[Operator Instructions] Your first question comes from the line of David Adelman with Morgan Stanley."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Hi, good morning, everyone. Murray, I want to ask you 2 things. First on Newport Menthol, the branch year was fairly consistent throughout 2010 and now it's stepped up in the first quarter. I'm just curious what do you attribute that to? Is there a differ",64,"Hi, good morning, everyone. Murray, I want to ask you 2 things. First on Newport Menthol, the branch year was fairly consistent throughout 2010 and now it's stepped up in the first quarter. I'm just curious what do you attribute that to? Is there a different competitive dynamic in the marketplace where your programs are any different than they had been throughout last year?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Actually David, some speculated that we have stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We're actually -- if you are able to get to the underlying numbers, you would see Newport Menthol's net pricing was ve",142,"Actually David, some speculated that we have stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We're actually -- if you are able to get to the underlying numbers, you would see Newport Menthol's net pricing was very robust in the first quarter as we actually pulled back on some buy down support. I just think the brand, for all the reasons I'LL talked about next week at the investor conference in great detail. It's just very strong and continues to organically grow, and I think I've always believed that if you sort of build it a little bit as the year goes along and then the biggest increases in the first half of the year and then it reaches the level and then you're lapping again, but that's the pattern for almost 7 or 8 years."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","And secondly, Murray, can you quantify to any extent the degree to which there's consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick presumably it's very low?",29,"And secondly, Murray, can you quantify to any extent the degree to which there's consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick presumably it's very low?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","It's a very low. I'll show you at the conference next week some volume analysis. But just to give you sort of some rough numbers, it's less than 7% or 8% that comes directly which when you translate that number, it tends to impact on percentage change on",56,"It's a very low. I'll show you at the conference next week some volume analysis. But just to give you sort of some rough numbers, it's less than 7% or 8% that comes directly which when you translate that number, it tends to impact on percentage change on Newport like 3/10 4/10 of a percent"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Thanks, good morning. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you on the FDA, and what is your understanding on how the FDA might be approaching the progress report that's due at some point?",42,"Thanks, good morning. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you on the FDA, and what is your understanding on how the FDA might be approaching the progress report that's due at some point?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well there's a lot of communication, but it's not really on the topic of menthol. It's been on substantial equivalence that the FDA has requested plant tours. There's been other dialogue as well as it relates to menthol. It's been pretty quiet. We may be",64,"Well there's a lot of communication, but it's not really on the topic of menthol. It's been on substantial equivalence that the FDA has requested plant tours. There's been other dialogue as well as it relates to menthol. It's been pretty quiet. We may be wrong but we speculate and it's pure speculation that this will be a procedural update, but we'll see."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe how much",80,"And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe how much of the growth you think is coming from some of the trials associated with the higher promos? Are you getting repeats at this, point just any color on the Newport Non-Menthol performance?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, I'm trying not to steal too much from next week because we have some volume analysis, we have repeat numbers, we have all that to show you. The brand is performing extremely well, and I'm going to emphasized that while people talk a lot about the d",187,"Again, I'm trying not to steal too much from next week because we have some volume analysis, we have repeat numbers, we have all that to show you. The brand is performing extremely well, and I'm going to emphasized that while people talk a lot about the discount level, the discount level is not even a little unusual for other premium brands that launch us.
It's basically $1 a pack discount versus the average premium priced products, so if you're in some of our big markets like New York where it's $10 or $11 per pack of cigarette, you're talking about a 10% discount. And if you get some of the averaged price market, you get as high as 20% to 25% discount during this trial period. That's nothing like the buy 1 get 1 free and deep, deep discount that make it hard to ultimately get to premium pricing. I'll walk you through store volumes, I'll walk you through repeat, I'll walk you through all that data next week, but I'm going to give you a little hungry, so you'll be ready to go next week."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","And then, David, just finally in the SG&A expenses, can you just quantify how much, I think in addition to the Engle progeny related legal cost, you also called out some spending related to the Menthol report, and perhaps some of the other advertising exp",97,"And then, David, just finally in the SG&A expenses, can you just quantify how much, I think in addition to the Engle progeny related legal cost, you also called out some spending related to the Menthol report, and perhaps some of the other advertising expenses related to Newport Non-Menthol. So again I'm just wondering how much those really contributed to the increases? And as you think about the trial for the rest of the year, is there a way to appropriately forecast how much of the legal expenses could be up for the balance of the year?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Okay, let me take this in parts. The increase in litigation defense cost accounted for more than 1/2 of the $26 million increase in SG&A. And at the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind",259,"Okay, let me take this in parts. The increase in litigation defense cost accounted for more than 1/2 of the $26 million increase in SG&A. And at the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind of cost running Newport Non-Menthol and all the other activities like taking the lead on the industry regarding menthol and number of consultants help in developing that report. I'd rather not try and quantify those, but those comprised less than other 2 things that I called out comprised less than 1/2 of that increased. And as we look forward to the trial calendar for the rest of the year, it's pretty difficult to forecast. I don't believe that our trial calendar over the next few quarters is as heavy as what we experienced in the first quarter of this year. But we really just have to take this as it comes. We're going to defend ourselves in every case to the maximum extent, and it's really just sort of activity driven. Unfortunately, we are reactive in this matter. Although, the Engle progeny cases are a big deal, not just a number of trials. I think we had something like 50% more active cases whether they were in trial or not. 50% more active Engle progeny cases in the first quarter this year than the first quarter last year. So this Engle defense cost is going to be with us for a while. It's just difficult to predict the peaks and valleys in it."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","And the spending related to the menthol report and the advertising costs, are they more heavily weighted towards the first quarter? I guess the Menthol report probably?",27,"And the spending related to the menthol report and the advertising costs, are they more heavily weighted towards the first quarter? I guess the Menthol report probably?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","This is Murray. The peak introductory advertising, which is not huge, but the print campaign and the initial point of sale in all of that which compares to nothing than a year ago period, is heavily skewed towards the introduction, although there's some s",94,"This is Murray. The peak introductory advertising, which is not huge, but the print campaign and the initial point of sale in all of that which compares to nothing than a year ago period, is heavily skewed towards the introduction, although there's some sustained advertising throughout the year, but not to that same level. And the Menthol reported, it depends. We're going to work with the FDA any way they want us to in this issue. So it depends on them, if they come back and they ask for support, we're going to support."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes of the line of Nik Modi with UBS.",12,"Your next question comes of the line of Nik Modi with UBS."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Good morning, guys. Sorry I come a little late just, but just 2 quick questions and an apology if they had been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about the deload actually",118,"Good morning, guys. Sorry I come a little late just, but just 2 quick questions and an apology if they had been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about the deload actually I just want to get your perspective if there was any of that in the quarter? And the second question is I noticed in 1 of your tables that the Menthol share gains is actually flat for Newport and just curious on your thoughts around that. Is the timing of shipments from some of your competitors or promotions you had from a year ago? Any perspective that will be helpful."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Inventory patterns. Industry's inventory build last year first quarter and they built in this year's first quarter. It's just that this year's first quarter didn't built as much as last year. So when you try to adjust those 2 factors out, it just didn't b",153,"Inventory patterns. Industry's inventory build last year first quarter and they built in this year's first quarter. It's just that this year's first quarter didn't built as much as last year. So when you try to adjust those 2 factors out, it just didn't build as much in the first quarter. So it only impacted our comparison by about 1/2%. Just to be clear, Nik, inventory didn't help us this quarter, it hurt us. The other couple of points there too, the industry-wide extra shipping day,, we adjusted our numbers. We didn't try to adjust the numbers for the rest of the industry. So we believe the industry decline, but probably worse than 3.4%. But we're only willing to sort of, kind of cleared transparent adjustment for shipments. As it relates to market share, I'm not sure where you're getting the numbers. Newport Non-Menthol gain share versus a year ago, it was up..."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","I was talking about Newport Menthol, Murray. So I was just looking at the table. Menthol, the category gained share, but it looks like Newport Menthol share was flat.",29,"I was talking about Newport Menthol, Murray. So I was just looking at the table. Menthol, the category gained share, but it looks like Newport Menthol share was flat."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","That is correct. Although, the Newport Menthol gained shares as a result of the category gaining share.",17,"That is correct. Although, the Newport Menthol gained shares as a result of the category gaining share."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","And I was just curious if there was any timing issues there, I'm just trying to get an understanding of what's behind.",22,"And I was just curious if there was any timing issues there, I'm just trying to get an understanding of what's behind."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Nik, there was also some competitive activity in the in the first quarter which I'm sure you're aware. It might have a little of a dampening effect.",27,"Nik, there was also some competitive activity in the in the first quarter which I'm sure you're aware. It might have a little of a dampening effect."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","We don't use scan data because of where we sell. So the best we do is using Excel data which shifts from wholesale to retail. That counts price line load and there were a lot of competitors menthol products that went into distribution in the first quarter",48,"We don't use scan data because of where we sell. So the best we do is using Excel data which shifts from wholesale to retail. That counts price line load and there were a lot of competitors menthol products that went into distribution in the first quarter."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America.",14,"Your next question comes from the line of Christine Farkas with Bank of America."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","David you were helpful with the SG&A breakdown. I appreciate that. A couple of questions, just on the shipping days in the first quarter, does that reverse at some point in the year where we see an additional day in the second quarter?",44,"David you were helpful with the SG&A breakdown. I appreciate that. A couple of questions, just on the shipping days in the first quarter, does that reverse at some point in the year where we see an additional day in the second quarter?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, it will reverse in the fourth quarter. So the total year, we'll have the same number of shipping days this year as last year. In the fourth quarter it will reverse.",32,"No, it will reverse in the fourth quarter. So the total year, we'll have the same number of shipping days this year as last year. In the fourth quarter it will reverse."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","okay that's helpful. This maybe a little bit of a stretch, but looking at the momentum of the Menthol, share gains in the first quarter, I'm just wondering your perspective with respect to consumer views of this category. Are they -- would you say they we",84,"okay that's helpful. This maybe a little bit of a stretch, but looking at the momentum of the Menthol, share gains in the first quarter, I'm just wondering your perspective with respect to consumer views of this category. Are they -- would you say they were aware of the discussion of around potential bans that something at heightened? How far do this concern or this attention really reach down to the consumer level, or there are just none of that in the numbers?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I'm speculating like you are, but we're not in front of consumers, we do focus on other topics. I hear none of that. I don't think there's general awareness enough in consumer population of smokers that isn't going on.",40,"Look, I'm speculating like you are, but we're not in front of consumers, we do focus on other topics. I hear none of that. I don't think there's general awareness enough in consumer population of smokers that isn't going on."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","So should the Menthol share of the category that we did see step up nicely sequentially and of course year-over-year, would you say again back to your pipeline still comments, or is it really the consumer demand and growing appeal of the flavor?",44,"So should the Menthol share of the category that we did see step up nicely sequentially and of course year-over-year, would you say again back to your pipeline still comments, or is it really the consumer demand and growing appeal of the flavor?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","I would say for us, it's just organic growth business as usual. And I would say that, I would agree with you that there was a number of SKUs that we launched and that's probably affected us to some extent that you just have to fill all the shelves around",78,"I would say for us, it's just organic growth business as usual. And I would say that, I would agree with you that there was a number of SKUs that we launched and that's probably affected us to some extent that you just have to fill all the shelves around the country and 250,000 300,000 stores. But I think at the heart of your question is, do I think that consumers are hoarding it anyway? No, I don't."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","And then last question just with respect to segment, you're not in We understand there maybe some shell resets whereby greater space is allocated to smokers. I'm just wondering if you've seen that retail impact your shelf space, clearly, not your volumes,",51,"And then last question just with respect to segment, you're not in We understand there maybe some shell resets whereby greater space is allocated to smokers. I'm just wondering if you've seen that retail impact your shelf space, clearly, not your volumes, but I'm just wondering what you're seeing at retail?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well all of the, we go through an annual reset ourselves based on are contracts, and all of the contracts are written both for us and for our competitors, some more aggressive than us, that we get share that's basically in the line with our shelf space, a",107,"Well all of the, we go through an annual reset ourselves based on are contracts, and all of the contracts are written both for us and for our competitors, some more aggressive than us, that we get share that's basically in the line with our shelf space, and we continue to gain share, and we or very focused and narrow product line. So we continue to discuss this. I've been in a number of talks with customers, but we haven't had a negative impact. It's more of a challenge of are growing fast enough for what we deserve, and that's the discussion I had with key retailers."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","That's great. Thanks, Murray.",5,"That's great. Thanks, Murray."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Murray, did you give the 8% Newport volume growth number, did you give the number excluding what it would have been without Newport Red?",24,"Murray, did you give the 8% Newport volume growth number, did you give the number excluding what it would have been without Newport Red?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, I do not. And I don't think we break it out by SKU.",14,"No, I do not. And I don't think we break it out by SKU."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","And then in the markets where Newport Red is doing particularly well, are you seeing competitors response at all in terms of their promotion on their non-menthol brands?",28,"And then in the markets where Newport Red is doing particularly well, are you seeing competitors response at all in terms of their promotion on their non-menthol brands?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, just to put it in perspective, they're already at those prices with competitive brands. So we're in no -- it just to take an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the same",57,"Again, just to put it in perspective, they're already at those prices with competitive brands. So we're in no -- it just to take an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the same already. So no, we haven't seen any major swings."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just wanted to ask you we're hearing a lot about [ph] changing some promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters? Or how will that play out and impact",47,"Okay. And then just wanted to ask you we're hearing a lot about [ph] changing some promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters? Or how will that play out and impact you?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Good question. It really depends on participation. We're watching it very carefully. There's a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leaders that feels like margins have b",206,"Good question. It really depends on participation. We're watching it very carefully. There's a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leaders that feels like margins have been expanding at the retail level at the expense of sort of the competitive position relative to the amount of money that they spent on buy downs and industry spent on buy downs and whether it's getting passed through and increasing their productivity. So we have in our contract a fair and equitable clause, so if margins come down for them, they come down for us. So presumably that would be a favorable impact. The other important thing to know if we sell a lot of volume which are not markets where they are even under contract. So presumably it's not effect there. There are some modest areas where they may get a little more competitive, and if we need to wheel adjust but there's a whole lot of other areas where you would think we would benefit, especially depending on the participation level. So we'll see how it plays out. It's a different answer if there's 10% participation or 90% participation."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that mostly to be sort of a procedural thing without much content, but I was wondering as we look longer term with when FDA would make a final assessment",84,"Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that mostly to be sort of a procedural thing without much content, but I was wondering as we look longer term with when FDA would make a final assessment, where do you think they would disagree with some of the more negative conclusions or recommendations from TPSAC, or I guess how they would reconcile some of the concerns that TPSAC raised in the report?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I believe, I think the industry believes, that Doctor Jason and Commissioner Hamburg will make sure that the FDA does their -- follows their charge which is to follow the signs. If they follow -- I don't think they don't have an obligation to respon",149,"Look, I believe, I think the industry believes, that Doctor Jason and Commissioner Hamburg will make sure that the FDA does their -- follows their charge which is to follow the signs. If they follow -- I don't think they don't have an obligation to respond to the TPSAC report, they have an obligation to evaluate this issue to follow the science. And if they follow the science, we believe it strongly comes to the conclusion that there's no disproportionate harm from a menthol cigarette versus a non-menthol. They also had to deal with issue that was really not even dealt with at all by the TPSAC report, which is countervailing effect like black market and unemployment and taxes and smuggling and youth access. And we think when you combine that with it, they'll come to the right conclusion. So hopefully, the worst is behind us on this issue."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Thank you.",3,"Okay. Thank you."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivian Acer with Citigroup.",12,"Your next question comes from the line of Vivian Acer with Citigroup."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Good morning. Not to take too much away from the analyst day presentation, but I was wondering if you could offer a little bit of color around the demographics of the Newport share gain, either for this total franchise or Menthol versus Non-menthol? In ot",69,"Good morning. Not to take too much away from the analyst day presentation, but I was wondering if you could offer a little bit of color around the demographics of the Newport share gain, either for this total franchise or Menthol versus Non-menthol? In other words, the incremental share that you're gaining is becoming disproportionately from adult smokers under authority or is it well balanced anything along this line?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","To do that question, gives us is a very important question. I have to answer it next week at the investor conference, because I'm going to go into great detail of how we believe the core Newport business performs and where it comes from all those good thi",89,"To do that question, gives us is a very important question. I have to answer it next week at the investor conference, because I'm going to go into great detail of how we believe the core Newport business performs and where it comes from all those good things and we'll deal with demographics and sort of the strengths of the brand and then we'll obviously deal with opportunities, but I don't want to give that 1 a quick answer. I have like 15 slides to answer that 1 well."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Separately, just in terms of new product launches and how long the payback takes, just can you offer some color in terms of your experience on how long generally it takes to generate enough trials that you can start pulling back promo new products?",44,"Separately, just in terms of new product launches and how long the payback takes, just can you offer some color in terms of your experience on how long generally it takes to generate enough trials that you can start pulling back promo new products?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now, out of the shoe. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money and it's almost completely incremental. So it's he",184,"Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now, out of the shoe. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money and it's almost completely incremental. So it's helping us. The answer on when you pull back is different than a lot of other category as in my experience. And basically, in the old days, even in this category you can do broad scale television advertising and things like that. There's just a lot more tools at your disposal to build trial. And right now, we're very limited, right? The tools that are left with us are priced a little bit direct mail, a little bit of print advertising, and the brand continues to build. So to me, I'm going to watch it grow for a while, and then we'll make our decisions appropriately. We're only out a couple months of the time ahead of ourselves on the promotion plans, but our goal is clearly on this brand is to come off introductory trial prices once it's appropriate."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes the line of Ann Gurkin with Davenport.",11,"Your next question comes the line of Ann Gurkin with Davenport."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","I was just wondering if you could comment in the quarter we had amount of money roughly spent towards brand building. Is that a level we should continue to see through the year or it does it accelerate, can you help me understand that? And then last into",67,"I was just wondering if you could comment in the quarter we had amount of money roughly spent towards brand building. Is that a level we should continue to see through the year or it does it accelerate, can you help me understand that? And then last into that, should we see Lorillard become more aggressive with innovations or product launches as we move through the year?"
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","So the first question was, do we expect to accelerate? No. I would say it will stabilize to decelerate for the consumer portion of it. That's what you'll see in the SG&A, the promotional spending still the pricing. Do we expect a higher level of innovatio",124,"So the first question was, do we expect to accelerate? No. I would say it will stabilize to decelerate for the consumer portion of it. That's what you'll see in the SG&A, the promotional spending still the pricing. Do we expect a higher level of innovation? You'll see that in the investor day presentation. But Newport's success comes from focus. So we're never going to be the company that's launching a zillion new products, that's not our style. We don't have a shelf space for that. It will be very, very disciplined than methodical as we go forward. When we see, we have appropriate new product. The good news is we got 1 now, and it's already in market, and it's called Newport Non-Menthol."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","I would like to turn the call back over too Mr. Kessler for any concluding remarks.",16,"I would like to turn the call back over too Mr. Kessler for any concluding remarks."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","We look forward to seeing everybody next week. Hopefully, we left your appetite. The brands continue to perform beautifully. The company continues to outperform in almost every financial measures that matters. Please join us on May 4 at the Mandarin Hotel",62,"We look forward to seeing everybody next week. Hopefully, we left your appetite. The brands continue to perform beautifully. The company continues to outperform in almost every financial measures that matters. Please join us on May 4 at the Mandarin Hotel in New York City. And we will talk about the business in more detail. Thank you for your interest in Lorillard."
4180255,129745129,117502,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now d",41,"This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now disconnect."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen. And welcome to the Lorillard, Inc. First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call. [Operator Instructions] As a reminder, this conference is being rec",67,"Good day, ladies and gentlemen. And welcome to the Lorillard, Inc. First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I'd like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",130,"Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. By now, you should have received a copy of our first quarter 2011 earnings release. They can be found on the company's website, lorillard.com, under News Releases. But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties as described in the company's earnings release and in other filings with the SEC. And I would now like to turn the call over to Murray Kessler."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be sharin",559,"Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be sharing our results and strategies going forward in great detail at the company's investor day next week. The  meeting will be held on Wednesday, May 4, from 9 a.m. to 12 p.m. at the Mandarin Hotel in New York City. We hope you can join us in person or by webcast.
Starting with volume. For the first quarter, Lorillard's domestic wholesale shipments increased 9.4% versus a year ago, while the industry in total declined 3.4%. That's a pretty remarkable difference in trend totaling 12.8 points.
Even after adjusting for the industry-wide benefit of 1 extra shipping day in the quarter and slightly offset by year-to-year inventory fluctuations, we estimate that Lorillard's domestic volume was up 8.3% versus a year ago.
Lorillard's domestic volume growth was driven by an 8% increase in total in Newport, a 22.7% increase in Maverick and a 26% increase in Old Gold.
Encouragingly, Newport Non-Menthol was a solid contributor to the quarter as weekly volume and share on this new brand continue to grow.
As Lorillard volume trends continue to outperform the industry, we gain market share. Total Lorillard retail market share as measured by our proprietary retail database, EXCEL, in the first quarter increased 150 basis points versus a year ago to 14.1%.
Newport Non-Menthol achieved about 3 quarters of a share point by the end of the quarter. Our core  Newport Menthol business also gained share vote versus the year ago, up 38 basis points, and sequentially versus the fourth quarter of 63 basis points.
Our discount brands, Maverick and Old Gold, also continued to gain share.
Total volume growth, along with higher prices net of promotion, translated to a 12.9% increase in net sales. Strong net sales growth coupled with the accretive impact of the company's share repurchase plan resulted in a 14% year-over-year gain in earnings per share. EPS finished at $1.71 for the quarter. 
A quick word on potential menthol regulation. The issue is now with the FDA and out of the hands of TPSAC. We believe that the evidence presented in both the industry reports and even in the TPSAC report itself supports the company's position that no disproportionate menthol regulation is warranted.
We believe that this is further supported by the [indiscernible] study from Vanderbilt University, funded by the National Cancer Institute, which was surprisingly published only moments after the March 23rd deadline for reports on this topic.
Beyond the scientific evidence, we believe that when the countervailing effects are seriously studied, such as the black market implications of an additional menthol restrictions, that the case that there should be no disproportionate menthol regulation becomes obvious.
So in conclusion, the Lorillard story for quarter 1 remains the same: strong volume, good cost control and a focus on returning cash to shareholders. 
Remember, we recently increased the dividend on February 17, and we continue to repurchase company's stock. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer, who will review the company's strong first quarter results in more detail. After David completes his review, we will answer your questions. David?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive, volume market share and profitability trends that we experienced all last year.Net sale",767,"Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive, volume market share and profitability trends that we experienced all last year.
Net sales for the first quarter of 2011 increased to 12.9%, to $1.535 billion as compared to the first quarter of 2010. Driven by the 9.5% increase in total shipment volume and higher average net selling prices, partially offset by higher sales promotion costs associated with the launch of Newport Non-Menthol. 
Unit volumes for Newport were up 8.2%, and Maverick volumes were up 22.7%. Shipments of Newport Non-Menthol, which was launched in the fourth quarter of last year, was a significant factor in the year-over-year comparison.
Fluctuations in wholesale inventory levels in this year and last year had some dampening effect on our volume comparison, but was not a significant factor. It was about 1/2 of 1%. So after adjusting for the 1 additional shipping day in the first quarter this year and the modest effect of different trade inventory patterns, we estimate that our total volume was up 8.3%.
While the quarter shipments included the introduction of Newport Non-Menthol, Newport Menthol continued its very strong trend.
In fact, as I look at the shipments from wholesale to retail in our database, which is a better indicator of consumer takeaway, Newport Menthol's volume was slightly up for the quarter. 
In addition, net pricing was up for the quarter compared to last year, as the significant price realization on Newport Menthol overshadowed the impact of the mix change, both from the Newport Non-Menthol and from higher Maverick volume.
Gross profit in the first quarter of 2011 increased by $65 million to $543 million from $478 million in last year's first quarter.
Cost of goods sold in 2011 first quarter reflects increases over last year uncertain cost, including increase FDA user fees.
Amounts due under the State Settlement Agreements and in Tobacco Growers' Assessment, increased $46 million compared to last year's first quarter.
Selling, general and administrative cost increased $26 million from last year's first quarter, primarily due to legal fees and expenses associated with increased litigation activity during the quarter.
This increase in litigation costs actually comprised most of the increase in SG&A, and is primarily due to an unusually high number of active trials of this year as compared to last year, many of which are Engle progeny cases underway in Florida. 
For example, this year we had 3 Engle trials in the first quarter: A filter case trial, the City of St. Louis trial and various post trial motions in the Evans case. Now that may not sound high for some, but it's high for Lorillard, so it impacts the comparison. Some other items included in SG&A were also higher this year than last. This includes various costs and expenses of all the activities surrounding the company's position and industry report to the FDA regarding menthol and some additional advertising and brand-building cost in support of Newport Non-Menthol. 
So first quarter operating income increased 10.2% to $421 million, or 27.4% of sales from $382 million or 28.1% of sales in last year's first quarter. Net sales per unit and operating income per unit were both up compared to last year's first quarter. 
Fully diluted earnings per share for the quarter increased 14% from last year's first quarter to $1.71 per share. Those results reflect the strong performance we've already discussed, but also the effect of a lower average share count this year. The lower share count, as compared to the year ago quarter, added $0.11 per share to EPS for this year's first quarter.
During the first quarter 2011, we substantially increased our dividend by 16% to an annualized dividend of $5.20 per share, and we continue to repurchase shares in the market. For the quarter, through March 31, we repurchased approximately 3.8 million shares at a cost of $289 million under the $1 billion share repurchase authorization that we announced last fall. That's an average cost of $76.76 per share. As of March 31, we still had $335 million remaining on that program.
So, we're off to good start in 2011, and we're pleased with the company's performance thus far. Of course, challenges remain for us on a number of fronts, macro economic, competitive, and regulatory. We believe that we have the ability to meet these challenges and continue to build value for our shareholders over the long term. 
And with that, we'd like to open the line for questions. Operator, can you help us with that?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of David Adelman with Morgan Stanley.",15,"[Operator Instructions] Your first question comes from the line of David Adelman with Morgan Stanley."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Murray, I wanted to ask you 2 things. First, on Newport Menthol, the brand share was fairly consistent throughout 2010 and now it stepped up in the first quarter. And I'm just curious, what do you attribute that to? Is there a different competitive dynami",60,"Murray, I wanted to ask you 2 things. First, on Newport Menthol, the brand share was fairly consistent throughout 2010 and now it stepped up in the first quarter. And I'm just curious, what do you attribute that to? Is there a different competitive dynamic in the marketplace? Were your programs any different than they had been throughout last year?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Actually, David, some had speculated that we had stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We actually -- if you were to be able to get to the underlying numbers, you would see Newport Menthol's net pricin",155,"Actually, David, some had speculated that we had stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We actually -- if you were to be able to get to the underlying numbers, you would see Newport Menthol's net pricing was very robust in the first quarter as we actually pulled back on some buy-down support. I just think the brand, for all the reasons I'll talk about next week at the Investor Conference in great detail, is just very strong and continues to organically grow. And I think I've always believed this, I see you sort of build it a little bit as the year along then you lap the year again and you get sort of the biggest increases in the first half of the year and then it reaches the level and then you lap it again. And that's been the pattern for almost 7 or 8 years."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And secondly, Murray, can you quantify to any extent the degree to which you think that there is consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick presumably it's very low?",34,"Okay. And secondly, Murray, can you quantify to any extent the degree to which you think that there is consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick presumably it's very low?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","It's a very low. I'll show you at the conference next week some sort of volume analysis, but it's -- just to give you sort of some rough numbers, it looks like less than 7% or 8% that comes directly, which when you sort of translate that numbers, it tempt",63,"It's a very low. I'll show you at the conference next week some sort of volume analysis, but it's -- just to give you sort of some rough numbers, it looks like less than 7% or 8% that comes directly, which when you sort of translate that numbers, it tempts impact on the percentage change on Newport, like 0.3%, 0.4% at tops."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Thank you very much.",5,"Okay. Thank you very much."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Thanks. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you and the FDA? And what is your understanding of how the FDA might be approaching the progress report that's due at some point?",40,"Thanks. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you and the FDA? And what is your understanding of how the FDA might be approaching the progress report that's due at some point?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, there's lots of communication, but it's not really on the topic of Menthol. It's been on substantial equivalents. The FDA has requested plant tours. There's been other dialogues as well. As it relates to menthol, it's been pretty quiet. We may be wr",61,"Well, there's lots of communication, but it's not really on the topic of Menthol. It's been on substantial equivalents. The FDA has requested plant tours. There's been other dialogues as well. As it relates to menthol, it's been pretty quiet. We may be wrong, but we speculate, and it's pure speculation that this will be a procedural update, but  we'll see."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe ho",80,"Okay. And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe how much of the growth you think is coming from some of the trials associated with the higher promos? Are you getting repeats at this point? Just any color on the Newport Non-Menthol performance."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, try not to steal too much thunder from that tweak as we have the source of volume analysis. We have repeat numbers. We have all that to show you. The brand's performing extremely well, and I'm going to emphasize that while people talk a lot about t",191,"Again, try not to steal too much thunder from that tweak as we have the source of volume analysis. We have repeat numbers. We have all that to show you. The brand's performing extremely well, and I'm going to emphasize that while people talk a lot about the discount level -- the discount level is not even a little unusual for other premium brand launches. It's basically $1 a pack discount versus the average premium-priced product. So if you're in with some of our big markets like New York, where it's $10 or $11 per pack of cigarettes, you're talking about a 10% discount. And if you get to some of the average-priced markets, you get as high as 20% to 25% discount during this trial period. Thats nothing like the buy 1, get 1 frees and deep, deep discounts that make it hard to ultimately get to premium pricing. I'll walk you through a source of volume. I'll walk you through a repeat. I'll walk you through all that data next week, but I'm going to keep you a little hungry so you'll be there ready to go next week."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, David, just finally, in the SG&A expenses, can you just quantify how much the -- I think, you all see -- in addition to Engle progeny-related legal cause, you also called out some spending related to the menthol reports and perhaps some of",106,"Okay. And then, David, just finally, in the SG&A expenses, can you just quantify how much the -- I think, you all see -- in addition to Engle progeny-related legal cause, you also called out some spending related to the menthol reports and perhaps some of the other advertising expenses related to Newport Non-Menthol. So, I guess I am just wondering how much of those really contributed to the increases. And as you think about the trial calendar for the rest of the year, is there way to appropriately forecast sort of how much the legal expenses could be up for the balance of the year?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Okay, let me take this in parts. The increase in litigation defense cost accounted for more 1/2 of the $26 million increase in SG&A.",24,"Okay, let me take this in parts. The increase in litigation defense cost accounted for more 1/2 of the $26 million increase in SG&A."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay.",1,"Okay."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","And the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind of cost surrounding Newport Non-Menthol, and there were all the other activities like taking the lead on the industry report regarding mentho",244,"And the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind of cost surrounding Newport Non-Menthol, and there were all the other activities like taking the lead on the industry report regarding menthol, a number of consultants helped in developing that report. I'd rather not try and quantify those, but those comprised less than -- the other 2 things that I called out comprised less than 1/2 of that increase. And as we look forward to the trial calendar for the rest of the year, it is pretty difficult to forecast. I don't believe that our trial calendar over the next few quarters is as heavy as what we experienced in the first quarter of this year, but we really just have to take this as it comes. We're going to defend ourselves in every case to our -- to the maximum extent, and it's really just sort of activity driven. And unfortunately, we are reactive in this matter. So although the Engle progeny cases are a big deal, not just the number of trials, I think we had something like 50% more active cases, whether they were in trial or not, 50% more active Engle-chased cases in the first quarter this year than the first quarter last year. So this Engle defense cost is going to be with us for a while.  It's just difficult to predict the peaks and valleys in it."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And the spending related to the menthol report on the advertising cost, are they more heavily weighted towards the first quarter, I guess, the menthol report probably?",28,"Okay. And the spending related to the menthol report on the advertising cost, are they more heavily weighted towards the first quarter, I guess, the menthol report probably?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, the -- this is Murray. The big introductory advertising, which is not huge, but the print campaign and initial point of sale and all that, which compares to nothing in the year ago period is heavily skewed towards the introduction, although there is",100,"Well, the -- this is Murray. The big introductory advertising, which is not huge, but the print campaign and initial point of sale and all that, which compares to nothing in the year ago period is heavily skewed towards the introduction, although there is some sustaining advertising throughout the year but not to the same level. And the menthol reported -- it depends. We're going to work with the FDA any way they want us to on this issue, and so it depends on them. If they come back to us and they ask for support, we're going to support."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Got it. Thank you.",5,"Okay. Got it. Thank you."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Nik Modi with UBS.",12,"Your next question comes from the line of Nik Modi with UBS."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Just sorry, hopped on a little late, but just 2 quick questions and apologies if they've been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about a trade deload, actually. So, just wan",116,"Just sorry, hopped on a little late, but just 2 quick questions and apologies if they've been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about a trade deload, actually. So, just wanted to get your perspective on it if there was any of that in the quarter. Then the second question is, I noticed in one of your tables that the menthol share gains were actually flat for Newport. I'm just curious on your thoughts around that. Is that timing of shipments from some of your competitors or promotions you had from year ago? Any perspective on that would be helpful."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Let me talk a little bit about the inventory patterns. Yes, industry inventory is built in last year's first quarter, and they built in this year's first quarter. It's just that this year's first quarter didn't build as much as last year. So, when you try",73,"Let me talk a little bit about the inventory patterns. Yes, industry inventory is built in last year's first quarter, and they built in this year's first quarter. It's just that this year's first quarter didn't build as much as last year. So, when you try and adjust those 2 factors out, it just didn't build as much in the first quarter. So that only impacted our comparison by about 1/2 a percent."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Fair enough.",3,"Okay. Fair enough."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","But just to be clear, Nik, inventory didn't help us this quarter. It hurt us.",15,"But just to be clear, Nik, inventory didn't help us this quarter. It hurt us."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Right. Yes, yes.",3,"Right. Yes, yes."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","The other couple of points there are, too, the industry-wide extra shipping date, we adjusted our numbers. We didn't try to adjust the numbers for the rest of the industry. So, we believe that the industry declined, but probably a little bit worse than 3.",88,"The other couple of points there are, too, the industry-wide extra shipping date, we adjusted our numbers. We didn't try to adjust the numbers for the rest of the industry. So, we believe that the industry declined, but probably a little bit worse than 3.4%. But we're only willing to sort of try to make that a clear, transparent adjustment for our own shipments. As it relates to market share, I'm not sure where you're getting the numbers. Newport Non-Menthol gained share versus year ago, it was up"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","I'm talking about Newport Menthol, Murray. So I was just looking in the table. Menthol, the category gained share, but it looks like Newport share -- Newport Menthol share was flat like the...",34,"I'm talking about Newport Menthol, Murray. So I was just looking in the table. Menthol, the category gained share, but it looks like Newport share -- Newport Menthol share was flat like the..."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Share hold of the menthol segment?",6,"Share hold of the menthol segment?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Yes, yes, yes.",3,"Yes, yes, yes."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Yes, it is -- that is correct, although Newport Menthol gained share as a result of the category gaining share.",20,"Yes, it is -- that is correct, although Newport Menthol gained share as a result of the category gaining share."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Yes, and I was just curious if there was any timing issues there? I'm just trying to get an understanding of what's behind.",23,"Yes, and I was just curious if there was any timing issues there? I'm just trying to get an understanding of what's behind."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Nik, there was also was some competitive activity in the Menthol stakes in the first quarter, as I am sure you are aware. That might have had a little bit of a dampening effect.",34,"Nik, there was also was some competitive activity in the Menthol stakes in the first quarter, as I am sure you are aware. That might have had a little bit of a dampening effect."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, it's more of a shipment issue.",7,"Okay, it's more of a shipment issue."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","I think -- we don't use scanned data because of where we sell. So the best we do is using EXCEL data, which ships from wholesale to retail. That counts pipeline load, and there were a lot of competitive menthol products that went into distribution into th",49,"I think -- we don't use scanned data because of where we sell. So the best we do is using EXCEL data, which ships from wholesale to retail. That counts pipeline load, and there were a lot of competitive menthol products that went into distribution into the first quarter."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, got you. Thank you.",5,"Okay, got you. Thank you."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America.",14,"Your next question comes from the line of Christine Farkas with Bank of America."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Thank you very much. David, you were helpful with the SG&A breakdown. I appreciate that. A couple of questions, just on the shipping days in the first quarter, does that reverse at some point in the year where we see an additional day in the second quarte",47,"Thank you very much. David, you were helpful with the SG&A breakdown. I appreciate that. A couple of questions, just on the shipping days in the first quarter, does that reverse at some point in the year where we see an additional day in the second quarter?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, it will reverse in the fourth quarter. So the total year will have the same number of shipping days this year as last year So that it will...",29,"No, it will reverse in the fourth quarter. So the total year will have the same number of shipping days this year as last year So that it will..."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","I the fourth quarter, it will reverse.",7,"I the fourth quarter, it will reverse."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's helpful. And then, this may be a bit of a stretch, but looking at the momentum of the menthol share gains in the first quarter. I'm just wondering your perspective with respect to consumer views of the category, are they -- would you say they",85,"Okay. That's helpful. And then, this may be a bit of a stretch, but looking at the momentum of the menthol share gains in the first quarter. I'm just wondering your perspective with respect to consumer views of the category, are they -- would you say they are aware of the discussions around potential band, if something been heightened? How far do these concerns or this attention really reach down to the consumer level or they're just none of that, of course, in the numbers?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I'm speculating like you are. But we know we're out in front of consumers. We do focus groups on other top topic. I hear none of that. I dont think there is general awareness in the consumer population of smokers that this is even going on.",47,"Look, I'm speculating like you are. But we know we're out in front of consumers. We do focus groups on other top topic. I hear none of that. I dont think there is general awareness in the consumer population of smokers that this is even going on."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","So should the menthol share of the category that we did see step up nicely sequentially and, of course, year-over-year, would you say again back to your pipeline fill comments, or is really the consumer demand and growing appeal of the flavor?",42,"So should the menthol share of the category that we did see step up nicely sequentially and, of course, year-over-year, would you say again back to your pipeline fill comments, or is really the consumer demand and growing appeal of the flavor?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","I would say for us, it's just organic growth business as usual. And I would say that -- I would agree with you that there was a number of SKUs that were launched and that probably affected it to some extent that you just have to fill all the shelves aroun",79,"I would say for us, it's just organic growth business as usual. And I would say that -- I would agree with you that there was a number of SKUs that were launched and that probably affected it to some extent that you just have to fill all the shelves around the country in 250,000, 300,000 stores. But I think at the heart of your question is, do I think the consumers were hoarding it anyway? No, I dont."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, great. And then last question, just with respect to segment you're not in and that's smokers, we understand there maybe some self resets whereby greater spaces allocated to smokers, I am wondering, if you've seen that at retail, does it impact your",57,"Okay, great. And then last question, just with respect to segment you're not in and that's smokers, we understand there maybe some self resets whereby greater spaces allocated to smokers, I am wondering, if you've seen that at retail, does it impact your shelf space, certainly not your volumes, but just wondering what you're seeing at retail?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, all of this, we go through an annual reset ourselves based on our contracts, and all of the contracts are written that -- both for us and for our competitors. Some, more aggressive than us, that we get share that is basically in line with our self s",112,"Well, all of this, we go through an annual reset ourselves based on our contracts, and all of the contracts are written that -- both for us and for our competitors. Some, more aggressive than us, that we get share that is basically in line with our self space, and we continue to gain share. And we have a very focus and narrow product line. So we continue to discuss this. I've been in a number of talk to talk with customers, but we haven't had a negative impact. It's more of a challenge of, are regrowing fast enough for what we deserve. And thats the discussion I have with key retailers."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's great. Thanks, Murray.",5,"Okay. That's great. Thanks, Murray."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Murray, did you give the 8% Newport volume growth number? Did you give the number excluding what it would have been without Newport Red?",24,"Murray, did you give the 8% Newport volume growth number? Did you give the number excluding what it would have been without Newport Red?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, I do not. Andrew, I don't think we'd break it out by SKU.",14,"No, I do not. Andrew, I don't think we'd break it out by SKU."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then the markets where Newport Red is doing particularly well, are you seeing competitors response at all in terms of promotion on their non-menthol brands?",27,"Okay. And then the markets where Newport Red is doing particularly well, are you seeing competitors response at all in terms of promotion on their non-menthol brands?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, just to put it in perspective, they're already at those prices with competitive brands. So, we're in no -- and just to pick an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the sam",58,"Again, just to put it in perspective, they're already at those prices with competitive brands. So, we're in no -- and just to pick an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the same already. So, no, we have haven't seen any major swings."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just wanted to ask, we're hearing a lot about Philip Morris changing some of the promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters, or how would that play",49,"Okay. And then just wanted to ask, we're hearing a lot about Philip Morris changing some of the promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters, or how would that play out and impact you?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Good question. It really depends on participation. Were watching it very carefully. There is a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leader that feels like margins have",209,"Good question. It really depends on participation. Were watching it very carefully. There is a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leader that feels like margins have been expanding at the retail level at the expense of sort of the competitive position relative to the amount of money that they spend on buy downs and the industry spends on buy downs and whether it's getting passed through and increasing their productivity. So, we have in our contract if they're an equitable clause, so, if margins come down for them, they come down for us. So, presumably, that would be a favorable impact. The other important thing to know is, we saw a lot of volume, which are not markets where they are even under contract. So, presumably, it's no effect there. There are some modest areas where they may get a little more competitive. And if we need to, we'll adjust. But there's a whole lot of other areas where you would think we would benefit, especially depending on the participation level. So, we'll see how it plays out, but it's a different answer if there's 10% participation or 90% participation."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","All right. Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that to be mostly a sort of procedural thing without much content. But I was wondering, as we look longer term when FDA would make a final ass",85,"All right. Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that to be mostly a sort of procedural thing without much content. But I was wondering, as we look longer term when FDA would make a final assessment, where do you think they would disagree with some of the more negative conclusions or recommendations from TPSAC or I guess how they would reconcile some of the concerns that TPSAC raised in their report?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I believe, I think the industry believes that Dr. Dayton and Commissioner Hubbard will make sure that the FDA does their -- follows their charge which is to follow the signs. If they follow -- I don't think they're ever -- they don't have an obligat",155,"Look, I believe, I think the industry believes that Dr. Dayton and Commissioner Hubbard will make sure that the FDA does their -- follows their charge which is to follow the signs. If they follow -- I don't think they're ever -- they don't have an obligation to respond to the TPSAC report. They have an obligation to evaluate this issue, to follow the signs and if they follow the signs, we believe it strongly comes to the conclusion that there is no disproportionate harm from a menthol cigarette versus a non-menthol cigarette. They also have to deal with the issue that was really not even dealt with at all by the TPSAC report which has countervailing effects like black market and unemployment and taxes and smuggling and youth access. And we think when you combine that with it, they'll come to the right conclusion. So, hopefully, the worse is behind us on this issue."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Thank you.",3,"Okay. Thank you."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivian Acer with Citigroup.",12,"Your next question comes from the line of Vivian Acer with Citigroup."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Not to take too much away from the Analyst Day presentation, but I was wondering if you could offer a little bit of color around the demographic of the Newport share gain, either for the total franchise or Menthol versus Non-Menthol. In other words, of th",70,"Not to take too much away from the Analyst Day presentation, but I was wondering if you could offer a little bit of color around the demographic of the Newport share gain, either for the total franchise or Menthol versus Non-Menthol. In other words, of the incremental share that you are gaining, is it coming disproportionately from adult smokers under authority or is it well balanced, anything along those lines?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","To do that question justice because it's a very important question, I have to answer it next week at the Investor Conference because I am going to go into great detail of how we believe the core Newport business performs and where it comes from and all th",92,"To do that question justice because it's a very important question, I have to answer it next week at the Investor Conference because I am going to go into great detail of how we believe the core Newport business performs and where it comes from and all those good things. And we'll deal with demographics and sort of the strengths of the brand. And then we'll obviously deal with opportunities. But I don't want to give that 1 a quick answer. I have like 15 slides to answer that 1 well."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","That's fair enough. I'll be looking forward to hearing that then. Separately, just in terms of new product launches and how long the payback takes, just can you offer some color just in terms of your experience on how long generally it takes to generate e",58,"That's fair enough. I'll be looking forward to hearing that then. Separately, just in terms of new product launches and how long the payback takes, just can you offer some color just in terms of your experience on how long generally it takes to generate enough trials that you can start pulling back promo on new products?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now out of the shoot. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money and it' almost completely incremental. So, it's he",188,"Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now out of the shoot. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money and it' almost completely incremental. So, it's helping us. The answer on when you pulled back is different than a lot of other categories in my experience. And basically, in the old days, even in this category, you could do broad-scale television advertising and things like that. You had a lot more tools at your disposal to build trial. And right now we're very limited, right? The tools that are left with us, are priced a little bit, a direct mail, a little bit of print advertising and the brand continues to build. So, to me, and I am going to watch it grow for a while and then we'll make our decisions appropriately. And we're only out a couple of months at a time ahead of ourselves on the promotion plan, but our goal is, clearly, on this brand is to come off the introductory trial prices when it's appropriate."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Terrific. Thanks so much. I look forward to seeing you next week.",12,"Terrific. Thanks so much. I look forward to seeing you next week."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Ann Gurkin with Davenport.",12,"Your next question comes from the line of Ann Gurkin with Davenport."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Just wondering if you could comment -- in the quarter, you highlighted the amount of money roughly you spent towards brand building. Is that a level we should continue to see through the year or does it accelerate, can you help me understand that? And the",67,"Just wondering if you could comment -- in the quarter, you highlighted the amount of money roughly you spent towards brand building. Is that a level we should continue to see through the year or does it accelerate, can you help me understand that? And then wrapped into that, should we see Lorillard become more aggressive with innovations or product launches as we move through the year?"
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","So, the first question was, do we expect it to accelerate? No. I would say, it will stabilize to decelerate for the consumer portion of it, right? That's what you would have seen in the SG&A. The promotional spending is built into the pricing. Do we expec",131,"So, the first question was, do we expect it to accelerate? No. I would say, it will stabilize to decelerate for the consumer portion of it, right? That's what you would have seen in the SG&A. The promotional spending is built into the pricing. Do we expect a higher level of innovation? You'll see that in the Investor Day presentation, but Newport success comes from focus. So, we're never going to be the company that's launching a zillion new products, that's not our style. We don't have the shelf space for that. It will be very, very disciplined and methodical as we go forward when we see we have an appropriate new product. The good news is, we got one now and it's already in market, and it's called Newport Non-Menthol."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Great. That helps. Thanks so much.",6,"Great. That helps. Thanks so much."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","I would like to turn the call back over to Mr. Kessler for any concluding remarks.",16,"I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","We look forward to seeing everybody next week. Hopefully we've wet your appetite. The brands continue to perform beautifully. The Company continues to outperform on almost every financial measure that matters. Please join us on May 4 on the Mandarin Hotel",62,"We look forward to seeing everybody next week. Hopefully we've wet your appetite. The brands continue to perform beautifully. The Company continues to outperform on almost every financial measure that matters. Please join us on May 4 on the Mandarin Hotel in New York City, and we will talk about the business in more detail. Thank you for your interest in Lorillard."
4180255,129745129,117539,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now d",41,"This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now disconnect."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen. And welcome to the Lorillard, Inc. First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call. [Operator Instructions] At this time, I'd like to turn the conferen",56,"Good day, ladies and gentlemen. And welcome to the Lorillard, Inc. First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call. [Operator Instructions] At this time, I'd like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",130,"Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. By now, you should have received a copy of our first quarter 2011 earnings release. It can be found on the company's website, lorillard.com, under News Releases. But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties as described in the company's earnings release and in other filings with the SEC. And I would now like to turn the call over to Murray Kessler."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard, both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be shari",558,"Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard, both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be sharing our results and strategies going forward in great detail at the company's Investor Day next week. The meeting will be held on Wednesday, May 4, from 9 a.m. to 12 p.m. at the Mandarin Hotel in New York City. We hope you can join us in person or by webcast.
Starting with volumes. For the first quarter, Lorillard domestic wholesale shipments increased 9.4% versus a year ago, while the industry in total declined 3.4%. That's a pretty remarkable difference in trend, totaling 12.8 points.
Even after adjusting for the industry-wide benefit of 1 extra shipping day in the quarter and slightly offset by year-to-year inventory fluctuations, we estimate that Lorillard's domestic volume was up 8.3% versus a year ago.
Lorillard's domestic volume growth was driven by an 8% increase in total Newport, a 22.7% increase in Maverick and a 26% increase in Old Gold.
Encouragingly, Newport Non-Menthol was a solid contributor to the quarter as weekly volume and share on this new brand continued to grow.
As Lorillard volume trends continue to outperform the industry, we gain market share. Total Lorillard retail market share as measured by our proprietary retail database, EXCEL, in the first quarter increased 150 basis points versus a year ago to 14.1%.
Newport Non-Menthol achieved about 3/4 of a share point by the end of the quarter. Our core  Newport Menthol business also gained share both versus the year ago, up 38 basis points, and sequentially versus the fourth quarter, up 63 basis points.
Our discount brands, Maverick and Old Gold, also continued to gain share.
Total volume growth, along with higher prices net of promotion, translated to a 12.9% increase in net sales. Strong net sales growth, coupled with the accretive impact of the company's share repurchase plan, resulted in a 14% year-over-year gain in earnings per share. EPS finished at $1.71 for the quarter. 
A quick word on potential menthol regulation. The issue is now with the FDA and out of the hands of TPSAC. We believe that the evidence presented in both the industry reports and even in the TPSAC report itself supports the company's position that no disproportionate menthol regulation is warranted.
We believe that this is further supported by the Gance [ph] study from Vanderbilt University, funded by the National Cancer Institute, which was surprisingly published only moments after the March 23rd deadline for reports on this topic.
Beyond the scientific evidence, we believe that when the countervailing effects are seriously studied, such as the black market implications of an additional menthol restriction, that the case that there should be no disproportionate menthol regulation becomes obvious.
So in conclusion, the Lorillard story for quarter 1 remains the same: strong volume, good cost control and a focus on returning cash to shareholders. 
Remember, we recently increased the dividend on February 17, and we continue to repurchase company stock. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer, who will review the company's strong first quarter results in more detail. After David completes his review, we will answer your questions. David?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive volume, market share and profitability trends that we experienced all last year.Net sale",768,"Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive volume, market share and profitability trends that we experienced all last year.
Net sales for the first quarter of 2011 increased to 12.9%, to $1.535 billion as compared to the first quarter of 2010. Driven by the 9.5% increase in total shipment volume and higher average net selling prices, partially offset by higher sales promotion costs associated with the launch of Newport Non-Menthol. 
Unit volumes for Newport were up 8.2%, and Maverick volumes were up 22.7%. Shipments of Newport Non-Menthol, which was launched in the fourth quarter of last year, was a significant factor in the year-over-year comparison.
Fluctuations in wholesale inventory levels in this year and last year had some dampening effect on our volume comparison but was not a significant factor. It was about 1/2 of 1%. So after adjusting for the 1 additional shipping day in the first quarter this year and the modest effect of different trade inventory patterns, we estimate that our total volume was up 8.3%.
While the quarter shipments included the introduction of Newport Non-Menthol, Newport Menthol continued its very strong trend.
In fact, as I look at the shipments from wholesale to retail in our database, which is a better indicator of consumer takeaway, Newport Menthol's volume was slightly up for the quarter. 
In addition, net pricing was up for the quarter compared to last year, as the significant price realization on Newport Menthol overshadowed the impact of the mix change, both from the Newport Non-Menthol and from higher Maverick volume.
Gross profit in the first quarter of 2011 increased by $65 million to $543 million from $478 million in last year's first quarter.
Cost of goods sold in 2011 first quarter reflects increases over last year in certain costs, including increased FDA user fees.
Amounts due under the State Settlement Agreements and the Tobacco Growers' Assessment increased $46 million compared to last year's first quarter.
Selling, general and administrative cost increased $26 million from last year's first quarter, primarily due to legal fees and expenses associated with increased litigation activity during the quarter.
This increase in litigation costs actually comprised most of the increase in SG&A and is primarily due to an unusually high number of active trials this year as compared to last year, many of which are Engle progeny cases underway in Florida. 
For example, this year we had 3 Engle trials in the first quarter: a filter case trial, the City of St. Louis trial and various post trial motions in the Evans case. Now that may not sound high for some, but it's high for Lorillard, so it impacts the comparison. Some other items included in SG&A were also higher this year than last. These includes various costs and expenses of all the activities surrounding the company's position and industry report to the FDA regarding menthol and some additional advertising and brand-building costs in support of Newport Non-Menthol. 
So first quarter operating income increased 10.2% to $421 million, or 27.4% of sales from $382 million or 28.1% of sales in last year's first quarter. Net sales per unit and operating income per unit were both up compared to last year's first quarter. 
Fully diluted earnings per share for the quarter increased 14% from last year's first quarter to $1.71 per share. Those results reflect the strong performance we've already discussed but also the effect of a lower average share count this year. The lower share count, as compared to the year ago quarter, added $0.11 per share to EPS for this year's first quarter.
During the first quarter 2011, we substantially increased our dividend by 16% to an annualized dividend of $5.20 per share, and we continue to repurchase shares in the market. For the quarter, through March 31, we repurchased approximately 3.8 million shares at a cost of $289 million under the $1 billion share repurchase authorization that we announced last fall. That's an average cost of $76.76 per share. As of March 31, we still had $335 million remaining on that program.
So, we're off to a good start in 2011, and we're pleased with the company's performance thus far. Of course, challenges remain for us on a number of fronts, macro economic, competitive, and regulatory. We believe that we have the ability to meet these challenges and continue to build value for our shareholders over the long term. 
And with that, we'd like to open the line for questions. Operator, can you help us with that?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of David Adelman with Morgan Stanley.",15,"[Operator Instructions] Your first question comes from the line of David Adelman with Morgan Stanley."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Murray, I wanted to ask you 2 things. First, on Newport Menthol, the brand share was fairly consistent throughout 2010, and now it stepped up in the first quarter. And I'm just curious, what do you attribute that to? Is there a different competitive dynam",60,"Murray, I wanted to ask you 2 things. First, on Newport Menthol, the brand share was fairly consistent throughout 2010, and now it stepped up in the first quarter. And I'm just curious, what do you attribute that to? Is there a different competitive dynamic in the marketplace? Were your programs any different than they had been throughout last year?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Actually, David, some had speculated that we had stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We actually -- if you were to be able to get to the underlying numbers, you would see Newport Menthol's net pricin",155,"Actually, David, some had speculated that we had stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We actually -- if you were to be able to get to the underlying numbers, you would see Newport Menthol's net pricing was very robust in the first quarter as we actually pulled back on some buy-down support. I just think the brand, for all the reasons I'll talk about next week at the Investor Conference in great detail, is just very strong and continues to organically grow. And I think, I've always believed this, that you sort of build it a little bit as the year goes along then you lap the year again and you get sort of the biggest increases in the first half of the year and then it reaches the level and then you lap it again. And that's been the pattern for almost 7 or 8 years."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And secondly, Murray, can you quantify to any extent the degree to which you think that there is consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick? Presumably it's very low.",34,"Okay. And secondly, Murray, can you quantify to any extent the degree to which you think that there is consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick? Presumably it's very low."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","It's a very low. I'll show you at the conference next week a source of volume analysis, but it's -- just to give you sort of some rough numbers, it looks like less than 7% or 8% that comes directly, which when you sort of translate that numbers, its te",63,"It's a very low. I'll show you at the conference next week a source of volume analysis, but it's -- just to give you sort of some rough numbers, it looks like less than 7% or 8% that comes directly, which when you sort of translate that numbers, its tenths impact on the percentage change on Newport, like 0.3%, 0.4% at tops."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Thank you very much.",5,"Okay. Thank you very much."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Thanks. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you and the FDA? And what is your understanding of how the FDA might be approaching the progress report that's due at some point?",40,"Thanks. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you and the FDA? And what is your understanding of how the FDA might be approaching the progress report that's due at some point?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, there's lots of communication, but it's not really on the topic of Menthol. It's been on substantial equivalents. The FDA has requested plant tours. There's been other dialogues as well. As it relates to menthol, it's been pretty quiet. We may be wr",61,"Well, there's lots of communication, but it's not really on the topic of Menthol. It's been on substantial equivalents. The FDA has requested plant tours. There's been other dialogues as well. As it relates to menthol, it's been pretty quiet. We may be wrong, but we speculate, and it's pure speculation, that this will be a procedural update, but we'll see."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and it looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe",81,"Okay. And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and it looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe how much of the growth you think is coming from some of the trials associated with the higher promos? Are you getting repeats at this point? Just any color on the Newport Non-Menthol performance."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, trying not to steal too much thunder from next week because we have the source of volume analysis. We have repeat numbers. We have all that to show you. The brand's performing extremely well, and I'm going to emphasize that while people talk a lot",190,"Again, trying not to steal too much thunder from next week because we have the source of volume analysis. We have repeat numbers. We have all that to show you. The brand's performing extremely well, and I'm going to emphasize that while people talk a lot about the discount level -- the discount level is not even a little unusual for other premium brand launches. It's basically $1 a pack discount versus the average premium-priced product. So if you're in with some of our big markets like New York, where it's $10 or $11 per pack of cigarettes, you're talking about a 10% discount. And if you get to some of the average-priced markets, you get as high as a 20% to 25% discount during this trial period. Thats nothing like the buy 1, get 1 frees and deep, deep discounts that make it hard to ultimately get to premium pricing. I'll walk you through source of volume. I'll walk you through repeat. I'll walk you through all that data next week, but I'm going to keep you a little hungry so you'll be there ready to go next week."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, David, just finally, in the SG&A expenses, can you just quantify how much the -- I think, you all see -- in addition to Engle progeny-related legal costs, you also called out some spending related to the menthol reports and perhaps some of",106,"Okay. And then, David, just finally, in the SG&A expenses, can you just quantify how much the -- I think, you all see -- in addition to Engle progeny-related legal costs, you also called out some spending related to the menthol reports and perhaps some of the other advertising expenses related to Newport Non-Menthol. So, I guess Im just wondering how much of those really contributed to the increases. And as you think about the trial calendar for the rest of the year, is there a way to appropriately forecast sort of how much the legal expenses could be up for the balance of the year?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Okay, let me take this in parts. The increase in litigation defense cost accounted for more than 1/2 of the $26 million increase in SG&A.",25,"Okay, let me take this in parts. The increase in litigation defense cost accounted for more than 1/2 of the $26 million increase in SG&A."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay.",1,"Okay."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","And the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind of cost surrounding Newport Non-Menthol, and there were all the other activities like taking the lead on the industry report regarding mentho",244,"And the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind of cost surrounding Newport Non-Menthol, and there were all the other activities like taking the lead on the industry report regarding menthol, a number of consultants helped in developing that report. I'd rather not try and quantify those, but those comprised less than -- the other 2 things that I called out comprised less than 1/2 of that increase. And as we look forward to the trial calendar for the rest of the year, it is pretty difficult to forecast. I don't believe that our trial calendar over the next few quarters is as heavy as what we experienced in the first quarter of this year, but we really just have to take this as it comes. We're going to defend ourselves in every case to our -- to the maximum extent, and it's really just sort of activity driven. And unfortunately, we are reactive in this matter, although the Engle progeny cases are a big deal, not just the number of trials. I think we had something like 50% more active cases, whether they were in trial or not, 50% more active Engle-chased [ph] cases in the first quarter this year than the first quarter last year. So this Engle defense cost is going to be with us for a while.  It's just difficult to predict the peaks and valleys in it."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And the spending related to the menthol report on the advertising cost, are they more heavily weighted towards the first quarter? I guess, the menthol report probably?",28,"Okay. And the spending related to the menthol report on the advertising cost, are they more heavily weighted towards the first quarter? I guess, the menthol report probably?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, the -- this is Murray. The big introductory advertising, which is not huge, but the print campaign and initial point of sale and all that, which compares to nothing in the year ago period, is heavily skewed towards the introduction, although there i",99,"Well, the -- this is Murray. The big introductory advertising, which is not huge, but the print campaign and initial point of sale and all that, which compares to nothing in the year ago period, is heavily skewed towards the introduction, although there is some sustaining advertising throughout the year but not to the same level. And the menthol report, it depends. We're going to work with the FDA any way they want us to on this issue, and so it depends on them. If they come back to us and they ask for support, we're going to support."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Got it. Thank you.",5,"Okay. Got it. Thank you."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Nik Modi with UBS.",12,"Your next question comes from the line of Nik Modi with UBS."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Just sorry, hopped on a little late, but just 2 quick questions and apologies if they've been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about a trade de-load, actually. So, just wa",116,"Just sorry, hopped on a little late, but just 2 quick questions and apologies if they've been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about a trade de-load, actually. So, just wanted to get your perspective on if there was any of that in the quarter. Then the second question is I noticed in one of your tables that the menthol share gains were actually flat for Newport. I'm just curious on your thoughts around that. Is that timing of shipments from some of your competitors or promotions you had from a year ago? Any perspective on that would be helpful."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Let me talk a little bit about the inventory patterns. Yes, industry inventory is built in last year's first quarter, and they built in this year's first quarter. It's just that this year's first quarter didn't build as much as last year. So, when you try",73,"Let me talk a little bit about the inventory patterns. Yes, industry inventory is built in last year's first quarter, and they built in this year's first quarter. It's just that this year's first quarter didn't build as much as last year. So, when you try and adjust those 2 factors out, it just didn't build as much in the first quarter. So that only impacted our comparison by about 1/2 a percent."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Fair enough.",3,"Okay. Fair enough."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","But just to be clear, Nik, inventory didn't help us this quarter. It hurt us.",15,"But just to be clear, Nik, inventory didn't help us this quarter. It hurt us."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Right. Yes, yes.",3,"Right. Yes, yes."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","The other couple of points there, too, the industry-wide extra shipping day, we adjusted our numbers. We didn't try to adjust the numbers for the rest of the industry. So, we believe that the industry decline was probably a little bit worse than 3.4%. But",86,"The other couple of points there, too, the industry-wide extra shipping day, we adjusted our numbers. We didn't try to adjust the numbers for the rest of the industry. So, we believe that the industry decline was probably a little bit worse than 3.4%. But we're only willing to sort of -- kind of a clear, transparent adjustment for our own shipments. As it relates to market share, I'm not sure where you're getting the numbers. Newport Non-Menthol gained share versus year ago, it was up"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","I'm talking about Newport Menthol, Murray. Sorry. I was just looking in the table. Menthol, the category gained share, but it looks like Newport share -- Newport Menthol share was flat like the...",34,"I'm talking about Newport Menthol, Murray. Sorry. I was just looking in the table. Menthol, the category gained share, but it looks like Newport share -- Newport Menthol share was flat like the..."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Share of the Menthol segment?",5,"Share of the Menthol segment?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Yes, yes, yes.",3,"Yes, yes, yes."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Yes, it is -- that is correct, although Newport Menthol gained share as a result of the category gaining share.",20,"Yes, it is -- that is correct, although Newport Menthol gained share as a result of the category gaining share."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Yes, and I was just curious if there was any timing issues there. I'm just trying to get an understanding of what's behind",23,"Yes, and I was just curious if there was any timing issues there. I'm just trying to get an understanding of what's behind"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Nik, there was also was some competitive activity in the Menthol stakes in the first quarter, as I am sure you are aware. That might have had a little bit of a dampening effect.",34,"Nik, there was also was some competitive activity in the Menthol stakes in the first quarter, as I am sure you are aware. That might have had a little bit of a dampening effect."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, it's more of a shipment issue.",7,"Okay, it's more of a shipment issue."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","I think -- we don't use scanned data because of where we sell. So the best we do is using EXCEL data, which ships from wholesale to retail. That counts pipeline load, and there were a lot of competitive menthol products that went into distribution into th",49,"I think -- we don't use scanned data because of where we sell. So the best we do is using EXCEL data, which ships from wholesale to retail. That counts pipeline load, and there were a lot of competitive menthol products that went into distribution into the first quarter."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, got you. Thank you.",5,"Okay, got you. Thank you."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America.",14,"Your next question comes from the line of Christine Farkas with Bank of America."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Thank you very much. David, you were helpful with the SG&A breakdown. I appreciate that. A couple of questions. Just on the shipping days in the first quarter, does that reverse at some point in the year? Will we see an additional day in the second quarte",47,"Thank you very much. David, you were helpful with the SG&A breakdown. I appreciate that. A couple of questions. Just on the shipping days in the first quarter, does that reverse at some point in the year? Will we see an additional day in the second quarter?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, it will reverse in the fourth quarter. So the total year will have the same number of shipping days this year as last year, so in the fourth quarter, it will reverse.",33,"No, it will reverse in the fourth quarter. So the total year will have the same number of shipping days this year as last year, so in the fourth quarter, it will reverse."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's helpful. And then, this may be a bit of a stretch, but looking at the momentum of the menthol share gains in the first quarter. I'm just wondering your perspective with respect to consumer views of the category, are they -- would you say they",86,"Okay. That's helpful. And then, this may be a bit of a stretch, but looking at the momentum of the menthol share gains in the first quarter. I'm just wondering your perspective with respect to consumer views of the category, are they -- would you say they are aware of the discussions around potential bans? Has something been heightened? How far do these concerns or this attention really reach down to the consumer level or is there just none of that, of course, in the numbers?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I'm speculating like you are. But we're out in front of consumers. We do focus groups on other top topic. I hear none of that. I dont think there is general awareness in the consumer population of smokers that this is even going on.",45,"Look, I'm speculating like you are. But we're out in front of consumers. We do focus groups on other top topic. I hear none of that. I dont think there is general awareness in the consumer population of smokers that this is even going on."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","So should the menthol share of the category that we did see step up nicely sequentially and, of course, year-over-year, would you say again back to your pipeline fill comments, or is really the consumer demand and growing appeal of the flavor?",42,"So should the menthol share of the category that we did see step up nicely sequentially and, of course, year-over-year, would you say again back to your pipeline fill comments, or is really the consumer demand and growing appeal of the flavor?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","I would say for us, it's just organic growth business as usual. And I would say that -- I would agree with you that there was a number of SKUs that were launched, and that probably affected it to some extent that you just have to fill all the shelves arou",79,"I would say for us, it's just organic growth business as usual. And I would say that -- I would agree with you that there was a number of SKUs that were launched, and that probably affected it to some extent that you just have to fill all the shelves around the country in 250,000, 300,000 stores. But I think at the heart of your question is, do I think the consumers were hoarding it anyway? No, I dont."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, great. And then last question, just with respect to a segment you're not in and that's Smokeless, we understand there maybe some shelf resets whereby greater space is allocated to Smokeless, I am wondering, if you've seen that at retail, if it impac",59,"Okay, great. And then last question, just with respect to a segment you're not in and that's Smokeless, we understand there maybe some shelf resets whereby greater space is allocated to Smokeless, I am wondering, if you've seen that at retail, if it impacts your shelf space, certainly not your volumes, but just wondering what you're seeing at retail."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, all of this, we go through an annual reset ourselves based on our contracts, and all of the contracts are written that -- both for us and for our competitors, some more aggressive than us, that we get share thats basically in line with our shelf",112,"Well, all of this, we go through an annual reset ourselves based on our contracts, and all of the contracts are written that -- both for us and for our competitors, some more aggressive than us, that we get share thats basically in line with our shelf space, and we continue to gain share. And we have a very focused and narrow product line. So we continue to discuss this. I've been in a number of talk to talks [ph] with customers, but we haven't had a negative impact. It's more of a challenge of are growing fast enough for what we deserve. And thats the discussion I have with key retailers."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's great. Thanks, Murray.",5,"Okay. That's great. Thanks, Murray."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Murray, did you give the 8% Newport volume growth number? Did you give the number excluding what it would have been without Newport Red?",24,"Murray, did you give the 8% Newport volume growth number? Did you give the number excluding what it would have been without Newport Red?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, I do not. And I don't think we break it out by SKU.",14,"No, I do not. And I don't think we break it out by SKU."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And in the markets where Newport Red is doing particularly well, are you seeing competitors respond at all in terms of promotion on their non-menthol brands?",27,"Okay. And in the markets where Newport Red is doing particularly well, are you seeing competitors respond at all in terms of promotion on their non-menthol brands?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, just to put it in perspective, they're already at those prices with competitive brands. So, we're in no -- and just to pick an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the sam",58,"Again, just to put it in perspective, they're already at those prices with competitive brands. So, we're in no -- and just to pick an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the same already. So, no, we have haven't seen any major swings."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just wanted to ask, we're hearing a lot about Philip Morris changing some of the promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters, or how would that play",49,"Okay. And then just wanted to ask, we're hearing a lot about Philip Morris changing some of the promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters, or how would that play out and impact you?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Good question. It really depends on participation. Were watching it very carefully. There is a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leader that feels like margins have",209,"Good question. It really depends on participation. Were watching it very carefully. There is a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leader that feels like margins have been expanding at the retail level at the expense of sort of the competitive position relative to the amount of money that they spend on buy downs and the industry spends on buy downs and whether it's getting passed through and increasing their productivity. So, we have in our contract a fair and equitable clause, so, if margins come down for them, they come down for us. So, presumably, that would be a favorable impact. The other important thing to know is, we saw a lot of volume, which are not markets where they are even under contract. So, presumably, it's no effect there. There are some modest areas where they may get a little more competitive. And if we need to, we'll adjust. But there's a whole lot of other areas where you would think we would benefit, especially depending on the participation level. So, we'll see how it plays out, but it's a different answer if there's 10% participation or 90% participation."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","All right. Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that to be mostly a sort of procedural thing without much content. But I was wondering, as we look longer term when FDA would make a final ass",85,"All right. Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that to be mostly a sort of procedural thing without much content. But I was wondering, as we look longer term when FDA would make a final assessment, where do you think they would disagree with some of the more negative conclusions or recommendations from TPSAC or I guess how they would reconcile some of the concerns that TPSAC raised in their report?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I believe -- I think the industry believes that Dr. Deyton [Lawrence Deyton] and Commissioner Hamburg [Margaret Hamburg] will make sure that the FDA does their -- follows their charge which is to follow the science. If they follow -- I don't think t",160,"Look, I believe -- I think the industry believes that Dr. Deyton [Lawrence Deyton] and Commissioner Hamburg [Margaret Hamburg] will make sure that the FDA does their -- follows their charge which is to follow the science. If they follow -- I don't think they're ever -- they don't have an obligation to respond to the TPSAC report. They have an obligation to evaluate this issue, to follow the science and if they follow the science, we believe it strongly comes to the conclusion that there is no disproportionate harm from a menthol cigarette versus a non-menthol cigarette. They also have to deal with the issue that was really not even dealt with at all by the TPSAC report which is countervailing effects like black market and unemployment and taxes and smuggling and youth access. And we think when you combine that with it, they'll come to the right conclusion. So, hopefully, the worst is behind us on this issue."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Thank you.",3,"Okay. Thank you."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivian Acer [ph] with Citigroup.",13,"Your next question comes from the line of Vivian Acer [ph] with Citigroup."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Not to take too much away from the Analyst Day presentation, but I was wondering if you could offer a little bit of color around the demographics of the Newport share gains, either for the total franchise or Menthol versus Non-Menthol. In other words, of",70,"Not to take too much away from the Analyst Day presentation, but I was wondering if you could offer a little bit of color around the demographics of the Newport share gains, either for the total franchise or Menthol versus Non-Menthol. In other words, of the incremental share that you are gaining, is it coming disproportionately from adult smokers under 30, or is it well balanced, anything along those lines?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","To do that question justice, because it's a very important question, I have to answer it next week at the Investor Conference because I am going to go into great detail of how we believe the core Newport business performs and where it comes from and all t",91,"To do that question justice, because it's a very important question, I have to answer it next week at the Investor Conference because I am going to go into great detail of how we believe the core Newport business performs and where it comes from and all those good things. And we'll deal with demographics and sort of the strengths of the brand. And then we'll obviously deal with opportunities. But I don't want to give that one a quick answer. I have like 15 slides to answer that one well."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","That's fair enough. I'll be looking forward to hearing that then. Separately, just in terms of new product launches and how long the payback takes, just can you offer some color just in terms of your experience on how long generally it takes to generate e",58,"That's fair enough. I'll be looking forward to hearing that then. Separately, just in terms of new product launches and how long the payback takes, just can you offer some color just in terms of your experience on how long generally it takes to generate enough trials that you can start pulling back promo on new products?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now out of the shoot. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money, and it's almost completely incremental. So, it's",187,"Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now out of the shoot. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money, and it's almost completely incremental. So, it's helping us. The answer on when you pull back is different than a lot of other categories in my experience. And basically, in the old days, even in this category, you could do broad-scale television advertising and things like that. You had a lot more tools at your disposal to build trial. And right now, we're very limited, right? The tools that are left with us are price, a little bit of direct mail, a little bit of print advertising, and the brand continues to build. So, to me, I am going to watch it grow for a while, and then we'll make our decisions appropriately. And we're only out a couple of months at a time ahead of ourselves on the promotion plan, but our goal is, clearly, on this brand is to come off the introductory trial prices when it's appropriate."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Terrific. Thanks so much. I look forward to seeing you next week.",12,"Terrific. Thanks so much. I look forward to seeing you next week."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Ann Gurkin with Davenport.",12,"Your next question comes from the line of Ann Gurkin with Davenport."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Was wondering if you could comment -- in the quarter, you highlighted the amount of money roughly you spent towards brand building. Is that a level we should continue to see through the year or does it accelerate? Can you help me understand that? And then",67,"Was wondering if you could comment -- in the quarter, you highlighted the amount of money roughly you spent towards brand building. Is that a level we should continue to see through the year or does it accelerate? Can you help me understand that? And then wrapped into that, should we see Lorillard become more aggressive with innovations or product launches as we move through the year?"
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","So, the first question was, do we expect it to accelerate? No. I would say, it will stabilize to decelerate for the consumer portion of it, right? That's what you would have seen in the SG&A. The promotional spending is built into the pricing. Do we expec",131,"So, the first question was, do we expect it to accelerate? No. I would say, it will stabilize to decelerate for the consumer portion of it, right? That's what you would have seen in the SG&A. The promotional spending is built into the pricing. Do we expect a higher level of innovation? You'll see that in the Investor Day presentation, but Newports success comes from focus. So, we're never going to be the company that's launching a zillion new products. That's not our style. We don't have the shelf space for that. It will be very, very disciplined and methodical as we go forward when we see we have an appropriate new product. The good news is we got one now, and it's already in market, and it's called Newport Non-Menthol."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Great. That helps. Thanks so much.",6,"Great. That helps. Thanks so much."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","I would like to turn the call back over to Mr. Kessler for any concluding remarks.",16,"I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","We look forward to seeing everybody next week. Hopefully we've whet your appetite. The brands continue to perform beautifully. The company continues to outperform on almost every financial measure that matters. Please join us on May 4 at the Mandarin Hote",62,"We look forward to seeing everybody next week. Hopefully we've whet your appetite. The brands continue to perform beautifully. The company continues to outperform on almost every financial measure that matters. Please join us on May 4 at the Mandarin Hotel in New York City, and we will talk about the business in more detail. Thank you for your interest in Lorillard."
4180255,129745129,117577,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now d",41,"This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now disconnect."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen. And welcome to the Lorillard, Inc. First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call. [Operator Instructions] As a reminder, this conference is being rec",67,"Good day, ladies and gentlemen. And welcome to the Lorillard, Inc. First Quarter 2011 Earnings Conference Call. My name is Nicole, and I will be your conference operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I'd like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",130,"Thank you, Nicole. And good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations, and joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. By now, you should have received a copy of our first quarter 2011 earnings release. It can be found on the company's website, lorillard.com, under News Releases. But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties as described in the company's earnings release and in other filings with the SEC. And I would now like to turn the call over to Murray Kessler."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard, both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be shari",558,"Thank you, Bob. And good morning, everyone. I'm pleased to show the results of another very strong quarter for Lorillard, both in absolute terms and relative to the rest of the tobacco industry. Our comments will be brief this morning, as we will be sharing our results and strategies going forward in great detail at the company's investor day next week. The meeting will be held on Wednesday, May 4, from 9 a.m. to 12 p.m. at the Mandarin Hotel in New York City. We hope you can join us in person or by webcast.
Starting with volumes. For the first quarter, Lorillard domestic wholesale shipments increased 9.4% versus a year ago, while the industry in total declined 3.4%. That's a pretty remarkable difference in trend, totaling 12.8 points.
Even after adjusting for the industry-wide benefit of 1 extra shipping day in the quarter and slightly offset by year-to-year inventory fluctuations, we estimate that Lorillard's domestic volume was up 8.3% versus a year ago.
Lorillard's domestic volume growth was driven by an 8% increase in total Newport, a 22.7% increase in Maverick and a 26% increase in Old Gold.
Encouragingly, Newport Non-Menthol was a solid contributor to the quarter as weekly volume and share on this new brand continued to grow.
As Lorillard volume trends continue to outperform the industry, we gain market share. Total Lorillard retail market share as measured by our proprietary retail database, EXCEL, in the first quarter increased 150 basis points versus a year ago to 14.1%.
Newport Non-Menthol achieved about 3/4 of a share point by the end of the quarter. Our core  Newport Menthol business also gained share both versus the year ago, up 38 basis points, and sequentially versus the fourth quarter, up 63 basis points.
Our discount brands, Maverick and Old Gold, also continued to gain share.
Total volume growth, along with higher prices net of promotion, translated to a 12.9% increase in net sales. Strong net sales growth, coupled with the accretive impact of the company's share repurchase plan, resulted in a 14% year-over-year gain in earnings per share. EPS finished at $1.71 for the quarter. 
A quick word on potential menthol regulation. The issue is now with the FDA and out of the hands of TPSAC. We believe that the evidence presented in both the industry reports and even in the TPSAC report itself supports the company's position that no disproportionate menthol regulation is warranted.
We believe that this is further supported by the Gance [ph] study from Vanderbilt University, funded by the National Cancer Institute, which was surprisingly published only moments after the March 23rd deadline for reports on this topic.
Beyond the scientific evidence, we believe that when the countervailing effects are seriously studied, such as the black market implications of an additional menthol restriction, that the case that there should be no disproportionate menthol regulation becomes obvious.
So in conclusion, the Lorillard story for quarter 1 remains the same: strong volume, good cost control and a focus on returning cash to shareholders. 
Remember, we recently increased the dividend on February 17, and we continue to repurchase company stock. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer, who will review the company's strong first quarter results in more detail. After David completes his review, we will answer your questions. David?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive volume, market share and profitability trends that we experienced all last year.Net sale",768,"Thanks, Murray. And good morning, everyone. As you've already heard from Murray, we're pleased with our first quarter results. We saw a continuation of the positive volume, market share and profitability trends that we experienced all last year.
Net sales for the first quarter of 2011 increased to 12.9%, to $1.535 billion as compared to the first quarter of 2010. Driven by the 9.5% increase in total shipment volume and higher average net selling prices, partially offset by higher sales promotion costs associated with the launch of Newport Non-Menthol. 
Unit volumes for Newport were up 8.2%, and Maverick volumes were up 22.7%. Shipments of Newport Non-Menthol, which was launched in the fourth quarter of last year, was a significant factor in the year-over-year comparison.
Fluctuations in wholesale inventory levels in this year and last year had some dampening effect on our volume comparison but was not a significant factor. It was about 1/2 of 1%. So after adjusting for the 1 additional shipping day in the first quarter this year and the modest effect of different trade inventory patterns, we estimate that our total volume was up 8.3%.
While the quarter shipments included the introduction of Newport Non-Menthol, Newport Menthol continued its very strong trend.
In fact, as I look at the shipments from wholesale to retail in our database, which is a better indicator of consumer takeaway, Newport Menthol's volume was slightly up for the quarter. 
In addition, net pricing was up for the quarter compared to last year, as the significant price realization on Newport Menthol overshadowed the impact of the mix change, both from the Newport Non-Menthol and from higher Maverick volume.
Gross profit in the first quarter of 2011 increased by $65 million to $543 million from $478 million in last year's first quarter.
Cost of goods sold in 2011 first quarter reflects increases over last year in certain costs, including increased FDA user fees.
Amounts due under the State Settlement Agreements and the Tobacco Growers' Assessment increased $46 million compared to last year's first quarter.
Selling, general and administrative cost increased $26 million from last year's first quarter, primarily due to legal fees and expenses associated with increased litigation activity during the quarter.
This increase in litigation costs actually comprised most of the increase in SG&A and is primarily due to an unusually high number of active trials this year as compared to last year, many of which are Engle progeny cases underway in Florida. 
For example, this year we had 3 Engle trials in the first quarter: a filter case trial, the City of St. Louis trial and various post trial motions in the Evans case. Now that may not sound high for some, but it's high for Lorillard, so it impacts the comparison. Some other items included in SG&A were also higher this year than last. These includes various costs and expenses of all the activities surrounding the company's position and industry report to the FDA regarding menthol and some additional advertising and brand-building costs in support of Newport Non-Menthol. 
So first quarter operating income increased 10.2% to $421 million, or 27.4% of sales from $382 million or 28.1% of sales in last year's first quarter. Net sales per unit and operating income per unit were both up compared to last year's first quarter. 
Fully diluted earnings per share for the quarter increased 14% from last year's first quarter to $1.71 per share. Those results reflect the strong performance we've already discussed but also the effect of a lower average share count this year. The lower share count, as compared to the year ago quarter, added $0.11 per share to EPS for this year's first quarter.
During the first quarter 2011, we substantially increased our dividend by 16% to an annualized dividend of $5.20 per share, and we continue to repurchase shares in the market. For the quarter, through March 31, we repurchased approximately 3.8 million shares at a cost of $289 million under the $1 billion share repurchase authorization that we announced last fall. That's an average cost of $76.76 per share. As of March 31, we still had $335 million remaining on that program.
So, we're off to a good start in 2011, and we're pleased with the company's performance thus far. Of course, challenges remain for us on a number of fronts, macro economic, competitive, and regulatory. We believe that we have the ability to meet these challenges and continue to build value for our shareholders over the long term. 
And with that, we'd like to open the line for questions. Operator, can you help us with that?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of David Adelman with Morgan Stanley.",15,"[Operator Instructions] Your first question comes from the line of David Adelman with Morgan Stanley."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Murray, I wanted to ask you 2 things. First, on Newport Menthol, the brand share was fairly consistent throughout 2010, and now it stepped up in the first quarter. And I'm just curious, what do you attribute that to? Is there a different competitive dynam",60,"Murray, I wanted to ask you 2 things. First, on Newport Menthol, the brand share was fairly consistent throughout 2010, and now it stepped up in the first quarter. And I'm just curious, what do you attribute that to? Is there a different competitive dynamic in the marketplace? Were your programs any different than they had been throughout last year?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Actually, David, some had speculated that we had stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We actually -- if you were to be able to get to the underlying numbers, you would see Newport Menthol's net pricin",155,"Actually, David, some had speculated that we had stepped up some promotional spending on Newport Menthol. That's 180 degrees from the truth. We actually -- if you were to be able to get to the underlying numbers, you would see Newport Menthol's net pricing was very robust in the first quarter as we actually pulled back on some buy-down support. I just think the brand, for all the reasons I'll talk about next week at the Investor Conference in great detail, is just very strong and continues to organically grow. And I think, I've always believed this, that you sort of build it a little bit as the year goes along then you lap the year again and you get sort of the biggest increases in the first half of the year and then it reaches the level and then you lap it again. And that's been the pattern for almost 7 or 8 years."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And secondly, Murray, can you quantify to any extent the degree to which you think that there is consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick? Presumably it's very low.",34,"Okay. And secondly, Murray, can you quantify to any extent the degree to which you think that there is consumer interaction or cannibalization across Newport Non-Menthol, Newport Menthol and Maverick? Presumably it's very low."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","It's a very low. I'll show you at the conference next week a source of volume analysis, but it's -- just to give you sort of some rough numbers, it looks like less than 7% or 8% that comes directly, which when you sort of translate that numbers, its te",63,"It's a very low. I'll show you at the conference next week a source of volume analysis, but it's -- just to give you sort of some rough numbers, it looks like less than 7% or 8% that comes directly, which when you sort of translate that numbers, its tenths impact on the percentage change on Newport, like 0.3%, 0.4% at tops."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Thank you very much.",5,"Okay. Thank you very much."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Thanks. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you and the FDA? And what is your understanding of how the FDA might be approaching the progress report that's due at some point?",40,"Thanks. Murray, on the menthol regulation, since the TPSAC report, has there been any communication with you and the FDA? And what is your understanding of how the FDA might be approaching the progress report that's due at some point?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, there's lots of communication, but it's not really on the topic of Menthol. It's been on substantial equivalents. The FDA has requested plant tours. There's been other dialogues as well. As it relates to menthol, it's been pretty quiet. We may be wr",61,"Well, there's lots of communication, but it's not really on the topic of Menthol. It's been on substantial equivalents. The FDA has requested plant tours. There's been other dialogues as well. As it relates to menthol, it's been pretty quiet. We may be wrong, but we speculate, and it's pure speculation, that this will be a procedural update, but we'll see."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and it looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe",81,"Okay. And then the Newport Non-Menthol, I think you called out the retail share being up of about 0.7 share in the quarter, and it looks like it's still growing on a week-to-week basis. So can you just give us your perspective on the brand's equity, maybe how much of the growth you think is coming from some of the trials associated with the higher promos? Are you getting repeats at this point? Just any color on the Newport Non-Menthol performance."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, trying not to steal too much thunder from next week because we have the source of volume analysis. We have repeat numbers. We have all that to show you. The brand's performing extremely well, and I'm going to emphasize that while people talk a lot",190,"Again, trying not to steal too much thunder from next week because we have the source of volume analysis. We have repeat numbers. We have all that to show you. The brand's performing extremely well, and I'm going to emphasize that while people talk a lot about the discount level -- the discount level is not even a little unusual for other premium brand launches. It's basically $1 a pack discount versus the average premium-priced product. So if you're in with some of our big markets like New York, where it's $10 or $11 per pack of cigarettes, you're talking about a 10% discount. And if you get to some of the average-priced markets, you get as high as a 20% to 25% discount during this trial period. Thats nothing like the buy 1, get 1 frees and deep, deep discounts that make it hard to ultimately get to premium pricing. I'll walk you through source of volume. I'll walk you through repeat. I'll walk you through all that data next week, but I'm going to keep you a little hungry so you'll be there ready to go next week."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, David, just finally, in the SG&A expenses, can you just quantify how much the -- I think, you all see -- in addition to Engle progeny-related legal costs, you also called out some spending related to the menthol reports and perhaps some of",106,"Okay. And then, David, just finally, in the SG&A expenses, can you just quantify how much the -- I think, you all see -- in addition to Engle progeny-related legal costs, you also called out some spending related to the menthol reports and perhaps some of the other advertising expenses related to Newport Non-Menthol. So, I guess Im just wondering how much of those really contributed to the increases. And as you think about the trial calendar for the rest of the year, is there a way to appropriately forecast sort of how much the legal expenses could be up for the balance of the year?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Okay, let me take this in parts. The increase in litigation defense cost accounted for more than 1/2 of the $26 million increase in SG&A.",25,"Okay, let me take this in parts. The increase in litigation defense cost accounted for more than 1/2 of the $26 million increase in SG&A."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay.",1,"Okay."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","And the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind of cost surrounding Newport Non-Menthol, and there were all the other activities like taking the lead on the industry report regarding mentho",244,"And the other portion of the increase in SG&A was partly due to the increased advertising and brand building kind of cost surrounding Newport Non-Menthol, and there were all the other activities like taking the lead on the industry report regarding menthol, a number of consultants helped in developing that report. I'd rather not try and quantify those, but those comprised less than -- the other 2 things that I called out comprised less than 1/2 of that increase. And as we look forward to the trial calendar for the rest of the year, it is pretty difficult to forecast. I don't believe that our trial calendar over the next few quarters is as heavy as what we experienced in the first quarter of this year, but we really just have to take this as it comes. We're going to defend ourselves in every case to our -- to the maximum extent, and it's really just sort of activity driven. And unfortunately, we are reactive in this matter, although the Engle progeny cases are a big deal, not just the number of trials. I think we had something like 50% more active cases, whether they were in trial or not, 50% more active Engle-chased [ph] cases in the first quarter this year than the first quarter last year. So this Engle defense cost is going to be with us for a while.  It's just difficult to predict the peaks and valleys in it."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And the spending related to the menthol report on the advertising cost, are they more heavily weighted towards the first quarter? I guess, the menthol report probably?",28,"Okay. And the spending related to the menthol report on the advertising cost, are they more heavily weighted towards the first quarter? I guess, the menthol report probably?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, the -- this is Murray. The big introductory advertising, which is not huge, but the print campaign and initial point of sale and all that, which compares to nothing in the year ago period, is heavily skewed towards the introduction, although there i",99,"Well, the -- this is Murray. The big introductory advertising, which is not huge, but the print campaign and initial point of sale and all that, which compares to nothing in the year ago period, is heavily skewed towards the introduction, although there is some sustaining advertising throughout the year but not to the same level. And the menthol report, it depends. We're going to work with the FDA any way they want us to on this issue, and so it depends on them. If they come back to us and they ask for support, we're going to support."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Got it. Thank you.",5,"Okay. Got it. Thank you."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Nik Modi with UBS.",12,"Your next question comes from the line of Nik Modi with UBS."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Just sorry, hopped on a little late, but just 2 quick questions and apologies if they've been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about a trade de-load, actually. So, just wa",116,"Just sorry, hopped on a little late, but just 2 quick questions and apologies if they've been asked already. Just on the trade load, I know 1 of your competitors was talking about that and another 1 was talking about a trade de-load, actually. So, just wanted to get your perspective on if there was any of that in the quarter. Then the second question is I noticed in one of your tables that the menthol share gains were actually flat for Newport. I'm just curious on your thoughts around that. Is that timing of shipments from some of your competitors or promotions you had from a year ago? Any perspective on that would be helpful."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Let me talk a little bit about the inventory patterns. Yes, industry inventory is built in last year's first quarter, and they built in this year's first quarter. It's just that this year's first quarter didn't build as much as last year. So, when you try",73,"Let me talk a little bit about the inventory patterns. Yes, industry inventory is built in last year's first quarter, and they built in this year's first quarter. It's just that this year's first quarter didn't build as much as last year. So, when you try and adjust those 2 factors out, it just didn't build as much in the first quarter. So that only impacted our comparison by about 1/2 a percent."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Fair enough.",3,"Okay. Fair enough."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","But just to be clear, Nik, inventory didn't help us this quarter. It hurt us.",15,"But just to be clear, Nik, inventory didn't help us this quarter. It hurt us."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Right. Yes, yes.",3,"Right. Yes, yes."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","The other couple of points there, too, the industry-wide extra shipping day, we adjusted our numbers. We didn't try to adjust the numbers for the rest of the industry. So, we believe that the industry decline was probably a little bit worse than 3.4%. But",86,"The other couple of points there, too, the industry-wide extra shipping day, we adjusted our numbers. We didn't try to adjust the numbers for the rest of the industry. So, we believe that the industry decline was probably a little bit worse than 3.4%. But we're only willing to sort of -- kind of a clear, transparent adjustment for our own shipments. As it relates to market share, I'm not sure where you're getting the numbers. Newport Non-Menthol gained share versus year ago, it was up"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","I'm talking about Newport Menthol, Murray. Sorry. I was just looking in the table. Menthol, the category gained share, but it looks like Newport share -- Newport Menthol share was flat like the...",34,"I'm talking about Newport Menthol, Murray. Sorry. I was just looking in the table. Menthol, the category gained share, but it looks like Newport share -- Newport Menthol share was flat like the..."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Share of the Menthol segment?",5,"Share of the Menthol segment?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Yes, yes, yes.",3,"Yes, yes, yes."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Yes, it is -- that is correct, although Newport Menthol gained share as a result of the category gaining share.",20,"Yes, it is -- that is correct, although Newport Menthol gained share as a result of the category gaining share."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Yes, and I was just curious if there was any timing issues there. I'm just trying to get an understanding of what's behind",23,"Yes, and I was just curious if there was any timing issues there. I'm just trying to get an understanding of what's behind"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Nik, there was also was some competitive activity in the Menthol stakes in the first quarter, as I am sure you are aware. That might have had a little bit of a dampening effect.",34,"Nik, there was also was some competitive activity in the Menthol stakes in the first quarter, as I am sure you are aware. That might have had a little bit of a dampening effect."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, it's more of a shipment issue.",7,"Okay, it's more of a shipment issue."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","I think -- we don't use scanned data because of where we sell. So the best we do is using EXCEL data, which ships from wholesale to retail. That counts pipeline load, and there were a lot of competitive menthol products that went into distribution into th",49,"I think -- we don't use scanned data because of where we sell. So the best we do is using EXCEL data, which ships from wholesale to retail. That counts pipeline load, and there were a lot of competitive menthol products that went into distribution into the first quarter."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, got you. Thank you.",5,"Okay, got you. Thank you."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America.",14,"Your next question comes from the line of Christine Farkas with Bank of America."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Thank you very much. David, you were helpful with the SG&A breakdown. I appreciate that. A couple of questions. Just on the shipping days in the first quarter, does that reverse at some point in the year? Will we see an additional day in the second quarte",47,"Thank you very much. David, you were helpful with the SG&A breakdown. I appreciate that. A couple of questions. Just on the shipping days in the first quarter, does that reverse at some point in the year? Will we see an additional day in the second quarter?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, it will reverse in the fourth quarter. So the total year will have the same number of shipping days this year as last year, so in the fourth quarter, it will reverse.",33,"No, it will reverse in the fourth quarter. So the total year will have the same number of shipping days this year as last year, so in the fourth quarter, it will reverse."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's helpful. And then, this may be a bit of a stretch, but looking at the momentum of the menthol share gains in the first quarter. I'm just wondering your perspective with respect to consumer views of the category, are they -- would you say they",86,"Okay. That's helpful. And then, this may be a bit of a stretch, but looking at the momentum of the menthol share gains in the first quarter. I'm just wondering your perspective with respect to consumer views of the category, are they -- would you say they are aware of the discussions around potential bans? Has something been heightened? How far do these concerns or this attention really reach down to the consumer level or is there just none of that, of course, in the numbers?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I'm speculating like you are. But we're out in front of consumers. We do focus groups on other top topic. I hear none of that. I dont think there is general awareness in the consumer population of smokers that this is even going on.",45,"Look, I'm speculating like you are. But we're out in front of consumers. We do focus groups on other top topic. I hear none of that. I dont think there is general awareness in the consumer population of smokers that this is even going on."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","So should the menthol share of the category that we did see step up nicely sequentially and, of course, year-over-year, would you say again back to your pipeline fill comments, or is really the consumer demand and growing appeal of the flavor?",42,"So should the menthol share of the category that we did see step up nicely sequentially and, of course, year-over-year, would you say again back to your pipeline fill comments, or is really the consumer demand and growing appeal of the flavor?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","I would say for us, it's just organic growth business as usual. And I would say that -- I would agree with you that there was a number of SKUs that were launched, and that probably affected it to some extent that you just have to fill all the shelves arou",79,"I would say for us, it's just organic growth business as usual. And I would say that -- I would agree with you that there was a number of SKUs that were launched, and that probably affected it to some extent that you just have to fill all the shelves around the country in 250,000, 300,000 stores. But I think at the heart of your question is, do I think the consumers were hoarding it anyway? No, I dont."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay, great. And then last question, just with respect to a segment you're not in and that's Smokeless, we understand there maybe some shelf resets whereby greater space is allocated to Smokeless, I am wondering, if you've seen that at retail, if it impac",59,"Okay, great. And then last question, just with respect to a segment you're not in and that's Smokeless, we understand there maybe some shelf resets whereby greater space is allocated to Smokeless, I am wondering, if you've seen that at retail, if it impacts your shelf space, certainly not your volumes, but just wondering what you're seeing at retail."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, all of this, we go through an annual reset ourselves based on our contracts, and all of the contracts are written that -- both for us and for our competitors, some more aggressive than us, that we get share thats basically in line with our shelf",112,"Well, all of this, we go through an annual reset ourselves based on our contracts, and all of the contracts are written that -- both for us and for our competitors, some more aggressive than us, that we get share thats basically in line with our shelf space, and we continue to gain share. And we have a very focused and narrow product line. So we continue to discuss this. I've been in a number of talk to talks [ph] with customers, but we haven't had a negative impact. It's more of a challenge of are growing fast enough for what we deserve. And thats the discussion I have with key retailers."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's great. Thanks, Murray.",5,"Okay. That's great. Thanks, Murray."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Murray, did you give the 8% Newport volume growth number? Did you give the number excluding what it would have been without Newport Red?",24,"Murray, did you give the 8% Newport volume growth number? Did you give the number excluding what it would have been without Newport Red?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","No, I do not. And I don't think we break it out by SKU.",14,"No, I do not. And I don't think we break it out by SKU."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And in the markets where Newport Red is doing particularly well, are you seeing competitors respond at all in terms of promotion on their non-menthol brands?",27,"Okay. And in the markets where Newport Red is doing particularly well, are you seeing competitors respond at all in terms of promotion on their non-menthol brands?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Again, just to put it in perspective, they're already at those prices with competitive brands. So, we're in no -- and just to pick an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the sam",58,"Again, just to put it in perspective, they're already at those prices with competitive brands. So, we're in no -- and just to pick an example, if you look at sort of the industry leader, they have a version of their product that are priced exactly the same already. So, no, we have haven't seen any major swings."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just wanted to ask, we're hearing a lot about Philip Morris changing some of the promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters, or how would that play",49,"Okay. And then just wanted to ask, we're hearing a lot about Philip Morris changing some of the promotional programs of the retailers recently. Do you expect that to competitively impact your brands at all in the next few quarters, or how would that play out and impact you?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Good question. It really depends on participation. Were watching it very carefully. There is a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leader that feels like margins have",209,"Good question. It really depends on participation. Were watching it very carefully. There is a number of scenarios. In general, I think the most important thing you need to know is that this is a push by the industry leader that feels like margins have been expanding at the retail level at the expense of sort of the competitive position relative to the amount of money that they spend on buy downs and the industry spends on buy downs and whether it's getting passed through and increasing their productivity. So, we have in our contract a fair and equitable clause, so, if margins come down for them, they come down for us. So, presumably, that would be a favorable impact. The other important thing to know is, we saw a lot of volume, which are not markets where they are even under contract. So, presumably, it's no effect there. There are some modest areas where they may get a little more competitive. And if we need to, we'll adjust. But there's a whole lot of other areas where you would think we would benefit, especially depending on the participation level. So, we'll see how it plays out, but it's a different answer if there's 10% participation or 90% participation."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","All right. Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that to be mostly a sort of procedural thing without much content. But I was wondering, as we look longer term when FDA would make a final ass",85,"All right. Okay. And then just lastly on FDA, it sounds like you -- if there's an update in mid-June, you expect that to be mostly a sort of procedural thing without much content. But I was wondering, as we look longer term when FDA would make a final assessment, where do you think they would disagree with some of the more negative conclusions or recommendations from TPSAC or I guess how they would reconcile some of the concerns that TPSAC raised in their report?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Look, I believe -- I think the industry believes that Dr. Deyton [Lawrence Deyton] and Commissioner Hamburg [Margaret Hamburg] will make sure that the FDA does their -- follows their charge which is to follow the science. If they follow -- I don't think t",160,"Look, I believe -- I think the industry believes that Dr. Deyton [Lawrence Deyton] and Commissioner Hamburg [Margaret Hamburg] will make sure that the FDA does their -- follows their charge which is to follow the science. If they follow -- I don't think they're ever -- they don't have an obligation to respond to the TPSAC report. They have an obligation to evaluate this issue, to follow the science and if they follow the science, we believe it strongly comes to the conclusion that there is no disproportionate harm from a menthol cigarette versus a non-menthol cigarette. They also have to deal with the issue that was really not even dealt with at all by the TPSAC report which is countervailing effects like black market and unemployment and taxes and smuggling and youth access. And we think when you combine that with it, they'll come to the right conclusion. So, hopefully, the worst is behind us on this issue."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Thank you.",3,"Okay. Thank you."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivien Azer with Citigroup.",12,"Your next question comes from the line of Vivien Azer with Citigroup."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Not to take too much away from the Analyst Day presentation, but I was wondering if you could offer a little bit of color around the demographics of the Newport share gains, either for the total franchise or Menthol versus Non-Menthol. In other words, of",70,"Not to take too much away from the Analyst Day presentation, but I was wondering if you could offer a little bit of color around the demographics of the Newport share gains, either for the total franchise or Menthol versus Non-Menthol. In other words, of the incremental share that you are gaining, is it coming disproportionately from adult smokers under 30, or is it well balanced, anything along those lines?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","To do that question justice, because it's a very important question, I have to answer it next week at the Investor Conference because I am going to go into great detail of how we believe the core Newport business performs and where it comes from and all t",91,"To do that question justice, because it's a very important question, I have to answer it next week at the Investor Conference because I am going to go into great detail of how we believe the core Newport business performs and where it comes from and all those good things. And we'll deal with demographics and sort of the strengths of the brand. And then we'll obviously deal with opportunities. But I don't want to give that 1 a quick answer. I have like 15 slides to answer that 1 well."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","That's fair enough. I'll be looking forward to hearing that then. Separately, just in terms of new product launches and how long the payback takes, just can you offer some color just in terms of your experience on how long generally it takes to generate e",58,"That's fair enough. I'll be looking forward to hearing that then. Separately, just in terms of new product launches and how long the payback takes, just can you offer some color just in terms of your experience on how long generally it takes to generate enough trials that you can start pulling back promo on new products?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now out of the shoot. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money, and it's almost completely incremental. So, it's",187,"Well, let me say 2 things. We're making money on Newport Non-Menthol right now, right now out of the shoot. We are not deficit spending. It's not the same margin as Newport Menthol, but we're making money, and it's almost completely incremental. So, it's helping us. The answer on when you pull back is different than a lot of other categories in my experience. And basically, in the old days, even in this category, you could do broad-scale television advertising and things like that. You had a lot more tools at your disposal to build trial. And right now, we're very limited, right? The tools that are left with us are price, a little bit of direct mail, a little bit of print advertising, and the brand continues to build. So, to me, I am going to watch it grow for a while, and then we'll make our decisions appropriately. And we're only out a couple of months at a time ahead of ourselves on the promotion plan, but our goal is, clearly, on this brand is to come off the introductory trial prices when it's appropriate."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Terrific. Thanks so much. I look forward to seeing you next week.",12,"Terrific. Thanks so much. I look forward to seeing you next week."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Ann Gurkin with Davenport.",12,"Your next question comes from the line of Ann Gurkin with Davenport."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Was wondering if you could comment -- in the quarter, you highlighted the amount of money roughly you spent towards brand building. Is that a level we should continue to see through the year or does it accelerate? Can you help me understand that? And then",67,"Was wondering if you could comment -- in the quarter, you highlighted the amount of money roughly you spent towards brand building. Is that a level we should continue to see through the year or does it accelerate? Can you help me understand that? And then wrapped into that, should we see Lorillard become more aggressive with innovations or product launches as we move through the year?"
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","So, the first question was, do we expect it to accelerate? No. I would say, it will stabilize to decelerate for the consumer portion of it, right? That's what you would have seen in the SG&A. The promotional spending is built into the pricing. Do we expec",131,"So, the first question was, do we expect it to accelerate? No. I would say, it will stabilize to decelerate for the consumer portion of it, right? That's what you would have seen in the SG&A. The promotional spending is built into the pricing. Do we expect a higher level of innovation? You'll see that in the Investor Day presentation, but Newports success comes from focus. So, we're never going to be the company that's launching a zillion new products. That's not our style. We don't have the shelf space for that. It will be very, very disciplined and methodical as we go forward when we see we have an appropriate new product. The good news is we got one now, and it's already in market, and it's called Newport Non-Menthol."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Analysts","Great. That helps. Thanks so much.",6,"Great. That helps. Thanks so much."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","I would like to turn the call back over to Mr. Kessler for any concluding remarks.",16,"I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Executives","We look forward to seeing everybody next week. Hopefully we've whet your appetite. The brands continue to perform beautifully. The company continues to outperform on almost every financial measure that matters. Please join us on May 4 at the Mandarin Hote",62,"We look forward to seeing everybody next week. Hopefully we've whet your appetite. The brands continue to perform beautifully. The company continues to outperform on almost every financial measure that matters. Please join us on May 4 at the Mandarin Hotel in New York City, and we will talk about the business in more detail. Thank you for your interest in Lorillard."
4180255,129745129,117644,"Lorillard, Inc., Q1 2011 Earnings Call, Apr 26, 2011",2011-04-26,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now d",41,"This concludes the Lorillard Incorporated First Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (800) 642-1687 or (706) 645-9291. The conference ID number for the replay is 59461547. Thank you for participating. You may now disconnect."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. My name is Sarah and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for rep",67,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. My name is Sarah and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, Sir."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorrilard Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorrilard Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Offi",128,"Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorrilard Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorrilard Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. 
By now, you should have received a copy of our second quarter 2011 earnings release. It can be found on the company's website, www.lorrilard.com, under News Releases. 
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties as described in the company's earnings release and in other filings with the SEC. 
I'd now like to turn the call over to Murray Kessler."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. In the face of a challenging macroeconomic environment, I'm extremely pleased to report another very strong quarter for Lorillard. The company's second quarter results continue to demonstrate the fundamental str",1147,"Thank you, Bob, and good morning, everyone. In the face of a challenging macroeconomic environment, I'm extremely pleased to report another very strong quarter for Lorillard. The company's second quarter results continue to demonstrate the fundamental strength of our brands and our organization. 
Let's start with a review of the key fundamentals on the business and how we are proceeding to responsibly bring Newport Pleasure to all adult smokers. First, total domestic Newport volume increased 9.6% versus year ago in Q2 with Newport Menthol domestic volume up 1% for the quarter. This includes what we believe is a relatively minor cannibalization effect from Newport Non-Menthol estimated as a negative 1% drag on the core menthol business. And this is also encouraging as we reduced Newport Menthol promotion spending in the quarter versus year ago. 
Second and driving the total Newport increase was a strong performance by Newport Non-Menthol. Newport Non-Menthol sales are way above our expectations for this point in the launch, crossing the 1% market share level vote by quarter end. Importantly, the second wave of our source of volume business study conducted in April continues to indicate that the branch volume is 90% incremental to the Newport franchise. That's 2/3 of purchasers claiming Newport Menthol as their usual brand. That positive purchase intent is expressed by virtually all purchasers, 96% and that the primary reason for purchase is the product's taste. This gives us confidence that long-term we can continue to migrate the brand's retail price in line with core Newport Menthol. 
Third, Maverick, our discount brand, continued to make strong gains, increasing 21% versus year ago in the quarter. 
Fourth, we made progress in the quarter with our selectively increased support on Newport Menthol in non-core markets. Four additional markets were added late in the quarter, as we mentioned at our investor conference, and our original test markets continued to experience double-digit volume growth. 
That all added to a substantial increase in Lorrilard domestic volume of 10.4% or almost 1 billion sticks more than we shipped a year ago. Even after adjusting for heightened wholesale inventories in advance of our at July first price increase, total Lorillard domestic revenue increased 8.1% a year ago. This is especially noteworthy, given the context of high unemployment, high gasoline prices and declining industry sale. We remain highly confident in our recently announced strategic plan, which places its primary focus on organic growth and outperformance relative to our peers in the U.S. cigarette industry. As always, when our brands outperforms the category, we gain market share. And this was the case in Q2.
At retail, where wholesale inventory fluctuations do not impact the numbers, industry volume was estimated to decline just under 4%. Therefore, according to our proprietary EXCEL database, which measures the shipments from wholesale to retail, total Lorillard market share increased to 14.2% or a 140 basis point increase over the second quarter last year.  
Likewise, total Newport share increased 109 basis points to 12% in Q2. Basically, we held onto the sizable gains achieved under the first quarter so we gained share versus year ago on total Lorillard, on total Lorrilard premium, on total Lorrilard discount, on total Newport including Newport Non-Menthol, on core Newport Menthol and on Maverick. This was not just a case of a successful new product. Share gains were experienced broadly across our portfolio. 
Strong organic volume growth combined with higher prices net of promotion translated to an 11.3% increase in net sales and a 9.4% operating income increase. This combined with the accretive impact of the company's share repurchase plan resulted in a 18% year-over-year quarterly gain in earnings per share. EPS finished at $2.05 for the quarter. Obviously, the quality of the earnings for the quarter was high.  At the six-month mark, EPS for Lorillard is up 16.5% versus year ago, making the company one of the top performers in the CPG industry during these difficult economic times. 
It also demonstrates that we are not just focused on growth but as always been the case, we are focused on profitable growth. While we don't necessarily expect this phase of growth to continue in the second half, I think you'd agree we're having a darn good year, especially when you add the dividend yield. In fact, relative to our tobacco peers and the broader group of consumer products in general, we are pleased we can deliver outsized top line growth leveraged through our income statement and showcase the strength of our business despite a difficult macro consumer environment. 
Let's move on now to the regulatory environment as it relates to menthol. We made an important organizationally move during the quarter, which will help shape our relationship with the FDA. Dr. Neil Wilcox joined us as our Senior Vice President of Regulatory Compliance. Neil came recently from an important position from the FDA. He is very experienced in agency process and policy. And we expect him to provide strong guidance and governance on the regulatory issues that face us. 
Now let's turn to the regulatory events in the quarter and their impact on the company. Although some headlines around several FDA announcements created intraquarter volatility on our stock price, we see the FDA review process moving as expected. Not faster, not slower. The FDA is conducting a preliminary independent peer-reviewed scientific assessment separate from TPSAC as they promised they would. We see that as a positive because, A, we believe that the TPSAC panel was biased, which is obviously why we are engaged in litigation on this topic. B, initial FDA white papers, while they still suffer from some of the same flaws that plague the TPSAC report, were more balanced than TPSAC. And, C, the peer review process is normal for FDA on this type of issue and is an appropriate first step. 
Of course, our current view depends on the quality of the peer review process and the objectivity of the reviewers selected. We believe a thorough objective and scientific process is critical. And overall, we haven't changed our opinion that this will be a very long process and that the overwhelming body of scientific evidence does not justify increased regulation on menthol cigarettes relative to non-menthol c6. 
Accordingly, we continue to focus on our business and believe the best reason to invest in Lorrilard are strong and growing dividend, balance sheet flexibility that is being being used to lower our cost of capital via increased leverage and share repurchases and a strategic plan that clearly identifies growth opportunities within the domestic cigarette market. We remain confident in our ability to deliver a double-digit shareholder return as measured by EPS growth and the dividend yield. And we remain confident in our ability to grow at a level that exceeds our domestic tobacco company peers. 
With that, I will turn the call over to David Taylor, our Chief Financial Officer."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers and then we'll open up the line for questions. Net sales for the second quarter of 2011 increased 11.3% to $1.7 billion as compared to our second quarter of 2010, driven by the",954,"Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers and then we'll open up the line for questions. 
Net sales for the second quarter of 2011 increased 11.3% to $1.7 billion as compared to our second quarter of 2010, driven by the 10.4% increase in domestic shipment volumes. 
Our average wholesale selling prices in the quarter were higher across the board but were partially offset by other factors. First, unit volumes for Newport were up 9.6% while Maverick volumes were up 21.2%. As we reported for the last several quarters, the continuing increase in Maverick unit volumes and the resulting shift in our mix of products sold has the effect of reducing the overall revenues per unit sold. 
Second, shipments of Newport Non-Menthol, which was launched in the fourth quarter last year, was also a significant factor in the year-over-year comparison. Newport Non-Menthol units carrying a promotional price in this year's quarter and therefore added to this mix effect on the calculation of net price per unit, if that's calculated on a consolidated basis. This year-over-year effect is not a surprise nor does it concern us. It does not reflect the deterioration of the price point of our brand. In fact, when I look at the calculations of price realization before excise taxes for Newport Menthol only, they work out to a healthy 5.7% increase for the second quarter. The other factors bring the total down. But as we've said before, this is incremental business for us. It is profitable on its own and it strengthens our portfolio in the long term. 
Fluctuations in the wholesale inventory levels in this year and last year had an effect on our second quarter volume comparison just like some others in the industry. After adjusting for the effect of the decline in wholesale inventories last year and a build this year, we estimate that our domestic wholesale shipments would've increased 8.1% for the quarter rather than a 10.4% as reported. 
These build and wholesale inventories will reverse itself in the outcoming quarter and will have the obvious effect of dampening our third quarter comparisons. 
Notably, it will also further impact reported net pricing and profitability in that quarter because of the consumer promotion, much of which follow retail movements, not wholesale movements. 
I mentioned this I know many of you develop expectations of financial performance on a quarter-by-quarter basis, in part by referring to last year. As you may recall, we reported strong unit volume increases in last year's third quarter, some of which was inflated due to an inventory build in that quarter. The opposite is likely to be true this year. But we believe the underlying trends of our portfolio will continue to be strong. 
Gross profit in the second quarter 2011 increased by $57 million to $599 million. 
Cost of goods sold in the 2011 quarter reflects increases over last year in certain costs including increased FDA user fees.  The amounts due under the state settlement agreement and the tobacco grower assessment increased $45 million compared to last year's second quarter. 
Selling, general and administrative costs increased $15 million from last or second quarter, primarily due to legal fees and expenses associated with increased litigation activities during the quarter just like it did in our first quarter. 
Other increases in SG&A included marketing and other costs associated with our strategic initiatives, including the continuing brand building costs in support of Newport Non-Menthol. 
Second quarter operating income increased 9.4% to $487 million from $445 million last year's second quarter. Operating income is up 9.8% for the first half of 2011. 
Fully diluted earnings per share for the second quarter increased 18.5% from last year's second quarter to $2.05 per share. Those results reflect the strong performance we've already discussed but also the effect of a lower average share count this year. The lower share count is compared to the year ago quarter added $0.14 per share to EPS in this year's second quarter. 
During the quarter through June 30, we repurchased approximately 4.5 million shares at a cost of $494 million under the current share repurchase authorization. The board increased this repurchase authorization from $1 billion to $1.4 billion in May, further demonstrating our intent to return cash to shareholders in both share dividend and share repurchases. As of June 30, we had $241 million remaining on that program. 
A quick comment about the voluntary recall of certain Newport Non-Menthol product last week. As we announced, the company became aware that there was a possibility that some of our products could contain pieces of plastic. We did not find any such plastic in any of our products but could not rule out the theoretical possibility. Out of abundance of caution, we removed all of the products that could've been affected from the supply chain and voluntarily implemented a recall of any of the products that could've reached retail shelves. 
We did not experience any significant stock-outs of Newport Non-Menthol in retail and we do not believe that the one-day interruption of supply had any effect on the positive momentum of the brand.  And the cost of the recall is expected to be insignificant. 
We are pleased with the company's performance this far for this quarter and for 2011 so far. While we expect this to be another outstanding year for Lorillard, I think we can agree that one should not expect EPS growth to continue to approach 20% on a regular and ongoing basis. We do believe, however, that we can continue to outperform the industry, build on our record of success and deliver value for our shareholders over the long term.
With that, we'd like to open the line for questions. Sarah?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] The first question comes from the line of Judy Hong with Goldman Sachs.",15,"[Operator Instructions] The first question comes from the line of Judy Hong with Goldman Sachs."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Murray, can you just give us a little bit more color just in terms of your promotional activity in the second quarter? I understand that year-over-year pricing is impacted by the mix issue. But just kind of looking at -- sequentially it looks like your ne",90,"Murray, can you just give us a little bit more color just in terms of your promotional activity in the second quarter? I understand that year-over-year pricing is impacted by the mix issue. But just kind of looking at -- sequentially it looks like your net revenue per unit was also down a little bit. So I'm just wondering if anything has changed in terms of the promotional activity in Q2 versus Q1 and then whether it was again the mix situation that has impacted the price per unit number?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","For us and the way we saw the industry, we saw this as a normal quarter. We had -- part of the pricing equation, you are correct, net pricing lift plus promotion. Just like the first quarter Newport Menthol promotions were down, reduced versus year ago at",104,"For us and the way we saw the industry, we saw this as a normal quarter. We had -- part of the pricing equation, you are correct, net pricing lift plus promotion. Just like the first quarter Newport Menthol promotions were down, reduced versus year ago at about the same level, nothing unusual, 1% volume, 5.7% pricing realization on Newport Menthol. You got a limited 10% operating income increase, which almost exclusively comes from Newport Menthol as the other brands carry much lower margins. So, no, there was nothing unusual. There is nothing to read into on pricing here. It continues to be robust."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then  just on the Newport Red, just the sustainability of the share performance, especially as the price points on that brands go up, how are you feeling about the sustainability?",32,"Okay. And then  just on the Newport Red, just the sustainability of the share performance, especially as the price points on that brands go up, how are you feeling about the sustainability?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","We feel great about it right now, but we'll see, right? We just took the price increase and it was pretty robust. It was an 11% price increase net-net on Newport Red. But having said that, our competitors went up as well. The goal is to have a pricing adv",148,"We feel great about it right now, but we'll see, right? We just took the price increase and it was pretty robust. It was an 11% price increase net-net on Newport Red. But having said that, our competitors went up as well. The goal is to have a pricing advantage in the beginning, kind of where other introductory brands -- brand introductory prices have been to establish and establish on the get trial, and that's working beautifully. So let's call it in the beginning it was a little over $1 discount or around $1 dollar discount. And with this increase is about $0.75, but our competitors went up. So instead of being $1 advantage relative to full price brands, it's going to be around $0.80, $0.85, which is still very attractive. So we think the momentum will continue, but we'll see and we'll adjust if we need to."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then finally just on the FDA review process, Murray, is there anything that gives you more comfort or discomfort just around in terms of who they might be picking in terms of the external peers who Piers will be looking at the menthol issue?",46,"Okay. And then finally just on the FDA review process, Murray, is there anything that gives you more comfort or discomfort just around in terms of who they might be picking in terms of the external peers who Piers will be looking at the menthol issue?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, but I don't have any insight to who they pick so far. I think they're clearly being cautious to do this in peer review and be transparent based on the challenges they've gotten from the industry on the TPSAC process. Hopefully, they'll pick a real tho",67,"No, but I don't have any insight to who they pick so far. I think they're clearly being cautious to do this in peer review and be transparent based on the challenges they've gotten from the industry on the TPSAC process. Hopefully, they'll pick a real thorough or pick a good panel that will do a thorough process. And if they do, we're confident with the results."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivien Azer with Citigroup.",12,"Your next question comes from the line of Vivien Azer with Citigroup."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","My first question has to do with Newport Menthol. It's really encouraging that you've posted 1% volume growth. I was wondering if you can offer some color on how that broke down in your core and non-core markets.",38,"My first question has to do with Newport Menthol. It's really encouraging that you've posted 1% volume growth. I was wondering if you can offer some color on how that broke down in your core and non-core markets."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","We do so much more volume in our current markets than our non-core markets. Our non-core markets, we break it down into more detail. But the growth is in those non-core markets because that's where we have added some promotional support to get back in lin",86,"We do so much more volume in our current markets than our non-core markets. Our non-core markets, we break it down into more detail. But the growth is in those non-core markets because that's where we have added some promotional support to get back in line with competition. And it continues obviously. The heart of our businesses is full-flavored Newport Menthol business, so it's also driven by that. It's a little bit but a lot of growth out west doesn't move the needle very far."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","In terms of the four new markets that you guys are adding, where does that leave us in terms of the total program in addressing some of your price issues?",30,"In terms of the four new markets that you guys are adding, where does that leave us in terms of the total program in addressing some of your price issues?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","It's more of you saying before we added, we were up to eight markets. I think those eight markets -- you probably have a number of states. But we're not looking at that way. We're looking at sort of the percentage of volume covered. And it's starting to g",66,"It's more of you saying before we added, we were up to eight markets. I think those eight markets -- you probably have a number of states. But we're not looking at that way. We're looking at sort of the percentage of volume covered. And it's starting to get to the majority of the volume that is actually menthol volume that's sold in those areas."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Our next question comes from Nik Modi with UBS.",9,"Our next question comes from Nik Modi with UBS."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Just quick question. Obviously, good momentum on core Newport. But when I look in the back, you have a table. It looks like  the share has been flat of this menthol segment in the first quarter and the second half. Just curious kind of what do you think i",79,"Just quick question. Obviously, good momentum on core Newport. But when I look in the back, you have a table. It looks like  the share has been flat of this menthol segment in the first quarter and the second half. Just curious kind of what do you think is going on there, you're just seeing more promotional activity by competitors or is it Newport Non-Menthol getting a lot of the research allocations, if you could just provide some thoughts."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","You want to know how Newport share within menthol is performing?",11,"You want to know how Newport share within menthol is performing?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Yes. It looks like in this table in the back of the release, it says Newport share menthol segment. It looks like it's flat, it's been flat for the first quarter and the second quarter, unless I'm reading it wrong. I don't think I am.",45,"Yes. It looks like in this table in the back of the release, it says Newport share menthol segment. It looks like it's flat, it's been flat for the first quarter and the second quarter, unless I'm reading it wrong. I don't think I am."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, I think we slightly -- it's basically flat. But we gained shares sequentially in the first quarter to the second quarter on Newport. And the segment itself gained shares. I think we were up 20 basis points from the first quarter to the second quarte",208,"Well, I think we slightly -- it's basically flat. But we gained shares sequentially in the first quarter to the second quarter on Newport. And the segment itself gained shares. I think we were up 20 basis points from the first quarter to the second quarter, Nick, and flat versus a year ago. But no, it's progressing well. I mean, my color is that Newport Menthol Full Flavored doesn't really go -- which is the core of our business is insulated relative to the rest of the brands. It doesn't go head-to-head with all these new products. The bulk of them obviously affects that share of total menthol and a little bit of stability. But the reality is we continue to gain share. We gained share in full-flavored menthol. Again, Newport, if you remember from the investor conference, had that north of 70% market share, and we gained share in that one more time. And the competitors are going against each other with their goal products. So no, I know it's your guys' job to look at it. But it was just a solid quarter across the board. We gained share everywhere. Margins expanded on our core business. We grew volume. It was a heck of a quarter."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from David Adelman with Morgan Stanley.",10,"Your next question comes from David Adelman with Morgan Stanley."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Did you make any change in your reserve for the Scott Case during the quarter?",15,"Did you make any change in your reserve for the Scott Case during the quarter?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, we didn't, David. That thing was fully reserved and it continues that way.",14,"No, we didn't, David. That thing was fully reserved and it continues that way."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","You don't think that you're over-reserved?",7,"You don't think that you're over-reserved?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, actually we don't. I know there were some incremental increases that we kept up with. But we're fully reserved on what we think we have to pay.",28,"No, actually we don't. I know there were some incremental increases that we kept up with. But we're fully reserved on what we think we have to pay."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, both you and Murray alluded to the fact that performance at this rate or the GAAP in our operating performance versus peers is unlikely to persist. Is that characterization out of conservatism? Is it because of the fact that you're coming",67,"Okay. And then, both you and Murray alluded to the fact that performance at this rate or the GAAP in our operating performance versus peers is unlikely to persist. Is that characterization out of conservatism? Is it because of the fact that you're coming into a quarter where you have a bit of a trade load? Is there something else that you see in the competitive marketplace?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Just the trade load. We look at the long-term algorithm and I continue to believe that the basic premise of the Newport model, David, is what I said at the investor conference. We want to outperform by 4 or 5 points on volume performance and capture the p",138,"Just the trade load. We look at the long-term algorithm and I continue to believe that the basic premise of the Newport model, David, is what I said at the investor conference. We want to outperform by 4 or 5 points on volume performance and capture the pricing flexibility in the category, and that gives us outperformance in our financial. We're just running at 18% EPS growth right now. We have the benefit -- which was on plan. But that wholesale inventory has increased towards the end of the quarter. They've already started to drop off in the third quarter. And last year you had an increase at the end of the quarter, which may or may not happen. I have no idea. We don't control the trade. Net-net, I'm just saying don't straight-line the numbers, that's all."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Bonnie Herzog [ph] with Wells Fargo.",14,"Your next question comes from the line of Bonnie Herzog [ph] with Wells Fargo."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Just a quick question on Maverick. Can you give us a bit more color on your strategy with the brand volume. It's still certainly very strong, but it does seem to be slowing a bit. And also you did lead the industry price increase on Newport a few weeks ag",94,"Just a quick question on Maverick. Can you give us a bit more color on your strategy with the brand volume. It's still certainly very strong, but it does seem to be slowing a bit. And also you did lead the industry price increase on Newport a few weeks ago but you didn't initially take pricing on Maverick. But then you took pricing up on the brand about a week later. So I'm curious to hear why you held Maverick pricing for a week and then causes you to increase it on the brand?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","The reason we waited on Maverick is -- you have to understand the complexity, Bonnie, of the cigarette contracts in there. Unfortunately, we're number three. We are sort of bound by some of the influence of our competitors. And Maverick to take a price in",125,"The reason we waited on Maverick is -- you have to understand the complexity, Bonnie, of the cigarette contracts in there. Unfortunately, we're number three. We are sort of bound by some of the influence of our competitors. And Maverick to take a price increase, unless one of the other major competitors have written into their contract that they have to be the lowest price in the store, if they don't go up, if we take the price, we don't get benefit for. I have to detail and lay it out for you. But we need to see the market to see that would there be any benefit to Lorillard to go ahead and change. So we're just a follower on Maverick, not the leader."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","A leader on the other clearly. You led second time in a row.",13,"A leader on the other clearly. You led second time in a row."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I think Maverick goes head-to-head with competition. I think that Newport, we have our own strategy pricing that is promotional pricing relative to competition. It's not an offensive weapon for us. We take pricing when we think it's right for our business",43,"I think Maverick goes head-to-head with competition. I think that Newport, we have our own strategy pricing that is promotional pricing relative to competition. It's not an offensive weapon for us. We take pricing when we think it's right for our business."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","That makes sense. I just wanted to clarify. Just switching over to West Coast in the promotion, I know you made some comments about an update on your strategy. But I'm curious if you made any tweaks or modifications to your program as you've seen how cons",71,"That makes sense. I just wanted to clarify. Just switching over to West Coast in the promotion, I know you made some comments about an update on your strategy. But I'm curious if you made any tweaks or modifications to your program as you've seen how consumers reacting to the increased promotions behind the brand versus what you are talking to us about at your investor's day a few months ago."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, we've made no tweaks. The four additional markets, we barely can read them. They started up -- I think I said in the investor conference we'd start them in June, and that's when we did start them. So you only have a couple of weeks of data there. The",100,"No, we've made no tweaks. The four additional markets, we barely can read them. They started up -- I think I said in the investor conference we'd start them in June, and that's when we did start them. So you only have a couple of weeks of data there. The other four markets are the same promotional levels they were, they have been for a year now. There was just no big spending there, it was immaterial. It have no effect or no material impact on our margins. Newport margins were -- Menthol margins were up strongly in the quarter."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from Chris Grove with Stifel, Nicholas.",10,"Your next question comes from Chris Grove with Stifel, Nicholas."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I Just wanted to ask you in relation to Newport Non-Menthol, should we just expect that there's more markets to be added? Does this happen slowly over time? Is it reasonable to assume there's more in the second half? I'm just trying to understand the phas",64,"I Just wanted to ask you in relation to Newport Non-Menthol, should we just expect that there's more markets to be added? Does this happen slowly over time? Is it reasonable to assume there's more in the second half? I'm just trying to understand the phasing of the new markets you may add -- new non-core markets you may add for that brand."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","For menthol or non-menthol?",5,"For menthol or non-menthol?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I'm talking menthol, sorry.",5,"I'm talking menthol, sorry."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","We just added the four additional markets. I don't think I've given any color on additional markets. I think we'll see how that goes before we make any adjustments. But I'm also not sure we'll share if we do make adjustments. But again, it's small relativ",74,"We just added the four additional markets. I don't think I've given any color on additional markets. I think we'll see how that goes before we make any adjustments. But I'm also not sure we'll share if we do make adjustments. But again, it's small relative to the total portfolio right now. These are long-term investments. They're not going to have a significant impact on either the financials or the volumes as of yet."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. So you had four and you added four more. I'm just trying to understand the phasing over time. So we should this a long term, maybe more, much to be added in 2012, for example?",36,"Sure. So you had four and you added four more. I'm just trying to understand the phasing over time. So we should this a long term, maybe more, much to be added in 2012, for example?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes. We wanted to be profitable. So we'll keep measuring and adjusting as we go. We've got a couple of factors, right? It's the amount of menthol that's sold in the markets, whether it's substantial enough to justify the investment to pay it out. And so f",155,"Yes. We wanted to be profitable. So we'll keep measuring and adjusting as we go. We've got a couple of factors, right? It's the amount of menthol that's sold in the markets, whether it's substantial enough to justify the investment to pay it out. And so far the four markets I think at the investor conference we were approaching payout. All four of those markets have now exceeded payout and continued to grow at double-digit levels. One more point. I just want to emphasize what I said at the investor conference. We're not investment spending in those markets. We were priced above competition, full priced competition. Newport consumer had to spend $.050 to 41 more to buy a pack of Newport than a pack of one of the other leading brands. And all we did is get competitive and take away that premium. We're not below them, and these are the results that were seeing"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","In relation to that, my other question is that you mentioned the Newport promotional spending was down in the quarter like it was in the second quarter. So just to be clear, you're funding these incremental promotions in non-core markets by reductions els",62,"In relation to that, my other question is that you mentioned the Newport promotional spending was down in the quarter like it was in the second quarter. So just to be clear, you're funding these incremental promotions in non-core markets by reductions elsewhere? Or is it just that they were so small they're not inflating the level of promotion for the brand?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I think you can answer that question no matter -- either way. What you're told is that promotional spending on Newport Menthol was down, including any additional investment in non-core geographies.",31,"I think you can answer that question no matter -- either way. What you're told is that promotional spending on Newport Menthol was down, including any additional investment in non-core geographies."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","My final question is just a bit of a follow-up on the FDA process from here. Are we going to learn who the peer reviewers are? Is there any update you expect before that peer review complete?",38,"My final question is just a bit of a follow-up on the FDA process from here. Are we going to learn who the peer reviewers are? Is there any update you expect before that peer review complete?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I have no inside information on that at all. I don't know whether they have any obligation or not to tell us who the peer reviewers were. What they said the other day was when they completed it, they would share their own analysis and the peer review anal",70,"I have no inside information on that at all. I don't know whether they have any obligation or not to tell us who the peer reviewers were. What they said the other day was when they completed it, they would share their own analysis and the peer review analysis. That's what I heard. I don't personally think we're going to hear anything of substance until the end of the year."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America Merrill Lynch.",16,"Your next question comes from the line of Christine Farkas with Bank of America Merrill Lynch."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","A couple of housekeeping items, I guess if I could. I appreciate the relatively limited guidance with respect to quarter to quarter. I jus want to understand if there are any timing factors, spending or otherwise and also the tax rates for the full year,",58,"A couple of housekeeping items, I guess if I could. I appreciate the relatively limited guidance with respect to quarter to quarter. I jus want to understand if there are any timing factors, spending or otherwise and also the tax rates for the full year, if you could imply perhaps similar to or near 37% for the year?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes. I think the tax rate was lower in the second quarter because we settled some state tax matters, which brought it down for the quarter. It's not an indication of what we think the full year will be. We still think the full year is be in that 37% neigh",51,"Yes. I think the tax rate was lower in the second quarter because we settled some state tax matters, which brought it down for the quarter. It's not an indication of what we think the full year will be. We still think the full year is be in that 37% neighborhood."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. As far as the spending or quarter-to-quarter legal costs, that kind of thing, is there anything in the second half that you would want to call out with respect to one-time factors?",33,"Okay. As far as the spending or quarter-to-quarter legal costs, that kind of thing, is there anything in the second half that you would want to call out with respect to one-time factors?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Not any one-time factors. We've experienced that increase in legal costs is associated with the litigation activities. They've been increasing for quite some time. I don't see any indication that that's going to let up. But predicting that level quarter t",47,"Not any one-time factors. We've experienced that increase in legal costs is associated with the litigation activities. They've been increasing for quite some time. I don't see any indication that that's going to let up. But predicting that level quarter to quarter is a difficult matter."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. Just moving to Puerto Rico, we're seeing volumes down midteens, cycling down midteens. I'm just wondering if there's anything else structurally that's suggesting this continues at that space?",29,"Sure. Just moving to Puerto Rico, we're seeing volumes down midteens, cycling down midteens. I'm just wondering if there's anything else structurally that's suggesting this continues at that space?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, I think if you look at the first half, you'll see the numbers are normal. That's the timing of when a boat shipped. And whether it's shipped like a day after the quarter ended instead of during the quarter, the timing of it was to the advantage of the",63,"No, I think if you look at the first half, you'll see the numbers are normal. That's the timing of when a boat shipped. And whether it's shipped like a day after the quarter ended instead of during the quarter, the timing of it was to the advantage of the first quarter. Look at the 6 months and you'll see nothing has changed."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay, great. And then just finally on the MPM arbitration, I'm wondering if I can get your perspective on how you think it's going with respect to the progress. Certainly there has been discussion of MOU circulating and that kind of thing. Is there any co",58,"Okay, great. And then just finally on the MPM arbitration, I'm wondering if I can get your perspective on how you think it's going with respect to the progress. Certainly there has been discussion of MOU circulating and that kind of thing. Is there any comment you could provide to help us understand how that process is going?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Slowly.",1,"Slowly."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Slowly. So it will take some time, several quarters, years, that kind of thing?",14,"Slowly. So it will take some time, several quarters, years, that kind of thing?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I don't know. It's in arbitration. The MOU got a lot of talk. Things are going back and forth. But From what they hear from our counsel, this is a slow process.",33,"I don't know. It's in arbitration. The MOU got a lot of talk. Things are going back and forth. But From what they hear from our counsel, this is a slow process."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Murray, just going back to Newport Red. Can you just talk about the growth driver there, where the ACV [ph] maybe stand versus Newport Menthol? And is it mostly adding new accounts and shelf space at this point? Is it faster velocity? I'm just trying to g",53,"Murray, just going back to Newport Red. Can you just talk about the growth driver there, where the ACV [ph] maybe stand versus Newport Menthol? And is it mostly adding new accounts and shelf space at this point? Is it faster velocity? I'm just trying to get some breakdown on the growth there?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","There hasn't been any significant change in the distribution since the initial launch, so it's all velocity. It's all trial turning into repeat purchase. We have broadscale distribution. The acceptance of Newport Red has been nationwide. It doesn't necess",115,"There hasn't been any significant change in the distribution since the initial launch, so it's all velocity. It's all trial turning into repeat purchase. We have broadscale distribution. The acceptance of Newport Red has been nationwide. It doesn't necessarily track in the same stores. In fact, it doesn't along with Newport Menthol. And I'm not sure if there's any other color I can give you. It continues to grow week to week. I can't tell you what's been the effect of both price increases because there's been a lot of inventories changing and there's lag in our retail data. But right up until that point, it continued to roar along well above our expectation."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Just on the repurchase. That accelerated quite a bit this quarter. I was wondering if you could just talk about your thoughts about the phase there, why the company maybe hasn't raised more debt at this point. Given where the share price is now, has that",64,"Just on the repurchase. That accelerated quite a bit this quarter. I was wondering if you could just talk about your thoughts about the phase there, why the company maybe hasn't raised more debt at this point. Given where the share price is now, has that changed at all? How do you think about the pace of repurchase, given that it strengthened so much?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Let me try to answer those one at a time. We did purchase more shares and spent more money in the second quarter than we did in the first quarter. I wouldn't really characterize that as a conscious acceleration. It had more to do with conscious decelerati",148,"Let me try to answer those one at a time. We did purchase more shares and spent more money in the second quarter than we did in the first quarter. I wouldn't really characterize that as a conscious acceleration. It had more to do with conscious deceleration in the first quarter because we wanted to sure that there was enough dry powder there toward the end of the first quarter because frankly, if you remember what went on at the end of the first quarter, we didn't know what was going to happen. Second, we know that we have not yet hit our 1.5x target for our leverage. And you do know the state of the credit markets. And so we look at those, evaluate those on a consistent basis and we have some more moves to make there. I can't give you any indication about timing, though."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Just a final question on FDA. Murray, did you say that you think this won't be published in the register until the end of the year? I'm just trying to clarify what exactly you think that publication would accomplish. Is it just a science review? Do you th",80,"Just a final question on FDA. Murray, did you say that you think this won't be published in the register until the end of the year? I'm just trying to clarify what exactly you think that publication would accomplish. Is it just a science review? Do you think there would be any kind of recommendation there or would that come further down the line? Would they discuss the contraband issue at that point or wait until a later date
?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I can tell you what I think but I have no -- and based on what they've said. What they said was at the end of the year they would publish a -- not even a full scientific, a preliminary scientific review in the peer process of their preliminary analysis. A",207,"I can tell you what I think but I have no -- and based on what they've said. What they said was at the end of the year they would publish a -- not even a full scientific, a preliminary scientific review in the peer process of their preliminary analysis. At that point, no, I don't think they're going to be writing rules or anything else. In fact, they said that -- I though they said during the meeting that wouldn't occur at the time, that they would look at that data, decide what was appropriate next step. I see that as just a kick off of the process. Does it dictate more research or analysis to contraband or whatever, that would be a separate process they would have come back with after that. So yes, I just think this is the start of them independently looking at the science themselves, getting some input and then there's some point where they have to finalize that as well because they did say that there will be comments to that I believe as part of it. So anyway, I think it's a long process. I don't think anything has changed here. I am glad they're doing their own review."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Just final, the white papers that have already been published by FDA in some of the journals, how do you read those? Do they seem like an official policy point of view or is that just a preliminary FDA review? How do you think about those?",47,"Okay. Just final, the white papers that have already been published by FDA in some of the journals, how do you read those? Do they seem like an official policy point of view or is that just a preliminary FDA review? How do you think about those?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I think comments on the softer science that suggests there's a lot more research or data. There's one that stands out to me important. I think everybody has concluded on the hard science that there is no justification or difference between a menthol cigar",118,"I think comments on the softer science that suggests there's a lot more research or data. There's one that stands out to me important. I think everybody has concluded on the hard science that there is no justification or difference between a menthol cigarette and a non-menthol cigarettes or any justifications to treat them differently. On the softer issues, there is a recognition I thought across a number of those white papers that there's limited data and weak data and lack of peer review studies, et cetera. We'll see how it plays out. To me, this issue, while it has gotten a lot of press, is clear-cut. The overwhelming body of scientific evidence doesn't justify a difference."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Karen Lamarck [ph] with Federated Investor [ph].",15,"Your next question comes from the line of Karen Lamarck [ph] with Federated Investor [ph]."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","If I understood you correctly, Newport Non-Menthol was about a point drag on Newport Menthol. Are you surprised that in particular in conjunction with the high-repeat intentions for Newport Non-Menthol? And would you expect the cadence to that cannibaliza",43,"If I understood you correctly, Newport Non-Menthol was about a point drag on Newport Menthol. Are you surprised that in particular in conjunction with the high-repeat intentions for Newport Non-Menthol? And would you expect the cadence to that cannibalization to change going forward?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Let's be clear about what we're talking about. We didn't say a point of share. What I was saying is that the volume growth was up 1%. And if there was a Newport Red cannibalization backing into numbers, you could've estimated that it might've been up 2% i",148,"Let's be clear about what we're talking about. We didn't say a point of share. What I was saying is that the volume growth was up 1%. And if there was a Newport Red cannibalization backing into numbers, you could've estimated that it might've been up 2% instead of 1%, which is a much smaller number than if I mistakenly gave you the impression that we were talking about share. So the data and the way I'm getting that is the data that says Newport Red is 90% incremental. And that's as good as an incremental number as you're ever going to find. So if it's one market share that says 0.1 of the market share, of that one, came from us. So 0.1 came from us, and we're a 10-11 share. You can see that as hundreds of share point impact or whatever, so very timely."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And would you expect that relationship to change for any reason going forward?",14,"Okay. And would you expect that relationship to change for any reason going forward?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No.",1,"No."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your last question comes from the line of Bill Reach [ph]  With Crest [ph].",14,"Your last question comes from the line of Bill Reach [ph]  With Crest [ph]."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","As a shareholder in your company, I was just wondering if you consider spitting the stock to decrease the volatility and increase liquidity?",23,"As a shareholder in your company, I was just wondering if you consider spitting the stock to decrease the volatility and increase liquidity?"
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Bill, there's an active debate going both ways on whether a company should split its stocks.  There has been a discussion here about it. We've talked about it. Thus far, we've reached the conclusion that now is not the time to split. Maybe there is a time",51,"Bill, there's an active debate going both ways on whether a company should split its stocks.  There has been a discussion here about it. We've talked about it. Thus far, we've reached the conclusion that now is not the time to split. Maybe there is a time someday down the line."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks.",22,"If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you for your continued interest in Lorrilard. We look forward to talking to you again next quarter.",18,"Thank you for your continued interest in Lorrilard. We look forward to talking to you again next quarter."
4180255,137327135,145277,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 and enter the conference ID 82413734. You may now disconnect.",32,"This concludes the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 and enter the conference ID 82413734. You may now disconnect."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for re",67,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorrilard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorrilard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",128,"Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorrilard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorrilard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. 
By now, you should have received a copy of our second quarter 2011 earnings release. It can be found on the company's website, lorrilard.com, under News Releases. 
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties, as described in the company's earnings release and in other filings with the SEC. 
I'd now like to turn the call over to Murray Kessler."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. In the face of a challenging macroeconomic environment, I am extremely pleased to report another very strong quarter for Lorillard. The company's second quarter results continue to demonstrate the fundamental st",1155,"Thank you, Bob, and good morning, everyone. In the face of a challenging macroeconomic environment, I am extremely pleased to report another very strong quarter for Lorillard. The company's second quarter results continue to demonstrate the fundamental strength of our brands and our organization. 
Let's start with a review of the key fundamentals on the business and how we are proceeding to responsibly bring Newport Pleasure to all adult smokers. First, total domestic Newport volume increased 9.6% versus year ago in Q2, with the  Newport Menthol domestic volume up 1% for the quarter. This includes what we believe is a relatively minor cannibalization effect from Newport Non-Menthol estimated as a negative 1% drag on the core menthol business. And this is also encouraging, as we reduced Newport Menthol promotion spending in the quarter versus year ago. 
Second, and driving the total Newport increase, was a strong performance by Newport Non-Menthol. Newport Non-Menthol sales are way above our expectations for this point in the launch, crossing the 1% market share level vote by quarter end. Importantly, the second wave of our source of volume business study conducted in April continues to indicate that the brand's volume is 90% incremental to the Newport franchise, that 2/3 of purchasers claim Newport Non-Menthol as their usual brand; that positive purchase intent is expressed by virtually all purchasers, 96%; and that the primary reason for purchase is the product's taste. This gives us confidence that long term, we can continue to migrate the brand's retail price in line with core Newport Menthol. 
Third, Maverick, our discount brand, continued to make strong gains, increasing 21% versus year ago in the quarter. 
Fourth, we made progress in the quarter with our selectively increased support on Newport Menthol in non-core markets. Four additional markets were added late in the quarter, as we mentioned at our investor conference. And our original test markets continued to experience double-digit volume growth.  That all added to a substantial increase in Lorillard domestic volume of 10.4% or almost 1 billion sticks more than we shipped a year ago. 
Even after adjusting for heightened wholesale inventories in advance of our July 1 price increase, total Lorillard domestic volume increased 8.1% versus year ago. This is especially noteworthy, given the context of high unemployment, high gasoline prices and declining industry sale. We remain highly confident in our recently announced strategic plan, which places its primary focus on organic growth and outperformance relative to our peers in the U.S. cigarette industry.  As always, when our brands outperform the category, we gain market share. And this was the case in Q2.  
At retail, where wholesale inventory fluctuations do not impact the numbers, industry volume was estimated to decline just under 4%. Therefore, according to our proprietary EXCEL database, which measures the shipments from wholesale to retail, total Lorillard market share increased to 14.2% or a 140 basis point increase over the second quarter last year.  
Likewise, total Newport share increased 109 basis points to 12% in Q2. Basically, we held on to the sizable gains achieved under the first quarter, so we gained share versus year ago on total Lorillard; on total Lorillard premium; on total Lorillard discount; on total Newport, including Newport Non-Menthol; on core Newport Menthol; and on Maverick. This was not just the case of a successful new product. Share gains were experienced broadly across our portfolio. 
Strong organic volume growth combined with higher prices net of promotion translated to an 11.3% increase in net sales and a 9.4% operating income increase. This combined with the accretive impact of the company's share repurchase plan, resulted in an 18% year-over-year quarterly gain in earnings per share. EPS finished at $2.05 for the quarter. So obviously, the quality of earnings for the quarter was high.  At the 6-month mark, EPS for Lorillard is up 16.5% versus year ago, making the company one of the top performers in the CPG industry during these difficult economic time.  It also demonstrates that we are not just focused on growth, but has as always been the case, we are focused on profitable growth. 
While we don't necessarily expect this pace of growth to continue in the second half, I think you'd agree we're having a darn good year, especially, when you add the dividend yield. In fact, relative to our tobacco peers and the broader group of consumer product goods companies, in general, we are pleased we can deliver outsized top line growth, leverage through our income statement and showcase the strength of our business, despite a difficult macro consumer environment. 
Let's move on now to the regulatory environment, as it relates to Menthol. We made an important organizational move during the quarter, which will help shape our relationship with the FDA. Dr. Neil Wilcox joined us as our Senior Vice President of Regulatory Compliance. Neil came most recently from an important position at the FDA. He is very experienced in agency process and policy, and we expect him to provide strong guidance and governance on the regulatory issues that face us. 
Now let's turn to the regulatory events in the quarter and their impact on the company. Although some headlines around several FDA announcements created intra-quarter volatility on our stock price, we see the FDA review process moving, as expected; not faster, not slower. The FDA is conducting a preliminary independent peer-reviewed scientific assessment separate from TPSAC, as they promised they would. We see that as a positive, because, a, we believe that the TPSAC panel was biased, which is obviously, why we are engaged in litigation on this topic; b, initial FDA white papers, while they still suffer from some of the same flaws that plagued the TPSAC report, were more balanced than TPSAC; and, c, the peer review process is normal for FDA on this type of issue and is an appropriate first step. 
Of course, our current view depends on the quality of the peer review process and the objectivity of the reviewers selected. We believe a thorough objective and scientific process is critical. And overall, we haven't changed our opinion that this will be a very long process, and that the overwhelming body of scientific evidence does not justify increased regulation on menthol cigarettes relative to non-menthol cigarettes. 
Accordingly, we continue to focus on our business and believe the best reason to invest in Lorillard are industry-leading fundamentals, a strong and growing dividend, balance sheet flexibility that is being used to lower our cost of capital via increased leverage and share repurchases and a strategic plan that clearly identifies growth opportunities within the domestic cigarette market. We remain confident in our ability to deliver a double-digit shareholder return, as measured by EPS growth and the dividend yield. And we remain confident in our ability to grow at a level that exceeds our domestic tobacco company peers. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for questions. Net sales for the second quarter of 2011 increased 11.3% to $1.7 billion as compared to our second quarter of 2010, driven by the 1",961,"Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for questions. 
Net sales for the second quarter of 2011 increased 11.3% to $1.7 billion as compared to our second quarter of 2010, driven by the 10.4% increase in domestic shipment volume.  Our average wholesale selling prices in the quarter were higher across the board but were partially offset by other factors. 
First, unit volumes for Newport were up 9.6%, while Maverick volumes were up 21.2%. As we've reported for the last several quarters, the continuing increase in Maverick unit volumes and the resulting shift in our mix of products sold has the effect of reducing the overall revenues per unit sold. 
Second, shipments of Newport Non-Menthol, which was launched in the fourth quarter of last year, was also a significant factor in the year-over-year comparison. Newport Non-Menthol units carried a promotional price in this year's quarter, and therefore, added to this mix effect on the calculation of net price per unit, if that's calculated on a consolidated basis. This year-over-year effect is not a surprise, nor does it concern us. It does not reflect the deterioration of the price point of our brand. In fact, when I look at the calculations of price realization before excise taxes for Newport Menthol only, they work out to a healthy 5.7% increase for the second quarter. The other factors bring the total down. But as we've said before, this is incremental business for us. It is profitable on its own, and it strengthens our portfolio over the long term. 
Fluctuations in wholesale inventory levels in this year and last year had an effect on our second quarter volume comparison, just like some others in the industry. After adjusting for the effect of the decline in wholesale inventories last year and a build this year, we estimate that our domestic wholesale shipments would've increased 8.1% for the quarter rather than the 10.4%, as reported.  These build and wholesale inventories will reverse itself in the upcoming quarter and will have the obvious effect of dampening our third quarter volume compare [ph].  
Notably, it will also further impact reported net pricing and profitability in that quarter because of the impact of consumer promotion, much of which follow retail movements, not wholesale movements.  I mentioned this, because I know many of you develop expectations of financial performance on a quarter-by-quarter basis, in part, by referring to last year. As you may recall, we reported strong unit volume increases in last year's third quarter, some of which was inflated due to an inventory build in that quarter. The opposite is likely to be true this year. But we believe the underlying trends of our portfolio will continue to be strong. 
Gross profit in the second quarter of 2011 increased by $57 million to $599 million.  Cost of goods sold in the 2011 quarter reflects increases over last year in certain costs, including increased FDA user fee.  The amounts due under the State Settlement Agreements and the tobacco grower's assessment increased $45 million compared to last year's second quarter. 
Selling, general and administrative costs increased $15 million from last year's second quarter, primarily due to legal fees and expenses associated with increased litigation activity during the quarter, just like it did in our first quarter.  Other increases in SG&A included marketing and other costs associated with our strategic initiatives, including the continuing brand-building costs in support of Newport Non-Menthol. 
Second quarter operating income increased 9.4% to $487 million from $445 million in last year's second quarter. Operating income is up 9.8% for the first half of 2011.  Fully diluted earnings per share for the second quarter increased 18.5% from last year's second quarter to $2.05 per share. Those results reflect the strong performance we've already discussed but also the effect of a lower average share count this year. The lower share count is compared to the year-ago quarter added $0.14 per share to EPS in this year's second quarter. 
During the quarter, through June 30, we repurchased approximately 4.5 million shares at a cost of $494 million under the current share repurchase authorization. The board increased this repurchase authorization from $1 billion to $1.4 billion in May, further demonstrating our intent to return cash to shareholders in the form of both dividends and share repurchases. As of June 30, we had $241 million remaining on that program. 
A quick comment about the voluntary recall of certain Newport Non-Menthol product last week. As we announced, the company became aware that there was a possibility that some of our products could contain pieces of plastic. We did not find any such plastic in any of our products but could not rule out the theoretical possibility. Out of abundance of caution, we removed all of the products that could've been affected from the supply chain and voluntarily implemented a recall of any of the product that could've reached retail shelves.  We did not experience any significant stock-outs of Newport Non-Menthol at retail, and we do not believe that the one-day interruption of supply had any effect on the positive momentum of the brand.  And the cost of the recall is expected to be insignificant. 
We are pleased with the company's performance this far for this quarter and for 2011 so far. While we expect this to be another outstanding year for Lorillard, I think we can agree that one should not expect EPS growth to continue to approach 20% on a regular and ongoing basis. We do believe, however, that we can continue to outperform the industry, build on our record of success and deliver value for our shareholders over the long term.
And with that, we'd like to open the line for questions. Sarah?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs.",15,"[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Murray, can you just give us a little bit more color just in terms of your promotional activity in the second quarter? Understand that year-over-year pricing is impacted by the mix issue, but just kind of looking at -- sequentially, it looks like your net",87,"Murray, can you just give us a little bit more color just in terms of your promotional activity in the second quarter? Understand that year-over-year pricing is impacted by the mix issue, but just kind of looking at -- sequentially, it looks like your net revenue per unit was also down a little bit. So I'm just wondering if anything's changed in terms of the promotional activity in 2Q versus Q1? And then whether, it's again the mix situation that has impacted the price per unit number?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","For us, and the way we saw the industry, we saw this as a normal quarter. We had -- part of the pricing equation, you are correct, is net pricing lift plus promotion. Just like the first quarter, Newport Menthol promotions were down, reduced versus year a",108,"For us, and the way we saw the industry, we saw this as a normal quarter. We had -- part of the pricing equation, you are correct, is net pricing lift plus promotion. Just like the first quarter, Newport Menthol promotions were down, reduced versus year ago at about the same level, Nothing unusual, 1%, volume; 5.7%, pricing realization on Newport Menthol. You got a limited 10% operating income increase, which almost exclusively comes from Newport Menthol, as the other brands carry much lower margins, so -- and no, there was -- there's nothing unusual. There's nothing to read into on pricing here. It continues to be robust."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then  just on the Newport Red, just the sustainability of the share performance, especially as the price points on that brands go up. How are you feeling about the sustainability?",32,"Okay. And then  just on the Newport Red, just the sustainability of the share performance, especially as the price points on that brands go up. How are you feeling about the sustainability?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, look, we feel great about it right now, but we'll see, right? We just took a price increase, and it was pretty robust. It was an 11% price increase on -- net-net on Newport Red. But having said that, our competitors went up as well. So the goal is t",153,"Well, look, we feel great about it right now, but we'll see, right? We just took a price increase, and it was pretty robust. It was an 11% price increase on -- net-net on Newport Red. But having said that, our competitors went up as well. So the goal is to have a pricing advantage in the beginning, kind of where other introductory brands -- brand introductory prices have been to establish and  establish them and get trial. And that's working beautifully. So let's call it -- in the beginning,  it was a little over $1 discount or around $1 dollar discount, and with this increase, it's about $0.75. But our competitors went up, so instead of being $1 advantage relative to full-priced brands, it's going to be around $0.80, $0.85, which is still pretty attractive. So we think the momentum will continue, but we'll see, and we'll adjust if we need to."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then finally, just on the FDA review process, Murray, is there anything that gives you more comfort or discomfort just around in terms of who they might be picking in terms of the external peers, who will be looking at the menthol issue?",45,"Okay. And then finally, just on the FDA review process, Murray, is there anything that gives you more comfort or discomfort just around in terms of who they might be picking in terms of the external peers, who will be looking at the menthol issue?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, but I don't have any insight to who they pick so far. They -- I think they're, clearly, being cautious to do this in peer review and be transparent based on the challenges they've gotten from the industry on the TPSAC process. So hopefully, they'll pi",71,"No, but I don't have any insight to who they pick so far. They -- I think they're, clearly, being cautious to do this in peer review and be transparent based on the challenges they've gotten from the industry on the TPSAC process. So hopefully, they'll pick a real thorough -- or pick a good panel that will do a thorough process. And if they do, we're confident in the results."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivien Azer with Citigroup.",12,"Your next question comes from the line of Vivien Azer with Citigroup."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","My first question has to do with Newport Menthol. It's really encouraging, actually. You guys posted 1% volume growth. I was wondering if you could offer some color on how that broke down in your core and non-core markets.",39,"My first question has to do with Newport Menthol. It's really encouraging, actually. You guys posted 1% volume growth. I was wondering if you could offer some color on how that broke down in your core and non-core markets."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, we do so much more volume in our current markets than -- in our non-core markets. Our non-core markets, we break it down into more detail than that, but it grew faster in those non-core markets, because that's where we have added some promotional su",92,"Well, we do so much more volume in our current markets than -- in our non-core markets. Our non-core markets, we break it down into more detail than that, but it grew faster in those non-core markets, because that's where we have added some promotional support to get back in line with competition. And it continues, obviously. The heart of our businesses is full-flavored Newport Menthol business, so it's also driven by that. It's a little bit, but it -- a lot of growth out west doesn't move the needle very far."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Understood. In terms of the 4 new markets that you guys are adding, where does that leave us in terms of the total program in addressing some of your pricing issues west of Mississippi?",34,"Understood. In terms of the 4 new markets that you guys are adding, where does that leave us in terms of the total program in addressing some of your pricing issues west of Mississippi?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","It's more [ph] -- you're saying -- the 4, we just added, so we're up to 8 markets. I think those 8 markets -- so you probably have a number of states. But we're not looking at that way. We're looking at sort of the percentage of volume covered. And it's s",71,"It's more [ph] -- you're saying -- the 4, we just added, so we're up to 8 markets. I think those 8 markets -- so you probably have a number of states. But we're not looking at that way. We're looking at sort of the percentage of volume covered. And it's starting to get to the majority of the volume that is actually menthol volume that's sold in those areas."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from Nik Modi with UBS.",9,"Your next question comes from Nik Modi with UBS."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Just quick question. So obviously, good momentum on core Newport. But when I look in the back, you have a table. It looks like share -- and it looks like share's been flat of this menthol segment in the first quarter and the first half. Just curious kind",85,"Just quick question. So obviously, good momentum on core Newport. But when I look in the back, you have a table. It looks like share -- and it looks like share's been flat of this menthol segment in the first quarter and the first half. Just curious kind of what you think is going on there? Are you just seeing more promotional activity by the competitors? Or is it Newport Non-Menthol, getting a lot of the research allocation? If you could just provide some thoughts."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","You want to know how Newport share within Menthol is performing?",11,"You want to know how Newport share within Menthol is performing?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Yes, because it looks like in this table in the back in the release, it says Newport share of Menthol segment. And it looks like it's flat -- it's been flat for the first quarter and the second quarter. Unless I'm reading it wrong. I don't think I am.",49,"Yes, because it looks like in this table in the back in the release, it says Newport share of Menthol segment. And it looks like it's flat -- it's been flat for the first quarter and the second quarter. Unless I'm reading it wrong. I don't think I am."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, I think we slightly -- I mean, it's basically flat. But we gained shares sequentially in the first quarter to the second quarter on Newport. And the segment itself gained shares. So I think we're up 20 basis points from the first quarter to the seco",215,"Well, I think we slightly -- I mean, it's basically flat. But we gained shares sequentially in the first quarter to the second quarter on Newport. And the segment itself gained shares. So I think we're up 20 basis points from the first quarter to the second quarter, Nik, and flat versus a year ago. But no, it's progressing well. I mean, my color is that Newport Menthol full flavor doesn't really go -- which is the core of our business, is insulated relative to the rest of the brands and doesn't go head-to-head in all these new products. The bulk of them that you've seen affects that share of total menthol and a little bit of stability. But the reality is we continue to gain share. We gained share in full-flavor Menthol. Again, we're -- Newport, if you remember from the investor conference, has that north of 70% market share. And we gained share in that one more time. And the competitors going against each other with the gold products. So, no. I know, it's your guys' job to look at it, but it was just a solid quarter across the board. We gained share everywhere. We -- margins expanded on our core business. We grew volume. It was a heck of a quarter."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Did you make any change in your reserve for the Scott Case during the quarter?",15,"Did you make any change in your reserve for the Scott Case during the quarter?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, we didn't, David. That thing was fully reserved and continues that way.",13,"No, we didn't, David. That thing was fully reserved and continues that way."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","You don't think that you're over-reserved?",7,"You don't think that you're over-reserved?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, actually, we don't. I know there were some incremental interest that we kept up with. But we're fully reserved on what we think we have to pay.",28,"No, actually, we don't. I know there were some incremental interest that we kept up with. But we're fully reserved on what we think we have to pay."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, both you and Murray alluded to the fact that performance at this rate or the GAAP in our operating performance versus peers is unlikely to persist. Is that characterization out of conservatism? Is it because of the fact that you're coming",66,"Okay. And then, both you and Murray alluded to the fact that performance at this rate or the GAAP in our operating performance versus peers is unlikely to persist. Is that characterization out of conservatism? Is it because of the fact that you're coming into a quarter, where you've a bit of a trade load? Is there something else that you see in the competitive marketplace?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, just the trade load. We -- look, the long-term algorithm -- and I continue to believe that the basic premise of the Newport model, David, is what I said at the investor conference. We want to outperform by 4 or 5 points on volume performance and captu",145,"No, just the trade load. We -- look, the long-term algorithm -- and I continue to believe that the basic premise of the Newport model, David, is what I said at the investor conference. We want to outperform by 4 or 5 points on volume performance and capture the pricing flexibility in the category, and that gives us outperformance in our financials. We're just running at 18% EPS growth right now. And we have the benefit of -- which was on plan. But that wholesale inventory's increased towards the end of the quarter. They've already started to drop off in the third quarter. And last year, you had an increase at the end of the quarter, which may or may not happen. I have no idea. We don't control the trade. The net-net is -- I'm just saying, don't straight line the numbers, that's all."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Bonnie Herzog with Wells Fargo.",13,"Your next question comes from the line of Bonnie Herzog with Wells Fargo."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I just had a quick question on Maverick. Can you just give us a bit more color on your strategy with the brand? Your volume, it's still certainly very strong, but it does seem to be slowing a bit. And also, you did lead the industry as the price increased",101,"I just had a quick question on Maverick. Can you just give us a bit more color on your strategy with the brand? Your volume, it's still certainly very strong, but it does seem to be slowing a bit. And also, you did lead the industry as the price increased on Newport a few weeks ago, but you didn't initially take pricing on Maverick, but then you took pricing up on the brand about a week later. So I'm curious to hear why you held Maverick pricing for a week and then what prompted you to increase it on the brand?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","The reason we waited on Maverick is the sort of -- you have to understand the complexity, Bonnie, of the cigarette contracts in there. And unfortunately, we're #3. And we are sort of bound by some of the influence of our competitors. And Maverick, to take",142,"The reason we waited on Maverick is the sort of -- you have to understand the complexity, Bonnie, of the cigarette contracts in there. And unfortunately, we're #3. And we are sort of bound by some of the influence of our competitors. And Maverick, to take a price increase, unless one of the other major competitors have written into their contract that they have to be the lowest price in the store, if they don't go up -- if we take the price -- we take the price that we don't get benefit for. So there is -- I have to detail and lay it out for you. But we needed to see the market move to see that -- would there be any benefit to Lorillard to go ahead and change. So we're just a follower on Maverick, not a leader."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","A leader on the other, clearly, with the -- you led second time in a row.",16,"A leader on the other, clearly, with the -- you led second time in a row."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I think Maverick goes head-to-head with competition. I think that Newport, we have our own strategy pricing. It is -- promotional pricing relative to competition  is not an offensive weapon for us, so we take pricing when we think it's right for our busin",45,"I think Maverick goes head-to-head with competition. I think that Newport, we have our own strategy pricing. It is -- promotional pricing relative to competition  is not an offensive weapon for us, so we take pricing when we think it's right for our business."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Well, that makes sense. I just wanted to clarify. And then just switching over to the West Coast and the promotion. I know you made some comments about an update on your strategy. But I'm curious if you've made any tweaks or modifications to your pr",78,"Okay. Well, that makes sense. I just wanted to clarify. And then just switching over to the West Coast and the promotion. I know you made some comments about an update on your strategy. But I'm curious if you've made any tweaks or modifications to your program, as you've seen how consumers reacting to the increased promotions behind the brand versus sort of what you were talking to us about at your investor day a few months ago."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, we've made no tweaks. The 4 additional markets, we barely can read them. They started up in -- I think I said in the investor conference we'd start them in June, and that's when we did start them. So you only got a couple of weeks of data there. The o",107,"No, we've made no tweaks. The 4 additional markets, we barely can read them. They started up in -- I think I said in the investor conference we'd start them in June, and that's when we did start them. So you only got a couple of weeks of data there. The other 4 markets are at the same promotional levels they were, they have been for a year now. And there was just no big spending there. It was immaterial that it had no effect on our -- or no material impact on our margins. Newport margins were -- Menthol margins were up strongly in the quarter."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicholas.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicholas."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I just wanted to ask you with -- in relation to Newport Non-Menthol, should we just expect that there's more markets to be added, if this happens slowly over time? Is it reasonable to assume there's more in the second half? Or I'm just trying to get to un",68,"I just wanted to ask you with -- in relation to Newport Non-Menthol, should we just expect that there's more markets to be added, if this happens slowly over time? Is it reasonable to assume there's more in the second half? Or I'm just trying to get to understand the phasing of the new markets you may add -- new non-core markets you may add for that brand."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","For Menthol or Non-Menthol?",5,"For Menthol or Non-Menthol?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I'm talking Menthol, sorry.",5,"I'm talking Menthol, sorry."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Menthol?",1,"Menthol?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Yes.",1,"Yes."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","We just added the 4 additional markets. I don't think, I've given any color on additional markets. I think, we'll see how that goes before we make any adjustments. But I'm also not sure we'll share, if we do make adjustments. But again, it's small relativ",74,"We just added the 4 additional markets. I don't think, I've given any color on additional markets. I think, we'll see how that goes before we make any adjustments. But I'm also not sure we'll share, if we do make adjustments. But again, it's small relative to the total portfolio right now. Those are long-term investments. They're not going to have a significant impact on either the financials or the volumes as of yet."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. So you had 4, and you added 4 more. I'm just trying to understand the phasing of the time. So we should see assume this is a long term -- maybe more markets to be added in 2012, for example?",41,"Sure. So you had 4, and you added 4 more. I'm just trying to understand the phasing of the time. So we should see assume this is a long term -- maybe more markets to be added in 2012, for example?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes. I mean, we wanted to be profitable. So we'll keep measuring and adjusting as we go. We've got a couple of factors, right? It's the amount of menthol that's sold in the markets, so whether it's substantial enough to justify the investment to pay it ou",165,"Yes. I mean, we wanted to be profitable. So we'll keep measuring and adjusting as we go. We've got a couple of factors, right? It's the amount of menthol that's sold in the markets, so whether it's substantial enough to justify the investment to pay it out -- and so far the 4 markets, I think, at the investor conference, we were approaching payout. All 4 of those markets have now exceeded payout and continued to grow at double-digit levels. And one more point. I just want to emphasize what I said at the investor conference. We're not investment spending in those markets. We were priced above competition, fully -- in a full-priced competition. We were -- Newport consumer had to spend $.050 to $1 more to buy a pack of Newport than a pack of one of the other leading brand. And all we did is get competitive and take away that premium. We're not below them. And these are the results we're seeing."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. And in relation to that, my other question is that you mentioned that Newport promotional spending was down in the quarter, like it was in the first quarter. So just to be clear, you're funding these incremental promotions in non-core markets by red",63,"Sure. And in relation to that, my other question is that you mentioned that Newport promotional spending was down in the quarter, like it was in the first quarter. So just to be clear, you're funding these incremental promotions in non-core markets by reductions elsewhere? Or is it just that they're still small, they're not inflating the level of promotion for the brand?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, I mean, I guess, you could answer that question no matter -- either way, right? The net result is that promotional spending on Newport Menthol was down, including any additional investment in non-core geographies.",35,"Well, I mean, I guess, you could answer that question no matter -- either way, right? The net result is that promotional spending on Newport Menthol was down, including any additional investment in non-core geographies."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then my final question is just a bit of a follow-up on the FDA process from here. Do you -- are we going to learn who the peer reviewers are? Is there any update you expect before that peer review is complete?",44,"Okay. And then my final question is just a bit of a follow-up on the FDA process from here. Do you -- are we going to learn who the peer reviewers are? Is there any update you expect before that peer review is complete?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I have no inside information on that at all. I think -- don't know whether they have any obligation or not to tell us who the peer reviewers were. What they said the other day was that when they completed it, they would share their own analysis and the pe",80,"I have no inside information on that at all. I think -- don't know whether they have any obligation or not to tell us who the peer reviewers were. What they said the other day was that when they completed it, they would share their own analysis and the peer review analysis. So that's what I heard. I don't think -- I don't personally think we're going to hear anything of substance until the end of the year on this."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America Merrill Lynch.",16,"Your next question comes from the line of Christine Farkas with Bank of America Merrill Lynch."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","A couple of housekeeping items, I guess if I could. I appreciate the relatively limited guidance with respect to quarter to quarter. I just want to understand if there are any timing factors, be it spending or otherwise. And also the tax rates for the ful",64,"A couple of housekeeping items, I guess if I could. I appreciate the relatively limited guidance with respect to quarter to quarter. I just want to understand if there are any timing factors, be it spending or otherwise. And also the tax rates for the full year, if you could imply perhaps that it would be similar to or near 37% for the year?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes. I think the tax rate was low in the second quarter, because we settled some state tax matters, which brought it down for the quarter. That's not an indication of what we think the full year will be. We still think the full year is in that 37% neighbo",50,"Yes. I think the tax rate was low in the second quarter, because we settled some state tax matters, which brought it down for the quarter. That's not an indication of what we think the full year will be. We still think the full year is in that 37% neighborhood."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And as far as the spending or the quarter-to-quarter legal costs, that kind of thing, is there anything in the second half that would -- that you would want to call out with respect to one-time factors?",38,"Okay. And as far as the spending or the quarter-to-quarter legal costs, that kind of thing, is there anything in the second half that would -- that you would want to call out with respect to one-time factors?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Not any one-time factors. We've experienced this increase in legal costs associated with the litigation activities. It's been increasing for quite some time. I don't see any indication that, that's going to let up. But predicting that level quarter to qua",46,"Not any one-time factors. We've experienced this increase in legal costs associated with the litigation activities. It's been increasing for quite some time. I don't see any indication that, that's going to let up. But predicting that level quarter to quarter is a difficult matter."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. Just moving to Puerto Rico, we're seeing volumes down mid-teens -- cycling down mid-teens. I'm just wondering, aside from tough macro, if there's anything else there structurally that's suggesting this continues at this space?",35,"Sure. Just moving to Puerto Rico, we're seeing volumes down mid-teens -- cycling down mid-teens. I'm just wondering, aside from tough macro, if there's anything else there structurally that's suggesting this continues at this space?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, I think if you look at the first half, you'll see the numbers are normal. It's -- that's the timing of like when a boat ships. And literally, it's shipped like a day after the quarter ended instead of during the quarter. And the timing of it was to th",66,"No, I think if you look at the first half, you'll see the numbers are normal. It's -- that's the timing of like when a boat ships. And literally, it's shipped like a day after the quarter ended instead of during the quarter. And the timing of it was to the advantage of the first quarter. Look at the 6 months, and you'll see nothing's changed."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay, great. And then just finally on the NPM arbitration, I'm wondering if I can get your perspective on how you think it's going, with respect to the progress. Certainly, there's been discussions of MOUs circulating, and that kind of thing. And is there",58,"Okay, great. And then just finally on the NPM arbitration, I'm wondering if I can get your perspective on how you think it's going, with respect to the progress. Certainly, there's been discussions of MOUs circulating, and that kind of thing. And is there any comment you could provide to help us understand how that process is going?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Slowly.",1,"Slowly."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Slowly. Okay. So will take some time, several quarters, years, that kind of thing?",14,"Slowly. Okay. So will take some time, several quarters, years, that kind of thing?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes -- I don't know. It's in arbitration. The MOU got a lot of talk. Those things have gone back and forth. But from what I hear from our counsel, this is a slow process.",35,"Yes -- I don't know. It's in arbitration. The MOU got a lot of talk. Those things have gone back and forth. But from what I hear from our counsel, this is a slow process."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Murray, just going back to Newport Red. Could you just talk about the growth driver there? I mean, where the ACVs maybe stand versus Newport Menthol? And is it mostly adding new accounts and shelf space at this point? Is it faster velocity? Just trying to",54,"Murray, just going back to Newport Red. Could you just talk about the growth driver there? I mean, where the ACVs maybe stand versus Newport Menthol? And is it mostly adding new accounts and shelf space at this point? Is it faster velocity? Just trying to get some more breakdown on the growth there."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","There hasn't been any significant change at distribution since the initial launch, so it's all velocity. It's all trial turning into repeat purchase. We have broadscale distribution. The acceptance of Newport Red has been nationwide. It doesn't necessaril",116,"There hasn't been any significant change at distribution since the initial launch, so it's all velocity. It's all trial turning into repeat purchase. We have broadscale distribution. The acceptance of Newport Red has been nationwide. It doesn't necessarily track in the same stores. In fact, it doesn't, along with Newport Menthol. And I'm not sure, if there's any other color I can give to it. It continues to grow week to week. I can't tell you what's been the effect post the price increases, because there's been a lot of inventories changing, and there's a lag in our retail data. But right up until that point, it continued to roar along well above our expectation."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. Now that helps. And then just on the repurchase, that accelerated quite a bit this quarter. I was wondering if you could just talk about your thoughts about the pace there, why the company maybe hasn't raised more debt at this point? And given where",70,"Okay. Now that helps. And then just on the repurchase, that accelerated quite a bit this quarter. I was wondering if you could just talk about your thoughts about the pace there, why the company maybe hasn't raised more debt at this point? And given where the share price is now, has does changed at all how you think about the pace of repurchase, given that it strengthened so much?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Let me try and answer those one at a time. We did purchase more shares and spent more money in the second quarter than we did in the first quarter. But I wouldn't really characterize that as a conscious acceleration. It had more to do with conscious decel",156,"Let me try and answer those one at a time. We did purchase more shares and spent more money in the second quarter than we did in the first quarter. But I wouldn't really characterize that as a conscious acceleration. It had more to do with conscious deceleration in the first quarter, because we wanted to be sure that there was enough dry powder there toward the end of the first quarter. Because frankly, if you remember what was going on the end of the first quarter, we didn't know what was going to happen, coming out of TPSAC. Second, we know that we have not yet hit our 1.5x target for our leverage. And you do know the state of the credit markets. And so we look at those, evaluate those on a consistent basis, and we know, we have some more moves to make there. I can't give you any indication about timing, though."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And just a final question on FDA. Murray, did you say that you think this won't be published in the register until the end of the year? And then I'm just trying to clarify what exactly you think that publication would accomplish. Is it just a scienc",83,"Okay. And just a final question on FDA. Murray, did you say that you think this won't be published in the register until the end of the year? And then I'm just trying to clarify what exactly you think that publication would accomplish. Is it just a science review? Do you think there would be any kind of recommendation there? Or would that come further down the line? And would they discuss the contraband issue at that point, or wait until later date?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I can tell you what I think, but I have no -- and as based on what they've said, what they said was at the end of the year, they would publish a -- not even a full scientific, a preliminary scientific review in the peer process of their preliminary analys",216,"I can tell you what I think, but I have no -- and as based on what they've said, what they said was at the end of the year, they would publish a -- not even a full scientific, a preliminary scientific review in the peer process of their preliminary analysis. At that point, no, I don't think they're going to be writing rules or anything else. In fact, they said that -- I thought they said during the meeting that wouldn't occur at that time, that they would then look at that data, decide what was the appropriate next step. So I see is -- that is just a kick off of the process. Then does it dictate more research or analysis or contraband or whatever, and then that would be a separate process, they would have come back with after that. So yes, I just think this is the start of them independently looking at the science themselves, getting some input, and then there's some point where they have to finalize that as well. Because they did say that there will be comments to that, I believe, as part of it. So anyway, yes, I think it's a long process. I don't think anything's changed here. And I'm glad they're doing their own review."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And just finally, your view -- the white papers that have already been published by FDA in some of the journals, how do you read those? I mean, did those seem like an official sort of policy stance to you or is that just preliminary FDA review? How",54,"Okay. And just finally, your view -- the white papers that have already been published by FDA in some of the journals, how do you read those? I mean, did those seem like an official sort of policy stance to you or is that just preliminary FDA review? How do you think about those?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","All right. I think comments on the softer science that suggests there's a lot more research or a paucity of data is one that stands out to me are important. Because I think everybody has concluded on the hard science that there's no justification or diffe",128,"All right. I think comments on the softer science that suggests there's a lot more research or a paucity of data is one that stands out to me are important. Because I think everybody has concluded on the hard science that there's no justification or difference between a menthol cigarette and a non-menthol cigarette or any justification to treat them differently. So on the softer issues, there were -- there was a recognition I thought across a number of those white papers that there's limited data and weak data and lack of peer-reviewed studies, et cetera. So we'll see how it plays out. But to me, this issue, while it's gotten a lot of press, is clear-cut that the overwhelming body of scientific evidence doesn't justify a difference."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Karen Lamark with Federated Investors.",13,"Your next question comes from the line of Karen Lamark with Federated Investors."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","If I understood you correctly, Newport Non-Menthol was about 1 point drag on Newport Menthol. Are you surprised to that, in particular, in conjunction with the high-repeat intentions for Newport Non-Menthol? And would you expect the cadence to that cannib",44,"If I understood you correctly, Newport Non-Menthol was about 1 point drag on Newport Menthol. Are you surprised to that, in particular, in conjunction with the high-repeat intentions for Newport Non-Menthol? And would you expect the cadence to that cannibalization to change going forward?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Okay. Let me -- let's be clear what we're talking -- we didn't say 1 point of share. We said 1% -- so what I was saying is that the volume growth was up 1%. And if there was a Newport Red cannibalization backing into numbers, you could've estimated that i",161,"Okay. Let me -- let's be clear what we're talking -- we didn't say 1 point of share. We said 1% -- so what I was saying is that the volume growth was up 1%. And if there was a Newport Red cannibalization backing into numbers, you could've estimated that it might've been up 2% instead of up 1%, which is a much smaller number than if I mistakenly gave you the impression that we were talking about share. So the data -- and the way I'm getting that is the data that says Newport Red is 90% incremental. And that's as good as an incremental number as you're ever going to find. So if it's a 1 share that says 0.1 of the market share, of that 1, came from us. Okay? So a 0.1 came from us, and we're a 10, 11 share. You can say that it's 1/100 of a share point impact or whatever, so very timely."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And would you expect that relationship to change for any reason going forward?",14,"Okay. And would you expect that relationship to change for any reason going forward?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No.",1,"No."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your last question comes from the line of Bill Reach [ph] with Crest [ph].",14,"Your last question comes from the line of Bill Reach [ph] with Crest [ph]."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","As a shareholder in your company, I was just wondering if you'd consider splitting the stock to decrease the volatility and increase liquidity?",23,"As a shareholder in your company, I was just wondering if you'd consider splitting the stock to decrease the volatility and increase liquidity?"
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Bill [ph], there's an active debate going both ways on whether the company should split its stock or not split stock. There's been a discussion here about it. We've talked about it, thus far, we've reached the conclusion that now is not the time to split",56,"Bill [ph], there's an active debate going both ways on whether the company should split its stock or not split stock. There's been a discussion here about it. We've talked about it, thus far, we've reached the conclusion that now is not the time to split it. Maybe there is a time, someday down the line."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks.",22,"If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you for your continued interest in Lorillard. We'll look forward to talking to you again next quarter.",18,"Thank you for your continued interest in Lorillard. We'll look forward to talking to you again next quarter."
4180255,137327135,145388,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 and enter the conference ID 82413734. You may now disconnect.",32,"This concludes the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 and enter the conference ID 82413734. You may now disconnect."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for re",67,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",128,"Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer. 
By now, you should have received a copy of our second quarter 2011 earnings release. It can be found on the company's website, lorillard.com, under News Releases. 
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties, as described in the company's earnings release and in other filings with the SEC. 
I'd now like to turn the call over to Murray Kessler."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. In the face of a challenging macroeconomic environment, I am extremely pleased to report another very strong quarter for Lorillard. The company's second quarter results continue to demonstrate the fundamental st",1150,"Thank you, Bob, and good morning, everyone. In the face of a challenging macroeconomic environment, I am extremely pleased to report another very strong quarter for Lorillard. The company's second quarter results continue to demonstrate the fundamental strength of our brands and our organization. 
Let's start with a review of the key fundamentals on the business and how we are proceeding to responsibly bring Newport Pleasure to all adult smokers. First, total domestic Newport volume increased 9.6% versus year ago in Q2 with Newport Menthol domestic volume up 1% for the quarter. This includes what we believe is a relatively minor cannibalization effect from Newport Non-Menthol estimated as a negative 1% drag on the core menthol business. And this is also encouraging, as we reduced Newport Menthol promotion spending in the quarter versus year ago. 
Second, and driving the total Newport increase, was a strong performance by Newport Non-Menthol. Newport Non-Menthol sales are way above our expectations for this point in the launch, crossing the 1% market share level by quarter end. Importantly, the second wave of our source of volume business study conducted in April continues to indicate that the brand's volume is 90% incremental to the Newport franchise; that 2/3 of purchasers claim Newport Non-Menthol as their usual brand; that positive purchase intent is expressed by virtually all purchasers, 96%; and that the primary reason for purchase is the product's taste. This gives us confidence that long term, we can continue to migrate the brand's retail price in line with core Newport Menthol. 
Third, Maverick, our discount brand, continued to make strong gains, increasing 21% versus year ago in the quarter. 
Fourth, we made progress in the quarter with our selectively increased support on Newport Menthol in non-core markets. Four additional markets were added late in the quarter, as we mentioned at our investor conference. And our original test markets continue to experience double-digit volume growth.  That all added to a substantial increase in Lorillard domestic volume of 10.4% or almost 1 billion sticks more than we shipped a year ago. 
Even after adjusting for heightened wholesale inventories in advance of our July 1 price increase, total Lorillard domestic volume increased 8.1% versus year ago. This is especially noteworthy, given the context of high unemployment, high gasoline prices and declining industry sale. We remain highly confident in our recently announced strategic plan, which places its primary focus on organic growth and outperformance relative to our peers in the U.S. cigarette industry.  As always, when our brands outperform the category, we gain market share. And this was the case in Q2.  
At retail, where wholesale inventory fluctuations do not impact the numbers, industry volume was estimated to decline just under 4%. Therefore, according to our proprietary EXCEL database, which measures shipments from wholesale to retail, total Lorillard market share increased to 14.2% or a 140-basis-point increase over the second quarter last year.  
Likewise, total Newport share increased 109 basis points to 12% in Q2. Basically, we held on to the sizable gains achieved into the first quarter, so we gained share versus year ago on total Lorillard; on total Lorillard premium; on total Lorillard discount; on total Newport, including Newport Non-Menthol; on core Newport Menthol; and on Maverick. This was not just the case of a successful new product. Share gains were experienced broadly across our portfolio. 
Strong organic volume growth combined with higher prices net of promotion translated to an 11.3% increase in net sales and a 9.4% operating income increase. This combined with the accretive impact of the company's share repurchase plan, resulted in an 18% year-over-year quarterly gain in earnings per share. EPS finished at $2.05 for the quarter. So obviously, the quality of earnings for the quarter was high.  At the 6-month mark, EPS for Lorillard is up 16.5% versus year ago, making the company one of the top performers in the CPG industry during these difficult economic times.  It also demonstrates that we are not just focused on growth, but has as always been the case, we are focused on profitable growth. 
While we don't necessarily expect this pace of growth to continue in the second half, I think you'd agree we're having a darn good year, especially when you add the dividend yield. In fact, relative to our tobacco peers and the broader group of consumer product goods companies, in general, we are pleased we can deliver outsized top line growth, leverage through our income statement and showcase the strength of our business, despite a difficult macro consumer environment. 
Let's move on now to the regulatory environment, as it relates to Menthol. We made an important organizational move during the quarter which will help shape our relationship with the FDA. Dr. Neil Wilcox joined us as our Senior Vice President of Regulatory Compliance. Neil came most recently from an important position at the FDA. He is very experienced in agency process and policy, and we expect him to provide strong guidance and governance on the regulatory issues that face us. 
Now let's turn to the regulatory events in the quarter and their impact on the company. Although some headlines around several FDA announcements created intra-quarter volatility on our stock price, we see the FDA review process moving, as expected; not faster, not slower. The FDA is conducting a preliminary independent peer-reviewed scientific assessment separate from TPSAC, as they promised they would. We see that as a positive, because, a, we believe that the TPSAC panel was biased, which is obviously why we are engaged in litigation on this topic; b, initial FDA white papers, while they still suffer from some of the same flaws that plagued the TPSAC report, were more balanced than TPSAC; and, c, the peer review process is normal for FDA on this type of issue and is an appropriate first step. 
Of course, our current view depends on the quality of the peer review process and the objectivity of the reviewers selected. We believe a thorough, objective and scientific process is critical. And overall, we haven't changed our opinion that this will be a very long process and that the overwhelming body of scientific evidence does not justify increased regulation on menthol cigarettes relative to non-menthol cigarettes. 
Accordingly, we continue to focus on our business and believe the best reason to invest in Lorillard are industry-leading fundamentals, a strong and growing dividend, balance sheet flexibility that is being used to lower our cost of capital via increased leverage and share repurchases and a strategic plan that clearly identifies growth opportunities within the domestic cigarette market. We remain confident in our ability to deliver a double-digit shareholder return, as measured by EPS growth and the dividend yield. And we remain confident in our ability to grow at a level that exceeds our domestic tobacco company peers. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for questions. Net sales for the second quarter of 2011 increased 11.3% to $1.7 billion as compared to our second quarter of 2010, driven by the 1",963,"Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for questions. 
Net sales for the second quarter of 2011 increased 11.3% to $1.7 billion as compared to our second quarter of 2010, driven by the 10.4% increase in domestic shipment volume.  Our average wholesale selling prices in the quarter were higher across the board but were partially offset by other factors. 
First, unit volumes for Newport were up 9.6%, while Maverick volumes were up 21.2%. As we've reported for the last several quarters, the continuing increase in Maverick unit volumes and the resulting shift in our mix of products sold has the effect of reducing the overall revenues per unit sold. 
Second, shipments of Newport Non-Menthol, which was launched in the fourth quarter of last year, was also a significant factor in the year-over-year comparison. Newport Non-Menthol units carried a promotional price in this year's quarter and, therefore, added to this mix effect on the calculation of net price per unit, if that's calculated on a consolidated basis. This year-over-year effect is not a surprise, nor does it concern us. It does not reflect the deterioration of the price point of our brand. In fact, when I look at the calculations of price realization before excise taxes for Newport Menthol only, they work out to a healthy 5.7% increase for the second quarter. The other factors bring the total down. But as we've said before, this is incremental business for us. It is profitable on its own, and it strengthens our portfolio over the long term. 
Fluctuations in wholesale inventory levels in this year and last year had an effect on our second quarter volume comparison, just like some others in the industry. After adjusting for the effect of a decline in wholesale inventories last year and a build this year, we estimate that our domestic wholesale shipments would have increased 8.1% for the quarter rather than the 10.4%, as reported.  These build in wholesale inventories will reverse itself in the upcoming quarter and will have the obvious effect of dampening our third quarter volume comparison.  
Notably, it will also further impact reported net pricing and profitability in that quarter because of the impact of consumer promotion, much of which follow retail movements, not wholesale movements.  I mention this because I know many of you develop expectations of financial performance on a quarter-by-quarter basis, in part, by referring to last year. As you may recall, we reported strong unit volume increases in last year's third quarter, some of which was inflated due to an inventory build in that quarter. The opposite is likely to be true this year. But we believe the underlying trends of our portfolio will continue to be strong. 
Gross profit in the second quarter of 2011 increased by $57 million to $599 million.  Cost of goods sold in the 2011 quarter reflects increases over last year in certain costs, including increased FDA user fees.  The amounts due under the State Settlement Agreements and the tobacco grower's assessment increased $45 million compared to last year's second quarter. 
Selling, general and administrative costs increased $15 million from last year's second quarter, primarily due to legal fees and expenses associated with increased litigation activity during the quarter, just like it did in our first quarter.  Other increases in SG&A included marketing and other costs associated with our strategic initiatives, including the continuing brand-building costs in support of Newport Non-Menthol. 
Second quarter operating income increased 9.4% to $487 million from $445 million in last year's second quarter. Operating income is up 9.8% for the first half of 2011.  Fully diluted earnings per share for the second quarter increased 18.5% from last year's second quarter to $2.05 per share. Those results reflect the strong performance we've already discussed but also the effect of a lower average share count this year. The lower share count, as compared to the year-ago quarter, added $0.14 per share to EPS in this year's second quarter. 
During the quarter, through June 30, we repurchased approximately 4.5 million shares at a cost of $494 million under the current share repurchase authorization. The board increased this repurchase authorization from $1 billion to $1.4 billion in May, further demonstrating our intent to return cash to shareholders in the form of both dividends and share repurchases. As of June 30, we had $241 million remaining on that program. 
A quick comment about the voluntary recall of certain Newport Non-Menthol product last week. As we announced, the company became aware that there was a possibility that some of our products could contain pieces of plastic. We did not find any such plastic in any of our products but could not rule out the theoretical possibility. Out of an abundance of caution, we removed all of the products that could've been affected from the supply chain and voluntarily implemented a recall of any of the product that could have reached retail shelves.  We did not experience any significant stock-outs of Newport Non-Menthol at retail, and we do not believe that the one-day interruption of supply had any effect on the positive momentum of the brand.  And the cost of the recall is expected to be insignificant. 
We are pleased with the company's performance this far for this quarter and for 2011 so far. While we expect this to be another outstanding year for Lorillard, I think we can agree that one should not expect EPS growth to continue to approach 20% on a regular and ongoing basis. We do believe, however, that we can continue to outperform the industry, build on our record of success and deliver value for our shareholders over the long term.
And with that, we'd like to open the line for questions. Sarah?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs.",15,"[Operator Instructions] Your first question comes from the line of Judy Hong with Goldman Sachs."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Murray, can you just give us a little bit more color just in terms of your promotional activity in the second quarter? Understand that year-over-year pricing is impacted by the mix issue, but just kind of looking at -- sequentially, it looks like your net",87,"Murray, can you just give us a little bit more color just in terms of your promotional activity in the second quarter? Understand that year-over-year pricing is impacted by the mix issue, but just kind of looking at -- sequentially, it looks like your net revenue per unit was also down a little bit. So I'm just wondering if anything's changed in terms of the promotional activity in 2Q versus Q1. And then whether it's again the mix situation that has impacted the price per unit number?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","For us, and the way we saw the industry, we saw this as a normal quarter. We had -- part of the pricing equation, you are correct, is net pricing lift plus promotion. Just like the first quarter, Newport Menthol promotions were down, reduced versus year a",106,"For us, and the way we saw the industry, we saw this as a normal quarter. We had -- part of the pricing equation, you are correct, is net pricing lift plus promotion. Just like the first quarter, Newport Menthol promotions were down, reduced versus year ago at about the same level. Nothing unusual, 1%, volume; 5.7%, pricing realization on Newport Menthol. You got almost a 10% operating income increase, which almost exclusively comes from Newport Menthol, as the other brands carry much lower margins, so no, there was -- there's nothing unusual. There's nothing to read into on pricing here. It continues to be robust."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just on the Newport Red, just the sustainability of the share performance, especially as the price points on that brand go up. How are you feeling about the sustainability?",32,"Okay. And then just on the Newport Red, just the sustainability of the share performance, especially as the price points on that brand go up. How are you feeling about the sustainability?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, look, we feel great about it right now, but we'll see, right? We just took the price increase, and it was pretty robust. It was an 11% price increase on -- net-net on Newport Red. But having said that, our competitors went up as well. So the goal is",156,"Well, look, we feel great about it right now, but we'll see, right? We just took the price increase, and it was pretty robust. It was an 11% price increase on -- net-net on Newport Red. But having said that, our competitors went up as well. So the goal is to have a pricing advantage in the beginning, kind of where other introductory brands -- brand introductory prices have been to establish and establish them and get trial. And that's working beautifully. So let's call it -- in the beginning, it was a little over a $1 discount or around a $1 dollar discount, and with this increase, it's about $0.75. But our competitors went up, so instead of being a $1 advantage relative to full-priced brands, it's going to be around $0.80, $0.85, which is still pretty attractive. So we think the momentum will continue, but we'll see, and we'll adjust if we need to."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then finally, just on the FDA review process, Murray, is there anything that gives you more comfort or discomfort just around in terms of who they might be picking in terms of the external peers, who will be looking at the menthol issue?",45,"Okay. And then finally, just on the FDA review process, Murray, is there anything that gives you more comfort or discomfort just around in terms of who they might be picking in terms of the external peers, who will be looking at the menthol issue?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, but I don't have any insight to who theyve picked so far. They -- I think they're, clearly, being cautious to do this and peer review and be transparent based on the challenges they've gotten from the industry on the TPSAC process. So hopefully, th",71,"No, but I don't have any insight to who theyve picked so far. They -- I think they're, clearly, being cautious to do this and peer review and be transparent based on the challenges they've gotten from the industry on the TPSAC process. So hopefully, they'll pick a real thorough -- or pick a good panel that will do a thorough process. And if they do, we're confident in the results."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivien Azer with Citigroup.",12,"Your next question comes from the line of Vivien Azer with Citigroup."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","My first question has to do with Newport Menthol. It's really encouraging, actually, that you guys posted 1% volume growth. I was wondering if you could offer some color on how that broke down in your core and non-core markets.",40,"My first question has to do with Newport Menthol. It's really encouraging, actually, that you guys posted 1% volume growth. I was wondering if you could offer some color on how that broke down in your core and non-core markets."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, we do so much more volume in our core market than in our non-core markets. Our non-core markets, we break it down into more detail than that, but it grew faster in those non-core markets, because that's where we have added some promotional support t",92,"Well, we do so much more volume in our core market than in our non-core markets. Our non-core markets, we break it down into more detail than that, but it grew faster in those non-core markets, because that's where we have added some promotional support to get back in line with competition. And it continues -- obviously, the heart of our businesses is full-flavored Newport Menthol business, so it's also driven by that. It's a little bit, but it -- a lot of growth out west doesn't move the needle very far."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Understood. In terms of the 4 new markets that you guys are adding, where does that leave us in terms of the total program in addressing some of your pricing issues west of Mississippi?",34,"Understood. In terms of the 4 new markets that you guys are adding, where does that leave us in terms of the total program in addressing some of your pricing issues west of Mississippi?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","It's small -- you're saying -- the 4 we just added, so we're up to 8 markets. I think those 8 markets -- so you probably have a number of states, but we're not looking at that way. We're looking at sort of the percentage of volume covered. And it's starti",70,"It's small -- you're saying -- the 4 we just added, so we're up to 8 markets. I think those 8 markets -- so you probably have a number of states, but we're not looking at that way. We're looking at sort of the percentage of volume covered. And it's starting to get to the majority of the volume that is actually menthol volume that's sold in those areas."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Nik Modi with UBS.",12,"Your next question comes from the line of Nik Modi with UBS."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Just quick question. So obviously, good momentum on core Newport. But when I look in the back, you have a table. It looks at share, and it looks like share's been flat of this menthol segment in the first quarter and the first half. Just curious kind of w",84,"Just quick question. So obviously, good momentum on core Newport. But when I look in the back, you have a table. It looks at share, and it looks like share's been flat of this menthol segment in the first quarter and the first half. Just curious kind of what you think is going on there. Are you just seeing more promotional activity by the competitors? Or is it Newport Non-Menthol getting a lot of the research allocation? If you could just provide some thoughts."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","You want to know how Newport share within Menthol is performing?",11,"You want to know how Newport share within Menthol is performing?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Yes, because it looks like in this table in the back in the release, it says Newport share of Menthol segment. And it looks like it's flat -- it's been flat for the first quarter and the second quarter, unless I'm reading it wrong. But I don't think I am.",50,"Yes, because it looks like in this table in the back in the release, it says Newport share of Menthol segment. And it looks like it's flat -- it's been flat for the first quarter and the second quarter, unless I'm reading it wrong. But I don't think I am."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, I think we slightly -- I mean, it's basically flat. But we gained share sequentially in the first quarter to the second quarter on Newport. And the segment itself gained share. So I think we were up 20 basis points from the first quarter to the seco",216,"Well, I think we slightly -- I mean, it's basically flat. But we gained share sequentially in the first quarter to the second quarter on Newport. And the segment itself gained share. So I think we were up 20 basis points from the first quarter to the second quarter, Nik, and flat versus a year ago. But no, it's progressing well. I mean, my color is that Newport Menthol full flavor doesn't really go -- which is the core of our business, is insulated relative to the rest of the brands and doesn't go head-to-head in all these new products. The bulk of them that you've seen affects that share of total menthol and a little bit of stability. But the reality is we continued to gain share. We gained share in full-flavor Menthol. Again, we're -- Newport, if you remember from the investor conference, has that north of 70% market share. And we gained share in that one more time. And the competitors going against each other with the gold products. So, no. I know it's your guys' job to look at it, but it was just a solid quarter across the board. We gained share everywhere. We -- margins expanded on our core business. We grew volume. It was a heck of a quarter."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Did you make any change in your reserve for the Scott Case during the quarter?",15,"Did you make any change in your reserve for the Scott Case during the quarter?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, we didn't, David. That thing was fully reserved and continues that way.",13,"No, we didn't, David. That thing was fully reserved and continues that way."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","You don't think that you're over-reserved?",7,"You don't think that you're over-reserved?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, actually, we don't. I know there was some incremental interest that we kept up with. But we're fully reserved on what we think we have to pay.",28,"No, actually, we don't. I know there was some incremental interest that we kept up with. But we're fully reserved on what we think we have to pay."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then both you and Murray alluded to the fact that performance at this rate or the gap in our operating performance versus peers is unlikely to persist. Is that characterization out of conservatism? Is it because of the fact that you're coming",67,"Okay. And then both you and Murray alluded to the fact that performance at this rate or the gap in our operating performance versus peers is unlikely to persist. Is that characterization out of conservatism? Is it because of the fact that you're coming into a quarter where you have a bit of a trade load? Is there something else that you see in the competitive marketplace?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, just the trade load. We -- look, the long-term algorithm -- and I continue to believe that the basic premise of the Newport model, David, is what I said at the investor conference. We want to outperform by 4 or 5 points on volume performance and captu",145,"No, just the trade load. We -- look, the long-term algorithm -- and I continue to believe that the basic premise of the Newport model, David, is what I said at the investor conference. We want to outperform by 4 or 5 points on volume performance and capture the pricing flexibility in the category, and that gives us outperformance in our financials. We're just running at 18% EPS growth right now. And we have the benefit of -- which was not planned, but that wholesale inventory's increased towards the end of the quarter. They've already started to drop off in the third quarter. And last year, you had an increase at the end of the quarter, which may or may not happen. I have no idea. We don't control the trade. The net-net is -- I'm just saying, don't straight line the numbers. That's all."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Bonnie Herzog with Wells Fargo.",13,"Your next question comes from the line of Bonnie Herzog with Wells Fargo."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I just had a quick question on Maverick. Can you just give us a bit more color on your strategy with the brand? Your volume is still certainly very strong, but it does seem to be slowing a bit. And also, you did lead the industry with a price increase on",101,"I just had a quick question on Maverick. Can you just give us a bit more color on your strategy with the brand? Your volume is still certainly very strong, but it does seem to be slowing a bit. And also, you did lead the industry with a price increase on Newport a few weeks ago, but you didn't initially take pricing on Maverick, but then you took pricing up on the brand about a week later. So I'm curious to hear why you held Maverick pricing for a week. And then what prompted you to increase it on the brand?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","The reason we waited on Maverick is the sort of -- you have to understand the complexity, Bonnie, of the cigarette contracts in there. And unfortunately, we're #3. And we are sort of bound by some of the influence of our competitors. And Maverick, to take",141,"The reason we waited on Maverick is the sort of -- you have to understand the complexity, Bonnie, of the cigarette contracts in there. And unfortunately, we're #3. And we are sort of bound by some of the influence of our competitors. And Maverick, to take a price increase, unless one of the other major competitors who have written into their contract that they have to be the lowest price in the store, if they don't go up -- if we take the price but we don't get benefit for it. So there is -- I have to detail and lay it out for you. But we needed to see the market move to see that -- would there be any benefit of it to Lorillard to go ahead and change. So we're just a follower on Maverick, not a leader."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","But a leader on the other, clearly, with the -- you led second time in a row.",17,"But a leader on the other, clearly, with the -- you led second time in a row."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I think Maverick goes head-to-head with competition. I think that Newport, we have our own strategy pricing. It is -- promotional pricing relative to competition is not an offensive weapon for us, so we take pricing when we think it's right for our busine",45,"I think Maverick goes head-to-head with competition. I think that Newport, we have our own strategy pricing. It is -- promotional pricing relative to competition is not an offensive weapon for us, so we take pricing when we think it's right for our business."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. No, that makes sense. I just wanted to clarify. And then just switching over to the West Coast and the promotions. I know you gave some comments about an update on your strategy. But I'm curious if you've made any tweaks or modifications to your pro",79,"Okay. No, that makes sense. I just wanted to clarify. And then just switching over to the West Coast and the promotions. I know you gave some comments about an update on your strategy. But I'm curious if you've made any tweaks or modifications to your program as you've seen how consumers are reacting to the increased promotions behind the brand versus sort of what you were talking to us about at your investor day a few months ago."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, we've made no tweaks. The 4 additional markets, we barely can read them. They started up in -- I think I had said in the investor conference we'd start them in June, and that's when we did start them. So you only got a couple of weeks of data there. T",108,"No, we've made no tweaks. The 4 additional markets, we barely can read them. They started up in -- I think I had said in the investor conference we'd start them in June, and that's when we did start them. So you only got a couple of weeks of data there. The other 4 markets are at the same promotional levels they were. They have been for a year now. And there was just no big spending there. It was immaterial that it had no effect on our -- or no material impact on our margins. Newport margins were -- Menthol margins were up strongly in the quarter."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I just wanted to ask you in relation to Newport Non-Menthol, should we just expect that there's more markets to be added, this happens slowly over time? Is it reasonable to assume there's more in the second half? Or I'm just trying to get to understand th",66,"I just wanted to ask you in relation to Newport Non-Menthol, should we just expect that there's more markets to be added, this happens slowly over time? Is it reasonable to assume there's more in the second half? Or I'm just trying to get to understand the phasing of the new markets you may add -- new non-core markets you may add for that brand."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","For Menthol or Non-Menthol?",5,"For Menthol or Non-Menthol?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","I'm talking Menthol, sorry.",5,"I'm talking Menthol, sorry."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Menthol?",1,"Menthol?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Yes.",1,"Yes."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","We just added the 4 additional markets. I don't think I've given any color on additional markets. I think we'll see how that goes before we make any adjustments. But I'm also not sure we'll share if we do make adjustments. But again, it's small relative t",74,"We just added the 4 additional markets. I don't think I've given any color on additional markets. I think we'll see how that goes before we make any adjustments. But I'm also not sure we'll share if we do make adjustments. But again, it's small relative to the total portfolio right now. Those are long-term investments. They're not going to have a significant impact on either the financials or the volumes as of yet."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. So you had 4, and you added 4 more. I'm just trying to understand the phasing over time. So we should have seen this as a long term -- maybe more markets to be added in 2012, for example?",40,"Sure. So you had 4, and you added 4 more. I'm just trying to understand the phasing over time. So we should have seen this as a long term -- maybe more markets to be added in 2012, for example?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes. I mean, we want it to be profitable. So we'll keep measuring and adjusting as we go. You've got a couple of factors, right? It's the amount of menthol that's sold in the market, so whether it's substantial enough to justify the investment to pay it o",168,"Yes. I mean, we want it to be profitable. So we'll keep measuring and adjusting as we go. You've got a couple of factors, right? It's the amount of menthol that's sold in the market, so whether it's substantial enough to justify the investment to pay it out -- and so far, the 4 markets -- and I think, at the investor conference, we were approaching payout. All 4 of those markets have now exceeded payout and continued to grow at double-digit levels. And one more point. I just want to emphasize what I said at the investor conference. We're not investment spending in those markets. We were priced above competition, fully -- in a full-priced competition. We were -- Newport consumer had to spend $0.50 to $1 more to buy a pack of Newport than a pack of one of the other leading brands. And all we did is get competitive and take away that premium. We're not below them. And these are the results we're seeing."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. And in relation to that, my other question just is that you had mentioned that Newport promotional spending was down in the quarter, like it was in the first quarter. So just to be clear, you're funding these incremental promotions in non-core marke",65,"Sure. And in relation to that, my other question just is that you had mentioned that Newport promotional spending was down in the quarter, like it was in the first quarter. So just to be clear, you're funding these incremental promotions in non-core markets by reductions elsewhere? Or is it just that they're so small, they're not inflating the level of promotion for the brand?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, I mean, I guess, you could answer that question no matter -- either way, right? The net result is, is that promotional spending on Newport Menthol was down, including any additional investment in non-core geographies.",36,"Well, I mean, I guess, you could answer that question no matter -- either way, right? The net result is, is that promotional spending on Newport Menthol was down, including any additional investment in non-core geographies."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then my final question just is a bit of a follow-up on the FDA process from here. Do you -- are we going to learn who the peer reviewers are? Is there any update you expect before that peer review is complete?",44,"Okay. And then my final question just is a bit of a follow-up on the FDA process from here. Do you -- are we going to learn who the peer reviewers are? Is there any update you expect before that peer review is complete?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I have no inside information on that at all. I think -- I don't know whether they have any obligation or not to tell us who the peer reviewers were. What they said the other day was that when they completed it, they would share their own analysis and the",81,"I have no inside information on that at all. I think -- I don't know whether they have any obligation or not to tell us who the peer reviewers were. What they said the other day was that when they completed it, they would share their own analysis and the peer review analysis. So that's what I heard. I don't think -- I don't personally think we're going to hear anything of substance until the end of the year on this."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Christine Farkas with Bank of America Merrill Lynch.",16,"Your next question comes from the line of Christine Farkas with Bank of America Merrill Lynch."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","A couple of housekeeping items, I guess if I could. I appreciate the relatively limited guidance with respect to quarter to quarter. I just wanted to understand if there are any timing factors, be it spending or otherwise. And also the tax rate for the fu",64,"A couple of housekeeping items, I guess if I could. I appreciate the relatively limited guidance with respect to quarter to quarter. I just wanted to understand if there are any timing factors, be it spending or otherwise. And also the tax rate for the full year, if you could imply perhaps that it would be similar to or near 37% for the year?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes. I think the tax rate was low in the second quarter because we settled some state tax matters, which brought it down for the quarter. That's not an indication of what we think the full year will be. We still think the full year is in that 37% neighbor",50,"Yes. I think the tax rate was low in the second quarter because we settled some state tax matters, which brought it down for the quarter. That's not an indication of what we think the full year will be. We still think the full year is in that 37% neighborhood."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And as far as the spending or the quarter-to-quarter legal costs, that kind of thing, is there anything in the second half that would -- that you would want to call out with respect to one-time factors?",38,"Okay. And as far as the spending or the quarter-to-quarter legal costs, that kind of thing, is there anything in the second half that would -- that you would want to call out with respect to one-time factors?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Not any one-time factors. We've experienced this increase in legal costs thats associated with the litigation activities. It's been increasing for quite some time. I don't see any indication that, that's going to let up. But predicting that level quart",47,"Not any one-time factors. We've experienced this increase in legal costs thats associated with the litigation activities. It's been increasing for quite some time. I don't see any indication that, that's going to let up. But predicting that level quarter to quarter is a difficult matter."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Sure. Just moving to Puerto Rico, we're seeing volumes down mid-teens -- cycling down mid-teens. I'm just wondering, aside from tough macro, if there's anything else there structurally that's suggesting this continues at this space?",35,"Sure. Just moving to Puerto Rico, we're seeing volumes down mid-teens -- cycling down mid-teens. I'm just wondering, aside from tough macro, if there's anything else there structurally that's suggesting this continues at this space?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No, I think if you look at the first half, you'll see the numbers are normal. It's -- that's the timing of like when a boat ships. And literally, it's shipped like a day after the quarter ended instead of during the quarter. And the timing of it was to th",66,"No, I think if you look at the first half, you'll see the numbers are normal. It's -- that's the timing of like when a boat ships. And literally, it's shipped like a day after the quarter ended instead of during the quarter. And the timing of it was to the advantage of the first quarter. Look at the 6 months, and you'll see nothing's changed."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay, great. And then just finally on the NPM arbitration, I'm wondering if I can get your perspective on how you think it's going, with respect to the progress. Certainly, there's been discussions of MOUs circulating and that kind of thing. And is there",58,"Okay, great. And then just finally on the NPM arbitration, I'm wondering if I can get your perspective on how you think it's going, with respect to the progress. Certainly, there's been discussions of MOUs circulating and that kind of thing. And is there any comment you could provide to help us understand how that process is going?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Slowly.",1,"Slowly."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Slowly. Okay. So will take some time, several quarters, years, that kind of thing?",14,"Slowly. Okay. So will take some time, several quarters, years, that kind of thing?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Yes, I don't know. It's in arbitration. The MOU got a lot of talk. Those things have gone back and forth. But from what I hear from our counsel, this is a slow process.",34,"Yes, I don't know. It's in arbitration. The MOU got a lot of talk. Those things have gone back and forth. But from what I hear from our counsel, this is a slow process."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Murray, just going back to Newport Red. Could you just talk about the growth driver there? I mean, where the ACVs maybe stand versus Newport Menthol. And is it mostly adding new accounts and shelf space at this point? Is it faster velocity? Just trying to",54,"Murray, just going back to Newport Red. Could you just talk about the growth driver there? I mean, where the ACVs maybe stand versus Newport Menthol. And is it mostly adding new accounts and shelf space at this point? Is it faster velocity? Just trying to get some more breakdown on the growth there."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","There hasn't been any significant change to distribution since the initial launch, so it's all velocity. It's all trial turning into repeat purchase. We have broad-scale distribution. The acceptance of Newport Red has been nationwide. It doesn't necessari",116,"There hasn't been any significant change to distribution since the initial launch, so it's all velocity. It's all trial turning into repeat purchase. We have broad-scale distribution. The acceptance of Newport Red has been nationwide. It doesn't necessarily track in the same stores. In fact, it doesn't, along with Newport Menthol. And I'm not sure if there's any other color I can give to it. It continues to grow week to week. I can't tell you what's been the effect post the price increase because there's been a lot of inventories changing, and there's a lag in our retail data. But right up until that point, it continued to roar along well above our expectation."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. No, that helps. And then just on the repurchase, that accelerated quite a bit this quarter. I was wondering if you could just talk about your thoughts about the pace there, why the company maybe hasn't raised more debt at this point. And given where",70,"Okay. No, that helps. And then just on the repurchase, that accelerated quite a bit this quarter. I was wondering if you could just talk about your thoughts about the pace there, why the company maybe hasn't raised more debt at this point. And given where the share price is now, does that change at all how you think about the pace of repurchase, given that it strengthened so much?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","All right, let me try and answer those one at a time. We did purchase more shares and spent more money in the second quarter than we did in the first quarter. But I wouldn't really characterize that as a conscious acceleration. It had more to do with a co",160,"All right, let me try and answer those one at a time. We did purchase more shares and spent more money in the second quarter than we did in the first quarter. But I wouldn't really characterize that as a conscious acceleration. It had more to do with a conscious deceleration in the first quarter because we wanted to be sure that there was enough dry powder there toward the end of the first quarter because, frankly, if you remember what was going on at the end of the first quarter, we didn't know what was going to happen coming out of TPSAC. Second, we know that we have not yet hit our 1.5x target for our leverage. And you do know the state of the credit markets. And so we look at those, evaluate those on a consistent basis, and we know we have some more moves to make there. I can't give you any indication about timing, though."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And just a final question on FDA. Murray, did you say that you think this won't be published in the register until the end of the year? And then I'm just trying to clarify what exactly you think that publication would encompass. Is it just a science",84,"Okay. And just a final question on FDA. Murray, did you say that you think this won't be published in the register until the end of the year? And then I'm just trying to clarify what exactly you think that publication would encompass. Is it just a science review? Do you think there would be any kind of recommendation there? Or would that come further down the line? And would they discuss the contraband issue at that point or wait until a later date?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","I can tell you what I think, but I have no -- and its based on what they've said. What theyve said was at the end of the year, they would publish a -- not even a full scientific, a preliminary scientific review in the peer process of their prelimina",213,"I can tell you what I think, but I have no -- and its based on what they've said. What theyve said was at the end of the year, they would publish a -- not even a full scientific, a preliminary scientific review in the peer process of their preliminary analysis. At that point, no, I don't think they're going to be writing rules or anything else. In fact, they said that -- I thought they said during the meeting that wouldn't occur at that time, that they would then look at that data, decide what was the appropriate next step. So I see that as just a kick-off of the process. Then does it dictate more research or analysis of contraband or whatever? And then that would be a separate process they would have come back with after that. So yes, I just think this is the start of them independently looking at the science themselves, getting some input, and then there's some point where they have to finalize that as well. Because they did say that there will be comments to that, I believe, as part of it. So anyway, yes, I think it's a long process. I don't think anything's changed here. And I'm glad they're doing their own review."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And just finally, your view -- the white papers that have already been published by FDA in some of the journals, how do you read those? I mean, did those seem like an official sort of policy stance to you? Or is that just preliminary FDA review? Or",55,"Okay. And just finally, your view -- the white papers that have already been published by FDA in some of the journals, how do you read those? I mean, did those seem like an official sort of policy stance to you? Or is that just preliminary FDA review? Or how do you think about those?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Well, I think comments on the softer science that suggests there's a lot more research or a paucity of data is one that stands out to me are important. Because I think everybody has concluded on the hard science that there's no justification or difference",127,"Well, I think comments on the softer science that suggests there's a lot more research or a paucity of data is one that stands out to me are important. Because I think everybody has concluded on the hard science that there's no justification or difference between a menthol cigarette and a non-menthol cigarette or any justification to treat them differently. So on these softer issues, there were -- there was a recognition, I thought, across a number of those white papers that there's limited data and weak data and lack of peer-reviewed studies, et cetera. So we'll see how it plays out. But to me, this issue, while it's gotten a lot of press, is clear-cut that the overwhelming body of scientific evidence doesn't justify a difference."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Karen Lamark with Federated Investors.",13,"Your next question comes from the line of Karen Lamark with Federated Investors."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","If I understood you correctly, Newport Non-Menthol was about 1 point drag on Newport Menthol. Are you surprised at that, in particular, in conjunction with the high-repeat intentions for Newport Non-Menthol? And would you expect the cadence of that cannib",44,"If I understood you correctly, Newport Non-Menthol was about 1 point drag on Newport Menthol. Are you surprised at that, in particular, in conjunction with the high-repeat intentions for Newport Non-Menthol? And would you expect the cadence of that cannibalization to change going forward?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Okay. Let me -- let's be clear what we're talking -- we didn't say 1 point of share. We said 1 -- so what I was saying is that the volume growth was up 1%. And if there wasnt Newport Red cannibalization backing into the numbers, you could've estimated",163,"Okay. Let me -- let's be clear what we're talking -- we didn't say 1 point of share. We said 1 -- so what I was saying is that the volume growth was up 1%. And if there wasnt Newport Red cannibalization backing into the numbers, you could've estimated that it might've been up 2% instead of up 1%, which is a much smaller number than if I mistakenly gave you the impression that we were talking about share. So the data -- and the way I'm getting that is the data that says that Newport Red is 90% incremental. And that's as good as an incremental number as you're ever going to find. So if it's a 1 market share that says 0.1 of the market share, of that 1, came from us. Okay? So if 0.1 came from us, and we're a 10, 11 share. You can say that it's 1/100 of a share point impact or whatever, so very tiny."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And would you expect that relationship to change for any reason going forward?",14,"Okay. And would you expect that relationship to change for any reason going forward?"
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","No.",1,"No."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","Your last question comes from the line of Bill Leach [ph] with Crest [ph].",14,"Your last question comes from the line of Bill Leach [ph] with Crest [ph]."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Analysts","As a shareholder in your company, I was just wondering if you'd consider splitting the stock to decrease the volatility and increase the liquidity.",24,"As a shareholder in your company, I was just wondering if you'd consider splitting the stock to decrease the volatility and increase the liquidity."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Bill [ph], there's an active debate going both ways on whether the company should split its stock or not split its stock. There's been a discussion here about it. We've talked about it. Thus far, we've reached the conclusion that now is not the time to sp",57,"Bill [ph], there's an active debate going both ways on whether the company should split its stock or not split its stock. There's been a discussion here about it. We've talked about it. Thus far, we've reached the conclusion that now is not the time to split it. Maybe there is a time, someday down the line."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks.",22,"If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Executives","Thank you for your continued interest in Lorillard, and we'll look forward to talking to you again next quarter.",19,"Thank you for your continued interest in Lorillard, and we'll look forward to talking to you again next quarter."
4180255,137327135,145441,"Lorillard, Inc., Q2 2011 Earnings Call, Jul 25, 2011",2011-07-25,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 and enter the conference ID 82413734. You may now disconnect.",32,"This concludes the Lorillard Inc. Second Quarter 2011 Earnings Conference Call. For a replay of this call, please dial 1 (800) 642-1687 and enter the conference ID 82413734. You may now disconnect."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for rep",67,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",129,"Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer.
By now, you should have received a copy of our third quarter 2011 earnings release. It can be found on the company's website, lorillard.com, under News Releases.
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties, as described in the company's earnings release and in other filings with the SEC. 
Now, I'd now like to turn the call over to Murray Kessler."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fu",1037,"Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fundamentals were masked by a significant comparative reduction in wholesale inventory, adversely affecting our reported volume growth by just over 400 basis points. But we can't emphasize enough that absent the inventory comparison which was simply a timing issue, our business is measured by retail shipments were there's strong as we've seen all year. This is especially encouraging as we reduced promotional spending versus a year ago on our flagship Newport Menthol brand and our recent round of price increases are all sticking. We also observed no unusual competitive promotional activity during the quarter. So let's take a closer look at third quarter highlights. 
First, total Lorillard domestic volume increased 2.8% versus a year ago in quarter three. Adjusting for inventory fluctuations, total Lorillard domestic volume was up an estimated 7%. This is about the same level of the growth adjusted for inventory changes we saw in the first and second quarters. The point is further illustrated by a look at shipments from wholesale to retail as measured by our proprietary EXCEL database which is unaffected by changes in wholesale inventory. 
Total Lorillard retail shipments were up over 8% versus a year ago in the quarter. Of note, Lorillard discount brand shipments to retail while still up double digits at about 12% actually slowed a little from prior quarters. So the acceleration of our retail shipment and market share growth was driven by our premium brand Newport which grew 8% in total versus a year ago during the quarter, following 5.5% growth in the second quarter and 6.3% in the first quarter. Again, I'm referring to retail shipments which are more indicative of consumer purchasing and eliminate the noise from quarter-to-quarter due to inventory swings. 
Given the difficult macro economic environment that continue during the third quarter, we were happy to see such a strong performance on our premium brand. Our premium strength, traced to the incremental volume this year associated with the Newport Non-Menthol launch and a very strong quarter and improvement in trend on our flagship Newport Menthol business. Newport Menthol benefited from our geographic expansion plan, which we highlighted during our Investor Day. Both of these initiatives are performing extremely well. Newport Non-Menthol continues to hold just under a 1% share despite our recent 20% price increase which has significantly enhanced profitability on this new brand and Newport Menthol in expansion markets continues to grow double digits. 
It's worth mentioning, as a number of investors are concerned about heightened promotional spending hurting industry pricing power, that even with our investment in these expansion markets, total Newport Menthol promotional spending was down versus year ago for the quarter and it is down for the year. This also includes the increased spending effect of volume previously sold non-promotive on Native American reservations in New York switching to promote in volume in other locations. 
So let me repeat my self, while I can't speak for the rest of the industry, Lorillard has reduced by spending this year and this quarter. We recognize that between mixed and more importantly this quarter, the negative inventory comparison, it is hard to see the impact of pricing. David will try and make this as transparent as possible during his comments. Let me reassure you however, that the price increases we took in July are being fully realized to the income statement. 
Turning to the broader industry. We estimate total industry domestic shipments declined 6.4%, similar to Lorillard, the total industry was negatively affected by inventory fluctuations. We estimate that impact to be about three percentage points. 
As our retail volume grew briskly in a declining industry, Lorillard once again gained share across all market categories. Total Lorillard share was 14.2%, up 1.3 points versus year ago. Total Newport gained 1.1 share point and our discount brands gained 0.3 share point. Total Lorillard share of Menthol was 39.2% up 0.9 share points versus a year ago, our strongest gain all year. Newport share of Menthol was 36.1%, up 0.3 share points versus a year ago, also our strongest gain all year. 
Operating profit for the quarter was down 2.2%. EPS is $1.94 per share was up 7.2%. Operating profit in EPS were obviously negatively affected by the inventory comparison. Keep in mind $400 million non-promoted units, primarily of Newport Menthol is worth about $35 million in operating profit or $0.16 per share. There were no other extraordinary variances in the quarter. 
So while we don't give earnings guidance, this is exactly what we expected. And had we given guidance for the year, we would not, and I repeat myself, would not be changing it right now. Notably, we believe the continued strength in our brand fundamentals combined with wholesale inventories now at more normal levels bode well for a very good fourth quarter. And for the same reasons, we are bullish on 2012 despite the outlook for a challenging 2012 macro economic environment. 
Finally, a brief word on the FDA's review of Menthol. We are currently awaiting the peer review of the FDA's preliminary assessment of the science which is due out shortly. We have no reason to believe that this is anything more than just that, a preliminary review. When it comes out, we will respond appropriately during the comment period. Again, we believe this is just one more step than what we believe will be a very long review process. 
You know our position. The best available scientific evidence does not support an assertion that menthol and cigarettes negatively or disproportionately impacts the public health. Smoking has serious risks, but menthol does not contribute to those risks. A menthol cigarette is just another cigarette and should be regulated no differently in totality or for any demographic group. Furthermore, any. draconian regulation will have real, unintended consequences, including the expansion of a contraband market, a loss of tax revenues and a significant loss of jobs. With that, I'll turn the call over to David Taylor, our Chief Financial Officer. David?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for questions. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8%",1017,"Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for questions. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8% increase in wholesale shipment volume. Like last quarter, our average wholesale selling prices in the quarter were higher across the board, but were partially offset by other factors. We spent considerable time on these calls over the last several quarters reviewing the impact of the shift in the mix of our product, as the relatively lower-priced Maverick and Newport Non-Menthol have grown at a more rapid pace than our premium-priced Newport Menthol product. That dynamic impacts the current year's third quarter as well. Newport Non-Menthol and Maverick wholesale volumes in this year's third quarter were greater than the prior year quarter while the rest of our portfolio showed decline. 
Also as we explained in last quarter's call, the impact of fluctuations in wholesale trade inventory levels can be seen in the third quarter's results. To be more specific, even at the risk of being repetitive, we saw strong volumes in last year's third quarter, some of which was aided by a build in wholesale trade inventory in that quarter. In this year's third quarter, we saw the opposite, with wholesale trade inventories declining after building in the second quarter. This was to be expected and the impact on volume comparisons and average net pricing should not surprising. After adjusting for the effect of the increase in wholesale trade inventories last year and the decline this year, we estimate that our wholesale domestic shipments would have increased 7% for the quarter rather than the 2.8% as reported. 
In addition, and as you know, the pattern of consumer promotion buy down programs follows movement at retail, not at wholesale. The cost of these programs are accounted for as a reduction in sales. So in a quarter like this one, they disproportionately impact the consolidated net price comparison to last year. The cost of consumer buy downs in the third quarter was about flat to the second quarter and down from last year's third quarter. We would estimate that the impact of this wholesale trade inventory pattern on a net pricing comparison to last year, calculated on a simple consolidated basis reduced the net price comparison by about 1% in 2011 from 2010. Likewise, the mix effect that I discussed a moment ago amounted to about a 3% reduction in the net price comparison. 
So to summarize, a simple calculation of net price per unit in the third quarter when done on a consolidated basis before excise tax results in a about a 1% per unit increase from last year. That actually is made up of higher realized prices of about 5% across our entire portfolio. However, that 5% was masked by the 3% product mix impact and the 1% impact of the wholesale inventory movement. 
Before percentage point difference in the third quarter unit volume comparisons to last year that arises from that wholesale inventory trade fluctuations would equate to about $75 million in sales and about $35 million in operating income, which more than accounts for the $10 million decline in operating income in the quarter. 
As we enter the fourth quarter, we estimate that wholesale trade inventories are closer to one would call normal. Gross profit in the third quarter of 2011 was roughly flat when compared to last year's third quarter. Cost of goods sold in the third quarter reflects increases over last year in certain cost, including increased FDA user fees. Amounts due to the State Settlement Agreements and the tobacco growers assessment increased $20 million compared to last year's third quarter. 
Selling, general and administrative cost increased $7 million from last year's third quarter, primarily due to higher salaries and benefits, legal fees and expenses associated with increased litigation activity during the quarter, and marketing and other costs associated with our strategic initiatives, including the continuing brand-building costs in support of Newport Non-Menthol. 
Third quarter operating income declined 2.2% to $455 million from $465 million in last year's third quarter. Year-to-date, operating income is up 5.5% compared to last year. 
Fully diluted earnings per share for the third quarter increased 7.2% from last year's third quarter to $1.94 per share. Year-to-date EPS is up 13% compared to last year. The lower share count as compared to the year-ago quarter added $0.18 per share to EPS in this year's third quarter accounting for the increase. 
We accessed the debt market in August, issuing $750 million in senior notes, $500 million in five-year notes at 3.5% and $250 million in 30-year notes at 7%. With this issue, we are close to our stated target of 1.5x EBITDA. We would expect that as our earnings grow, we would access the market again in the future in order to stay close to that ratio. The board would authorize a $750 million share repurchase shortly after we closed the debt transaction. That program is ongoing. 
During the quarter, through September 30, we repurchased approximately 4 million shares at a cost of $438 million under two separate share repurchase authorizations. As of September 30, we had $553 million remaining on the new $750 million program. These actions clearly demonstrate our intent to return cash to shareholders in the form of both dividends and share repurchases. 
We are pleased with the company's performance this quarter and for 2011 so far. As Murray indicated, the fundamentals of our business remain strong and vibrant and we remain confident that we can outperform the industry and deliver superior value to our shareholders. 
When we spoke on this call three months ago, we were bullish on our future and we remain so. Nothing in the third quarter has changed our view or our expectations for 2011 volume and earnings nor our outlook beyond that, and we expect to continue the positive momentum that we've experienced thus far in 2011. And with that, we'd like to open the line for questions. Sarah?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","[Operator Instructions] Your first question comes from the line of Nik Modi of UBS.",14,"[Operator Instructions] Your first question comes from the line of Nik Modi of UBS."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the first quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?",41,"Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the first quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize and then you can take from it what you want is that the trends have been extre",94,"Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize and then you can take from it what you want is that the trends have been extremely predictable, extremely consistent all year long and the only thing that changes underneath it was the inventory. And I said I am bullish about the fourth quarter and next year. So there was nothing that I said that would suggest a change in fundamental."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Great. And then David, one quick housekeeping item. The dividend, clearly your payout ratio was below the target payout you've indicated it should be. Any thoughts on that and your philosophy there ever change or do you anticipate keeping in line with the",45,"Great. And then David, one quick housekeeping item. The dividend, clearly your payout ratio was below the target payout you've indicated it should be. Any thoughts on that and your philosophy there ever change or do you anticipate keeping in line with the historic number?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No. Clearly, our target has not changed and our philosophy hasn't changed and yes, clearly we have, we're paying out dividends in late lower than that stated target. So one could expect a dividend increase at some point in the future.",41,"No. Clearly, our target has not changed and our philosophy hasn't changed and yes, clearly we have, we're paying out dividends in late lower than that stated target. So one could expect a dividend increase at some point in the future."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Can we speak, for example, Murray about pricing for the quarter or price mix up 0.7. I just want to understand that if you go back to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think that was it signi",128,"Can we speak, for example, Murray about pricing for the quarter or price mix up 0.7. I just want to understand that if you go back to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think that was it significant inventory movement that quarter. Maverick is less of the total volume this period. You've taken pricing across the board since then and you had a substantial price increase on Newport Non-Menthol coming into the third quarter. So is there something else at play? I know you went through a lot of details. But just stepping back, I would have thought given those dynamics, you would have seen more of an increase in your sequential and year-on-year pricing?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I really think you got two things at play in the quarter. With the way we look at it. And I've been telling you that we've been reducing buy down spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was d",331,"I really think you got two things at play in the quarter. With the way we look at it. And I've been telling you that we've been reducing buy down spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was down prior quarters.  And I think your notes sort of nailed it. You had roughly 4% to 5% of your volume going through Native American reservations completely non-promoted in New York, and we didn't know how that was going to exactly play out, but you see our total volume trends out. So therefore, consumers kept buying the products and they had to move from a non-promotive location to a promotive location. So you had a, it's not a permanent. We'll lap it. But you had this effect of non-promoted volume becoming promoted volume in the quarter. And then the second one that I still think it's hard for all the analysts out there to model that weekend which is based on our go to market design, our buy downs are relatively larger percentage. We have a higher list price and a higher buy down. So when you get a quarter like this, where inventory is reduced, the buy down still fully occur. And when you take that volume, if you don't take out that sort of a deep enough buy down level, you also get a distortion and that's completely timing and it's not real at all. It's just in the modeling. So those two numbers alone in my estimation account for 2/3 of the variance in a model like yours and then we had a couple of small cost things with the recall, and then signing a union contract to get it. So it's not complicated. We took the price increases and those all passed through. We didn't spend back a penny more on it. We just had a couple variables, mostly timing that will work their way through."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And Murray, have you considered altering your buy down rates towards where the volume has migrated? Do you think that will be an overreaction?",24,"And Murray, have you considered altering your buy down rates towards where the volume has migrated? Do you think that will be an overreaction?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We.",1,"We."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I know introducing your buy down levels where some of the Native American volumes has moved towards?",17,"I know introducing your buy down levels where some of the Native American volumes has moved towards?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much New York's up, neighboring states are up. We modify buy down rates all of the time. I think I know where you're going with the question. And the ans",63,"Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much New York's up, neighboring states are up. We modify buy down rates all of the time. I think I know where you're going with the question. And the answer is probably we did that kind of stuff all the time as a matter of routine."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay, and then as it relates to the FDA. Do have a greater insight into that what the FDA itself has publicly said, with respect to when its view of the menthol science would be publicized?",36,"Okay, and then as it relates to the FDA. Do have a greater insight into that what the FDA itself has publicly said, with respect to when its view of the menthol science would be publicized?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I continue to rely on Neil Wilcox who we hired who's been terrific for us because he comes with that FDA perspective. And if you remember, we had sort of the bunch of rumors flying around the speculation a few months back about a modification to the menth",127,"I continue to rely on Neil Wilcox who we hired who's been terrific for us because he comes with that FDA perspective. And if you remember, we had sort of the bunch of rumors flying around the speculation a few months back about a modification to the menthol report. And he continues to remind me that generally speaking, what they say, they do. And what they said this time was the preliminary reveal of the science out at the end of the year, November, or -- early November, early December somewhere in there. So I believe we're going to see a peer review of the preliminary assessment of the science that will be open for comment and nothing more. And I take it at face value."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And you don't know now and probably won't know after its published who the peer reviewers that were selected are.  Is that correct?",24,"And you don't know now and probably won't know after its published who the peer reviewers that were selected are.  Is that correct?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do. Sometimes they don't.",24,"I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do. Sometimes they don't."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook. And just the ability for the industry to maintain relatively rational pricing, I guess I'm just wondering with respect to your outperformance on the vo",95,"Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook. And just the ability for the industry to maintain relatively rational pricing, I guess I'm just wondering with respect to your outperformance on the volume side, industry is down 3.5% underlying and you're up 8% or so. The risk is that, that dynamic sort of forces your competitors to step up spending, just given that share shift that you've seen and how would you think about your pricing or promotional strategy in the context of that risk?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Okay, it's hard for me to speak to my competitors. But remember we're going to lap the introduction of Newport Non-Menthol here and another couple of months of, from an industry standpoint. It's kind of to weather the storm of new brand being launched. It",271,"Okay, it's hard for me to speak to my competitors. But remember we're going to lap the introduction of Newport Non-Menthol here and another couple of months of, from an industry standpoint. It's kind of to weather the storm of new brand being launched. It's big for us. It's little for the industry. One share for us is and then take fair share that for the competitor worked its worked its way very few tents for everybody else. I doubt they would do something sort of Draconian or crazy over a few tenths of a share point. For us, we have a very clear strategy. We intend to bring Newport and pleasure to all adult smokers, responsibly bring Newport Pleasure to all adult smokers. And our intent to do that is through the pillars that we talked about which is right now building our Newport Non-Menthol business profitably and we took a big price increase this time and getting those geographic expansion markets back in line competitively, so they have a normalized level of promotion instead of being milked the way they were. We're in about eight markets. That's the bulk of the volume so don't expect another big increase in spending coming there. Either, they're growing double digits. We've already lapped two of those markets. And as we go out exit this year, we'll lap another two of those markets and that will effect basically go away sometime next year. So for us, it's blocking and tackling and doing what we've always done, but it starts with superior advertising and working that strategic plan we showed you at Investor Day."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just in terms of Newport's performance, both on the non-menthol side and on the menthol side, I think in Q2, you ended the quarter with red up about just over a share point and it sounds like that sort have been the share level the last thr",112,"Okay. And then just in terms of Newport's performance, both on the non-menthol side and on the menthol side, I think in Q2, you ended the quarter with red up about just over a share point and it sounds like that sort have been the share level the last three months or so. Are you comfortable saying that's kind where we should see the Newport Red settling? Is there more opportunity to see that brand get much bigger? And then on the Newport Menthol performance, you talked about the acceleration in 3Q. Just maybe talk a little bit about mostly geographic expansion, what's been helping the menthol performance on the Newport side?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand and j",137,"So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand and just like we did with Maverick and others, there will be initiatives overtime to grow that business. So our expectation will be to grow it from here. But sort of it sounded the level at that price. So I think you're accurate in that statement. the price increase has a dramatic effect on the profitability of those billions of units that were incrementally selling. On Newport Menthol, I was really pleased in the third quarter. And it was a large part of that was driven by geographic expansion markets."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay, and then just finally, the clarification on Q4 volume because I guess you're lapping the Newport launched and I remember having one last shipping day as well. Is that correct or was the shipping day comparison comparable?",38,"Okay, and then just finally, the clarification on Q4 volume because I guess you're lapping the Newport launched and I remember having one last shipping day as well. Is that correct or was the shipping day comparison comparable?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, you're correct.",3,"No, you're correct."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","So we just have to take us to with the inventory now being pretty normal, we have to take into consideration that shipping day comparison and then that's really the only thing to really think about from a year-over-year comparison perspective?",41,"So we just have to take us to with the inventory now being pretty normal, we have to take into consideration that shipping day comparison and then that's really the only thing to really think about from a year-over-year comparison perspective?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol. But on the other hand, you have 13 weeks. You have the full quarter of shipping it, s",86,"Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol. But on the other hand, you have 13 weeks. You have the full quarter of shipping it, so those are countervailing effects. But yes, you should have -- you should rebuild the volume modeling based on those factors that you've just said and that would be accurate, with the fundamentals that we have been talking about."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Right and then on the positive side, the price mix impact should be much better and what you saw in 3Q just because you don't have the inventory situation and then the mix impact from red would be also muted?",40,"Right and then on the positive side, the price mix impact should be much better and what you saw in 3Q just because you don't have the inventory situation and then the mix impact from red would be also muted?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about.",22,"Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And how much was that, just in terms of the Native American impact? You said it was 2 points or 3 points?",22,"And how much was that, just in terms of the Native American impact? You said it was 2 points or 3 points?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said is that we had roughly 5% of our volume going through",93,"It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said is that we had roughly 5% of our volume going through those Native American reservations previously that was non-promoted. And you can see what happened to our volume comparison. And so if that moved, theoretically, if all that volume moved to promoted locations, that would increase our buy down spending, but exactly how much is very, very difficult."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Right. And did they go to non-promoted stores, promoted stores. But it wouldn't be a big an impact.",18,"Right. And did they go to non-promoted stores, promoted stores. But it wouldn't be a big an impact."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","A couple of questions for you. The first is, you still have eight expansion markets, is that correct that has not changed in the quarter?",25,"A couple of questions for you. The first is, you still have eight expansion markets, is that correct that has not changed in the quarter?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then I guess in related to that, the level of promotion that you're assigning to those new markets, is just the -- you still have Newport promotion down in the quarter. And as a result, that incorporates all that incremental promotion to the exp",48,"Okay. And then I guess in related to that, the level of promotion that you're assigning to those new markets, is just the -- you still have Newport promotion down in the quarter. And as a result, that incorporates all that incremental promotion to the expansion markets. Correct?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And then I just want to ask about the Maverick growth. Are you reading much into that the price is pretty steady if you look it that way between some of the premium brands. Is there anyway as we did do related to that to believe led to Maverick in the qua",52,"And then I just want to ask about the Maverick growth. Are you reading much into that the price is pretty steady if you look it that way between some of the premium brands. Is there anyway as we did do related to that to believe led to Maverick in the quarter?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, we took a healthy price increase for the first time in the year that could have affected a little bit. Our reaction is it's gotten, it's over 5 billion units now, so it's gotten to be quite a big brand. And to be able to take a dime price increase pl",127,"Yes, we took a healthy price increase for the first time in the year that could have affected a little bit. Our reaction is it's gotten, it's over 5 billion units now, so it's gotten to be quite a big brand. And to be able to take a dime price increase plus continue growing it at 12% on a 5 billion unit brand, I'll take back all day long. But the year and 1.5 years ago, it was growing 30-something percent. So as it's gotten scale and gotten bigger and bigger and bigger, it's harder to slow down, I would say that it's fair to say that the pricing had a little bit of effect on it as well, but again, it's very profitable move for us."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Sure.  I would assume that they've been a model and I just want to make sure. And then the last question I just have is your timing for share purchase. And honestly, you're holding a lot of cash in the balance sheet. We went through this a couple years ag",82,"Sure.  I would assume that they've been a model and I just want to make sure. And then the last question I just have is your timing for share purchase. And honestly, you're holding a lot of cash in the balance sheet. We went through this a couple years ago as well as you take on a lot of debt. Is there any motivation to move more quickly on buying back stock now or is it just opportunistic around the stock price?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized to go there and we will continue to repurchase shares. It's not really opportunistic, but it's really more a term of change",77,"No, there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized to go there and we will continue to repurchase shares. It's not really opportunistic, but it's really more a term of change of our capital structure to reduce the weighted average cost capital and we will continue to buyback shows, but I can't really comment on whether that's going to accelerate or decelerate, Chris, I'm sorry."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I just add to it to. There's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares and we intend to stay at the 70% to 75% dividend payout ratio. So it's, th",73,"I just add to it to. There's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares and we intend to stay at the 70% to 75% dividend payout ratio. So it's, that's what we do and the timing of which are little bit we're trying to execute it the most efficient way possible."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Bonnie Herzog with Wells Fargo.",13,"Your next question comes from the line of Bonnie Herzog with Wells Fargo."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I just had a question circling back on pricing. You mentioned of course your net pricing was pretty strong after you make all of these adjustment. But I was kind of wonder if you get a little more detail and sort of what you're seeing regarding the health",83,"I just had a question circling back on pricing. You mentioned of course your net pricing was pretty strong after you make all of these adjustment. But I was kind of wonder if you get a little more detail and sort of what you're seeing regarding the health of the consumer and the acceptance of pricing in general across the overall industry? And then also could you talk a little bit about the price count between Premium Breads and the discount brands overall?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I'll try to answer those questions. I mean, let be just picking up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buy downs in total were down versus the year ago and our volume accelerated in the",350,"I'll try to answer those questions. I mean, let be just picking up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buy downs in total were down versus the year ago and our volume accelerated in the third quarter, so this was one of our strongest if not the strongest all year performances on our premium Newport Menthol brand. It accelerated by a few hundred basis points from the second quarter to the third quarter. So I'm delighted to see that going into what sort of a tough economy and everything that's out there. Our premium brand, it was Maverick that slowed done a little bit. So that's what drove the overall 8% retail consumer takeaway which is our measure -- which is wholesale to retail shipments through EXCEL. But look, we are up about 8% in the first quarter. We're about 8% in the second quarter. We're up about 8% in the third quarter retail. The difference is Maverick slowed a little bit and the different than you already know that Newport Non-Menthol Statesville and the kind of flattish during the quarter, versus the previous quarter so what made the difference up? It was our premium brand. So from a consumer standpoint, we feel very bullish and that all of the things that we've done continue and the fundamentals of our brand, I feel great about the quarter. I wished inventory didn't happen. But I feel good about the quarter in terms of what consumers are purchasing. Our price GAAP strategy is unchanged. We don't like to compete on price. We like to compete with the superior product, rate advertising and fundamental marketing. And when appropriate, carefully launching a new product. So we remain the most expensive cigarette on the market of the traditional premium brands. There's a couple smaller ones. And we try to keep that gap close, but not be the cheapest. For the discount, the deep discount I didn't see anything dramatic I think. I think it was about even in the quarter."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay, that's helpful. Maybe a final quick question on NewPort Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue at you and possibly tweak",51,"Okay, that's helpful. Maybe a final quick question on NewPort Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue at you and possibly tweak your strategy behind these two brands?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Bonne, it went up compared to the third quarter of the prior year which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building cost in the third quarter from the first half of the year.",46,"Bonne, it went up compared to the third quarter of the prior year which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building cost in the third quarter from the first half of the year."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","And I think you said research. I think David said on the call brand building. If we are advertising the brand and we advertise it consistently throughout the year, there was no way increase in more dramatic increase in advertising from prior quarters.",43,"And I think you said research. I think David said on the call brand building. If we are advertising the brand and we advertise it consistently throughout the year, there was no way increase in more dramatic increase in advertising from prior quarters."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Ann Gurkin with Davenport.",12,"Your next question comes from the line of Ann Gurkin with Davenport."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Just wanted to say a follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from incremental brand support in this market or do you need to tweak that?",36,"Just wanted to say a follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from incremental brand support in this market or do you need to tweak that?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, we are -- we are exceeding our expectations. We are -- we wanted to make it competitive even if we took a little bit of a hit. Because remember I keep saying it over and over again, we're not promoting below the price of the competition. We're just el",199,"No, we are -- we are exceeding our expectations. We are -- we wanted to make it competitive even if we took a little bit of a hit. Because remember I keep saying it over and over again, we're not promoting below the price of the competition. We're just eliminating our disadvantage and those markets have responded beautifully. We have now fully lapped and about 14, 15 months into the first two markets where we started and those have fully paid out. So now we have gone in those original two markets from brands that were declining to brands that are more profitable than they were before and growing double digits in those markets. The same pattern is repeating itself with the second wave of markets which we will lap probably this quarter and we're up to a great start on the remaining four which is somewhere around mid-2012 that we lapped then. So the long and short of it is we went from probably a 17 to 20 point, I'm not sure of the exact number, but they were in the kinds and other going is somewhere between maybe the site 20 to 30-point turnaround in those markets."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, in terms of the Newport Menthol expansion, the eight markets, it sounds like any expansion beyond those eight markets, is that capped or stable for a while here?",29,"Murray, in terms of the Newport Menthol expansion, the eight markets, it sounds like any expansion beyond those eight markets, is that capped or stable for a while here?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We -- in essence, the amount of Newport excuse me, the amount of full flavor menthol in the expansion of markets available for us to become more price, more competitively with, we captured 80%, 90% of that at this point. So could we tweak another market?",165,"We -- in essence, the amount of Newport excuse me, the amount of full flavor menthol in the expansion of markets available for us to become more price, more competitively with, we captured 80%, 90% of that at this point. So could we tweak another market? It's not going to add up to much money. So if you're trying to model in your P&L, the amount of money we're going to spend, we are spending for the most part, right and we'll lap those over time and hopefully continue to have growing markets like we've seen in our original markets. And as we grow in the west and other areas, that's going to have to be beyond that, beyond Newport Full Flavor Menthol. It's going to have -- we're going to have to work Newport non-menthol et cetera in markets where those opportunities exist. So we have plans to grow, but the spending effect is for the most part in the P&L at this point."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay and then the decision to take the pricing on Newport Red, I guess I expect a little bit longer runway of this promotions since the brand is ramping up so nicely. Is it just that you want to reallocate some of the promotional dollars to these other th",72,"Okay and then the decision to take the pricing on Newport Red, I guess I expect a little bit longer runway of this promotions since the brand is ramping up so nicely. Is it just that you want to reallocate some of the promotional dollars to these other things? And how quickly do you think Newport Red would ultimately get to what your objective of a standard Newport price point I guess?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","So we said it would take years to get it up there and no, we didn't do anything to reallocate it. We thought that get into a point -- remember, Newport starts to around 11-plus shares, so getting a full share point in there. We're not trying to sell volum",128,"So we said it would take years to get it up there and no, we didn't do anything to reallocate it. We thought that get into a point -- remember, Newport starts to around 11-plus shares, so getting a full share point in there. We're not trying to sell volumes is for volumes take. We sell a lot of volume, you got to put in machinery, you got to all kinds of things are affected.  You've got to run the plants, is going to make money for us. In the business to make money and this price increase has a significant effect. So I mean, our levels of profitability and volume at the end of our first year of launch are dramatically higher than anything we originally modeled."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay and then one for David, as you get closer on the share repurchase, I understand you're not going to give the timing as you get closer to the leverage target here, can you say what levels of cash the company supposed to be holding or how should we thi",52,"Okay and then one for David, as you get closer on the share repurchase, I understand you're not going to give the timing as you get closer to the leverage target here, can you say what levels of cash the company supposed to be holding or how should we think about that?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","As we look at the cash of the balance sheet, we do have -- we have a revolving credit facility of roughly $805 million that accounts are a part of our liquidity. We typically would not want to get the cash in the left side of the balance sheet much greate",90,"As we look at the cash of the balance sheet, we do have -- we have a revolving credit facility of roughly $805 million that accounts are a part of our liquidity. We typically would not want to get the cash in the left side of the balance sheet much greater than $100 million to $200 million. That's about right. Now that is net of any MSA accruals. But I would like to think about that is what they have cash equal to the MSA accrual plus some excess liquidity."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay, and then just finally, Murray I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands and Libya and Evans case how do you look at the appeal here and it's a bit in the quarter was continue to hold the",69,"Okay, and then just finally, Murray I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands and Libya and Evans case how do you look at the appeal here and it's a bit in the quarter was continue to hold the full amount of the VERDICT and cash, is that the case or is that not the case?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, no, on the cash they're not requiring them. They're not requiring them fact that the original judge we went to a field that a judge reversed that. And so know we are not required to hold the cash, so that's incorrect. On the Evans case itself, we be",245,"Well, no, on the cash they're not requiring them. They're not requiring them fact that the original judge we went to a field that a judge reversed that. And so know we are not required to hold the cash, so that's incorrect. On the Evans case itself, we believe we have meritorious defenses and we're appealing that. The judge did reduce the original compensatory damages, not the punitive damages so the number's a lower number have any added interest on that. So long and short of it, we think they got it wrong and we think we will appeal that case and hopefully get ourselves into a more favorable court on tips and we continue to make those challenges, and we believe that is a case that has been worth the doing. The government as far as I understand it my lawyers can clarify this and follow-up calls. But as far as I understand, the defense of the government has not wanted whether right or not he wants standing and whether or not we've been damaged at this point. And in the meantime, there has been progress made in TPSAC and some people have moved up, some others haven't and even some of the things we're seeing we think that standing up for ourselves is having an effect on the whole process. And that alone is it has been worthwhile to the company and to the industry and hopefully will win the case as well."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivian Azor.",10,"Your next question comes from the line of Vivian Azor."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","As we think about the margins this quarter, you spoke obviously about the mix impact and the inventory volume shift, you quickly mentioned in Q&A the Newport recall. I'm curious if you could frame for us kind of the order of magnitude how that big of a de",72,"As we think about the margins this quarter, you spoke obviously about the mix impact and the inventory volume shift, you quickly mentioned in Q&A the Newport recall. I'm curious if you could frame for us kind of the order of magnitude how that big of a deal that was? And also some of the manufacturing over time issues that you highlighted maybe six weeks ago whether that has impact as well?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Vivian, there a few things that impacted the cost structure in the quarter. None of which individually have material. We do have a cost of the recall that's where he said, it was a couple of million dollars. We signed a new four-year contract with our lab",133,"Vivian, there a few things that impacted the cost structure in the quarter. None of which individually have material. We do have a cost of the recall that's where he said, it was a couple of million dollars. We signed a new four-year contract with our labor union during the quarter, which gives us some certainty going forward and that at the signing bonus attached to it which is about $3 million in total. They're was some cost pressures during the quarter, of input cost we see so the eight mid-single digit increases and things like tobacco and some other ingredient cost, but nothing individually added up to anything material. But other things like the recall and the new union contract, you would say those are -- those wouldn't repeat themselves going forward."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Understood.  My other question has to do about the lawsuit regarding graphic warnings. Can you give us an update on that?",21,"Understood.  My other question has to do about the lawsuit regarding graphic warnings. Can you give us an update on that?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, the case was argued. not the case was argued, just the junction, preliminary injunction was argued. The actually case itself would be probably a few months from now or into the spring that judge had indicated that he would evaluate the preliminary i",135,"Well, the case was argued. not the case was argued, just the junction, preliminary injunction was argued. The actually case itself would be probably a few months from now or into the spring that judge had indicated that he would evaluate the preliminary injunction. We think that our lawyer Floyd Abrams did a great job arguing. Why we believe this is a violation of both the First Amendment and the administrative procedures there. We believe that governments has cost, has violated both and we are optimistic we're winning the case itself and we're hopeful that since we're optimistic on the case itself for a give you injunction. He said that he would hopeful to have an opinion on that by the end of October and I really do it a commitment on November so anytime."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Karen Lamark with Federated Investors.",13,"Your next question comes from the line of Karen Lamark with Federated Investors."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I had a question on SG&A. I believe you said there will be no dramatic increase or there was no dramatic increase in advertising cost and I understand there's always one offs. But SG&A to sales it's up in the quarter and year-to-date. I'm just wondering s",56,"I had a question on SG&A. I believe you said there will be no dramatic increase or there was no dramatic increase in advertising cost and I understand there's always one offs. But SG&A to sales it's up in the quarter and year-to-date. I'm just wondering should we expect a higher run rate going forward?"
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Karen, I think the run rate for SG&A could be variable for quarter-to-quarter, mostly going to vary as a result of litigation activity. The legal defense costs are very obviously with the number of cases in trial, varies cases and physicians to there. The",151,"Karen, I think the run rate for SG&A could be variable for quarter-to-quarter, mostly going to vary as a result of litigation activity. The legal defense costs are very obviously with the number of cases in trial, varies cases and physicians to there. The increase in advertising or brand-building costs and annualized basis is probably basically level now. I don't expect to see that material or dramatically increase over time, but we're going to see upward pressures on the SG&A just from things like salary and benefit cost of others other cost increases but most of the change quarter-to-quarter revolves around legal defense costs. And as you do the comparison to revenues in the current quarter, we have to continue to take into account that inventory movement that we continue to talk about. And I'm also reminded that sequentially, SG&A is not really up in the third quarter by any measure."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I was looking year-over-year.",5,"I was looking year-over-year."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks.",22,"If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you for your continued interest in Lorillard. Where -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest.",29,"Thank you for your continued interest in Lorillard. Where -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest."
4180255,141600488,176194,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You ma",42,"This concludes the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You may now disconnect."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for rep",67,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",129,"Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer.
By now, you should have received a copy of our third quarter 2011 earnings release. It can be found on the company's website, lorillard.com, under News Releases.
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties, as described in the company's earnings release and in other filings with the SEC. 
Now, I'd now like to turn the call over to Murray Kessler."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fu",1027,"Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fundamentals were masked by a significant comparative reduction in wholesale inventory, adversely affecting our reported volume growth by just over 400 basis points. But we can't emphasize enough that absent the inventory comparison, which was simply a timing issue, our business, as measured by retail shipments, was as strong as we've seen all year. This is especially encouraging as we reduced promotional spending versus year ago on our flagship Newport Menthol brand, and our recent round of price increases are all sticking. We also observed no unusual competitive promotional activity during the quarter. 
So let's take a closer look at third quarter highlights.  First, total Lorillard domestic volume increased 2.8% versus year ago in quarter 3. Adjusting for inventory fluctuations, total Lorillard domestic volume was up an estimated 7%. This is about the same level of the growth adjusted for inventory changes we saw in the first and second quarters. The point is further illustrated by a look at shipments from wholesale to retail, as measured by our proprietary EXCEL database, which is unaffected by changes in wholesale inventory. 
Total Lorillard retail shipments were up over 8% versus year ago in the quarter. Of note, Lorillard discount brand shipments to retail, while still up double digits at about 12%, actually slowed a little from prior quarters. So the acceleration of our retail shipment and market share growth was driven by our premium brand Newport, which grew 8% in total versus year ago during the quarter, following 5.5% growth in the second quarter and 6.3% in the first quarter. Again, I'm referring to retail shipments, which are more indicative of consumer purchasing and eliminate the noise from quarter-to-quarter due to inventory swings.  Given the difficult macro-economic environment that continue during the third quarter, we were happy to see such a strong performance on our premium brand. 
Our premium strength traced to the incremental volume this year associated with the Newport Non-Menthol launch and a very strong quarter and improvement in trend on our flagship Newport Menthol business. Newport Menthol benefited from our geographic expansion plan, which we highlighted during our Investor Day. Both of these initiatives are performing extremely well. Newport Non-Menthol continues to hold just under a 1% share despite our recent 20% price increase which has significantly enhanced profitability on this new brand, and Newport Menthol, in expansion markets, continues to grow double digits. 
It's worth mentioning, as a number of investors are concerned about heightened promotional spending hurting industry pricing power, that even with our investment in these expansion markets, total Newport Menthol promotional spending was down versus year ago for the quarter, and it is down for the year. This also includes the increased spending effect of volume previously sold non-promotive on Native American reservations in New York, switching to promoted volumes in other locations. 
So let me repeat my self. While I can't speak for the rest of the industry, Lorillard has reduced by down-spending this year and this quarter. We recognize that between mix, and more importantly this quarter, the negative inventory comparison, it is hard to see the impact of pricing. David will try and make this as transparent as possible during his comments. Let me reassure you, however, that the price increases we took in July are being fully realized to the income statement. 
Turning to the broader industry. We estimate total industry domestic shipments declined 6.4%. Similar to Lorillard, the total industry was negatively affected by inventory fluctuations. We estimate that impact to be about 3 percentage points. 
As our retail volume grew briskly in a declining industry, Lorillard, once again, gained share across all market categories. Total Lorillard share was 14.2%, up 1.3 points versus year ago. Total Newport gained 1.1 share points, and our discount brands gained 0.3 share point. Total Lorillard share of Menthol was 39.2%, up 0.9 share points versus year ago, our strongest gain all year. Newport share of Menthol was 36.1%, up 0.3 share points versus year ago, also our strongest gain all year. 
Operating profit for the quarter was down 2.2%. EPS at $1.94 per share was up 7.2%. Operating profit in EPS were, obviously, negatively affected by the inventory comparison. Keep in mind, $400 million non-promoted units, primarily of Newport Menthol, is worth about $35 million in operating profit or $0.16 per share. There were no other extraordinary variances in the quarter. 
So while we don't give earnings guidance, this is exactly what we expected. And had we given guidance for the year, we would not, and I repeat myself, would not be changing it right now. Notably, we believe the continued strength in our brand fundamentals combined with wholesale inventories now at more normal levels, bode well for a very good fourth quarter. And for these same reasons, we are bullish on 2012 despite the outlook for a challenging 2012 macro-economic environment. 
Finally, a brief word on the FDA's review of Menthol. We are currently awaiting the peer review of the FDA's preliminary assessment of the science, which is due out shortly. We have no reason to believe this is anything more than just that, a preliminary review. When it comes out, we will respond appropriately during the comment period. Again, we believe this is just one more step than what we believe will be a very long review process. 
You know our position. The best available scientific evidence does not support an assertion that menthol and cigarettes negatively or disproportionately impacts the public health. Smoking has serious risks, but menthol does not contribute to those risks. A menthol cigarette is just another cigarette and should be regulated no differently in totality or for any demographic group. Furthermore, any. draconian regulation would have real, unintended consequences, including the expansion of a contraband market, a loss of tax revenues and a significant loss of jobs. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer. David?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for question. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8% i",1016,"Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for question. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8% increase in wholesale shipment volume. 
Like last quarter, our average wholesale selling prices in the quarter were higher across the board but were partially offset by other factors. We spent considerable time on these calls over the last several quarters, reviewing the impact of the shift in the mix of our product, as the relatively lower-priced Maverick and Newport Non-Menthol have grown at a more rapid pace than our premium-priced Newport Menthol product. That dynamic impacts the current year's third quarter as well. Newport Non-Menthol and Maverick wholesale volumes, in this year's third quarter, were greater than the prior year quarter, while the rest of our portfolio showed decline. 
Also, as we explained in last quarter's call, the impact of fluctuations in wholesale trade inventory levels can be seen in the third quarter's results. To be more specific, even at the risk of being repetitive, we saw strong volumes in last year's third quarter, some of which was aided by a build in wholesale trade inventory in that quarter. In this year's third quarter, we saw the opposite, with wholesale trade inventories declining after building in the second quarter. This was to be expected, and the impact on volume comparisons and average net pricing should not surprise anyone. After adjusting for the effect of the increase in wholesale trade inventories last year and the decline this year, we estimate that our wholesale domestic shipments would have increased 7% for the quarter, rather than the 2.8% as reported. 
In addition, and as you know, the pattern of consumer promotion buydown programs follows movement at retail, not at wholesale. The cost of these programs are accounted for as a reduction in sales. So in a quarter like this one, they disproportionately impact the consolidated net price comparison to last year. The cost of consumer buydowns in the third quarter was about flat to the second quarter and down from last year's third quarter. We would estimate that the impact of this wholesale trade inventory pattern on a net pricing comparison to last year, calculated on a simple consolidated basis, reduced the net price comparison by about 1% in 2011 from 2010. Likewise, the mix effect that I discussed a moment ago amounted to about a 3% reduction in the net price comparison. 
So to summarize, a simple calculation of net price per unit in the third quarter, when done on a consolidated basis before excise tax, results in a about a 1% per unit increase from last year. That, actually, is made up of higher realized prices of about 5% across our entire portfolio. However, that 5% was masked by the 3% product mix impact and the 1% impact of the wholesale inventory movement. 
The 4 percentage point difference in the third quarter unit volume comparisons to last year that arises from that wholesale inventory trade fluctuations would equate to about $75 million in sales and about $35 million in operating income, which more than accounts for the $10 million decline in operating income in the quarter. 
As we enter the fourth quarter, we estimate that wholesale trade inventories are closer to one would call normal. Gross profit in the third quarter of 2011 was roughly flat when compared to last year's third quarter. Cost of goods sold in the third quarter reflects increases over last year in certain costs, including increased FDA user fees. Amounts due under the State Settlement Agreements and the tobacco growers assessment increased $20 million compared to last year's third quarter. 
Selling, general and administrative costs increased $7 million from last year's third quarter, primarily due to higher salaries and benefits, legal fees and expenses associated with increased litigation activity during the quarter and marketing and other costs associated with our strategic initiatives, including the continuing brand-building costs in support of Newport Non-Menthol. 
Third quarter operating income declined 2.2% to $455 million from $465 million in last year's third quarter. Year-to-date, operating income is up 5.5% compared to last year.  Fully diluted earnings per share for the third quarter increased 7.2% from last year's third quarter to $1.94 per share. Year-to-date EPS is up 13% compared to last year. The lower share count as compared to the year-ago quarter added $0.18 per share to EPS in this year's third quarter, accounting for the increase. 
We accessed the debt market in August, issuing $750 million in senior notes, $500 million in 5-year notes at 3 1/2% and $250 million in 30-year notes at 7%. With this issue, we are close to our stated target of 1.5x EBITDA. We would expect that as our earnings grow, we would access the market again in the future in order to stay close to that ratio. The board authorized a $750 million share repurchase shortly after we closed the debt transaction. That program is ongoing. 
During the quarter, through September 30, we repurchased approximately 4 million shares at a cost of $438 million under 2 separate share repurchase authorizations. As of September 30, we had $553 million remaining on the new $750 million program. These actions clearly demonstrate our intent to return cash to shareholders in the form of both dividends and share repurchases. 
We're pleased with the company's performance this quarter and for 2011 so far. As Murray indicated, the fundamentals of our business remain strong and vibrant, and we remain confident that we can outperform the industry and deliver superior value to our shareholders. 
When we spoke on this call three months ago, we were bullish on our future, and we remain so. Nothing in the third quarter has changed our view or our expectations for 2011 volume and earnings, nor our outlook beyond that, and we expect to continue the positive momentum that we've experienced thus far in 2011. 
And with that, we'd like to open the line for questions. Sarah?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","[Operator Instructions] Your first question comes from the line of Nik Modi with UBS.",14,"[Operator Instructions] Your first question comes from the line of Nik Modi with UBS."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the fourth quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?",41,"Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the fourth quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize, and then you can take from it what you want, is that the trends have been ext",94,"Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize, and then you can take from it what you want, is that the trends have been extremely predictable, extremely consistent all year long, and the only thing that changes underneath it was the inventory. And I said I was bullish about the fourth quarter and next year, so there was nothing that I said that would suggest a change in fundamental."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Great. And then David, one real quick housekeeping item. On the dividends, I mean, clearly, your payout ratio is below where the target payout as you've indicated should be. Any thoughts on that? And your philosophy there, has it changed? Or do you antici",51,"Great. And then David, one real quick housekeeping item. On the dividends, I mean, clearly, your payout ratio is below where the target payout as you've indicated should be. Any thoughts on that? And your philosophy there, has it changed? Or do you anticipate keeping in line with the historic number?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Clearly, our target has not changed, and our philosophy hasn't changed. And yes, clearly, we've-- we're paying out dividends at a rate lower than that stated target, so one could expect a dividend increase at some point in the future.",40,"Clearly, our target has not changed, and our philosophy hasn't changed. And yes, clearly, we've-- we're paying out dividends at a rate lower than that stated target, so one could expect a dividend increase at some point in the future."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Can we speak for a moment more, Murray, about pricing for the quarter, or price mix up to 0.7. I just want to understand, like if you go back say, to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think t",131,"Can we speak for a moment more, Murray, about pricing for the quarter, or price mix up to 0.7. I just want to understand, like if you go back say, to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think there was significant inventory movement that quarter. Maverick is less of the total volume this period. You've taken pricing across the board since then, and you had a substantial price increase on Newport Non-Menthol coming into the third quarter. So is there something else at play? I know you went through a lot of details. But just stepping back, I would have thought, given those dynamics, you would have seen more of an increase in your sequential and year-on-year pricing?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I really think you've got 2 things at play in the quarter. With the way we look at them. I've been telling you that we've been reducing buydown spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was dow",326,"I really think you've got 2 things at play in the quarter. With the way we look at them. I've been telling you that we've been reducing buydown spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was down prior quarters.  And I think your note sort of nailed it. You had roughly 4% to 5% of your volume going through Native American reservations completely non-promoted in New York. And we didn't know how that was going to exactly play out, but you see our total volume trends out. So therefore, consumers kept buying the products, and they had to move from a non-promoted location to a promoted location. So you had a -- it's not a permanent. We'll lap it. But you had this effect of non-promoted volume becoming promoted volume in the quarter. And then the second one that I still think it's hard for all the analysts out there to model that we can, which is based on our go-to-market design, our buydowns are a relatively larger percentage. We have a higher list price and a higher buydown. So when you get a quarter like this, where inventory is reduced, the buydown still fully occur. And when you take out that volume -- if you don't take out sort of a deep enough buydown level, you also get a distortion, and that's completely timing, and it's not real at all. It's just in the modeling. So those 2 numbers alone, in my estimation, account for 2/3 of the variance in a model like yours. And then we had a couple of small cost things with the recall and signing a new union contract to get it. So it's not complicated. We took the price increases, and those all passed through. We didn't spend back $0.01 more on it. We just had a couple variables, mostly timings that'll work their way through."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And Murray, have you considered altering your buydown rates towards where the volume has migrated? Do you think that, that would be an overreaction?",24,"And Murray, have you considered altering your buydown rates towards where the volume has migrated? Do you think that, that would be an overreaction?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We've...",2,"We've..."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","In other words, reducing buydown levels where some of the Native American volume has moved towards?",16,"In other words, reducing buydown levels where some of the Native American volume has moved towards?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much -- New York's up, neighboring states are up. We modify buydown rates all of the time. So I think I know where you're going with the question. And th",64,"Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much -- New York's up, neighboring states are up. We modify buydown rates all of the time. So I think I know where you're going with the question. And the answer is probably we do that kind of stuff all the time as a matter of routine."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then as it relates to the FDA. Murray, do you have any greater insight into then what the FDA itself has publicly said, with respect to when its view of the Menthol science would be publicized?",38,"Okay. And then as it relates to the FDA. Murray, do you have any greater insight into then what the FDA itself has publicly said, with respect to when its view of the Menthol science would be publicized?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I continue to rely on Neil Wilcox, who we hired who's been terrific for us, because he comes with that FDA perspective. And if you remember, we had sort of the -- there was a bunch of rumors flying around in speculation a few months back about a modificat",128,"I continue to rely on Neil Wilcox, who we hired who's been terrific for us, because he comes with that FDA perspective. And if you remember, we had sort of the -- there was a bunch of rumors flying around in speculation a few months back about a modification to the menthol report. And he continues to remind me that -- generally speaking, what they say, they do. And what they said this time was a preliminary review of the science out at the end of the year, November -- early November, early December somewhere in there. So I believe we're going to see a peer review of the preliminary assessment of the science that'll be open for comment, nothing more. And I take it at face value."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","You don't know now and probably won't know after its published who the peer reviewers that were selected are, is that correct?",23,"You don't know now and probably won't know after its published who the peer reviewers that were selected are, is that correct?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do, sometimes they don't.",24,"I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do, sometimes they don't."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook and just the ability for the industry to maintain relatively rational pricing. I guess, I'm just wondering, just with respect to your outperformance on",97,"Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook and just the ability for the industry to maintain relatively rational pricing. I guess, I'm just wondering, just with respect to your outperformance on the volume side, industry is down 3.5% underlying, and you're up 8% or so. The risk that, that dynamic sort of forces your competitors to step up spending, just given that share shift that you've seen, and how would you sort of think about your pricing or promotional strategy in the context of that risk?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Okay. It's hard for me to speak to my competitors. But remember, we're going to lap the introduction of Newport Non-Menthol here another couple of months of so they -- from an industry standpoint, it's kind of weathered the storm of a new brand being laun",278,"Okay. It's hard for me to speak to my competitors. But remember, we're going to lap the introduction of Newport Non-Menthol here another couple of months of so they -- from an industry standpoint, it's kind of weathered the storm of a new brand being launched. It's big for us, it's little for the industry. One share for us is -- and then take fair share of that for the competitors. It works its way to a few tenths for everybody else. I doubt they would do something sort of draconian or crazy over a few tenths of a share point. For us, we have a very clear strategy. We intend to bring Newport pleasure to all adult smokers -- responsibly bring Newport pleasure to all adult smokers. And our intent to do that is through the pillars that we talked about which is right now building our Newport Non-Menthol business profitably, and we took a big price increase this time, and getting those geographic expansion markets back in line competitively, so they have a normalized level of promotion instead of being milked the way they were. We're in about 8 markets. That's the bulk of the volume, so don't expect another big increase in spending coming there. Either, they're growing double digits. We've already lapped 2 of those markets. And as we go out -- exit this year, we'll lap another 2 of those markets, and that effect will basically go away sometime next year. So for us, it's blocking and tackling and doing what we've always done and -- but it starts with superior advertising and working that strategic plan we showed you at Investor Day."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just in terms of Newport's performance, both on the Non-Menthol side and on the Menthol side, I think in Q2, you ended the quarter with Red up about a -- just over a share point, and it sounds like that sort have been the share level the la",117,"Okay. And then just in terms of Newport's performance, both on the Non-Menthol side and on the Menthol side, I think in Q2, you ended the quarter with Red up about a -- just over a share point, and it sounds like that sort have been the share level the last 3 months or so. Are you comfortable saying that's kind of where we should see the Newport Red settling? Is there more opportunity to see that brand get much bigger? And then on the Newport Menthol performance, you talked about the acceleration in 3Q. Just maybe talk a little bit about was that mostly geographic expansion? What's been helping the Menthol performance on the Newport side?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand, and",147,"So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand, and just like we did with Maverick and others, there will be initiatives overtime to grow that business. So our expectation will -- to be to grow it from here. But the sort of -- it found its level with that -- at that price. So I think you're accurate in that statement. I mean, the price increase has a dramatic effect on the profitability of those billions of units that were incrementally selling. On Newport Menthol, I was real pleased in the third quarter, and it was -- a large part of that was driven by geographic expansion markets."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just finally, the clarification on Q4 volume, because, I guess, you're lapping the Newport launched and I remember having one last shipping day as well. Is that correct? Or was the shipping day comparison comparable?",38,"Okay. And then just finally, the clarification on Q4 volume, because, I guess, you're lapping the Newport launched and I remember having one last shipping day as well. Is that correct? Or was the shipping day comparison comparable?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, you're correct.",3,"No, you're correct."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. So we just have to take it to -- with the inventory now being pretty normal, we have to take into consideration that shipping day comparison, and then -- and that's really the only thing to really think about from a year-over-year comparison perspec",45,"Okay. So we just have to take it to -- with the inventory now being pretty normal, we have to take into consideration that shipping day comparison, and then -- and that's really the only thing to really think about from a year-over-year comparison perspective?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol, but on the other hand, you have 13 weeks. You have the full quarter of shipping it, s",87,"Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol, but on the other hand, you have 13 weeks. You have the full quarter of shipping it, so those are countervailing effects. But yes, you should have a -- you should rebuild the volume modeling based on those factors that you just said and that would be accurate, with the fundamentals that we have been talking about."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Right. And then on the positive side, the price mix impact should be much better than what you saw in -- since 3Q, just because you don't have the inventory situation. And then the mix impact from Red would be also muted?",42,"Right. And then on the positive side, the price mix impact should be much better than what you saw in -- since 3Q, just because you don't have the inventory situation. And then the mix impact from Red would be also muted?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about.",22,"Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And how much was that, just in terms of the Native American impact? You said it was 2 points or 3 points on the...",24,"And how much was that, just in terms of the Native American impact? You said it was 2 points or 3 points on the..."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said was that we had roughly 5% of our volume going through",117,"It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said was that we had roughly 5% of our volume going through those Native American reservations previously that was non-promoted. And you can see what happened to our volume comparisons. And so if that moved, theoretically, if all that volume moved to promoted locations, that would have increases our buydown spending, but exactly how much is very, very difficult.  And did they go to non-promoted store, promoted stores, which -- but it wouldn't be as big an impact as you just said though."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I just have a couple of questions for you. The first is, you still have 8 expansion markets, is that correct? That has not changed in the quarter?",28,"I just have a couple of questions for you. The first is, you still have 8 expansion markets, is that correct? That has not changed in the quarter?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, I guess, in related to that, the level of promotion that you're signing deals to those new markets, just -- you still have Newport promotion down starting the quarter. And as a result, that incorporates all that incremental promotion espec",48,"Okay. And then, I guess, in related to that, the level of promotion that you're signing deals to those new markets, just -- you still have Newport promotion down starting the quarter. And as a result, that incorporates all that incremental promotion especially with those expansion markets, correct?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And I just want to ask about the Maverick growth slowing. Do you read much into that or -- because I think, the price goes pretty steady if you look it that way between some of the premium brands. Is anything related to that, that you believe led to",58,"Okay. And I just want to ask about the Maverick growth slowing. Do you read much into that or -- because I think, the price goes pretty steady if you look it that way between some of the premium brands. Is anything related to that, that you believe led to Maverick slowing a little bit in the quarter?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, we took a healthy price increase for the first time in a year that could have affected a little bit. I mean, our reaction is it's gotten -- it's over 5 billion units now, so it's gotten to be quite a big brand. And to be able to take a $0.10 price in",131,"Yes, we took a healthy price increase for the first time in a year that could have affected a little bit. I mean, our reaction is it's gotten -- it's over 5 billion units now, so it's gotten to be quite a big brand. And to be able to take a $0.10 price increase plus continue growing at 12% on a 5 billion unit brand, I'll take that all day long. But 1 year and 1.5 years ago, it started growing 30-something percent. So as it's gotten scale and gotten bigger and bigger and bigger, it's harder to slow down. But I would say that it's fair to say that the pricing had a little bit of effect on it as well, but again, it's a very profitable mode for us."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Sure.  I had assume that was the case and that's the way I modeled it. I just want to make sure it was clear there's nothing else going on there, sure. And the last question I just have was on your timing for share purchase. And honestly, you're holding a",96,"Sure.  I had assume that was the case and that's the way I modeled it. I just want to make sure it was clear there's nothing else going on there, sure. And the last question I just have was on your timing for share purchase. And honestly, you're holding a lot of cash from the balance sheet. We went through this a couple years ago as well, and take on a lot of debt. Is there any motivation to move more quickly on buying back stock now? Or was it just opportunistic around the stock price?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I don't know if there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized us go there, and we will continue to repurchase shares. It's not really opportunistic, but it's really more a te",81,"I don't know if there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized us go there, and we will continue to repurchase shares. It's not really opportunistic, but it's really more a term of changing our capital structure to reduce the weight average cost of capital, and we will continue to buyback shares. But I can't really comment on whether that's going to accelerate or decelerate, Chris, I'm sorry."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes. I mean, Chris, if was to add to it to. I mean, look, there's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares, and we intend to stay at the 70% to",82,"Yes. I mean, Chris, if was to add to it to. I mean, look, there's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares, and we intend to stay at the 70% to 75% dividend payout ratio. So it's -- that's what we do, and the timing of which a little bit we're trying to execute it the most efficient way possible."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Bonnie Herzog with Wells Fargo.",13,"Your next question comes from the line of Bonnie Herzog with Wells Fargo."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I just had a question kind of circling back on pricing. You mentioned, of course, your net pricing was pretty strong after you make all of the adjustments. But I was quite of wondering if you could get a little more detail and sort of what you're seeing r",86,"I just had a question kind of circling back on pricing. You mentioned, of course, your net pricing was pretty strong after you make all of the adjustments. But I was quite of wondering if you could get a little more detail and sort of what you're seeing regarding the health of the consumer and the acceptance of pricing, in general, across the overall industry? And then also could you talk a little bit about the price gap between premium brands and the discount brands overall?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I'll try to answer those questions. Let me just break them up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buydowns in total were down versus the year ago and our volume accelerated in the third",355,"I'll try to answer those questions. Let me just break them up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buydowns in total were down versus the year ago and our volume accelerated in the third quarter, so this was one of our strongest if not the strongest all-year performances on our premium Newport Menthol brand. It accelerated by a few hundred basis points from the second quarter to the third quarter. So I'm delighted to see that, right? Going into what, sort of a tough economy and everything that's out there, our premium brands -- it was Maverick that slowed done a little bit. So that's what drove the overall 8% retail consumer takeaway which is our measure -- which is wholesale to retail shipments through EXCEL. But we're -- look, we were up about 8% in the first quarter. We're up about 8% in the second quarter. We're up about 8% in the third quarter retail. The difference is Maverick slowed a little bit, so our retail -- and you already know that Newport Non-Menthol stayed still and the kind of flattish during the quarter versus the previous quarter. So what made the difference up? It was our premium brand. So from a consumer standpoint, we feel very bullish, and that all the things that we've done continue and the fundamentals of our brand. I feel great about the quarter. I wish the inventory didn't happen. But I feel great about the quarter, in terms of what consumers are purchasing. Our price gap strategy is unchanged. We don't like to compete on price. We like to compete with a superior product, right advertising and fundamental marketing, and when appropriate, carefully launching a new product. So we remain the most expensive cigarette on the market of the sort of traditional premium brands. There's a couple smaller ones. And we try to keep that gap close, but not be the cheapest. For the discount -- the deep discount, I didn't see anything dramatic, I think it was about even in the quarter."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's helpful. And just maybe a final quick question on Newport Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue as you monitor an",54,"Okay. That's helpful. And just maybe a final quick question on Newport Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue as you monitor and then possibly tweak your strategy behind new brand?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Bonnie, it went up compared to the third quarter of the prior year, which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building costs in the third quarter from the first half of the year.",46,"Bonnie, it went up compared to the third quarter of the prior year, which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building costs in the third quarter from the first half of the year."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","And I think you said research but you -- I think David said on the call brand building. We're advertising the brand, and we advertise it consistently throughout the year, as they said, but there was no increase or dramatic increase in advertising from pri",46,"And I think you said research but you -- I think David said on the call brand building. We're advertising the brand, and we advertise it consistently throughout the year, as they said, but there was no increase or dramatic increase in advertising from prior quarters."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Ann Gurkin with Davenport.",12,"Your next question comes from the line of Ann Gurkin with Davenport."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Just wanted to follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from the incremental brand support in these markets, or do you need to tweak that?",35,"Just wanted to follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from the incremental brand support in these markets, or do you need to tweak that?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, we're-- it's exceeding our expectations. We wanted to make it competitive, even if we took a little bit of a hit. Because remember, I keep saying it over and over again, we're not promoting below the price of competition, we were just eliminating our",204,"No, we're-- it's exceeding our expectations. We wanted to make it competitive, even if we took a little bit of a hit. Because remember, I keep saying it over and over again, we're not promoting below the price of competition, we were just eliminating our disadvantage. And those markets have responded beautifully. We have now fully lapped, and we're about 14, 15 months into the first 2 markets where we started, and those have fully paid out. So now we have gone in those original 2 markets from brands that were declining to brands that are more profitable than they were before and growing double digits in those markets. The same pattern is repeating itself with the second wave of markets which we will lap probably this quarter, and then -- and we're off to a great start on the remaining 4 which is somewhere around mid-2012 that we lap them. So the long and short of it is as we went from a -- we probably have a 17 to 20 point -- I'm not sure of the exact number, but they were in declines and now they're growing at somewhere between -- maybe even aside 20- to 30-point turnaround in those markets."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, in terms of the Newport Menthol expansion, the 8 markets, it sounds like the -- any expansion beyond those 8 markets? Is that capped or stable for a while here?",31,"Murray, in terms of the Newport Menthol expansion, the 8 markets, it sounds like the -- any expansion beyond those 8 markets? Is that capped or stable for a while here?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We -- in essence, the amount of Newport -- or excuse me, in essence, the amount of Full Flavor menthol that in expansion markets available for us to become more priced, more competitively with, we've captured 80%, 90% of that at this point. So could we tw",167,"We -- in essence, the amount of Newport -- or excuse me, in essence, the amount of Full Flavor menthol that in expansion markets available for us to become more priced, more competitively with, we've captured 80%, 90% of that at this point. So could we tweak another market? It's just not going to add up too much money. So if you're trying to model in your P&L, the amount of money we're going to spend, we're spending for the most part, right? And we'll lap those over time and hopefully continue to have growing markets like we've seen in our original markets. As we grow in the west and other areas, that's going to have to be beyond that, beyond Newport Full Flavor Menthol. It's going to have -- we're going to have to work Newport Non-Menthol et cetera in markets where those opportunities exist. So we have plans to grow, but the spending effect is, for the most part, in the P&L at this point."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then the decision to take up the pricing on Newport Red, I guess, I expect a little bit longer runway of this promotions, since the brand is ramping up so nicely. Is it just that you wanted to reallocate some of the promotional dollars to other",71,"Okay. And then the decision to take up the pricing on Newport Red, I guess, I expect a little bit longer runway of this promotions, since the brand is ramping up so nicely. Is it just that you wanted to reallocate some of the promotional dollars to other things? And how quickly do you think Newport Red would ultimately get towards your objective of a standard Newport price point, I guess?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, we said it would take years to get it up there. And no, we didn't do anything to reallocate it. We thought that getting to a point -- remember, we, Newport starts at around 11-plus shares, so getting a full share point in there. We're not trying to",140,"Well, we said it would take years to get it up there. And no, we didn't do anything to reallocate it. We thought that getting to a point -- remember, we, Newport starts at around 11-plus shares, so getting a full share point in there. We're not trying to sell volume just for volume's take. When you sell a lot of volume, you got to put in machinery, you got to -- all kinds of things are affected.  You've got to run the plants. You have got MSA cost and all that. It's got to make money for us. We're in the business to make money, and this price increase has a significant effect. So I mean, our levels of profitability and volume at the end of our first year of launch are dramatically higher than anything we originally modeled."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then one for David, I guess. As you get closer on the share repurchase, I understand you're not going to give us timing our future amount, but as you get closer to the leverage target here, can you say what levels of cash the company's comfortab",56,"Okay. And then one for David, I guess. As you get closer on the share repurchase, I understand you're not going to give us timing our future amount, but as you get closer to the leverage target here, can you say what levels of cash the company's comfortable holding? Or how we should think about that?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","As we look at the cash and the balance sheet, we do have -- we have a revolving credit facility of roughly $185 million that counts as a part of our liquidity. We typically would not want to get the cash on the left side of the balance sheet much greater",98,"As we look at the cash and the balance sheet, we do have -- we have a revolving credit facility of roughly $185 million that counts as a part of our liquidity. We typically would not want to get the cash on the left side of the balance sheet much greater than $100 million to $200 million. That's about right. Now that is net of any MSA accruals. So what I like to -- the way I like think to think about that is I want to have cash equal to the MSA accrual plus some excess liquidity."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And just finally, Murray, I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands? And maybe on the Evans case, how you look at the appeal here? And is it -- I've read something that the court was req",72,"Okay. And just finally, Murray, I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands? And maybe on the Evans case, how you look at the appeal here? And is it -- I've read something that the court was requiring you to hold the full amount of the verdict in cash? Is that the case, or is that not the case?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, no, on the cash they're not requiring them. They had filed that the original judge we went to, we appealed that, and a judge reversed that. And so no, we are not required to hold the cash, so that's incorrect. On the Evans case itself, we believe we",246,"Well, no, on the cash they're not requiring them. They had filed that the original judge we went to, we appealed that, and a judge reversed that. And so no, we are not required to hold the cash, so that's incorrect. On the Evans case itself, we believe we have meritorious defenses, and we're appealing that. The judge did reduce the original compensatory damages, not the punitive damages, so the number's a lower number but then you add interest on it. So long and short of it, we think they got it wrong. And we will appeal that case, and hopefully, get ourselves into a more favorable court. On TPSAC, we continue to make those challenges, and we believe that is a case that has been worth doing. The government, as far as I understand, and my lawyers can clarify this and follow-up calls. But as far as I understand, the defense of the government is not one of whether we're right or not, there's this more on standing and whether or not we've been damaged at this point. And in the meantime, there has been progress made in TPSAC and some people have moved off, some others haven't. And even some of the things we're seeing, we think that standing up for ourselves is having an effect on the whole process. And that alone is -- it has been worthwhile to the company and to the industry, and hopefully, we'll win the case as well."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivien Azer.",10,"Your next question comes from the line of Vivien Azer."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","As we think about the margins this quarter, you spoke to, obviously, about the mix impact and the inventory volume shifts, and you quickly mentioned in Q&A the Newport recall. I'm curious, if you could frame for us kind of order of magnitude how big of a",72,"As we think about the margins this quarter, you spoke to, obviously, about the mix impact and the inventory volume shifts, and you quickly mentioned in Q&A the Newport recall. I'm curious, if you could frame for us kind of order of magnitude how big of a deal that was? And also some of the manufacturing over time issues that you highlighted maybe 6 weeks ago, whether there was impact as well?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Okay. Vivien, there were a few things that impacted the cost structure in the quarter, none of which individually were material. We did have a cost of the recall. As Murray said, that was just a couple of million dollars. We signed a new 4-year contract w",141,"Okay. Vivien, there were a few things that impacted the cost structure in the quarter, none of which individually were material. We did have a cost of the recall. As Murray said, that was just a couple of million dollars. We signed a new 4-year contract with our labor union during the quarter, which gives us some certainty going forward. And that had a signing bonus attached to it which was about $3 million in total. There was some other cost pressures during the quarter of input costs. We see sort of mid-single digit price increases on things like tobacco and some other ingredients cost, but none of the -- nothing individually added up to anything material. But the other things like the recall and the new union contract, you would say those are -- those wouldn't repeat themselves going forward."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Understood.  My other question has to do with the lawsuit around graphic warnings. Can you give us an update on that?",21,"Understood.  My other question has to do with the lawsuit around graphic warnings. Can you give us an update on that?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, you'd see the case was argued -- not the case was argued, just the junction. Preliminary injunction was argued. The actual case itself would be probably a few months from now or into the spring. The judge had indicated that he would evaluate the pre",141,"Well, you'd see the case was argued -- not the case was argued, just the junction. Preliminary injunction was argued. The actual case itself would be probably a few months from now or into the spring. The judge had indicated that he would evaluate the preliminary injunction. We think that our lawyer Floyd Abrams did a great job arguing why we believe this is a violation of both the First Amendment and the Administrative Procedures Act. We believe the government has crossed -- has violated both. And we are optimistic on winning the case itself, and we're hopeful that since we're optimistic on the case itself that we'll be granted an injunction. That he said that he would hopeful to have an opinion on that by the end of October. And I believe there was a commitment for November. So anytime."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Karen Lamark with Federated Investors.",13,"Your next question comes from the line of Karen Lamark with Federated Investors."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I have a question on SG&A. I believe you said there'd be no dramatic increase, or there was no dramatic increase in the advertising cost. And I understand there's always one-offs. But SG&A to sales is up in the quarter and year-to-date. And I'm just wonde",56,"I have a question on SG&A. I believe you said there'd be no dramatic increase, or there was no dramatic increase in the advertising cost. And I understand there's always one-offs. But SG&A to sales is up in the quarter and year-to-date. And I'm just wondering, should we expect a higher run rate going forward?"
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Karen, I think the run rate for SG&A could be variable quarter-to-quarter and is mostly going to vary as a result of litigation activity. The legal defense costs vary, obviously, with the number of cases in trial, number of cases at various positions thro",153,"Karen, I think the run rate for SG&A could be variable quarter-to-quarter and is mostly going to vary as a result of litigation activity. The legal defense costs vary, obviously, with the number of cases in trial, number of cases at various positions through there. The increase in advertising or brand-building costs on an annualized basis is probably basically level now. I don't expect to see that material or dramatically increase over time, but we're going to see upward pressures on SG&A, just from things like salary and benefit cost increases and other cost increases. But most of the change quarter-to-quarter revolves around legal defense costs. And as you do the comparison to revenues in the current quarter, you have to continue to take into account that inventory movement that we continue to talk about. And I'm also reminded that sequentially, SG&A is not really up in the third quarter by any measure."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks.",22,"If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you for your continued interest in Lorillard. We're -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest.",29,"Thank you for your continued interest in Lorillard. We're -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest."
4180255,141600488,176361,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard, Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You m",42,"This concludes the Lorillard, Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You may now disconnect."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for rep",67,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",129,"Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer.
By now, you should have received a copy of our third quarter 2011 earnings release. It can be found on the company's website, lorillard.com, under News Releases.
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties, as described in the company's earnings release and in other filings with the SEC. 
Now, I'd now like to turn the call over to Murray Kessler."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fu",1027,"Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fundamentals were masked by a significant comparative reduction in wholesale inventory, adversely affecting our reported volume growth by just over 400 basis points. But we can't emphasize enough that absent the inventory comparison, which was simply a timing issue, our business, as measured by retail shipments, was as strong as we've seen all year. This is especially encouraging as we reduced promotional spending versus year ago on our flagship Newport Menthol brand, and our recent round of price increases are all sticking. We also observed no unusual competitive promotional activity during the quarter. 
So let's take a closer look at third quarter highlights.  First, total Lorillard domestic volume increased 2.8% versus year ago in quarter 3. Adjusting for inventory fluctuations, total Lorillard domestic volume was up an estimated 7%. This is about the same level of the growth adjusted for inventory changes we saw in the first and second quarters. The point is further illustrated by a look at shipments from wholesale to retail, as measured by our proprietary Excel database, which is unaffected by changes in wholesale inventory. 
Total Lorillard retail shipments were up over 8% versus year ago in the quarter. Of note, Lorillard discount brand shipments to retail, while still up double digits at about 12%, actually slowed a little from prior quarters. So the acceleration of our retail shipment and market share growth was driven by our premium brand Newport, which grew 8% in total versus year ago during the quarter, following 5.5% growth in the second quarter and 6.3% in the first quarter. Again, I'm referring to retail shipments, which are more indicative of consumer purchasing and eliminate the noise from quarter-to-quarter due to inventory swings.  Given the difficult macro-economic environment that continued during the third quarter, we were happy to see such a strong performance on our premium brand. 
Our premium strength traced to the incremental volume this year associated with the Newport Non-Menthol launch and a very strong quarter and improvement in trend on our flagship Newport Menthol business. Newport Menthol benefited from our geographic expansion plan, which we highlighted during our Investor Day. Both of these initiatives are performing extremely well. Newport Non-Menthol continues to hold just under a 1% share despite our recent 20% price increase which has significantly enhanced profitability on this new brand, and Newport Menthol, in expansion markets, continues to grow double digits. 
It's worth mentioning, as a number of investors are concerned about heightened promotional spending hurting industry pricing power, that even with our investment in these expansion markets, total Newport Menthol promotional spending was down versus year ago for the quarter, and it is down for the year. This also includes the increased spending effect of volume previously sold non-promotive on Native American reservations in New York, switching to promoted volumes in other locations. 
So let me repeat my self. While I can't speak for the rest of the industry, Lorillard has reduced by down-spending this year and this quarter. We recognize that between mix, and more importantly this quarter, the negative inventory comparison, it is hard to see the impact of pricing. David will try and make this as transparent as possible during his comments. Let me reassure you, however, that the price increases we took in July are being fully realized to the income statement. 
Turning to the broader industry. We estimate total industry domestic shipments declined 6.4%. Similar to Lorillard, the total industry was negatively affected by inventory fluctuations. We estimate that impact to be about three percentage points. 
As our retail volume grew briskly in a declining industry, Lorillard, once again, gained share across all market categories. Total Lorillard share was 14.2%, up 1.3 points versus year ago. Total Newport gained 1.1 share points, and our discount brands gained 0.3 share point. Total Lorillard share of Menthol was 39.2%, up 0.9 share points versus year ago, our strongest gain all year. Newport share of Menthol was 36.1%, up 0.3 share points versus year ago, also our strongest gain all year. 
Operating profit for the quarter was down 2.2%. EPS at $1.94 per share was up 7.2%. Operating profit in EPS were, obviously, negatively affected by the inventory comparison. Keep in mind, $400 million non-promoted units, primarily of Newport Menthol, is worth about $35 million in operating profit or $0.16 per share. There were no other extraordinary variances in the quarter. 
So while we don't give earnings guidance, this is exactly what we expected. And had we given guidance for the year, we would not, and I repeat myself, would not be changing it right now. Notably, we believe the continued strength in our brand fundamentals combined with wholesale inventories now at more normal levels, bode well for a very good fourth quarter. And for these same reasons, we are bullish on 2012 despite the outlook for a challenging 2012 macroeconomic environment. 
Finally, a brief word on the FDA's review of Menthol. We are currently awaiting the peer review of the FDA's preliminary assessment of the science, which is due out shortly. We have no reason to believe this is anything more than just that, a preliminary review. When it comes out, we will respond appropriately during the comment period. Again, we believe this is just one more step than what we believe will be a very long review process. 
You know our position. The best available scientific evidence does not support an assertion that menthol and cigarettes negatively or disproportionately impacts the public health. Smoking has serious risks, but menthol does not contribute to those risks. A menthol cigarette is just another cigarette and should be regulated no differently in totality or for any demographic group. Furthermore, any. draconian regulation would have real, unintended consequences, including the expansion of a contraband market, a loss of tax revenues and a significant loss of jobs. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer. David?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for question. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8% i",1016,"Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for question. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8% increase in wholesale shipment volume. 
Like last quarter, our average wholesale selling prices in the quarter were higher across the board but were partially offset by other factors. We spent considerable time on these calls over the last several quarters, reviewing the impact of the shift in the mix of our product, as the relatively lower-priced Maverick and Newport Non-Menthol have grown at a more rapid pace than our premium-priced Newport Menthol product. That dynamic impacts the current year's third quarter as well. Newport Non-Menthol and Maverick wholesale volumes, in this year's third quarter, were greater than the prior year quarter, while the rest of our portfolio showed decline. 
Also, as we explained in last quarter's call, the impact of fluctuations in wholesale trade inventory levels can be seen in the third quarter's results. To be more specific, even at the risk of being repetitive, we saw strong volumes in last year's third quarter, some of which was aided by a build in wholesale trade inventory in that quarter. In this year's third quarter, we saw the opposite, with wholesale trade inventories declining after building in the second quarter. This was to be expected, and the impact on volume comparisons and average net pricing should not surprise anyone. After adjusting for the effect of the increase in wholesale trade inventories last year and the decline this year, we estimate that our wholesale domestic shipments would have increased 7% for the quarter, rather than the 2.8% as reported. 
In addition, and as you know, the pattern of consumer promotion buydown programs follows movement at retail, not at wholesale. The costs of these programs are accounted for as a reduction in sales. So in a quarter like this one, they disproportionately impact the consolidated net price comparison to last year. The cost of consumer buydowns in the third quarter was about flat to the second quarter and down from last year's third quarter. We would estimate that the impact of this wholesale trade inventory pattern on the net pricing comparison to last year, calculated on a simple consolidated basis, reduced the net price comparison by about 1% in 2011 from 2010. Likewise, the mix effect that I discussed a moment ago amounted to about a 3% reduction in the net price comparison. 
So to summarize, a simple calculation of net price per unit in the third quarter, when done on a consolidated basis before excise tax, results in a about a 1% per unit increase from last year. That, actually, is made up of higher realized prices of about 5% across our entire portfolio. However, that 5% was masked by the 3% product mix impact and the 1% impact of the wholesale inventory movement. 
The four percentage point difference in the third quarter unit volume comparisons to last year that arises from that wholesale inventory trade fluctuations would equate to about $75 million in sales and about $35 million in operating income, which more than accounts for the $10 million decline in operating income in the quarter. 
As we enter the fourth quarter, we estimate that wholesale trade inventories are closer to one would call normal. Gross profit in the third quarter of 2011 was roughly flat when compared to last year's third quarter. Cost of goods sold in the third quarter reflects increases over last year in certain costs, including increased FDA user fees. Amounts due under the State Settlement Agreements and the tobacco growers assessment increased $20 million compared to last year's third quarter. 
Selling, general and administrative costs increased $7 million from last year's third quarter, primarily due to higher salaries and benefits, legal fees and expenses associated with increased litigation activity during the quarter and marketing and other costs associated with our strategic initiatives, including the continuing brand-building costs in support of Newport Non-Menthol. 
Third quarter operating income declined 2.2% to $455 million from $465 million in last year's third quarter. Year-to-date, operating income is up 5.5% compared to last year.  Fully diluted earnings per share for the third quarter increased 7.2% from last year's third quarter to $1.94 per share. Year-to-date EPS is up 13% compared to last year. The lower share count as compared to the year-ago quarter added $0.18 per share to EPS in this year's third quarter, accounting for the increase. 
We accessed the debt market in August, issuing $750 million in senior notes, $500 million in 5-year notes at 3 1/2% and $250 million in 30-year notes at 7%. With this issue, we are close to our stated target of 1.5x EBITDA. We would expect that as our earnings grow, we would access the market again in the future in order to stay close to that ratio. The board authorized a $750 million share repurchase shortly after we closed the debt transaction. That program is ongoing. 
During the quarter, through September 30, we repurchased approximately four million shares at a cost of $438 million under two separate share repurchase authorizations. As of September 30, we had $553 million remaining on the new $750 million program. These actions clearly demonstrate our intent to return cash to shareholders in the form of both dividends and share repurchases. 
We're pleased with the company's performance this quarter and for 2011 so far. As Murray indicated, the fundamentals of our business remain strong and vibrant, and we remain confident that we can outperform the industry and deliver superior value to our shareholders. 
When we spoke on this call three months ago, we were bullish on our future, and we remain so. Nothing in the third quarter has changed our view or our expectations for 2011 volume and earnings, nor our outlook beyond that, and we expect to continue the positive momentum that we've experienced thus far in 2011. 
And with that, we'd like to open the line for questions. Sarah?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of Nik Modi with UBS.",14,"[Operator Instructions] Your first question comes from the line of Nik Modi with UBS."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the fourth quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?",41,"Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the fourth quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize, and then you can take from it what you want, is that the trends have been ext",94,"Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize, and then you can take from it what you want, is that the trends have been extremely predictable, extremely consistent all year long, and the only thing that changes underneath it was the inventory. And I said I was bullish about the fourth quarter and next year, so there was nothing that I said that would suggest a change in fundamental."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Great. And then David, one real quick housekeeping item. On the dividends, I mean, clearly, your payout ratio is below where the target payout as you've indicated should be. Any thoughts on that? And your philosophy there, has it changed? Or do you antici",51,"Great. And then David, one real quick housekeeping item. On the dividends, I mean, clearly, your payout ratio is below where the target payout as you've indicated should be. Any thoughts on that? And your philosophy there, has it changed? Or do you anticipate keeping in line with the historic number?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Clearly, our target has not changed, and our philosophy hasn't changed. And yes, clearly, we've-- we're paying out dividends at a rate lower than that stated target, so one could expect a dividend increase at some point in the future.",40,"Clearly, our target has not changed, and our philosophy hasn't changed. And yes, clearly, we've-- we're paying out dividends at a rate lower than that stated target, so one could expect a dividend increase at some point in the future."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Can we speak for a moment more, Murray, about pricing in the quarter, or price mix up to 0.7. I just want to understand, like if you go back say, to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think th",131,"Can we speak for a moment more, Murray, about pricing in the quarter, or price mix up to 0.7. I just want to understand, like if you go back say, to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think there was significant inventory movement that quarter. Maverick is less of the total volume this period. You've taken pricing across the board since then, and you had a substantial price increase on Newport Non-Menthol coming into the third quarter. So is there something else at play? I know you went through a lot of details. But just stepping back, I would have thought, given those dynamics, you would have seen more of an increase in your sequential and year-on-year pricing?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I really think you've got two things at play in the quarter. With the way we look at them. I've been telling you that we've been reducing buydown spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was d",327,"I really think you've got two things at play in the quarter. With the way we look at them. I've been telling you that we've been reducing buydown spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was down prior quarters.  And I think your note sort of nailed it. You had roughly 4% to 5% of your volume going through Native American reservations completely non-promoted in New York. And we didn't know how that was going to exactly play out, but you see our total volume trends out. So therefore, consumers kept buying the products, and they had to move from a non-promoted location to a promoted location. So you had a -- it's not a permanent. We'll lap it. But you had this effect of non-promoted volume becoming promoted volume in the quarter. And then the second one that I still think it's hard for all the analysts out there to model that we can, which is based on our go-to-market design, our buydowns are a relatively larger percentage. We have a higher list price and a higher buydown. So when you get a quarter like this, where inventory is reduced, the buydowns still fully occur. And when you take out that volume -- if you don't take out at sort of a deep enough buydown level, you also get a distortion, and that's completely timing, and it's not real at all. It's just in the modeling. So those 2 numbers alone, in my estimation, account for 2/3 of the variance in a model like yours. And then we had a couple of small cost things with the recall and signing a new union contract to get it. So it's not complicated. We took the price increases, and those all passed through. We didn't spend back $0.01 more on it. We just had a couple variables, mostly timings that'll work their way through."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And Murray, have you considered altering your buydown rates towards where the volume has migrated? Do you think that, that would be an overreaction?",24,"And Murray, have you considered altering your buydown rates towards where the volume has migrated? Do you think that, that would be an overreaction?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We've...",2,"We've..."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","In other words, reducing buydown levels where some of the Native American volume has moved towards?",16,"In other words, reducing buydown levels where some of the Native American volume has moved towards?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much -- New York's up, neighboring states are up. We modify buydown rates all of the time. So I think I know where you're going with the question. And th",64,"Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much -- New York's up, neighboring states are up. We modify buydown rates all of the time. So I think I know where you're going with the question. And the answer is probably we do that kind of stuff all the time as a matter of routine."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then as it relates to the FDA. Murray, do you have any greater insight into then what the FDA itself has publicly said, with respect to when its view of the Menthol science would be publicized?",38,"Okay. And then as it relates to the FDA. Murray, do you have any greater insight into then what the FDA itself has publicly said, with respect to when its view of the Menthol science would be publicized?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I continue to rely on Neil Wilcox, who we hired who's been terrific for us, because he comes with that FDA perspective. And if you remember, we had sort of the -- there was a bunch of rumors flying around in speculation a few months back about a modificat",128,"I continue to rely on Neil Wilcox, who we hired who's been terrific for us, because he comes with that FDA perspective. And if you remember, we had sort of the -- there was a bunch of rumors flying around in speculation a few months back about a modification to the menthol report. And he continues to remind me that -- generally speaking, what they say, they do. And what they said this time was a preliminary review of the science out at the end of the year, November -- early November, early December somewhere in there. So I believe we're going to see a peer review of the preliminary assessment of the science that'll be open for comment, nothing more. And I take it at face value."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","You don't know now and probably won't know after its published who the peer reviewers that were selected are, is that correct?",23,"You don't know now and probably won't know after its published who the peer reviewers that were selected are, is that correct?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do, sometimes they don't.",24,"I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do, sometimes they don't."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook and just the ability for the industry to maintain relatively rational pricing. I guess, I'm just wondering, just with respect to your outperformance on",97,"Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook and just the ability for the industry to maintain relatively rational pricing. I guess, I'm just wondering, just with respect to your outperformance on the volume side, industry is down 3.5% underlying, and you're up 8% or so. The risk that, that dynamic sort of forces your competitors to step up spending, just given that share shift that you've seen, and how would you sort of think about your pricing or promotional strategy in the context of that risk?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Okay. It's hard for me to speak to my competitors. But remember, we're going to lap the introduction of Newport Non-Menthol here another couple of months of so they -- from an industry standpoint, it's kind of weathered the storm of a new brand being laun",278,"Okay. It's hard for me to speak to my competitors. But remember, we're going to lap the introduction of Newport Non-Menthol here another couple of months of so they -- from an industry standpoint, it's kind of weathered the storm of a new brand being launched. It's big for us, it's little for the industry. One share for us is -- and then take fair share of that for the competitors. It works its way to a few tenths for everybody else. I doubt they would do something sort of draconian or crazy over a few tenths of a share point. For us, we have a very clear strategy. We intend to bring Newport pleasure to all adult smokers -- responsibly bring Newport pleasure to all adult smokers. And our intent to do that is through the pillars that we talked about which is right now building our Newport Non-Menthol business profitably, and we took a big price increase this time, and getting those geographic expansion markets back in line competitively, so they have a normalized level of promotion instead of being milked the way they were. We're in about 8 markets. That's the bulk of the volume, so don't expect another big increase in spending coming there. Either, they're growing double digits. We've already lapped 2 of those markets. And as we go out -- exit this year, we'll lap another 2 of those markets, and that effect will basically go away sometime next year. So for us, it's blocking and tackling and doing what we've always done and -- but it starts with superior advertising and working that strategic plan we showed you at Investor Day."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just in terms of Newport's performance, both on the Non-Menthol side and on the Menthol side, I think in Q2, you ended the quarter with Red up about a -- just over a share point, and it sounds like that sort have been the share level the la",117,"Okay. And then just in terms of Newport's performance, both on the Non-Menthol side and on the Menthol side, I think in Q2, you ended the quarter with Red up about a -- just over a share point, and it sounds like that sort have been the share level the last three months or so. Are you comfortable saying that's kind of where we should see the Newport Red settling? Is there more opportunity to see that brand get much bigger? And then on the Newport Menthol performance, you talked about the acceleration in 3Q. Just maybe talk a little bit about was that mostly geographic expansion? What's been helping the Menthol performance on the Newport side?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand, and",144,"So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand, and just like we did with Maverick and others, there will be initiatives overtime to grow that business. So our expectation will -- to be to grow it from here. But the sort of -- it found its level at that price. So I think you're accurate in that statement. I mean, the price increase has a dramatic effect on the profitability of those billions of units that were incrementally selling. On Newport Menthol, I was real pleased in the third quarter, and it was -- a large part of that was driven by geographic expansion markets."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just finally, the clarification on Q4 volume, because, I guess, you're lapping the Newport launch and I remember having one less shipping day as well. Is that correct? Or was the shipping day comparison comparable?",38,"Okay. And then just finally, the clarification on Q4 volume, because, I guess, you're lapping the Newport launch and I remember having one less shipping day as well. Is that correct? Or was the shipping day comparison comparable?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, you're correct.",3,"No, you're correct."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. So we just have to take it to -- with the inventory now being pretty normal, we have to take into consideration that shipping day comparison, and then -- and that's really the only thing to really think about from a year-over-year comparison perspec",45,"Okay. So we just have to take it to -- with the inventory now being pretty normal, we have to take into consideration that shipping day comparison, and then -- and that's really the only thing to really think about from a year-over-year comparison perspective?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol, but on the other hand, you have 13 weeks. You have the full quarter of shipping it, s",87,"Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol, but on the other hand, you have 13 weeks. You have the full quarter of shipping it, so those are countervailing effects. But yes, you should have a -- you should rebuild the volume modeling based on those factors that you just said and that would be accurate, with the fundamentals that we have been talking about."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Right. And then on the positive side, the price mix impact should be much better than what you saw in -- since 3Q, just because you don't have the inventory situation. And then the mix impact from Red would be also muted?",42,"Right. And then on the positive side, the price mix impact should be much better than what you saw in -- since 3Q, just because you don't have the inventory situation. And then the mix impact from Red would be also muted?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about.",22,"Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And how much was that, just in terms of the Native American impact? You said it was two points or three points on the...",24,"And how much was that, just in terms of the Native American impact? You said it was two points or three points on the..."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said was that we had roughly 5% of our volume going through",117,"It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said was that we had roughly 5% of our volume going through those Native American reservations previously that was non-promoted. And you can see what happened to our volume comparisons. And so if that moved, theoretically, if all that volume moved to promoted locations, that would have increased our buydown spending, but exactly how much is very, very difficult.  And did they go to non-promoted store, promoted stores, which -- but it wouldn't be as big an impact as you just said though."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I just have a couple of questions for you. The first is, you still have eight expansion markets, is that correct? That has not changed in the quarter?",28,"I just have a couple of questions for you. The first is, you still have eight expansion markets, is that correct? That has not changed in the quarter?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, I guess, in related to that, the level of promotion that you're signing deals to those new markets, just -- you still have Newport promotion down starting the quarter. And as a result, that incorporates all that incremental promotion espec",48,"Okay. And then, I guess, in related to that, the level of promotion that you're signing deals to those new markets, just -- you still have Newport promotion down starting the quarter. And as a result, that incorporates all that incremental promotion especially with those expansion markets, correct?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And I just want to ask about the Maverick growth slowing. Do you read much into that or -- because I think, the price goes from pretty steady if you look it that way between some of the premium brands. Is anything related to that, that you believe l",59,"Okay. And I just want to ask about the Maverick growth slowing. Do you read much into that or -- because I think, the price goes from pretty steady if you look it that way between some of the premium brands. Is anything related to that, that you believe led to Maverick slowing a little bit in the quarter?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, we took a healthy price increase for the first time in a year that could have affected a little bit. I mean, our reaction is it's gotten -- it's over five billion units now, so it's gotten to be quite a big brand. And to be able to take a $0.10 price",131,"Yes, we took a healthy price increase for the first time in a year that could have affected a little bit. I mean, our reaction is it's gotten -- it's over five billion units now, so it's gotten to be quite a big brand. And to be able to take a $0.10 price increase plus continue growing at 12% on a five billion unit brand, I'll take that all day long. But one year and 1.5 years ago, it started growing 30-something percent. So as it's gotten scale and gotten bigger and bigger and bigger, it's harder to slow down. But I would say that it's fair to say that the pricing had a little bit of effect on it as well, but again, it's a very profitable mode for us."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Sure.  I had assume that was the case and that's the way I modeled it. I just want to make sure it was clear there's nothing else going on there, sure. And the last question I just have was on your timing for share purchase. And honestly, you're holding a",97,"Sure.  I had assume that was the case and that's the way I modeled it. I just want to make sure it was clear there's nothing else going on there, sure. And the last question I just have was on your timing for share purchase. And honestly, you're holding a lot of cash from the balance sheet. We went through this a couple years ago as well, and you took on a lot of debt. Is there any motivation to move more quickly on buying back stock now? Or was it just opportunistic around the stock price?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I don't know if there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized us to go there, and we will continue to repurchase shares. It's not really opportunistic, but it's really more a",83,"I don't know if there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized us to go there, and we will continue to repurchase shares. It's not really opportunistic, but it's really more a term of changing our capital structure to reduce the weight of average cost of capital, and we will continue to buyback shares. But I can't really comment on whether that's going to accelerate or decelerate, Chris, I'm sorry."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes. I mean, Chris, I will just add to it to. I mean, look, there's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares, and we intend to stay at the 70% t",82,"Yes. I mean, Chris, I will just add to it to. I mean, look, there's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares, and we intend to stay at the 70% to 75% dividend payout ratio. So it's -- that's what we do, and the timing of which a little bit we're trying to execute it the most efficient way possible."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Bonnie Herzog with Wells Fargo.",13,"Your next question comes from the line of Bonnie Herzog with Wells Fargo."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I just had a question kind of circling back on pricing. You mentioned, of course, your net pricing was pretty strong after you make all of the adjustments. But I was kind of wondering if you could get a little more detail and sort of what you're seeing re",86,"I just had a question kind of circling back on pricing. You mentioned, of course, your net pricing was pretty strong after you make all of the adjustments. But I was kind of wondering if you could get a little more detail and sort of what you're seeing regarding the health of the consumer and the acceptance of pricing, in general, across the overall industry? And then also could you talk a little bit about the price gap between premium brands and the discount brands overall?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I'll try to answer those questions. Let me just break them up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buydowns in total were down versus the year ago and our volume accelerated in the third",355,"I'll try to answer those questions. Let me just break them up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buydowns in total were down versus the year ago and our volume accelerated in the third quarter, so this was one of our strongest if not the strongest all-year performances on our premium Newport Menthol brand. It accelerated by a few hundred basis points from the second quarter to the third quarter. So I'm delighted to see that, right? Going into what, sort of a tough economy and everything that's out there, our premium brands -- it was Maverick that slowed down a little bit. So that's what drove the overall 8% retail consumer takeaway which is our measure -- which is wholesale to retail shipments through Excel. But we're -- look, we were up about 8% in the first quarter. We're up about 8% in the second quarter. We're up about 8% in the third quarter retail. The difference is Maverick slowed a little bit, so our retail -- and you already know that Newport Non-Menthol stayed still and the kind of flattish during the quarter versus the previous quarter. So what made the difference up? It was our premium brand. So from a consumer standpoint, we feel very bullish, and that all the things that we've done continue and the fundamentals of our brand. I feel great about the quarter. I wish the inventory didn't happen. But I feel great about the quarter, in terms of what consumers are purchasing. Our price gap strategy is unchanged. We don't like to compete on price. We like to compete with a superior product, right advertising and fundamental marketing, and when appropriate, carefully launching a new product. So we remain the most expensive cigarette on the market of the sort of traditional premium brands. There's a couple smaller ones. And we try to keep that gap close, but not be the cheapest. For the discount -- the deep discount, I didn't see anything dramatic, I think it was about even in the quarter."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's helpful. And just maybe a final quick question on Newport Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue as you monitor an",55,"Okay. That's helpful. And just maybe a final quick question on Newport Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue as you monitor and then possibly tweak your strategy behind this new brand?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Bonnie, it went up compared to the third quarter of the prior year, which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building costs in the third quarter from the first half of the year.",46,"Bonnie, it went up compared to the third quarter of the prior year, which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building costs in the third quarter from the first half of the year."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","And I think you said research but you -- I think David said on the call brand building. We're advertising the brand, and we advertised it consistently throughout the year, as he said, but there was no increase or dramatic increase in advertising from prio",46,"And I think you said research but you -- I think David said on the call brand building. We're advertising the brand, and we advertised it consistently throughout the year, as he said, but there was no increase or dramatic increase in advertising from prior quarters."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Ann Gurkin with Davenport.",12,"Your next question comes from the line of Ann Gurkin with Davenport."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Just wanted to follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from the incremental brand support in those markets, or do you need to tweak that?",35,"Just wanted to follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from the incremental brand support in those markets, or do you need to tweak that?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, we're-- it's exceeding our expectations. We wanted to make it competitive, even if we took a little bit of a hit. Because remember, I keep saying it over and over again, we're not promoting below the price of competition, we were just eliminating our",204,"No, we're-- it's exceeding our expectations. We wanted to make it competitive, even if we took a little bit of a hit. Because remember, I keep saying it over and over again, we're not promoting below the price of competition, we were just eliminating our disadvantage. And those markets have responded beautifully. We have now fully lapped, and we're about 14, 15 months into the first two markets where we started, and those have fully paid out. So now we have gone in those original two markets from brands that were declining to brands that are more profitable than they were before and growing double digits in those markets. The same pattern is repeating itself with the second wave of markets which we will lap probably this quarter, and then -- and we're off to a great start on the remaining four which is somewhere around mid-2012 that we lap them. So the long and short of it is as we went from a -- we probably have a 17 to 20 point -- I'm not sure of the exact number, but they were in declines and now they're growing at somewhere between -- maybe even aside 20- to 30-point turnaround in those markets."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, in terms of the Newport Menthol expansion, the eight markets, it sounds like the -- any expansion beyond those eight markets? Is that capped or stable for a while here?",31,"Murray, in terms of the Newport Menthol expansion, the eight markets, it sounds like the -- any expansion beyond those eight markets? Is that capped or stable for a while here?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We -- in essence, the amount of Newport -- or excuse me, in essence, the amount of Full Flavor menthol that in expansion markets available for us to become more priced, more competitively with, we've captured 80%, 90% of that at this point. So could we tw",167,"We -- in essence, the amount of Newport -- or excuse me, in essence, the amount of Full Flavor menthol that in expansion markets available for us to become more priced, more competitively with, we've captured 80%, 90% of that at this point. So could we tweak another market? It's just not going to add up too much money. So if you're trying to model in your P&L, the amount of money we're going to spend, we're spending for the most part, right? And we'll lap those over time and hopefully continue to have growing markets like we've seen in our original markets. As we grow in the west and other areas, that's going to have to be beyond that, beyond Newport Full Flavor Menthol. It's going to have -- we're going to have to work Newport Non-Menthol et cetera in markets where those opportunities exist. So we have plans to grow, but the spending effect is, for the most part, in the P&L at this point."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then the decision to take up the pricing on Newport Red, I guess, I expect a little bit longer runway on those promotions, since the brand is ramping up so nicely. Is it just that you wanted to reallocate some of the promotional dollars to other",71,"Okay. And then the decision to take up the pricing on Newport Red, I guess, I expect a little bit longer runway on those promotions, since the brand is ramping up so nicely. Is it just that you wanted to reallocate some of the promotional dollars to other things? And how quickly do you think Newport Red would ultimately get towards your objective of a standard Newport price point, I guess?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, we said it would take years to get it up there. And no, we didn't do anything to reallocate it. We thought that getting to a point -- remember, we, Newport starts at around 11-plus shares, so getting a full share point in there. We're not trying to",140,"Well, we said it would take years to get it up there. And no, we didn't do anything to reallocate it. We thought that getting to a point -- remember, we, Newport starts at around 11-plus shares, so getting a full share point in there. We're not trying to sell volume just for volume's take. When you sell a lot of volume, you got to put in machinery, you got to -- all kinds of things are affected.  You've got to run the plants. You have got MSA cost and all that. It's got to make money for us. We're in the business to make money, and this price increase has a significant effect. So I mean, our levels of profitability and volume at the end of our first year of launch are dramatically higher than anything we originally modeled."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then one for David, I guess. As you get closer on the share repurchase, I understand you're not going to give us timing our future amount, but as you get closer to the leverage target here, can you say what levels of cash the company's comfortab",56,"Okay. And then one for David, I guess. As you get closer on the share repurchase, I understand you're not going to give us timing our future amount, but as you get closer to the leverage target here, can you say what levels of cash the company's comfortable holding? Or how we should think about that?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","As we look at the cash on the balance sheet, we do have -- we have a revolving credit facility of roughly $185 million that counts as a part of our liquidity. We typically would not want to get the cash on the left side of the balance sheet much greater t",98,"As we look at the cash on the balance sheet, we do have -- we have a revolving credit facility of roughly $185 million that counts as a part of our liquidity. We typically would not want to get the cash on the left side of the balance sheet much greater than $100 million to $200 million. That's about right. Now that is net of any MSA accruals. So what I like to -- the way I like think to think about that is I want to have cash equal to the MSA accrual plus some excess liquidity."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And just finally, Murray, I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands? And maybe on the Evans case, how you look at the appeals there? And is it -- I've read something that the court was r",72,"Okay. And just finally, Murray, I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands? And maybe on the Evans case, how you look at the appeals there? And is it -- I've read something that the court was requiring you to hold the full amount of the verdict in cash? Is that the case, or is that not the case?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, no, on the cash they're not requiring them. They had filed that the original judge we went to, we appealed that, and a judge reversed that. And so no, we are not required to hold the cash, so that's incorrect. On the Evans case itself, we believe we",246,"Well, no, on the cash they're not requiring them. They had filed that the original judge we went to, we appealed that, and a judge reversed that. And so no, we are not required to hold the cash, so that's incorrect. On the Evans case itself, we believe we have meritorious defenses, and we're appealing that. The judge did reduce the original compensatory damages, not the punitive damages, so the number's a lower number but then you add interest on it. So long and short of it, we think they got it wrong. And we will appeal that case, and hopefully, get ourselves into a more favorable court. On TPSAC, we continue to make those challenges, and we believe that is a case that has been worth doing. The government, as far as I understand, and my lawyers can clarify this and follow-up calls. But as far as I understand, the defense of the government is not one of whether we're right or not, there's is more on standing and whether or not we've been damaged at this point. And in the meantime, there has been progress made in TPSAC and some people have moved off, some others haven't. And even some of the things we're seeing, we think that standing up for ourselves is having an effect on the whole process. And that alone is -- it has been worthwhile to the company and to the industry, and hopefully, we'll win the case as well."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivien Azer.",10,"Your next question comes from the line of Vivien Azer."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","As we think about the margins this quarter, you spoke to, obviously, some of the mix impact and the inventory volume shifts, and you quickly mentioned in Q&A the Newport recall. I'm curious, if you could frame for us kind of order of magnitude how big of",72,"As we think about the margins this quarter, you spoke to, obviously, some of the mix impact and the inventory volume shifts, and you quickly mentioned in Q&A the Newport recall. I'm curious, if you could frame for us kind of order of magnitude how big of a deal that was? And also some of the manufacturing overtime issues that you highlighted maybe six weeks ago, whether that was impact as well?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Okay. Vivien, there were a few things that impacted the cost structure in the quarter, none of which individually were material. We did have a cost of the recall. As Murray said, that was just a couple of million dollars. We signed a new four-year contrac",141,"Okay. Vivien, there were a few things that impacted the cost structure in the quarter, none of which individually were material. We did have a cost of the recall. As Murray said, that was just a couple of million dollars. We signed a new four-year contract with our labor union during the quarter, which gives us some certainty going forward. And that had a signing bonus attached to it which was about $3 million in total. There was some other cost pressures during the quarter of input costs. We see sort of mid-single digit price increases on things like tobacco and some other ingredients cost, but none of the -- nothing individually added up to anything material. But the other things like the recall and the new union contract, you would say those are -- those wouldn't repeat themselves going forward."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Understood.  My other question has to do with the lawsuit around graphic warnings. Can you give us an update on that?",21,"Understood.  My other question has to do with the lawsuit around graphic warnings. Can you give us an update on that?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, you'd see the case was argued -- not the case was argued, just the injunction. Preliminary injunction was argued. The actual case itself would be probably a few months from now or into the spring. The judge had indicated that he would evaluate the p",140,"Well, you'd see the case was argued -- not the case was argued, just the injunction. Preliminary injunction was argued. The actual case itself would be probably a few months from now or into the spring. The judge had indicated that he would evaluate the preliminary injunction. We think that our lawyer Floyd Abrams did a great job arguing why we believe this is a violation of both the First Amendment and the Administrative Procedures Act. We believe the government has crossed -- has violated both. And we are optimistic on winning the case itself, and we're hopeful that since we're optimistic on the case itself that we'll be granted an injunction. That he said he was hopeful to have an opinion on that by the end of October. And I believe there was a commitment for November. So anytime."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Karen Lamark with Federated Investors.",13,"Your next question comes from the line of Karen Lamark with Federated Investors."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I have a question on SG&A. I believe you said there'd be no dramatic increase, or there was no dramatic increase in the advertising cost. And I understand there's always one-offs. But SG&A to sales is up in the quarter and year-to-date. And I'm just wonde",56,"I have a question on SG&A. I believe you said there'd be no dramatic increase, or there was no dramatic increase in the advertising cost. And I understand there's always one-offs. But SG&A to sales is up in the quarter and year-to-date. And I'm just wondering, should we expect a higher run rate going forward?"
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Karen, I think the run rate for SG&A could be variable quarter-to-quarter and is mostly going to vary as a result of litigation activity. The legal defense costs vary, obviously, with the number of cases in trial, number of cases at various positions thro",153,"Karen, I think the run rate for SG&A could be variable quarter-to-quarter and is mostly going to vary as a result of litigation activity. The legal defense costs vary, obviously, with the number of cases in trial, number of cases at various positions through there. The increase in advertising or brand-building costs on an annualized basis is probably basically level now. I don't expect to see that material or dramatically increase over time, but we're going to see upward pressures on SG&A, just from things like salary and benefit cost increases and other cost increases. But most of the change quarter-to-quarter revolves around legal defense costs. And as you do the comparison to revenues in the current quarter, you have to continue to take into account that inventory movement that we continue to talk about. And I'm also reminded that sequentially, SG&A is not really up in the third quarter by any measure."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks.",22,"If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you for your continued interest in Lorillard. We're -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest.",29,"Thank you for your continued interest in Lorillard. We're -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest."
4180255,141600488,176440,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard, Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You m",42,"This concludes the Lorillard, Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You may now disconnect."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for rep",67,"Good day, ladies and gentlemen, and welcome to the Lorillard Inc. Third Quarter 2011 Earnings Conference Call. My name is Sarah, and I will be your operator for today's call. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes. At this time, I would like to turn the conference over to your host for today's call, Mr. Bob Bannon. You may begin, sir."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial",129,"Thank you, Sarah, and good morning, everyone. I'm Bob Bannon, Lorillard's Director of Investor Relations. And joining me on today's call is Murray Kessler, Lorillard's Chairman, President and Chief Executive Officer; and David Taylor, its Chief Financial Officer.
By now, you should have received a copy of our third quarter 2011 earnings release. It can be found on the company's website, lorillard.com, under News Releases.
But before we begin, I'd like to remind you that some of the comments on today's call and some of the responses to your questions may contain forward-looking statements. These statements are subject to the risks and uncertainties, as described in the company's earnings release and in other filings with the SEC. 
Now, I'd now like to turn the call over to Murray Kessler."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fu",1026,"Thank you, Bob, and good morning, everyone. Lorillard's third quarter played out just as we expected and just as we said it would during our last conference call. I'm pleased to report that very strong fundamentals continue. We acknowledged that strong fundamentals were masked by a significant comparative reduction in wholesale inventory, adversely affecting our reported volume growth by just over 400 basis points. But we can't emphasize enough that absent the inventory comparison, which was simply a timing issue, our business, as measured by retail shipments, was as strong as we've seen all year. This is especially encouraging as we reduced promotional spending versus year ago on our flagship Newport Menthol brand, and our recent round of price increases are all sticking. We also observed no unusual competitive promotional activity during the quarter. 
So let's take a closer look at third quarter highlights.  First, total Lorillard domestic volume increased 2.8% versus year ago in quarter 3. Adjusting for inventory fluctuations, total Lorillard domestic volume was up an estimated 7%. This is about the same level of the growth adjusted for inventory changes we saw in the first and second quarters. The point is further illustrated by a look at shipments from wholesale to retail, as measured by our proprietary Excel database, which is unaffected by changes in wholesale inventory. 
Total Lorillard retail shipments were up over 8% versus year ago in the quarter. Of note, Lorillard discount brand shipments to retail, while still up double digits at about 12%, actually slowed a little from prior quarters. So the acceleration of our retail shipment and market share growth was driven by our premium brand Newport, which grew 8% in total versus year ago during the quarter, following 5.5% growth in the second quarter and 6.3% in the first quarter. Again, I'm referring to retail shipments, which are more indicative of consumer purchasing and eliminate the noise from quarter-to-quarter due to inventory swings.  Given the difficult macro-economic environment that continued during the third quarter, we were happy to see such a strong performance on our premium brand. 
Our premium strength traced to the incremental volume this year associated with the Newport Non-Menthol launch and a very strong quarter and improvement in trend on our flagship Newport Menthol business. Newport Menthol benefited from our geographic expansion plan, which we highlighted during our Investor Day. Both of these initiatives are performing extremely well. Newport Non-Menthol continues to hold just under a 1% share despite our recent 20% price increase which has significantly enhanced profitability on this new brand, and Newport Menthol, in expansion markets, continues to grow double digits. 
It's worth mentioning, as a number of investors are concerned about heightened promotional spending hurting industry pricing power, that even with our investment in these expansion markets, total Newport Menthol promotional spending was down versus year ago for the quarter, and it is down for the year. This also includes the increased spending effect of volume previously sold non-promotive on Native American reservations in New York, switching to promoted volumes in other locations. 
So let me repeat myself. While I can't speak for the rest of the industry, Lorillard has reduced by down-spending this year and this quarter. We recognize that between mix, and more importantly this quarter, the negative inventory comparison, it is hard to see the impact of pricing. David will try and make this as transparent as possible during his comments. Let me reassure you, however, that the price increases we took in July are being fully realized to the income statement. 
Turning to the broader industry. We estimate total industry domestic shipments declined 6.4%. Similar to Lorillard, the total industry was negatively affected by inventory fluctuations. We estimate that impact to be about 3 percentage points. 
As our retail volume grew briskly in a declining industry, Lorillard, once again, gained share across all market categories. Total Lorillard share was 14.2%, up 1.3 points versus year ago. Total Newport gained 1.1 share points, and our discount brands gained 0.3 share point. Total Lorillard share of Menthol was 39.2%, up 0.9 share points versus year ago, our strongest gain all year. Newport share of Menthol was 36.1%, up 0.3 share points versus year ago, also our strongest gain all year. 
Operating profit for the quarter was down 2.2%. EPS at $1.94 per share was up 7.2%. Operating profit in EPS were, obviously, negatively affected by the inventory comparison. Keep in mind, $400 million non-promoted units, primarily of Newport Menthol, is worth about $35 million in operating profit or $0.16 per share. There were no other extraordinary variances in the quarter. 
So while we don't give earnings guidance, this is exactly what we expected. And had we given guidance for the year, we would not, and I repeat myself, would not be changing it right now. Notably, we believe the continued strength in our brand fundamentals combined with wholesale inventories now at more normal levels, bode well for a very good fourth quarter. And for these same reasons, we are bullish on 2012 despite the outlook for a challenging 2012 macroeconomic environment. 
Finally, a brief word on the FDA's review of Menthol. We are currently awaiting the peer review of the FDA's preliminary assessment of the science, which is due out shortly. We have no reason to believe this is anything more than just that, a preliminary review. When it comes out, we will respond appropriately during the comment period. Again, we believe this is just one more step than what we believe will be a very long review process. 
You know our position. The best available scientific evidence does not support an assertion that menthol and cigarettes negatively or disproportionately impacts the public health. Smoking has serious risks, but menthol does not contribute to those risks. A menthol cigarette is just another cigarette and should be regulated no differently in totality or for any demographic group. Furthermore, any. draconian regulation would have real, unintended consequences, including the expansion of a contraband market, a loss of tax revenues and a significant loss of jobs. 
With that, I'll turn the call over to David Taylor, our Chief Financial Officer. David?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for question. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8% i",1016,"Thanks, Murray, and good morning, everyone. I'll briefly discuss the numbers, and then we'll open the line for question. Net sales in the third quarter of 2011 increased 3.5% to $1.622 billion as compared to the third quarter of 2010, driven by the 2.8% increase in wholesale shipment volume. 
Like last quarter, our average wholesale selling prices in the quarter were higher across the board but were partially offset by other factors. We spent considerable time on these calls over the last several quarters, reviewing the impact of the shift in the mix of our product, as the relatively lower-priced Maverick and Newport Non-Menthol have grown at a more rapid pace than our premium-priced Newport Menthol product. That dynamic impacts the current year's third quarter as well. Newport Non-Menthol and Maverick wholesale volumes, in this year's third quarter, were greater than the prior year quarter, while the rest of our portfolio showed decline. 
Also, as we explained in last quarter's call, the impact of fluctuations in wholesale trade inventory levels can be seen in the third quarter's results. To be more specific, even at the risk of being repetitive, we saw strong volumes in last year's third quarter, some of which was aided by a build in wholesale trade inventory in that quarter. In this year's third quarter, we saw the opposite, with wholesale trade inventories declining after building in the second quarter. This was to be expected, and the impact on volume comparisons and average net pricing should not surprise anyone. After adjusting for the effect of the increase in wholesale trade inventories last year and the decline this year, we estimate that our wholesale domestic shipments would have increased 7% for the quarter, rather than the 2.8% as reported. 
In addition, and as you know, the pattern of consumer promotion buydown programs follows movement at retail, not at wholesale. The costs of these programs are accounted for as a reduction in sales. So in a quarter like this one, they disproportionately impact the consolidated net price comparison to last year. The cost of consumer buydowns in the third quarter was about flat to the second quarter and down from last year's third quarter. We would estimate that the impact of this wholesale trade inventory pattern on the net pricing comparison to last year, calculated on a simple consolidated basis, reduced the net price comparison by about 1% in 2011 from 2010. Likewise, the mix effect that I discussed a moment ago amounted to about a 3% reduction in the net price comparison. 
So to summarize, a simple calculation of net price per unit in the third quarter, when done on a consolidated basis before excise tax, results in a about a 1% per unit increase from last year. That, actually, is made up of higher realized prices of about 5% across our entire portfolio. However, that 5% was masked by the 3% product mix impact and the 1% impact of the wholesale inventory movement. 
The 4 percentage point difference in the third quarter unit volume comparisons to last year that arises from that wholesale inventory trade fluctuations would equate to about $75 million in sales and about $35 million in operating income, which more than accounts for the $10 million decline in operating income in the quarter. 
As we enter the fourth quarter, we estimate that wholesale trade inventories are closer to one would call normal. Gross profit in the third quarter of 2011 was roughly flat when compared to last year's third quarter. Cost of goods sold in the third quarter reflects increases over last year in certain costs, including increased FDA user fees. Amounts due under the State Settlement Agreements and the tobacco growers assessment increased $20 million compared to last year's third quarter. 
Selling, general and administrative costs increased $7 million from last year's third quarter, primarily due to higher salaries and benefits, legal fees and expenses associated with increased litigation activity during the quarter and marketing and other costs associated with our strategic initiatives, including the continuing brand-building costs in support of Newport Non-Menthol. 
Third quarter operating income declined 2.2% to $455 million from $465 million in last year's third quarter. Year-to-date, operating income is up 5.5% compared to last year.  Fully diluted earnings per share for the third quarter increased 7.2% from last year's third quarter to $1.94 per share. Year-to-date EPS is up 13% compared to last year. The lower share count as compared to the year-ago quarter added $0.18 per share to EPS in this year's third quarter, accounting for the increase. 
We accessed the debt market in August, issuing $750 million in senior notes, $500 million in 5-year notes at 3 1/2% and $250 million in 30-year notes at 7%. With this issue, we are close to our stated target of 1.5x EBITDA. We would expect that as our earnings grow, we would access the market again in the future in order to stay close to that ratio. The board authorized a $750 million share repurchase shortly after we closed the debt transaction. That program is ongoing. 
During the quarter, through September 30, we repurchased approximately 4 million shares at a cost of $438 million under 2 separate share repurchase authorizations. As of September 30, we had $553 million remaining on the new $750 million program. These actions clearly demonstrate our intent to return cash to shareholders in the form of both dividends and share repurchases. 
We're pleased with the company's performance this quarter and for 2011 so far. As Murray indicated, the fundamentals of our business remain strong and vibrant, and we remain confident that we can outperform the industry and deliver superior value to our shareholders. 
When we spoke on this call 3 months ago, we were bullish on our future, and we remain so. Nothing in the third quarter has changed our view or our expectations for 2011 volume and earnings, nor our outlook beyond that, and we expect to continue the positive momentum that we've experienced thus far in 2011. 
And with that, we'd like to open the line for questions. Sarah?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","[Operator Instructions] Your first question comes from the line of Nik Modi with UBS.",14,"[Operator Instructions] Your first question comes from the line of Nik Modi with UBS."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the fourth quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?",41,"Murray or David, can you just provide any perspective on October? I mean, if the inventories have weaned out in the fourth quarter, are you seeing the volumes track in line with what you've been seeing with the retail trends lately?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize, and then you can take from it what you want, is that the trends have been ext",94,"Well, we don't give forward-looking estimates, but I try to sort of say that as well as I could in my comments to say that inventories are normal. So what I'll just reemphasize, and then you can take from it what you want, is that the trends have been extremely predictable, extremely consistent all year long, and the only thing that changes underneath it was the inventory. And I said I was bullish about the fourth quarter and next year, so there was nothing that I said that would suggest a change in fundamental."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Great. And then David, one real quick housekeeping item. On the dividends, I mean, clearly, your payout ratio is below where the target payout as you've indicated should be. Any thoughts on that? And your philosophy there, has it changed? Or do you antici",51,"Great. And then David, one real quick housekeeping item. On the dividends, I mean, clearly, your payout ratio is below where the target payout as you've indicated should be. Any thoughts on that? And your philosophy there, has it changed? Or do you anticipate keeping in line with the historic number?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Clearly, our target has not changed, and our philosophy hasn't changed. And yes, clearly, we've-- we're paying out dividends at a rate lower than that stated target, so one could expect a dividend increase at some point in the future.",40,"Clearly, our target has not changed, and our philosophy hasn't changed. And yes, clearly, we've-- we're paying out dividends at a rate lower than that stated target, so one could expect a dividend increase at some point in the future."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of David Adelman with Morgan Stanley.",13,"Your next question comes from the line of David Adelman with Morgan Stanley."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Can we speak for a moment more, Murray, about pricing in the quarter, or price mix up to 0.7. I just want to understand, like if you go back say, to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think th",131,"Can we speak for a moment more, Murray, about pricing in the quarter, or price mix up to 0.7. I just want to understand, like if you go back say, to the first quarter, net pricing per pack is down versus that point. You didn't have the -- I don't think there was significant inventory movement that quarter. Maverick is less of the total volume this period. You've taken pricing across the board since then, and you had a substantial price increase on Newport Non-Menthol coming into the third quarter. So is there something else at play? I know you went through a lot of details. But just stepping back, I would have thought, given those dynamics, you would have seen more of an increase in your sequential and year-on-year pricing?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I really think you've got 2 things at play in the quarter. With the way we look at them. I've been telling you that we've been reducing buydown spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was dow",327,"I really think you've got 2 things at play in the quarter. With the way we look at them. I've been telling you that we've been reducing buydown spending all year long. And it was down again this quarter, but it wasn't down as much this quarter. It was down prior quarters.  And I think your note sort of nailed it. You had roughly 4% to 5% of your volume going through Native American reservations completely non-promoted in New York. And we didn't know how that was going to exactly play out, but you see our total volume trends out. So therefore, consumers kept buying the products, and they had to move from a non-promoted location to a promoted location. So you had a -- it's not a permanent. We'll lap it. But you had this effect of non-promoted volume becoming promoted volume in the quarter. And then the second one that I still think it's hard for all the analysts out there to model that we can, which is based on our go-to-market design, our buydowns are a relatively larger percentage. We have a higher list price and a higher buydown. So when you get a quarter like this, where inventory is reduced, the buydowns still fully occur. And when you take out that volume -- if you don't take out at sort of a deep enough buydown level, you also get a distortion, and that's completely timing, and it's not real at all. It's just in the modeling. So those 2 numbers alone, in my estimation, account for 2/3 of the variance in a model like yours. And then we had a couple of small cost things with the recall and signing a new union contract to get it. So it's not complicated. We took the price increases, and those all passed through. We didn't spend back $0.01 more on it. We just had a couple variables, mostly timings that'll work their way through."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And Murray, have you considered altering your buydown rates towards where the volume has migrated? Do you think that, that would be an overreaction?",24,"And Murray, have you considered altering your buydown rates towards where the volume has migrated? Do you think that, that would be an overreaction?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We've...",2,"We've..."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","In other words, reducing buydown levels where some of the Native American volume has moved towards?",16,"In other words, reducing buydown levels where some of the Native American volume has moved towards?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much -- New York's up, neighboring states are up. We modify buydown rates all of the time. So I think I know where you're going with the question. And th",64,"Well, it's almost impossible to answer that question, to try to understand exactly where it went, how much -- New York's up, neighboring states are up. We modify buydown rates all of the time. So I think I know where you're going with the question. And the answer is probably we do that kind of stuff all the time as a matter of routine."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then as it relates to the FDA. Murray, do you have any greater insight into then what the FDA itself has publicly said, with respect to when its view of the Menthol science would be publicized?",38,"Okay. And then as it relates to the FDA. Murray, do you have any greater insight into then what the FDA itself has publicly said, with respect to when its view of the Menthol science would be publicized?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I continue to rely on Neil Wilcox, who we hired who's been terrific for us, because he comes with that FDA perspective. And if you remember, we had sort of the -- there was a bunch of rumors flying around in speculation a few months back about a modificat",128,"I continue to rely on Neil Wilcox, who we hired who's been terrific for us, because he comes with that FDA perspective. And if you remember, we had sort of the -- there was a bunch of rumors flying around in speculation a few months back about a modification to the menthol report. And he continues to remind me that -- generally speaking, what they say, they do. And what they said this time was a preliminary review of the science out at the end of the year, November -- early November, early December somewhere in there. So I believe we're going to see a peer review of the preliminary assessment of the science that'll be open for comment, nothing more. And I take it at face value."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","You don't know now and probably won't know after its published who the peer reviewers that were selected are, is that correct?",23,"You don't know now and probably won't know after its published who the peer reviewers that were selected are, is that correct?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do, sometimes they don't.",24,"I don't know if that's true or not whether they'll share the peer reviewers at that point. Sometimes, they do, sometimes they don't."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Judy Hong with Goldman Sachs.",13,"Your next question comes from the line of Judy Hong with Goldman Sachs."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook and just the ability for the industry to maintain relatively rational pricing. I guess, I'm just wondering, just with respect to your outperformance on",97,"Murray, just in terms of the industry outlook for 2012, you said you're pretty bullish on your outlook and just the ability for the industry to maintain relatively rational pricing. I guess, I'm just wondering, just with respect to your outperformance on the volume side, industry is down 3.5% underlying, and you're up 8% or so. The risk that, that dynamic sort of forces your competitors to step up spending, just given that share shift that you've seen, and how would you sort of think about your pricing or promotional strategy in the context of that risk?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Okay. It's hard for me to speak to my competitors. But remember, we're going to lap the introduction of Newport Non-Menthol here another couple of months of so they -- from an industry standpoint, it's kind of weathered the storm of a new brand being laun",278,"Okay. It's hard for me to speak to my competitors. But remember, we're going to lap the introduction of Newport Non-Menthol here another couple of months of so they -- from an industry standpoint, it's kind of weathered the storm of a new brand being launched. It's big for us, it's little for the industry. One share for us is -- and then take fair share of that for the competitors. It works its way to a few tenths for everybody else. I doubt they would do something sort of draconian or crazy over a few tenths of a share point. For us, we have a very clear strategy. We intend to bring Newport pleasure to all adult smokers -- responsibly bring Newport pleasure to all adult smokers. And our intent to do that is through the pillars that we talked about which is right now building our Newport Non-Menthol business profitably, and we took a big price increase this time, and getting those geographic expansion markets back in line competitively, so they have a normalized level of promotion instead of being milked the way they were. We're in about 8 markets. That's the bulk of the volume, so don't expect another big increase in spending coming there. Either, they're growing double digits. We've already lapped 2 of those markets. And as we go out -- exit this year, we'll lap another 2 of those markets, and that effect will basically go away sometime next year. So for us, it's blocking and tackling and doing what we've always done and -- but it starts with superior advertising and working that strategic plan we showed you at Investor Day."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just in terms of Newport's performance, both on the Non-Menthol side and on the Menthol side, I think in Q2, you ended the quarter with Red up about a -- just over a share point, and it sounds like that sort have been the share level the la",117,"Okay. And then just in terms of Newport's performance, both on the Non-Menthol side and on the Menthol side, I think in Q2, you ended the quarter with Red up about a -- just over a share point, and it sounds like that sort have been the share level the last 3 months or so. Are you comfortable saying that's kind of where we should see the Newport Red settling? Is there more opportunity to see that brand get much bigger? And then on the Newport Menthol performance, you talked about the acceleration in 3Q. Just maybe talk a little bit about was that mostly geographic expansion? What's been helping the Menthol performance on the Newport side?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand, and",144,"So the first one, Newport Non-Menthol, I think right now with that big price increase, the volume has held very steady on that, but the growth has slowed. And I think for now, that's probably a good place to stay. But we will, like every other brand, and just like we did with Maverick and others, there will be initiatives overtime to grow that business. So our expectation will -- to be to grow it from here. But the sort of -- it found its level at that price. So I think you're accurate in that statement. I mean, the price increase has a dramatic effect on the profitability of those billions of units that were incrementally selling. On Newport Menthol, I was real pleased in the third quarter, and it was -- a large part of that was driven by geographic expansion markets."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then just finally, the clarification on Q4 volume, because, I guess, you're lapping the Newport launch and I remember having one less shipping day as well. Is that correct? Or was the shipping day comparison comparable?",38,"Okay. And then just finally, the clarification on Q4 volume, because, I guess, you're lapping the Newport launch and I remember having one less shipping day as well. Is that correct? Or was the shipping day comparison comparable?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, you're correct.",3,"No, you're correct."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. So we just have to take it to -- with the inventory now being pretty normal, we have to take into consideration that shipping day comparison, and then -- and that's really the only thing to really think about from a year-over-year comparison perspec",45,"Okay. So we just have to take it to -- with the inventory now being pretty normal, we have to take into consideration that shipping day comparison, and then -- and that's really the only thing to really think about from a year-over-year comparison perspective?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol, but on the other hand, you have 13 weeks. You have the full quarter of shipping it, s",87,"Yes, I think you're thinking about it the right way. You have one less shipping day. You do have the inventory pipeline load from the new product on Newport Non-Menthol, but on the other hand, you have 13 weeks. You have the full quarter of shipping it, so those are countervailing effects. But yes, you should have a -- you should rebuild the volume modeling based on those factors that you just said and that would be accurate, with the fundamentals that we have been talking about."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Right. And then on the positive side, the price mix impact should be much better than what you saw in -- since 3Q, just because you don't have the inventory situation. And then the mix impact from Red would be also muted?",42,"Right. And then on the positive side, the price mix impact should be much better than what you saw in -- since 3Q, just because you don't have the inventory situation. And then the mix impact from Red would be also muted?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about.",22,"Right. And the only thing you will have continuing for a couple of quarters is that Native American effect I talked about."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","And how much was that, just in terms of the Native American impact? You said it was 2 points or 3 points on the...",24,"And how much was that, just in terms of the Native American impact? You said it was 2 points or 3 points on the..."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said was that we had roughly 5% of our volume going through",117,"It's really hard to quantify exactly how much the Native American effect impacted net pricing, Judy, because we really don't know -- it's hard to track exactly where that volume went. What Murray said was that we had roughly 5% of our volume going through those Native American reservations previously that was non-promoted. And you can see what happened to our volume comparisons. And so if that moved, theoretically, if all that volume moved to promoted locations, that would have increased our buydown spending, but exactly how much is very, very difficult.  And did they go to non-promoted store, promoted stores, which -- but it wouldn't be as big an impact as you just said though."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Chris Growe with Stifel, Nicolaus.",13,"Your next question comes from the line of Chris Growe with Stifel, Nicolaus."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I just have a couple of questions for you. The first is, you still have 8 expansion markets, is that correct? That has not changed in the quarter?",28,"I just have a couple of questions for you. The first is, you still have 8 expansion markets, is that correct? That has not changed in the quarter?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then, I guess, in related to that, the level of promotion that you're signing deals to those new markets, just -- you still have Newport promotion down starting the quarter. And as a result, that incorporates all that incremental promotion espec",48,"Okay. And then, I guess, in related to that, the level of promotion that you're signing deals to those new markets, just -- you still have Newport promotion down starting the quarter. And as a result, that incorporates all that incremental promotion especially with those expansion markets, correct?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Correct.",1,"Correct."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And I just want to ask about the Maverick growth slowing. Do you read much into that or -- because I think, the price goes from pretty steady if you look it that way between some of the premium brands. Is anything related to that, that you believe l",59,"Okay. And I just want to ask about the Maverick growth slowing. Do you read much into that or -- because I think, the price goes from pretty steady if you look it that way between some of the premium brands. Is anything related to that, that you believe led to Maverick slowing a little bit in the quarter?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes, we took a healthy price increase for the first time in a year that could have affected a little bit. I mean, our reaction is it's gotten -- it's over 5 billion units now, so it's gotten to be quite a big brand. And to be able to take a $0.10 price in",131,"Yes, we took a healthy price increase for the first time in a year that could have affected a little bit. I mean, our reaction is it's gotten -- it's over 5 billion units now, so it's gotten to be quite a big brand. And to be able to take a $0.10 price increase plus continue growing at 12% on a 5 billion unit brand, I'll take that all day long. But one year and 1.5 years ago, it started growing 30-something percent. So as it's gotten scale and gotten bigger and bigger and bigger, it's harder to slow down. But I would say that it's fair to say that the pricing had a little bit of effect on it as well, but again, it's a very profitable mode for us."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Sure.  I had assume that was the case and that's the way I modeled it. I just want to make sure it was clear there's nothing else going on there, sure. And the last question I just have was on your timing for share purchase. And honestly, you're holding a",97,"Sure.  I had assume that was the case and that's the way I modeled it. I just want to make sure it was clear there's nothing else going on there, sure. And the last question I just have was on your timing for share purchase. And honestly, you're holding a lot of cash from the balance sheet. We went through this a couple years ago as well, and you took on a lot of debt. Is there any motivation to move more quickly on buying back stock now? Or was it just opportunistic around the stock price?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I don't know if there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized us to go there, and we will continue to repurchase shares. It's not really opportunistic, but it's really more a",83,"I don't know if there's any motivation to accelerate or decelerate those purchases where we have been in the market since the board authorized us to go there, and we will continue to repurchase shares. It's not really opportunistic, but it's really more a term of changing our capital structure to reduce the weight of average cost of capital, and we will continue to buyback shares. But I can't really comment on whether that's going to accelerate or decelerate, Chris, I'm sorry."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Yes. I mean, Chris, I will just add to it to. I mean, look, there's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares, and we intend to stay at the 70% t",82,"Yes. I mean, Chris, I will just add to it to. I mean, look, there's no magic in our model. We believe our job is to generate a lot of cash and give it back to shareholders. And we've been aggressively buying back shares, and we intend to stay at the 70% to 75% dividend payout ratio. So it's -- that's what we do, and the timing of which a little bit we're trying to execute it the most efficient way possible."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Bonnie Herzog with Wells Fargo.",13,"Your next question comes from the line of Bonnie Herzog with Wells Fargo."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I just had a question kind of circling back on pricing. You mentioned, of course, your net pricing was pretty strong after you make all of the adjustments. But I was kind of wondering if you could get a little more detail and sort of what you're seeing re",86,"I just had a question kind of circling back on pricing. You mentioned, of course, your net pricing was pretty strong after you make all of the adjustments. But I was kind of wondering if you could get a little more detail and sort of what you're seeing regarding the health of the consumer and the acceptance of pricing, in general, across the overall industry? And then also could you talk a little bit about the price gap between premium brands and the discount brands overall?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","I'll try to answer those questions. Let me just break them up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buydowns in total were down versus the year ago and our volume accelerated in the third",355,"I'll try to answer those questions. Let me just break them up in pieces. It's harder for me to talk to the industry. For Newport Menthol, we took a price increase, our buydowns in total were down versus the year ago and our volume accelerated in the third quarter, so this was one of our strongest if not the strongest all-year performances on our premium Newport Menthol brand. It accelerated by a few hundred basis points from the second quarter to the third quarter. So I'm delighted to see that, right? Going into what, sort of a tough economy and everything that's out there, our premium brands -- it was Maverick that slowed down a little bit. So that's what drove the overall 8% retail consumer takeaway which is our measure -- which is wholesale to retail shipments through Excel. But we're -- look, we were up about 8% in the first quarter. We're up about 8% in the second quarter. We're up about 8% in the third quarter retail. The difference is Maverick slowed a little bit, so our retail -- and you already know that Newport Non-Menthol stayed still and the kind of flattish during the quarter versus the previous quarter. So what made the difference up? It was our premium brand. So from a consumer standpoint, we feel very bullish, and that all the things that we've done continue and the fundamentals of our brand. I feel great about the quarter. I wish the inventory didn't happen. But I feel great about the quarter, in terms of what consumers are purchasing. Our price gap strategy is unchanged. We don't like to compete on price. We like to compete with a superior product, right advertising and fundamental marketing, and when appropriate, carefully launching a new product. So we remain the most expensive cigarette on the market of the sort of traditional premium brands. There's a couple smaller ones. And we try to keep that gap close, but not be the cheapest. For the discount -- the deep discount, I didn't see anything dramatic, I think it was about even in the quarter."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. That's helpful. And just maybe a final quick question on Newport Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue as you monitor an",55,"Okay. That's helpful. And just maybe a final quick question on Newport Red. I think you mentioned in your press release that the market research cost went up behind this brand in the third quarter. So are these costs expected to continue as you monitor and then possibly tweak your strategy behind this new brand?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Bonnie, it went up compared to the third quarter of the prior year, which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building costs in the third quarter from the first half of the year.",46,"Bonnie, it went up compared to the third quarter of the prior year, which would contribute to that difference in SG&A. But I -- we didn't see any acceleration in any of those brand-building costs in the third quarter from the first half of the year."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","And I think you said research but you -- I think David said on the call brand building. We're advertising the brand, and we advertised it consistently throughout the year, as he said, but there was no increase or dramatic increase in advertising from prio",46,"And I think you said research but you -- I think David said on the call brand building. We're advertising the brand, and we advertised it consistently throughout the year, as he said, but there was no increase or dramatic increase in advertising from prior quarters."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Ann Gurkin with Davenport.",12,"Your next question comes from the line of Ann Gurkin with Davenport."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Just wanted to follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from the incremental brand support in those markets, or do you need to tweak that?",35,"Just wanted to follow-up a little bit on the expansion markets. Are you pleased with the return you're getting from the incremental brand support in those markets, or do you need to tweak that?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","No, we're-- it's exceeding our expectations. We wanted to make it competitive, even if we took a little bit of a hit. Because remember, I keep saying it over and over again, we're not promoting below the price of competition, we were just eliminating our",204,"No, we're-- it's exceeding our expectations. We wanted to make it competitive, even if we took a little bit of a hit. Because remember, I keep saying it over and over again, we're not promoting below the price of competition, we were just eliminating our disadvantage. And those markets have responded beautifully. We have now fully lapped, and we're about 14, 15 months into the first 2 markets where we started, and those have fully paid out. So now we have gone in those original 2 markets from brands that were declining to brands that are more profitable than they were before and growing double digits in those markets. The same pattern is repeating itself with the second wave of markets which we will lap probably this quarter, and then -- and we're off to a great start on the remaining 4 which is somewhere around mid-2012 that we lap them. So the long and short of it is as we went from a -- we probably have a 17 to 20 point -- I'm not sure of the exact number, but they were in declines and now they're growing at somewhere between -- maybe even aside 20- to 30-point turnaround in those markets."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Andrew Kieley with Deutsche Bank.",13,"Your next question comes from the line of Andrew Kieley with Deutsche Bank."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Murray, in terms of the Newport Menthol expansion, the 8 markets, it sounds like the -- any expansion beyond those 8 markets? Is that capped or stable for a while here?",31,"Murray, in terms of the Newport Menthol expansion, the 8 markets, it sounds like the -- any expansion beyond those 8 markets? Is that capped or stable for a while here?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","We -- in essence, the amount of Newport -- or excuse me, in essence, the amount of Full Flavor menthol that in expansion markets available for us to become more priced, more competitively with, we've captured 80%, 90% of that at this point. So could we tw",167,"We -- in essence, the amount of Newport -- or excuse me, in essence, the amount of Full Flavor menthol that in expansion markets available for us to become more priced, more competitively with, we've captured 80%, 90% of that at this point. So could we tweak another market? It's just not going to add up too much money. So if you're trying to model in your P&L, the amount of money we're going to spend, we're spending for the most part, right? And we'll lap those over time and hopefully continue to have growing markets like we've seen in our original markets. As we grow in the west and other areas, that's going to have to be beyond that, beyond Newport Full Flavor Menthol. It's going to have -- we're going to have to work Newport Non-Menthol et cetera in markets where those opportunities exist. So we have plans to grow, but the spending effect is, for the most part, in the P&L at this point."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then the decision to take up the pricing on Newport Red, I guess, I expect a little bit longer runway on those promotions, since the brand is ramping up so nicely. Is it just that you wanted to reallocate some of the promotional dollars to other",71,"Okay. And then the decision to take up the pricing on Newport Red, I guess, I expect a little bit longer runway on those promotions, since the brand is ramping up so nicely. Is it just that you wanted to reallocate some of the promotional dollars to other things? And how quickly do you think Newport Red would ultimately get towards your objective of a standard Newport price point, I guess?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, we said it would take years to get it up there. And no, we didn't do anything to reallocate it. We thought that getting to a point -- remember, we, Newport starts at around 11-plus shares, so getting a full share point in there. We're not trying to",140,"Well, we said it would take years to get it up there. And no, we didn't do anything to reallocate it. We thought that getting to a point -- remember, we, Newport starts at around 11-plus shares, so getting a full share point in there. We're not trying to sell volume just for volume's take. When you sell a lot of volume, you got to put in machinery, you got to -- all kinds of things are affected.  You've got to run the plants. You have got MSA cost and all that. It's got to make money for us. We're in the business to make money, and this price increase has a significant effect. So I mean, our levels of profitability and volume at the end of our first year of launch are dramatically higher than anything we originally modeled."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And then one for David, I guess. As you get closer on the share repurchase, I understand you're not going to give us timing our future amount, but as you get closer to the leverage target here, can you say what levels of cash the company's comfortab",56,"Okay. And then one for David, I guess. As you get closer on the share repurchase, I understand you're not going to give us timing our future amount, but as you get closer to the leverage target here, can you say what levels of cash the company's comfortable holding? Or how we should think about that?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","As we look at the cash on the balance sheet, we do have -- we have a revolving credit facility of roughly $185 million that counts as a part of our liquidity. We typically would not want to get the cash on the left side of the balance sheet much greater t",98,"As we look at the cash on the balance sheet, we do have -- we have a revolving credit facility of roughly $185 million that counts as a part of our liquidity. We typically would not want to get the cash on the left side of the balance sheet much greater than $100 million to $200 million. That's about right. Now that is net of any MSA accruals. So what I like to -- the way I like think to think about that is I want to have cash equal to the MSA accrual plus some excess liquidity."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Okay. And just finally, Murray, I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands? And maybe on the Evans case, how you look at the appeals there? And is it -- I've read something that the court was r",72,"Okay. And just finally, Murray, I was wondering on the legal side, if you could just give us an update on where the TPSAC lawsuit stands? And maybe on the Evans case, how you look at the appeals there? And is it -- I've read something that the court was requiring you to hold the full amount of the verdict in cash? Is that the case, or is that not the case?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, no, on the cash they're not requiring them. They had filed that the original judge we went to, we appealed that, and a judge reversed that. And so no, we are not required to hold the cash, so that's incorrect. On the Evans case itself, we believe we",246,"Well, no, on the cash they're not requiring them. They had filed that the original judge we went to, we appealed that, and a judge reversed that. And so no, we are not required to hold the cash, so that's incorrect. On the Evans case itself, we believe we have meritorious defenses, and we're appealing that. The judge did reduce the original compensatory damages, not the punitive damages, so the number's a lower number but then you add interest on it. So long and short of it, we think they got it wrong. And we will appeal that case, and hopefully, get ourselves into a more favorable court. On TPSAC, we continue to make those challenges, and we believe that is a case that has been worth doing. The government, as far as I understand, and my lawyers can clarify this and follow-up calls. But as far as I understand, the defense of the government is not one of whether we're right or not, there's is more on standing and whether or not we've been damaged at this point. And in the meantime, there has been progress made in TPSAC and some people have moved off, some others haven't. And even some of the things we're seeing, we think that standing up for ourselves is having an effect on the whole process. And that alone is -- it has been worthwhile to the company and to the industry, and hopefully, we'll win the case as well."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Vivien Azer.",10,"Your next question comes from the line of Vivien Azer."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","As we think about the margins this quarter, you spoke to, obviously, some of the mix impact and the inventory volume shifts, and you quickly mentioned in Q&A the Newport recall. I'm curious, if you could frame for us kind of order of magnitude how big of",72,"As we think about the margins this quarter, you spoke to, obviously, some of the mix impact and the inventory volume shifts, and you quickly mentioned in Q&A the Newport recall. I'm curious, if you could frame for us kind of order of magnitude how big of a deal that was? And also some of the manufacturing overtime issues that you highlighted maybe 6 weeks ago, whether that was impact as well?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Okay. Vivien, there were a few things that impacted the cost structure in the quarter, none of which individually were material. We did have a cost of the recall. As Murray said, that was just a couple of million dollars. We signed a new 4-year contract w",141,"Okay. Vivien, there were a few things that impacted the cost structure in the quarter, none of which individually were material. We did have a cost of the recall. As Murray said, that was just a couple of million dollars. We signed a new 4-year contract with our labor union during the quarter, which gives us some certainty going forward. And that had a signing bonus attached to it which was about $3 million in total. There was some other cost pressures during the quarter of input costs. We see sort of mid-single digit price increases on things like tobacco and some other ingredients cost, but none of the -- nothing individually added up to anything material. But the other things like the recall and the new union contract, you would say those are -- those wouldn't repeat themselves going forward."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","Understood.  My other question has to do with the lawsuit around graphic warnings. Can you give us an update on that?",21,"Understood.  My other question has to do with the lawsuit around graphic warnings. Can you give us an update on that?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Well, you'd see the case was argued -- not the case was argued, just the injunction. Preliminary injunction was argued. The actual case itself would be probably a few months from now or into the spring. The judge had indicated that he would evaluate the p",140,"Well, you'd see the case was argued -- not the case was argued, just the injunction. Preliminary injunction was argued. The actual case itself would be probably a few months from now or into the spring. The judge had indicated that he would evaluate the preliminary injunction. We think that our lawyer Floyd Abrams did a great job arguing why we believe this is a violation of both the First Amendment and the Administrative Procedures Act. We believe the government has crossed -- has violated both. And we are optimistic on winning the case itself, and we're hopeful that since we're optimistic on the case itself that we'll be granted an injunction. That he said he was hopeful to have an opinion on that by the end of October. And I believe there was a commitment for November. So anytime."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","Your next question comes from the line of Karen Lamark with Federated Investors.",13,"Your next question comes from the line of Karen Lamark with Federated Investors."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Analysts","I have a question on SG&A. I believe you said there'd be no dramatic increase, or there was no dramatic increase in the advertising cost. And I understand there's always one-offs. But SG&A to sales is up in the quarter and year-to-date. And I'm just wonde",56,"I have a question on SG&A. I believe you said there'd be no dramatic increase, or there was no dramatic increase in the advertising cost. And I understand there's always one-offs. But SG&A to sales is up in the quarter and year-to-date. And I'm just wondering, should we expect a higher run rate going forward?"
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Karen, I think the run rate for SG&A could be variable quarter-to-quarter and is mostly going to vary as a result of litigation activity. The legal defense costs vary, obviously, with the number of cases in trial, number of cases at various positions thro",153,"Karen, I think the run rate for SG&A could be variable quarter-to-quarter and is mostly going to vary as a result of litigation activity. The legal defense costs vary, obviously, with the number of cases in trial, number of cases at various positions through there. The increase in advertising or brand-building costs on an annualized basis is probably basically level now. I don't expect to see that material or dramatically increase over time, but we're going to see upward pressures on SG&A, just from things like salary and benefit cost increases and other cost increases. But most of the change quarter-to-quarter revolves around legal defense costs. And as you do the comparison to revenues in the current quarter, you have to continue to take into account that inventory movement that we continue to talk about. And I'm also reminded that sequentially, SG&A is not really up in the third quarter by any measure."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks.",22,"If there are no further questions, I would like to turn the call back over to Mr. Kessler for any concluding remarks."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Executives","Thank you for your continued interest in Lorillard. We're -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest.",29,"Thank you for your continued interest in Lorillard. We're -- as I said, fundamentals remain strong. We're optimistic about the fourth quarter and 2012. Thank you for your interest."
4180255,141600488,176826,"Lorillard, Inc., Q3 2011 Earnings Call, Oct 24, 2011",2011-10-24,"Earnings Calls","Lorillard, LLC","Operator","This concludes the Lorillard, Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You m",42,"This concludes the Lorillard, Inc. Third Quarter 2011 Earnings Conference Call. For a replay of this call, please dial (888) 859-2056 or for international participants, please dial (404) 537-3406. The conference ID number for the replay is 17389350. You may now disconnect."
